Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-04-01
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| LINC02446 | 5.897655 |
| AC120193.1 | -5.436573 |
| BEX4 | -4.956471 |
| TEX14 | -4.908063 |
| MIR4458HG | -4.803092 |
| MSC-AS1 | 4.605663 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 14682 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 10982 |
| num_profile_genes_not_in_sets | 3700 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets: c5.go.v2023.2.Hs.symbols.gmt| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 4720 |
| num_genesets_included | 5741 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 5 | 2.14e-03 | -0.793 | 0.060900 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 5 | 2.25e-03 | -0.789 | 0.063400 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 2.66e-03 | 0.776 | 0.069100 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 2.88e-03 | 0.770 | 0.071900 |
| GOMF ADENYLATE CYCLASE BINDING | 5 | 3.09e-03 | 0.764 | 0.075400 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 6 | 1.34e-03 | 0.756 | 0.045100 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 6 | 2.08e-03 | 0.726 | 0.059500 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 5.08e-03 | 0.724 | 0.105000 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 9 | 1.77e-04 | -0.722 | 0.009990 |
| GOMF NERVE GROWTH FACTOR BINDING | 5 | 5.95e-03 | -0.710 | 0.114000 |
| GOMF NEUROTROPHIN BINDING | 5 | 5.95e-03 | -0.710 | 0.114000 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 8 | 5.09e-04 | 0.710 | 0.023000 |
| GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT | 5 | 6.42e-03 | -0.704 | 0.117000 |
| GOCC PARANODAL JUNCTION | 5 | 7.09e-03 | -0.695 | 0.123000 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 7.41e-03 | -0.692 | 0.126000 |
| GOCC ZONULA ADHERENS | 5 | 8.43e-03 | 0.680 | 0.137000 |
| GOMF GALACTOSIDE BINDING | 7 | 1.87e-03 | -0.679 | 0.056000 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 5 | 9.10e-03 | -0.674 | 0.143000 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 8 | 9.94e-04 | 0.672 | 0.038000 |
| GOMF T CELL RECEPTOR BINDING | 11 | 1.28e-04 | 0.667 | 0.007560 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 1.07e-02 | 0.659 | 0.158000 |
| GOMF TELOMERASE ACTIVITY | 5 | 1.07e-02 | 0.659 | 0.158000 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 8 | 1.25e-03 | 0.659 | 0.043500 |
| GOCC GAMMA DELTA T CELL RECEPTOR COMPLEX | 6 | 5.63e-03 | 0.653 | 0.111000 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.00e-03 | -0.648 | 0.114000 |
| GOCC PARANODE REGION OF AXON | 6 | 6.29e-03 | -0.644 | 0.116000 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 5 | 1.26e-02 | 0.644 | 0.172000 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 5 | 1.32e-02 | -0.640 | 0.177000 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 1.33e-02 | 0.640 | 0.177000 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 6.67e-03 | 0.640 | 0.118000 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 3.40e-03 | 0.639 | 0.080700 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 5 | 1.34e-02 | 0.638 | 0.178000 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 5 | 1.36e-02 | 0.637 | 0.179000 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 1.37e-02 | -0.637 | 0.179000 |
| GOBP PSEUDOPODIUM ORGANIZATION | 6 | 7.21e-03 | 0.633 | 0.124000 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 5 | 1.43e-02 | 0.633 | 0.183000 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 7 | 3.88e-03 | -0.630 | 0.088100 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 10 | 5.86e-04 | 0.628 | 0.025500 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 13 | 9.37e-05 | 0.626 | 0.005840 |
| GOBP DETOXIFICATION OF COPPER ION | 6 | 8.00e-03 | 0.625 | 0.131000 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 1.58e-02 | 0.623 | 0.191000 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 9 | 1.22e-03 | -0.623 | 0.043100 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 7 | 4.42e-03 | -0.621 | 0.095900 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 8 | 2.39e-03 | 0.620 | 0.064500 |
| GOCC MHC PROTEIN COMPLEX | 20 | 1.61e-06 | 0.620 | 0.000204 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 7 | 4.57e-03 | 0.619 | 0.097600 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 1.67e-02 | -0.618 | 0.197000 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 5 | 1.72e-02 | -0.615 | 0.200000 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 1.40e-03 | 0.615 | 0.046100 |
| GOMF LIPASE INHIBITOR ACTIVITY | 7 | 4.90e-03 | 0.614 | 0.102000 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 5 | 2.14e-03 | -7.93e-01 | 6.09e-02 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 5 | 2.25e-03 | -7.89e-01 | 6.34e-02 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 2.66e-03 | 7.76e-01 | 6.91e-02 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 2.88e-03 | 7.70e-01 | 7.19e-02 |
| GOMF ADENYLATE CYCLASE BINDING | 5 | 3.09e-03 | 7.64e-01 | 7.54e-02 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 6 | 1.34e-03 | 7.56e-01 | 4.51e-02 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 6 | 2.08e-03 | 7.26e-01 | 5.95e-02 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 5.08e-03 | 7.24e-01 | 1.05e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 9 | 1.77e-04 | -7.22e-01 | 9.99e-03 |
| GOMF NERVE GROWTH FACTOR BINDING | 5 | 5.95e-03 | -7.10e-01 | 1.14e-01 |
| GOMF NEUROTROPHIN BINDING | 5 | 5.95e-03 | -7.10e-01 | 1.14e-01 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 8 | 5.09e-04 | 7.10e-01 | 2.30e-02 |
| GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT | 5 | 6.42e-03 | -7.04e-01 | 1.17e-01 |
| GOCC PARANODAL JUNCTION | 5 | 7.09e-03 | -6.95e-01 | 1.23e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 7.41e-03 | -6.92e-01 | 1.26e-01 |
| GOCC ZONULA ADHERENS | 5 | 8.43e-03 | 6.80e-01 | 1.37e-01 |
| GOMF GALACTOSIDE BINDING | 7 | 1.87e-03 | -6.79e-01 | 5.60e-02 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 5 | 9.10e-03 | -6.74e-01 | 1.43e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 8 | 9.94e-04 | 6.72e-01 | 3.80e-02 |
| GOMF T CELL RECEPTOR BINDING | 11 | 1.28e-04 | 6.67e-01 | 7.56e-03 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 1.07e-02 | 6.59e-01 | 1.58e-01 |
| GOMF TELOMERASE ACTIVITY | 5 | 1.07e-02 | 6.59e-01 | 1.58e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 8 | 1.25e-03 | 6.59e-01 | 4.35e-02 |
| GOCC GAMMA DELTA T CELL RECEPTOR COMPLEX | 6 | 5.63e-03 | 6.53e-01 | 1.11e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.00e-03 | -6.48e-01 | 1.14e-01 |
| GOCC PARANODE REGION OF AXON | 6 | 6.29e-03 | -6.44e-01 | 1.16e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 5 | 1.26e-02 | 6.44e-01 | 1.72e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 5 | 1.32e-02 | -6.40e-01 | 1.77e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 1.33e-02 | 6.40e-01 | 1.77e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 6.67e-03 | 6.40e-01 | 1.18e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 3.40e-03 | 6.39e-01 | 8.07e-02 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 5 | 1.34e-02 | 6.38e-01 | 1.78e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 5 | 1.36e-02 | 6.37e-01 | 1.79e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 1.37e-02 | -6.37e-01 | 1.79e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 6 | 7.21e-03 | 6.33e-01 | 1.24e-01 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 5 | 1.43e-02 | 6.33e-01 | 1.83e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 7 | 3.88e-03 | -6.30e-01 | 8.81e-02 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 10 | 5.86e-04 | 6.28e-01 | 2.55e-02 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 13 | 9.37e-05 | 6.26e-01 | 5.84e-03 |
| GOBP DETOXIFICATION OF COPPER ION | 6 | 8.00e-03 | 6.25e-01 | 1.31e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 1.58e-02 | 6.23e-01 | 1.91e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 9 | 1.22e-03 | -6.23e-01 | 4.31e-02 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 7 | 4.42e-03 | -6.21e-01 | 9.59e-02 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 8 | 2.39e-03 | 6.20e-01 | 6.45e-02 |
| GOCC MHC PROTEIN COMPLEX | 20 | 1.61e-06 | 6.20e-01 | 2.04e-04 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 7 | 4.57e-03 | 6.19e-01 | 9.76e-02 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 1.67e-02 | -6.18e-01 | 1.97e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 5 | 1.72e-02 | -6.15e-01 | 2.00e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 1.40e-03 | 6.15e-01 | 4.61e-02 |
| GOMF LIPASE INHIBITOR ACTIVITY | 7 | 4.90e-03 | 6.14e-01 | 1.02e-01 |
| GOBP ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 1.74e-02 | -6.14e-01 | 2.01e-01 |
| GOBP TRNA TRANSPORT | 5 | 1.80e-02 | 6.11e-01 | 2.05e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 8 | 2.85e-03 | 6.09e-01 | 7.15e-02 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 7 | 5.35e-03 | 6.08e-01 | 1.08e-01 |
| GOBP CARNITINE TRANSPORT | 5 | 1.89e-02 | -6.06e-01 | 2.09e-01 |
| GOMF ICOSANOID BINDING | 6 | 1.06e-02 | -6.03e-01 | 1.57e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 2.02e-02 | 6.00e-01 | 2.18e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 12 | 3.39e-04 | 5.97e-01 | 1.63e-02 |
| GOBP LEUKOTRIENE SIGNALING PATHWAY | 5 | 2.09e-02 | -5.96e-01 | 2.23e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 6 | 1.19e-02 | -5.93e-01 | 1.68e-01 |
| GOMF AROMATASE ACTIVITY | 5 | 2.22e-02 | -5.91e-01 | 2.30e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 5 | 2.24e-02 | -5.90e-01 | 2.31e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 2.35e-03 | 5.86e-01 | 6.41e-02 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 7 | 7.39e-03 | -5.85e-01 | 1.26e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 1.33e-02 | 5.84e-01 | 1.77e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 2.45e-02 | 5.81e-01 | 2.43e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 7 | 7.82e-03 | -5.81e-01 | 1.30e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 1.42e-02 | 5.78e-01 | 1.82e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 6 | 1.45e-02 | 5.76e-01 | 1.85e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 2.67e-02 | 5.72e-01 | 2.54e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 7 | 8.93e-03 | 5.71e-01 | 1.42e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 5 | 2.81e-02 | 5.67e-01 | 2.61e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 2.83e-02 | 5.66e-01 | 2.62e-01 |
| GOBP NEGATIVE T CELL SELECTION | 9 | 3.28e-03 | 5.66e-01 | 7.89e-02 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 9 | 3.38e-03 | 5.64e-01 | 8.07e-02 |
| GOBP B CELL LINEAGE COMMITMENT | 5 | 2.89e-02 | 5.64e-01 | 2.66e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 1.67e-02 | 5.64e-01 | 1.97e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 8 | 5.76e-03 | -5.64e-01 | 1.12e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 2.93e-02 | 5.63e-01 | 2.68e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 9.94e-03 | 5.63e-01 | 1.50e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 7 | 9.96e-03 | 5.62e-01 | 1.50e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 2.98e-02 | 5.61e-01 | 2.69e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 3.08e-02 | 5.58e-01 | 2.74e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 6.31e-03 | 5.58e-01 | 1.16e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 11 | 1.49e-03 | 5.53e-01 | 4.81e-02 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 9 | 4.11e-03 | -5.52e-01 | 9.14e-02 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 1.16e-02 | 5.51e-01 | 1.66e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 1.16e-02 | 5.51e-01 | 1.66e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 1.16e-02 | 5.51e-01 | 1.67e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 1.59e-03 | 5.50e-01 | 4.99e-02 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 3.35e-02 | 5.49e-01 | 2.84e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 5 | 3.40e-02 | 5.48e-01 | 2.86e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 6 | 2.05e-02 | -5.46e-01 | 2.21e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 9.38e-08 | 5.45e-01 | 1.67e-05 |
| GOBP STRAND INVASION | 5 | 3.53e-02 | -5.44e-01 | 2.91e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 2.73e-04 | 5.43e-01 | 1.38e-02 |
| GOBP MEIOTIC CYTOKINESIS | 6 | 2.14e-02 | 5.42e-01 | 2.26e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 4.84e-03 | 5.42e-01 | 1.02e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 1.32e-02 | 5.41e-01 | 1.77e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 2.19e-02 | 5.40e-01 | 2.29e-01 |
| GOMF CD4 RECEPTOR BINDING | 6 | 2.19e-02 | 5.40e-01 | 2.29e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 5 | 3.65e-02 | 5.40e-01 | 2.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 3.65e-02 | 5.40e-01 | 2.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 3.70e-02 | 5.39e-01 | 2.97e-01 |
| GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS | 5 | 3.73e-02 | -5.38e-01 | 2.99e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.38e-02 | 5.37e-01 | 1.80e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 12 | 1.28e-03 | 5.37e-01 | 4.39e-02 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 22 | 1.33e-05 | 5.36e-01 | 1.18e-03 |
| GOBP LEUKOTRIENE TRANSPORT | 6 | 2.30e-02 | 5.36e-01 | 2.35e-01 |
| GOBP SNRNA TRANSPORT | 6 | 2.31e-02 | 5.35e-01 | 2.35e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 10 | 3.39e-03 | 5.35e-01 | 8.07e-02 |
| GOBP LENS FIBER CELL DEVELOPMENT | 8 | 8.94e-03 | 5.34e-01 | 1.42e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 6 | 2.39e-02 | 5.32e-01 | 2.40e-01 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 3.95e-02 | 5.32e-01 | 3.08e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 5.90e-03 | 5.30e-01 | 1.13e-01 |
| GOMF TAP BINDING | 7 | 1.53e-02 | 5.30e-01 | 1.89e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.08e-02 | 5.28e-01 | 3.13e-01 |
| GOMF RETINAL BINDING | 5 | 4.08e-02 | -5.28e-01 | 3.13e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 9 | 6.18e-03 | 5.27e-01 | 1.15e-01 |
| GOBP CGMP MEDIATED SIGNALING | 9 | 6.19e-03 | -5.27e-01 | 1.15e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 7 | 1.60e-02 | 5.26e-01 | 1.92e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 7 | 1.62e-02 | 5.25e-01 | 1.93e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 2.72e-02 | 5.21e-01 | 2.57e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 5 | 4.41e-02 | -5.20e-01 | 3.27e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 12 | 1.85e-03 | 5.19e-01 | 5.54e-02 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 1.10e-02 | -5.19e-01 | 1.61e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 7 | 1.76e-02 | 5.18e-01 | 2.01e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 4.82e-03 | 5.15e-01 | 1.02e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 6 | 2.91e-02 | -5.15e-01 | 2.66e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 12 | 2.06e-03 | -5.14e-01 | 5.94e-02 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 6 | 2.96e-02 | 5.13e-01 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 6 | 2.97e-02 | 5.13e-01 | 2.69e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 5 | 4.85e-02 | 5.10e-01 | 3.47e-01 |
| GOBP REGULATION OF HEAT GENERATION | 8 | 1.26e-02 | -5.09e-01 | 1.72e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 4.86e-02 | 5.09e-01 | 3.47e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 2.07e-02 | 5.05e-01 | 2.22e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 7 | 2.12e-02 | 5.03e-01 | 2.25e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 6 | 3.29e-02 | -5.03e-01 | 2.84e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 5.17e-02 | 5.02e-01 | 3.58e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 5.34e-02 | 4.99e-01 | 3.64e-01 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 5 | 5.47e-02 | 4.96e-01 | 3.67e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 4.42e-03 | 4.96e-01 | 9.59e-02 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 5 | 5.52e-02 | -4.95e-01 | 3.69e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 4.15e-04 | 4.95e-01 | 1.98e-02 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 6 | 3.60e-02 | 4.94e-01 | 2.94e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 5 | 5.57e-02 | -4.94e-01 | 3.70e-01 |
| GOBP INSEMINATION | 5 | 5.68e-02 | -4.92e-01 | 3.74e-01 |
| GOBP RESPONSE TO SORBITOL | 5 | 5.74e-02 | 4.91e-01 | 3.75e-01 |
| GOBP POSITIVE REGULATION OF HISTONE DEACETYLATION | 5 | 5.77e-02 | 4.90e-01 | 3.76e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 5.77e-02 | 4.90e-01 | 3.76e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 5 | 5.78e-02 | 4.90e-01 | 3.76e-01 |
| GOBP VOCALIZATION BEHAVIOR | 8 | 1.65e-02 | -4.89e-01 | 1.96e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 5.82e-02 | 4.89e-01 | 3.77e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 5 | 5.85e-02 | 4.89e-01 | 3.78e-01 |
| GOCC PROTEASOME CORE COMPLEX | 19 | 2.27e-04 | 4.89e-01 | 1.20e-02 |
| GOCC U2AF COMPLEX | 5 | 5.88e-02 | 4.88e-01 | 3.79e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 7 | 2.54e-02 | 4.88e-01 | 2.48e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 9 | 1.15e-02 | -4.87e-01 | 1.65e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 5 | 6.09e-02 | 4.84e-01 | 3.86e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 5 | 6.12e-02 | -4.83e-01 | 3.86e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 6 | 4.04e-02 | -4.83e-01 | 3.12e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 8 | 1.81e-02 | 4.83e-01 | 2.05e-01 |
| GOBP TOXIN METABOLIC PROCESS | 5 | 6.18e-02 | -4.82e-01 | 3.87e-01 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 5 | 6.23e-02 | -4.81e-01 | 3.89e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 6 | 4.16e-02 | -4.80e-01 | 3.16e-01 |
| GOBP MOTOR NEURON MIGRATION | 5 | 6.44e-02 | -4.78e-01 | 3.95e-01 |
| GOCC RETROMER COMPLEX | 12 | 4.20e-03 | 4.77e-01 | 9.31e-02 |
| GOBP SYNAPTIC VESICLE DOCKING | 5 | 6.51e-02 | -4.76e-01 | 3.96e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 2.96e-02 | 4.75e-01 | 2.69e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 7 | 2.96e-02 | 4.75e-01 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 6.63e-02 | -4.74e-01 | 3.99e-01 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 5 | 6.65e-02 | -4.74e-01 | 3.99e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 14 | 2.16e-03 | 4.73e-01 | 6.12e-02 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 11 | 6.57e-03 | 4.73e-01 | 1.18e-01 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 6 | 4.48e-02 | 4.73e-01 | 3.31e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 5 | 6.79e-02 | -4.71e-01 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 4.57e-02 | 4.71e-01 | 3.35e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 6 | 4.59e-02 | 4.71e-01 | 3.35e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 8 | 2.15e-02 | -4.69e-01 | 2.27e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 9 | 1.49e-02 | 4.69e-01 | 1.87e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 11 | 7.13e-03 | 4.69e-01 | 1.23e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 6.97e-02 | 4.69e-01 | 4.07e-01 |
| GOBP ACROSOME REACTION | 13 | 3.45e-03 | -4.68e-01 | 8.13e-02 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 14 | 2.41e-03 | -4.68e-01 | 6.51e-02 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 6 | 4.73e-02 | 4.68e-01 | 3.42e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 7 | 3.26e-02 | 4.66e-01 | 2.84e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 6 | 4.81e-02 | 4.66e-01 | 3.46e-01 |
| GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.13e-02 | -4.66e-01 | 4.13e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 7.15e-02 | -4.65e-01 | 4.13e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 7.22e-02 | 4.64e-01 | 4.16e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 11 | 7.71e-03 | 4.64e-01 | 1.30e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 11 | 7.87e-03 | 4.63e-01 | 1.31e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 4.98e-02 | 4.62e-01 | 3.51e-01 |
| GOMF SUMO POLYMER BINDING | 5 | 7.35e-02 | 4.62e-01 | 4.18e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 24 | 8.92e-05 | 4.62e-01 | 5.65e-03 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 3.44e-02 | 4.62e-01 | 2.88e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 7 | 3.44e-02 | -4.62e-01 | 2.88e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 3.48e-02 | -4.61e-01 | 2.89e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 1.67e-02 | 4.61e-01 | 1.97e-01 |
| GOBP RESPONSE TO WATER | 8 | 2.41e-02 | -4.60e-01 | 2.41e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 18 | 7.21e-04 | 4.60e-01 | 3.02e-02 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 5.11e-02 | 4.60e-01 | 3.55e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 3.54e-02 | 4.59e-01 | 2.91e-01 |
| GOBP SEGMENT SPECIFICATION | 6 | 5.15e-02 | 4.59e-01 | 3.57e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 7.60e-02 | -4.58e-01 | 4.23e-01 |
| GOBP DETECTION OF CALCIUM ION | 7 | 3.59e-02 | 4.58e-01 | 2.94e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 9 | 1.74e-02 | 4.58e-01 | 2.01e-01 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 5.23e-02 | -4.57e-01 | 3.60e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 6 | 5.26e-02 | 4.57e-01 | 3.61e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 6 | 5.27e-02 | 4.57e-01 | 3.61e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 13 | 4.37e-03 | 4.57e-01 | 9.55e-02 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 1.25e-02 | -4.56e-01 | 1.72e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 8 | 2.63e-02 | 4.54e-01 | 2.53e-01 |
| GOBP TRICUSPID VALVE DEVELOPMENT | 5 | 7.92e-02 | 4.53e-01 | 4.30e-01 |
| GOBP TRICUSPID VALVE MORPHOGENESIS | 5 | 7.92e-02 | 4.53e-01 | 4.30e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 5 | 7.92e-02 | -4.53e-01 | 4.30e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 7 | 3.79e-02 | 4.53e-01 | 3.00e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 7 | 3.86e-02 | 4.51e-01 | 3.04e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 6 | 5.56e-02 | 4.51e-01 | 3.70e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 10 | 1.38e-02 | 4.50e-01 | 1.80e-01 |
| GOCC BBAF COMPLEX | 9 | 1.99e-02 | 4.48e-01 | 2.16e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 6 | 5.73e-02 | -4.48e-01 | 3.75e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 7 | 4.02e-02 | 4.48e-01 | 3.10e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 7.27e-03 | 4.48e-01 | 1.24e-01 |
| GOCC MUSCLE MYOSIN COMPLEX | 5 | 8.32e-02 | -4.47e-01 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 6 | 5.80e-02 | -4.47e-01 | 3.76e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 7 | 4.07e-02 | -4.47e-01 | 3.13e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 8.40e-02 | 4.46e-01 | 4.41e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 7 | 4.09e-02 | -4.46e-01 | 3.14e-01 |
| GOMF OXYSTEROL BINDING | 7 | 4.11e-02 | -4.46e-01 | 3.14e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 1.48e-02 | 4.45e-01 | 1.87e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 8.50e-02 | -4.45e-01 | 4.43e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 5.94e-02 | -4.44e-01 | 3.80e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 7 | 4.27e-02 | -4.42e-01 | 3.20e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 5.81e-03 | 4.42e-01 | 1.13e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 8.07e-03 | 4.42e-01 | 1.32e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 8 | 3.07e-02 | 4.41e-01 | 2.73e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 6 | 6.13e-02 | 4.41e-01 | 3.86e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 8.81e-02 | 4.40e-01 | 4.49e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 3.11e-02 | 4.40e-01 | 2.75e-01 |
| GOBP CEREBROSPINAL FLUID CIRCULATION | 6 | 6.19e-02 | -4.40e-01 | 3.87e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 7 | 4.40e-02 | 4.40e-01 | 3.27e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 11 | 1.17e-02 | 4.39e-01 | 1.67e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 6.34e-02 | 4.38e-01 | 3.92e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 7 | 4.50e-02 | 4.37e-01 | 3.31e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 6 | 6.38e-02 | -4.37e-01 | 3.92e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 11 | 1.23e-02 | -4.36e-01 | 1.70e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 3.27e-02 | 4.36e-01 | 2.84e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 4.58e-02 | 4.36e-01 | 3.35e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 9 | 2.38e-02 | 4.35e-01 | 2.39e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 6.54e-02 | 4.34e-01 | 3.97e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 6.54e-02 | 4.34e-01 | 3.97e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 7 | 4.69e-02 | 4.34e-01 | 3.40e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 10 | 1.76e-02 | 4.34e-01 | 2.01e-01 |
| GOBP PONS DEVELOPMENT | 6 | 6.61e-02 | 4.33e-01 | 3.99e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 5 | 9.38e-02 | -4.33e-01 | 4.58e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 5 | 9.41e-02 | 4.32e-01 | 4.59e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 6 | 6.67e-02 | 4.32e-01 | 3.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 5 | 9.48e-02 | -4.31e-01 | 4.60e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 2.50e-02 | 4.31e-01 | 2.45e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 7 | 4.82e-02 | -4.31e-01 | 3.46e-01 |
| GOBP HEAT GENERATION | 11 | 1.34e-02 | -4.30e-01 | 1.78e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 10 | 1.85e-02 | 4.30e-01 | 2.07e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 5 | 9.60e-02 | -4.30e-01 | 4.61e-01 |
| GOCC MICOS COMPLEX | 8 | 3.54e-02 | 4.30e-01 | 2.91e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 11 | 1.36e-02 | 4.30e-01 | 1.79e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 9 | 2.57e-02 | 4.29e-01 | 2.49e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 9 | 2.57e-02 | 4.29e-01 | 2.49e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 14 | 5.42e-03 | 4.29e-01 | 1.09e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 9.67e-02 | 4.29e-01 | 4.62e-01 |
| GOBP MICROVILLUS ASSEMBLY | 16 | 2.99e-03 | 4.29e-01 | 7.38e-02 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 9.70e-02 | 4.29e-01 | 4.62e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 6.91e-02 | 4.28e-01 | 4.05e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 11 | 1.40e-02 | 4.28e-01 | 1.81e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 1.91e-02 | 4.28e-01 | 2.10e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 12 | 1.03e-02 | -4.28e-01 | 1.54e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 20 | 9.60e-04 | 4.27e-01 | 3.73e-02 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 5 | 9.91e-02 | 4.26e-01 | 4.69e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 7 | 5.17e-02 | 4.25e-01 | 3.57e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 7 | 5.24e-02 | -4.23e-01 | 3.60e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 8 | 3.82e-02 | 4.23e-01 | 3.02e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 17 | 2.57e-03 | 4.22e-01 | 6.77e-02 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 6 | 7.34e-02 | -4.22e-01 | 4.18e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 19 | 1.45e-03 | 4.22e-01 | 4.73e-02 |
| GOCC INHIBITORY SYNAPSE | 6 | 7.45e-02 | 4.20e-01 | 4.20e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 3.65e-07 | 4.20e-01 | 5.45e-05 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 17 | 2.73e-03 | 4.20e-01 | 6.98e-02 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 1.05e-01 | -4.19e-01 | 4.81e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 6 | 7.61e-02 | -4.18e-01 | 4.23e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 47 | 7.18e-07 | 4.18e-01 | 9.53e-05 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 10 | 2.21e-02 | 4.18e-01 | 2.30e-01 |
| GOCC FLOTILLIN COMPLEX | 7 | 5.56e-02 | 4.18e-01 | 3.70e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 1.06e-01 | -4.18e-01 | 4.81e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 1.06e-01 | 4.18e-01 | 4.81e-01 |
| GOBP LIPID DROPLET FORMATION | 9 | 3.01e-02 | 4.17e-01 | 2.71e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 1.06e-01 | 4.17e-01 | 4.82e-01 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 6 | 7.69e-02 | 4.17e-01 | 4.24e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 7 | 5.63e-02 | 4.17e-01 | 3.71e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 12 | 1.27e-02 | -4.16e-01 | 1.72e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 1.28e-02 | 4.15e-01 | 1.73e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 1.08e-01 | 4.15e-01 | 4.85e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 1.09e-01 | 4.14e-01 | 4.88e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 3.18e-02 | 4.13e-01 | 2.79e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 9 | 3.19e-02 | -4.13e-01 | 2.79e-01 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 5 | 1.10e-01 | -4.13e-01 | 4.89e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 12 | 1.34e-02 | 4.12e-01 | 1.77e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 7 | 5.90e-02 | 4.12e-01 | 3.79e-01 |
| GOCC SPECTRIN | 8 | 4.38e-02 | -4.12e-01 | 3.26e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 8.10e-02 | -4.11e-01 | 4.34e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 73 | 1.29e-09 | 4.11e-01 | 3.38e-07 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 1.12e-01 | 4.10e-01 | 4.92e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 7 | 6.08e-02 | -4.09e-01 | 3.85e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 9 | 3.36e-02 | 4.09e-01 | 2.84e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 1.13e-01 | 4.09e-01 | 4.94e-01 |
| GOBP CGMP METABOLIC PROCESS | 5 | 1.13e-01 | -4.09e-01 | 4.94e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 8.28e-02 | 4.09e-01 | 4.38e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 11 | 1.89e-02 | -4.09e-01 | 2.09e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 1.14e-01 | -4.08e-01 | 4.96e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 8 | 4.62e-02 | -4.07e-01 | 3.36e-01 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 6 | 8.44e-02 | 4.07e-01 | 4.42e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 16 | 4.88e-03 | 4.07e-01 | 1.02e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 9 | 3.48e-02 | -4.06e-01 | 2.89e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 6 | 8.52e-02 | -4.06e-01 | 4.43e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 6 | 8.54e-02 | -4.06e-01 | 4.43e-01 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 6 | 8.54e-02 | 4.05e-01 | 4.43e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 6.59e-03 | 4.05e-01 | 1.18e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 6 | 8.57e-02 | 4.05e-01 | 4.43e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 6 | 8.57e-02 | 4.05e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 21 | 1.31e-03 | 4.05e-01 | 4.45e-02 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 10 | 2.67e-02 | -4.05e-01 | 2.54e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 6.39e-02 | 4.04e-01 | 3.92e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 12 | 1.53e-02 | 4.04e-01 | 1.89e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 7 | 6.41e-02 | 4.04e-01 | 3.94e-01 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 1.18e-01 | 4.04e-01 | 5.00e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 6 | 8.67e-02 | -4.04e-01 | 4.45e-01 |
| GOBP ELASTIC FIBER ASSEMBLY | 6 | 8.68e-02 | -4.04e-01 | 4.45e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 6 | 8.68e-02 | 4.04e-01 | 4.45e-01 |
| GOBP LIPOPHAGY | 7 | 6.45e-02 | 4.04e-01 | 3.95e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 8 | 4.82e-02 | -4.03e-01 | 3.46e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 3.61e-02 | 4.03e-01 | 2.94e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 7 | 6.51e-02 | 4.03e-01 | 3.96e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 5 | 1.19e-01 | -4.03e-01 | 5.03e-01 |
| GOCC ISWI TYPE COMPLEX | 12 | 1.58e-02 | 4.02e-01 | 1.91e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 8 | 4.88e-02 | -4.02e-01 | 3.48e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 5 | 1.20e-01 | 4.02e-01 | 5.04e-01 |
| GOMF RS DOMAIN BINDING | 5 | 1.20e-01 | -4.02e-01 | 5.05e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 13 | 1.23e-02 | -4.01e-01 | 1.70e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 8 | 4.98e-02 | -4.01e-01 | 3.51e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 8.97e-02 | 4.00e-01 | 4.54e-01 |
| GOMF U4 SNRNA BINDING | 6 | 9.00e-02 | 4.00e-01 | 4.54e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 6 | 9.03e-02 | 3.99e-01 | 4.54e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 5 | 1.22e-01 | -3.99e-01 | 5.11e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 10 | 2.92e-02 | 3.98e-01 | 2.67e-01 |
| GOCC SPERMATOPROTEASOME COMPLEX | 5 | 1.23e-01 | 3.98e-01 | 5.13e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 1.23e-01 | 3.98e-01 | 5.14e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 6 | 9.18e-02 | -3.98e-01 | 4.56e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 6 | 9.20e-02 | -3.97e-01 | 4.56e-01 |
| GOBP COPULATION | 7 | 6.88e-02 | -3.97e-01 | 4.04e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 12 | 1.72e-02 | 3.97e-01 | 2.00e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 6 | 9.22e-02 | -3.97e-01 | 4.56e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 7 | 6.91e-02 | 3.97e-01 | 4.05e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 16 | 6.02e-03 | 3.97e-01 | 1.14e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 9.28e-02 | 3.96e-01 | 4.56e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 9.44e-02 | 3.94e-01 | 4.60e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 7 | 7.09e-02 | 3.94e-01 | 4.11e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 5.03e-04 | 3.94e-01 | 2.30e-02 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 14 | 1.07e-02 | 3.94e-01 | 1.58e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 8.36e-03 | 3.93e-01 | 1.36e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 6 | 9.54e-02 | -3.93e-01 | 4.61e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 17 | 5.05e-03 | 3.93e-01 | 1.05e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 17 | 5.07e-03 | 3.93e-01 | 1.05e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 5 | 1.28e-01 | 3.93e-01 | 5.20e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 20 | 2.38e-03 | -3.92e-01 | 6.45e-02 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 45 | 5.32e-06 | 3.92e-01 | 5.29e-04 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 7 | 7.28e-02 | 3.92e-01 | 4.17e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 5 | 1.30e-01 | 3.91e-01 | 5.22e-01 |
| GOMF POTASSIUM ION BINDING | 7 | 7.32e-02 | 3.91e-01 | 4.18e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 6 | 9.72e-02 | 3.91e-01 | 4.62e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 19 | 3.19e-03 | 3.91e-01 | 7.74e-02 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 1.30e-01 | 3.91e-01 | 5.23e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 13 | 1.47e-02 | 3.91e-01 | 1.87e-01 |
| GOBP FIBROBLAST ACTIVATION | 10 | 3.25e-02 | 3.91e-01 | 2.83e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 12 | 1.92e-02 | 3.90e-01 | 2.11e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 15 | 8.99e-03 | 3.90e-01 | 1.42e-01 |
| GOCC WASH COMPLEX | 9 | 4.31e-02 | 3.89e-01 | 3.22e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 7 | 7.45e-02 | 3.89e-01 | 4.20e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 10 | 3.36e-02 | 3.88e-01 | 2.85e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 13 | 1.54e-02 | 3.88e-01 | 1.90e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 6 | 1.00e-01 | 3.87e-01 | 4.73e-01 |
| GOBP RESPONSE TO VITAMIN A | 6 | 1.01e-01 | -3.87e-01 | 4.73e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 5 | 1.34e-01 | -3.87e-01 | 5.31e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 5 | 1.34e-01 | -3.87e-01 | 5.31e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 7 | 7.67e-02 | 3.86e-01 | 4.24e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 5 | 1.35e-01 | -3.86e-01 | 5.32e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 7.69e-02 | 3.86e-01 | 4.24e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 2.67e-02 | 3.86e-01 | 2.54e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 8 | 5.90e-02 | 3.86e-01 | 3.79e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 10 | 3.48e-02 | -3.86e-01 | 2.89e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 7 | 7.75e-02 | 3.85e-01 | 4.27e-01 |
| GOBP GENOMIC IMPRINTING | 11 | 2.71e-02 | -3.85e-01 | 2.57e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 10 | 3.54e-02 | 3.84e-01 | 2.91e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 17 | 6.27e-03 | 3.83e-01 | 1.16e-01 |
| GOCC PINOSOME | 6 | 1.05e-01 | 3.82e-01 | 4.81e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 6 | 1.05e-01 | 3.82e-01 | 4.81e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 9 | 4.74e-02 | -3.82e-01 | 3.42e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 8.07e-02 | 3.81e-01 | 4.34e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 6 | 1.06e-01 | 3.81e-01 | 4.82e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 7 | 8.13e-02 | -3.81e-01 | 4.34e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 16 | 8.52e-03 | 3.80e-01 | 1.37e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 6.28e-02 | 3.80e-01 | 3.89e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 8 | 6.29e-02 | 3.80e-01 | 3.89e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 8.20e-02 | 3.80e-01 | 4.36e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 1.42e-01 | 3.79e-01 | 5.43e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 5 | 1.42e-01 | -3.79e-01 | 5.43e-01 |
| GOCC ASTROCYTE PROJECTION | 6 | 1.08e-01 | 3.79e-01 | 4.85e-01 |
| GOBP CHIASMA ASSEMBLY | 6 | 1.08e-01 | -3.79e-01 | 4.85e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 1.43e-01 | 3.79e-01 | 5.44e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 9 | 4.92e-02 | -3.79e-01 | 3.50e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 1.08e-01 | 3.78e-01 | 4.86e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 6.39e-02 | 3.78e-01 | 3.92e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 7.08e-10 | 3.78e-01 | 2.28e-07 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 1.09e-01 | -3.78e-01 | 4.87e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 9 | 4.96e-02 | -3.78e-01 | 3.51e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 6 | 1.09e-01 | -3.77e-01 | 4.88e-01 |
| GOMF PRE MIRNA BINDING | 8 | 6.47e-02 | 3.77e-01 | 3.95e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 18 | 5.61e-03 | 3.77e-01 | 1.11e-01 |
| GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 1.44e-01 | 3.77e-01 | 5.47e-01 |
| GOBP GLOMERULUS MORPHOGENESIS | 5 | 1.45e-01 | 3.77e-01 | 5.47e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 32 | 2.27e-04 | 3.77e-01 | 1.20e-02 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 11 | 3.06e-02 | -3.77e-01 | 2.73e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 31 | 2.88e-04 | 3.76e-01 | 1.42e-02 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 14 | 1.48e-02 | 3.76e-01 | 1.87e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 8 | 6.56e-02 | 3.76e-01 | 3.97e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 1.46e-01 | 3.76e-01 | 5.48e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 6 | 1.11e-01 | -3.76e-01 | 4.90e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 8 | 6.58e-02 | 3.76e-01 | 3.98e-01 |
| GOBP NEPHRIC DUCT DEVELOPMENT | 5 | 1.46e-01 | -3.76e-01 | 5.49e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 5 | 1.46e-01 | 3.75e-01 | 5.49e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 6 | 1.11e-01 | -3.75e-01 | 4.91e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 26 | 9.31e-04 | 3.75e-01 | 3.67e-02 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 8 | 6.64e-02 | 3.75e-01 | 3.99e-01 |
| GOBP CHOLESTEROL IMPORT | 6 | 1.12e-01 | -3.75e-01 | 4.91e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 1.47e-01 | 3.74e-01 | 5.51e-01 |
| GOBP PROLINE TRANSPORT | 7 | 8.64e-02 | 3.74e-01 | 4.45e-01 |
| GOBP OTOLITH DEVELOPMENT | 5 | 1.47e-01 | 3.74e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 6.70e-02 | 3.74e-01 | 4.00e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 1.13e-01 | 3.74e-01 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 9 | 5.30e-02 | 3.73e-01 | 3.62e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 4.15e-02 | 3.72e-01 | 3.15e-01 |
| GOMF CARDIOLIPIN BINDING | 6 | 1.15e-01 | 3.72e-01 | 4.96e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 10 | 4.18e-02 | -3.72e-01 | 3.16e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 11 | 3.31e-02 | -3.71e-01 | 2.84e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 3.31e-02 | 3.71e-01 | 2.84e-01 |
| GOBP NADH METABOLIC PROCESS | 6 | 1.16e-01 | 3.71e-01 | 4.98e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 8.95e-02 | 3.71e-01 | 4.53e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 6 | 1.16e-01 | -3.71e-01 | 4.98e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 9 | 5.44e-02 | -3.70e-01 | 3.66e-01 |
| GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS | 5 | 1.52e-01 | 3.70e-01 | 5.60e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 1.17e-01 | 3.70e-01 | 4.99e-01 |
| GOMF ANKYRIN BINDING | 9 | 5.48e-02 | -3.70e-01 | 3.67e-01 |
| GOBP MACROPHAGE PROLIFERATION | 6 | 1.17e-01 | 3.69e-01 | 4.99e-01 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 5 | 1.53e-01 | -3.69e-01 | 5.61e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 1.17e-01 | 3.69e-01 | 4.99e-01 |
| GOBP AMP SALVAGE | 5 | 1.53e-01 | 3.69e-01 | 5.61e-01 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 5 | 1.53e-01 | -3.69e-01 | 5.61e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 16 | 1.07e-02 | 3.69e-01 | 1.58e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 11 | 3.43e-02 | 3.69e-01 | 2.87e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 6 | 1.19e-01 | -3.68e-01 | 5.02e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 6 | 1.19e-01 | 3.67e-01 | 5.03e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 7 | 9.27e-02 | -3.67e-01 | 4.56e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 1.55e-01 | 3.67e-01 | 5.65e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 8 | 7.24e-02 | -3.67e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 15 | 1.40e-02 | 3.66e-01 | 1.81e-01 |
| GOBP PARTURITION | 5 | 1.56e-01 | -3.66e-01 | 5.65e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 19 | 5.71e-03 | -3.66e-01 | 1.12e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 11 | 3.56e-02 | 3.66e-01 | 2.93e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 7 | 9.39e-02 | 3.66e-01 | 4.58e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 6 | 1.21e-01 | -3.65e-01 | 5.08e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 7.42e-02 | 3.65e-01 | 4.20e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 9 | 5.86e-02 | -3.64e-01 | 3.79e-01 |
| GOCC SEPTIN CYTOSKELETON | 10 | 4.64e-02 | 3.64e-01 | 3.37e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 17 | 9.43e-03 | 3.64e-01 | 1.46e-01 |
| GOCC CUTICULAR PLATE | 5 | 1.59e-01 | -3.64e-01 | 5.70e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 18 | 7.66e-03 | -3.63e-01 | 1.29e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 7 | 9.65e-02 | 3.63e-01 | 4.62e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 6 | 1.24e-01 | -3.63e-01 | 5.14e-01 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 1.60e-01 | 3.63e-01 | 5.72e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 1.24e-01 | 3.62e-01 | 5.15e-01 |
| GOCC CYTOLYTIC GRANULE | 13 | 2.38e-02 | 3.62e-01 | 2.39e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 91 | 2.48e-09 | 3.62e-01 | 6.28e-07 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 6 | 1.25e-01 | 3.62e-01 | 5.15e-01 |
| GOBP REGULATION OF ACROSOME REACTION | 6 | 1.26e-01 | -3.61e-01 | 5.16e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 19 | 6.55e-03 | 3.60e-01 | 1.18e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 16 | 1.27e-02 | -3.60e-01 | 1.72e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 24 | 2.30e-03 | 3.60e-01 | 6.36e-02 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 1.64e-01 | 3.59e-01 | 5.75e-01 |
| GOBP HEART FIELD SPECIFICATION | 6 | 1.27e-01 | -3.59e-01 | 5.18e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 6 | 1.27e-01 | -3.59e-01 | 5.18e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 1.64e-01 | 3.59e-01 | 5.75e-01 |
| GOBP REGULATION OF PIGMENTATION | 9 | 6.21e-02 | 3.59e-01 | 3.88e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 1.64e-01 | 3.59e-01 | 5.76e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 5 | 1.65e-01 | 3.59e-01 | 5.77e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.65e-01 | 3.59e-01 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 5 | 1.66e-01 | -3.58e-01 | 5.77e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 9 | 6.29e-02 | -3.58e-01 | 3.89e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 1.29e-01 | 3.58e-01 | 5.20e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 8.55e-03 | 3.58e-01 | 1.38e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 6 | 1.29e-01 | -3.58e-01 | 5.21e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 5 | 1.66e-01 | 3.58e-01 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 1.67e-01 | 3.57e-01 | 5.77e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 8 | 8.04e-02 | -3.57e-01 | 4.33e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 25 | 2.03e-03 | 3.57e-01 | 5.94e-02 |
| GOBP REGULATION OF ICOSANOID SECRETION | 9 | 6.45e-02 | -3.56e-01 | 3.95e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 6.48e-02 | 3.55e-01 | 3.95e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 11 | 4.13e-02 | -3.55e-01 | 3.15e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 1.69e-01 | 3.55e-01 | 5.80e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 2.42e-06 | 3.55e-01 | 2.70e-04 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 45 | 3.80e-05 | 3.55e-01 | 2.76e-03 |
| GOCC EKC KEOPS COMPLEX | 5 | 1.69e-01 | 3.55e-01 | 5.80e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 3.33e-02 | -3.55e-01 | 2.84e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 6 | 1.33e-01 | -3.55e-01 | 5.28e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 8 | 8.27e-02 | 3.54e-01 | 4.38e-01 |
| GOBP RESPONSE TO HYPEROXIA | 12 | 3.37e-02 | 3.54e-01 | 2.85e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 15 | 1.76e-02 | 3.54e-01 | 2.02e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 7 | 1.05e-01 | 3.54e-01 | 4.81e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 1.05e-01 | -3.54e-01 | 4.81e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 13 | 2.74e-02 | -3.53e-01 | 2.57e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 12 | 3.41e-02 | -3.53e-01 | 2.86e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 1.72e-01 | 3.53e-01 | 5.83e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 8 | 8.38e-02 | 3.53e-01 | 4.40e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 8 | 8.39e-02 | -3.53e-01 | 4.40e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 13 | 2.77e-02 | -3.53e-01 | 2.58e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 3.47e-02 | 3.52e-01 | 2.89e-01 |
| GOBP KERATINIZATION | 10 | 5.41e-02 | -3.52e-01 | 3.65e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 9 | 6.78e-02 | -3.52e-01 | 4.02e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 9 | 6.81e-02 | -3.51e-01 | 4.03e-01 |
| GOBP MEMBRANE DISASSEMBLY | 10 | 5.45e-02 | 3.51e-01 | 3.66e-01 |
| GOMF PROTEASOME BINDING | 15 | 1.86e-02 | 3.51e-01 | 2.07e-01 |
| GOMF TITIN BINDING | 7 | 1.08e-01 | 3.51e-01 | 4.85e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 7 | 1.09e-01 | 3.50e-01 | 4.87e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 1.90e-02 | 3.50e-01 | 2.09e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 13 | 2.89e-02 | 3.50e-01 | 2.66e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 22 | 4.50e-03 | 3.50e-01 | 9.65e-02 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 9 | 6.94e-02 | 3.50e-01 | 4.06e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS | 5 | 1.76e-01 | -3.49e-01 | 5.89e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 16 | 1.56e-02 | -3.49e-01 | 1.91e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 20 | 6.89e-03 | 3.49e-01 | 1.20e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 10 | 5.62e-02 | -3.49e-01 | 3.71e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 7 | 1.11e-01 | -3.48e-01 | 4.90e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 19 | 8.73e-03 | 3.48e-01 | 1.40e-01 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 1.78e-01 | -3.47e-01 | 5.92e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 25 | 2.65e-03 | 3.47e-01 | 6.91e-02 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 8.90e-02 | -3.47e-01 | 4.52e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 1.41e-01 | 3.47e-01 | 5.43e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 5 | 1.79e-01 | 3.47e-01 | 5.93e-01 |
| GOBP SEROTONIN UPTAKE | 6 | 1.41e-01 | -3.47e-01 | 5.43e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 9 | 7.17e-02 | -3.47e-01 | 4.13e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 21 | 5.97e-03 | 3.47e-01 | 1.14e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 1.42e-01 | 3.46e-01 | 5.43e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 6 | 1.42e-01 | -3.46e-01 | 5.43e-01 |
| GOBP MACROPINOCYTOSIS | 8 | 9.00e-02 | 3.46e-01 | 4.54e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 6 | 1.42e-01 | 3.46e-01 | 5.44e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 24 | 3.35e-03 | -3.46e-01 | 8.06e-02 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 5 | 1.81e-01 | 3.46e-01 | 5.96e-01 |
| GOMF INSULIN BINDING | 5 | 1.81e-01 | -3.46e-01 | 5.96e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 10 | 5.90e-02 | 3.45e-01 | 3.79e-01 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 1.82e-01 | 3.44e-01 | 5.97e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 1.44e-01 | 3.44e-01 | 5.47e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 6 | 1.45e-01 | 3.44e-01 | 5.47e-01 |
| GOBP HYPOTONIC RESPONSE | 6 | 1.45e-01 | 3.44e-01 | 5.47e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 8 | 9.20e-02 | -3.44e-01 | 4.56e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 16 | 1.73e-02 | 3.44e-01 | 2.00e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 8 | 9.23e-02 | 3.44e-01 | 4.56e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 8 | 9.23e-02 | 3.44e-01 | 4.56e-01 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 9 | 7.44e-02 | -3.43e-01 | 4.20e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 11 | 4.92e-02 | -3.43e-01 | 3.50e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 7 | 1.17e-01 | -3.42e-01 | 4.99e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 9 | 7.52e-02 | -3.42e-01 | 4.22e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 5 | 1.85e-01 | -3.42e-01 | 5.99e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 1.47e-01 | 3.42e-01 | 5.51e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 1.47e-01 | 3.42e-01 | 5.51e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 5.49e-07 | 3.42e-01 | 7.52e-05 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 1.18e-01 | -3.41e-01 | 5.00e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 2.37e-06 | 3.41e-01 | 2.68e-04 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 30 | 1.24e-03 | 3.41e-01 | 4.35e-02 |
| GOBP BONE CELL DEVELOPMENT | 12 | 4.11e-02 | 3.41e-01 | 3.14e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 1.49e-01 | 3.40e-01 | 5.55e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 26 | 2.66e-03 | -3.40e-01 | 6.91e-02 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 5 | 1.87e-01 | 3.40e-01 | 6.02e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 6.24e-02 | 3.40e-01 | 3.89e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 6.25e-02 | 3.40e-01 | 3.89e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 42 | 1.37e-04 | 3.40e-01 | 8.01e-03 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 1.88e-01 | 3.40e-01 | 6.03e-01 |
| GOMF MANNOSE BINDING | 11 | 5.09e-02 | 3.40e-01 | 3.55e-01 |
| GOMF IGG BINDING | 6 | 1.50e-01 | 3.40e-01 | 5.57e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 1.89e-01 | -3.39e-01 | 6.03e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 8 | 9.68e-02 | 3.39e-01 | 4.62e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 1.90e-01 | 3.39e-01 | 6.03e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 12 | 4.22e-02 | -3.39e-01 | 3.18e-01 |
| GOBP TAURINE TRANSPORT | 6 | 1.51e-01 | 3.39e-01 | 5.59e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 12 | 4.24e-02 | 3.38e-01 | 3.19e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 17 | 1.57e-02 | -3.38e-01 | 1.91e-01 |
| GOCC PROTEASOME COMPLEX | 58 | 8.39e-06 | 3.38e-01 | 7.80e-04 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 16 | 1.92e-02 | 3.38e-01 | 2.10e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 12 | 4.25e-02 | -3.38e-01 | 3.19e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 9 | 7.94e-02 | 3.38e-01 | 4.31e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 11 | 5.26e-02 | -3.38e-01 | 3.61e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 5.27e-02 | 3.37e-01 | 3.61e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 4.32e-02 | 3.37e-01 | 3.22e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 9 | 8.00e-02 | -3.37e-01 | 4.32e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 5 | 1.92e-01 | -3.37e-01 | 6.04e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 10 | 6.54e-02 | -3.37e-01 | 3.97e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 21 | 7.64e-03 | 3.36e-01 | 1.29e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 11 | 5.35e-02 | -3.36e-01 | 3.64e-01 |
| GOCC PREFOLDIN COMPLEX | 7 | 1.24e-01 | 3.36e-01 | 5.14e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 9 | 8.10e-02 | -3.36e-01 | 4.34e-01 |
| GOBP CAMP CATABOLIC PROCESS | 7 | 1.24e-01 | -3.36e-01 | 5.14e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 11 | 5.38e-02 | 3.36e-01 | 3.64e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 1.55e-01 | 3.36e-01 | 5.65e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 7 | 1.24e-01 | -3.35e-01 | 5.15e-01 |
| GOCC U7 SNRNP | 7 | 1.24e-01 | 3.35e-01 | 5.15e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 13 | 3.65e-02 | 3.35e-01 | 2.95e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 4.45e-02 | 3.35e-01 | 3.29e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 6 | 1.56e-01 | 3.34e-01 | 5.65e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 1.56e-01 | -3.34e-01 | 5.65e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 90 | 4.26e-08 | 3.34e-01 | 8.90e-06 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 18 | 1.41e-02 | 3.34e-01 | 1.82e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 1.02e-01 | 3.34e-01 | 4.76e-01 |
| GOBP MRNA POLYADENYLATION | 23 | 5.58e-03 | 3.34e-01 | 1.11e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 12 | 4.53e-02 | 3.34e-01 | 3.32e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 29 | 1.89e-03 | 3.33e-01 | 5.60e-02 |
| GOBP HISTIDINE METABOLIC PROCESS | 7 | 1.27e-01 | -3.33e-01 | 5.17e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 35 | 6.45e-04 | 3.33e-01 | 2.73e-02 |
| GOMF EPOXIDE HYDROLASE ACTIVITY | 5 | 1.97e-01 | -3.33e-01 | 6.10e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 8 | 1.03e-01 | -3.33e-01 | 4.78e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 28 | 2.30e-03 | 3.33e-01 | 6.36e-02 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 4.59e-02 | 3.33e-01 | 3.35e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.28e-01 | -3.32e-01 | 5.20e-01 |
| GOBP THYMIC T CELL SELECTION | 17 | 1.78e-02 | 3.32e-01 | 2.03e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 1.99e-01 | -3.32e-01 | 6.11e-01 |
| GOBP REGULATION OF FERTILIZATION | 5 | 1.99e-01 | 3.32e-01 | 6.11e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 15 | 2.63e-02 | -3.31e-01 | 2.53e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 8 | 1.05e-01 | 3.31e-01 | 4.81e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 5 | 1.99e-01 | 3.31e-01 | 6.11e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 1.05e-01 | 3.31e-01 | 4.81e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 7 | 1.30e-01 | -3.31e-01 | 5.22e-01 |
| GOBP CELL PROLIFERATION IN HINDBRAIN | 6 | 1.61e-01 | -3.31e-01 | 5.73e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 9 | 8.60e-02 | 3.31e-01 | 4.44e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 1.61e-01 | 3.30e-01 | 5.73e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 10 | 7.07e-02 | -3.30e-01 | 4.10e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 13 | 3.94e-02 | 3.30e-01 | 3.07e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 17 | 1.86e-02 | -3.30e-01 | 2.07e-01 |
| GOBP ATP METABOLIC PROCESS | 117 | 7.56e-10 | 3.30e-01 | 2.34e-07 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 25 | 4.36e-03 | 3.29e-01 | 9.55e-02 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 14 | 3.30e-02 | 3.29e-01 | 2.84e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 10 | 7.17e-02 | -3.29e-01 | 4.13e-01 |
| GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 5 | 2.03e-01 | -3.29e-01 | 6.16e-01 |
| GOCC CALYX OF HELD | 9 | 8.76e-02 | 3.29e-01 | 4.48e-01 |
| GOMF PRIMARY MIRNA BINDING | 9 | 8.82e-02 | -3.28e-01 | 4.49e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 5 | 2.04e-01 | 3.28e-01 | 6.17e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 1.08e-01 | 3.28e-01 | 4.85e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 23 | 6.49e-03 | 3.28e-01 | 1.17e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 1.64e-01 | -3.28e-01 | 5.76e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 129 | 1.35e-10 | 3.28e-01 | 5.64e-08 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 7.85e-03 | 3.27e-01 | 1.31e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 11 | 6.02e-02 | -3.27e-01 | 3.84e-01 |
| GOCC ASTER | 9 | 8.92e-02 | -3.27e-01 | 4.53e-01 |
| GOBP RESPONSE TO GLUCAGON | 10 | 7.33e-02 | -3.27e-01 | 4.18e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 8 | 1.09e-01 | -3.27e-01 | 4.88e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 10 | 7.34e-02 | 3.27e-01 | 4.18e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 6 | 1.66e-01 | 3.27e-01 | 5.77e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 16 | 2.36e-02 | -3.27e-01 | 2.38e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 20 | 1.14e-02 | 3.27e-01 | 1.65e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 6 | 1.66e-01 | 3.27e-01 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 8.99e-02 | 3.27e-01 | 4.54e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 11 | 6.08e-02 | -3.26e-01 | 3.85e-01 |
| GOMF DELTA CATENIN BINDING | 5 | 2.06e-01 | 3.26e-01 | 6.20e-01 |
| GOBP MESENCHYMAL CELL APOPTOTIC PROCESS | 5 | 2.06e-01 | -3.26e-01 | 6.20e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 26 | 4.02e-03 | 3.26e-01 | 9.00e-02 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 5 | 2.07e-01 | -3.26e-01 | 6.21e-01 |
| GOBP POSITIVE REGULATION OF ACROSOME REACTION | 5 | 2.07e-01 | -3.26e-01 | 6.21e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 8 | 1.11e-01 | -3.25e-01 | 4.90e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 2.08e-01 | 3.25e-01 | 6.22e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 12 | 5.13e-02 | -3.25e-01 | 3.56e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 2.08e-01 | 3.25e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 5 | 2.08e-01 | 3.25e-01 | 6.22e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 7 | 1.37e-01 | -3.25e-01 | 5.35e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 10 | 7.54e-02 | 3.25e-01 | 4.22e-01 |
| GOBP HISTONE METHYLATION | 34 | 1.05e-03 | 3.25e-01 | 3.85e-02 |
| GOCC CKM COMPLEX | 5 | 2.09e-01 | 3.25e-01 | 6.22e-01 |
| GOMF NADPH BINDING | 15 | 2.97e-02 | 3.24e-01 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 1.69e-01 | -3.24e-01 | 5.80e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 18 | 1.75e-02 | 3.24e-01 | 2.01e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 51 | 6.42e-05 | 3.24e-01 | 4.40e-03 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 1.22e-02 | 3.24e-01 | 1.70e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 7.65e-02 | 3.23e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 31 | 1.84e-03 | -3.23e-01 | 5.54e-02 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 16 | 2.52e-02 | 3.23e-01 | 2.46e-01 |
| GOBP VESICLE UNCOATING | 5 | 2.11e-01 | 3.23e-01 | 6.24e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 8 | 1.14e-01 | -3.23e-01 | 4.96e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 15 | 3.05e-02 | -3.23e-01 | 2.73e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 2.12e-01 | 3.23e-01 | 6.26e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 8 | 1.14e-01 | 3.23e-01 | 4.96e-01 |
| GOMF G PROTEIN ACTIVITY | 32 | 1.60e-03 | 3.23e-01 | 5.00e-02 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 10 | 7.75e-02 | 3.22e-01 | 4.27e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 33 | 1.36e-03 | 3.22e-01 | 4.54e-02 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 2.12e-01 | 3.22e-01 | 6.26e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 1.15e-01 | 3.22e-01 | 4.96e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 5 | 2.12e-01 | -3.22e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 12 | 5.35e-02 | 3.22e-01 | 3.64e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 6 | 1.72e-01 | -3.22e-01 | 5.85e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 7 | 1.41e-01 | 3.21e-01 | 5.43e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 9 | 9.50e-02 | 3.21e-01 | 4.60e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 13 | 4.49e-02 | 3.21e-01 | 3.31e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 2.13e-01 | 3.21e-01 | 6.28e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 7 | 1.41e-01 | -3.21e-01 | 5.43e-01 |
| GOBP FEVER GENERATION | 6 | 1.73e-01 | -3.21e-01 | 5.87e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 24 | 6.54e-03 | 3.21e-01 | 1.18e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 2.15e-01 | -3.21e-01 | 6.29e-01 |
| GOBP OSTEOCLAST PROLIFERATION | 5 | 2.15e-01 | -3.20e-01 | 6.29e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 8 | 1.17e-01 | 3.20e-01 | 4.99e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 1.88e-02 | 3.20e-01 | 2.08e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 2.24e-02 | 3.20e-01 | 2.31e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 23 | 8.00e-03 | 3.20e-01 | 1.31e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 6 | 1.76e-01 | 3.19e-01 | 5.89e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 53 | 5.85e-05 | 3.19e-01 | 4.11e-03 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 7 | 1.44e-01 | 3.19e-01 | 5.47e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 1.76e-01 | -3.19e-01 | 5.89e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 8.10e-02 | 3.19e-01 | 4.34e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 19 | 1.62e-02 | 3.19e-01 | 1.93e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 11 | 6.74e-02 | -3.18e-01 | 4.01e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 12 | 5.62e-02 | 3.18e-01 | 3.71e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 6.77e-02 | 3.18e-01 | 4.02e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 13 | 4.70e-02 | -3.18e-01 | 3.41e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 2.18e-01 | 3.18e-01 | 6.31e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 2.18e-01 | -3.18e-01 | 6.31e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 5 | 2.19e-01 | -3.17e-01 | 6.32e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 6.84e-02 | 3.17e-01 | 4.03e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 16 | 2.80e-02 | 3.17e-01 | 2.60e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 8 | 1.20e-01 | 3.17e-01 | 5.06e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 2.19e-01 | 3.17e-01 | 6.33e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 23 | 8.48e-03 | 3.17e-01 | 1.37e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 29 | 3.14e-03 | 3.17e-01 | 7.64e-02 |
| GOBP MITOCHONDRIAL TRANSLATION | 128 | 6.23e-10 | 3.17e-01 | 2.15e-07 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 37 | 8.64e-04 | -3.17e-01 | 3.46e-02 |
| GOCC NURF COMPLEX | 6 | 1.80e-01 | 3.16e-01 | 5.94e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 11 | 6.93e-02 | -3.16e-01 | 4.06e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 5 | 2.21e-01 | 3.16e-01 | 6.34e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 7 | 1.47e-01 | 3.16e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 29 | 3.21e-03 | -3.16e-01 | 7.75e-02 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 5 | 2.21e-01 | -3.16e-01 | 6.34e-01 |
| GOBP CRISTAE FORMATION | 17 | 2.40e-02 | 3.16e-01 | 2.40e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 1.80e-01 | 3.16e-01 | 5.95e-01 |
| GOCC RESPIRASOME | 89 | 2.69e-07 | 3.16e-01 | 4.24e-05 |
| GOCC B WICH COMPLEX | 7 | 1.48e-01 | 3.16e-01 | 5.54e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 6 | 1.81e-01 | -3.16e-01 | 5.96e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 6 | 1.81e-01 | 3.15e-01 | 5.96e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 11 | 7.03e-02 | -3.15e-01 | 4.09e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 144 | 6.85e-11 | 3.15e-01 | 3.18e-08 |
| GOMF RIBONUCLEASE P ACTIVITY | 9 | 1.02e-01 | 3.15e-01 | 4.77e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 7 | 1.49e-01 | 3.15e-01 | 5.57e-01 |
| GOCC SPERM PRINCIPAL PIECE | 17 | 2.48e-02 | -3.14e-01 | 2.45e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 10 | 8.54e-02 | -3.14e-01 | 4.43e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 6 | 1.83e-01 | 3.14e-01 | 5.98e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 1.25e-01 | 3.14e-01 | 5.15e-01 |
| GOBP REGULATION OF CELL MATURATION | 8 | 1.25e-01 | -3.13e-01 | 5.15e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 1.84e-01 | 3.13e-01 | 5.98e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 1.51e-01 | 3.13e-01 | 5.60e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 6 | 1.84e-01 | -3.13e-01 | 5.98e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 34 | 1.58e-03 | 3.13e-01 | 4.99e-02 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 2.26e-01 | 3.13e-01 | 6.39e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 1.85e-01 | 3.13e-01 | 5.98e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 1.04e-01 | 3.13e-01 | 4.81e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 15 | 3.62e-02 | -3.12e-01 | 2.95e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 6 | 1.85e-01 | 3.12e-01 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 14 | 4.33e-02 | 3.12e-01 | 3.23e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 8 | 1.27e-01 | 3.12e-01 | 5.17e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 6 | 1.86e-01 | 3.12e-01 | 6.00e-01 |
| GOMF HISTONE READER ACTIVITY | 11 | 7.38e-02 | 3.11e-01 | 4.19e-01 |
| GOBP PROTEIN TRIMERIZATION | 10 | 8.83e-02 | 3.11e-01 | 4.50e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 20 | 1.60e-02 | 3.11e-01 | 1.92e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 11 | 7.42e-02 | 3.11e-01 | 4.20e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 2.29e-01 | 3.11e-01 | 6.41e-01 |
| GOMF PHOSPHATIDYLSERINE FLIPPASE ACTIVITY | 5 | 2.30e-01 | 3.10e-01 | 6.42e-01 |
| GOBP POSITIVE REGULATION OF FEVER GENERATION | 5 | 2.30e-01 | -3.10e-01 | 6.42e-01 |
| GOBP REGULATION OF FEVER GENERATION | 5 | 2.30e-01 | -3.10e-01 | 6.42e-01 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 2.30e-01 | 3.10e-01 | 6.42e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 6 | 1.89e-01 | 3.10e-01 | 6.03e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 6 | 1.89e-01 | 3.10e-01 | 6.03e-01 |
| GOMF PHOSPHATE ION BINDING | 6 | 1.89e-01 | -3.10e-01 | 6.03e-01 |
| GOBP NEUROTRANSMITTER CATABOLIC PROCESS | 5 | 2.31e-01 | -3.10e-01 | 6.42e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 23 | 1.02e-02 | 3.10e-01 | 1.53e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 11 | 7.55e-02 | 3.10e-01 | 4.22e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 2.31e-01 | 3.10e-01 | 6.42e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 9 | 1.08e-01 | 3.09e-01 | 4.85e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 9 | 1.08e-01 | 3.09e-01 | 4.85e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 6 | 1.90e-01 | -3.09e-01 | 6.03e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 6 | 1.90e-01 | 3.09e-01 | 6.03e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 9.06e-02 | 3.09e-01 | 4.54e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 1.57e-01 | 3.09e-01 | 5.67e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 5 | 2.32e-01 | 3.09e-01 | 6.43e-01 |
| GOCC PORE COMPLEX | 18 | 2.34e-02 | 3.09e-01 | 2.37e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 6 | 1.91e-01 | -3.09e-01 | 6.04e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 1.23e-02 | 3.08e-01 | 1.70e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 1.91e-01 | 3.08e-01 | 6.04e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 6 | 1.91e-01 | -3.08e-01 | 6.04e-01 |
| GOMF RNA CAP BINDING | 19 | 2.01e-02 | 3.08e-01 | 2.17e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 19 | 2.01e-02 | 3.08e-01 | 2.17e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 11 | 7.69e-02 | 3.08e-01 | 4.24e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 5 | 2.33e-01 | -3.08e-01 | 6.44e-01 |
| GOBP FATTY ACID ELONGATION | 9 | 1.10e-01 | 3.08e-01 | 4.88e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 12 | 6.48e-02 | 3.08e-01 | 3.95e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 3.30e-02 | 3.08e-01 | 2.84e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 6 | 1.92e-01 | -3.08e-01 | 6.04e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 1.10e-01 | 3.08e-01 | 4.89e-01 |
| GOMF TAU PROTEIN BINDING | 36 | 1.41e-03 | 3.08e-01 | 4.61e-02 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 1.92e-01 | 3.07e-01 | 6.04e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 2.34e-01 | 3.07e-01 | 6.46e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 9 | 1.11e-01 | -3.07e-01 | 4.90e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 9 | 1.11e-01 | 3.07e-01 | 4.90e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 2.35e-01 | 3.07e-01 | 6.47e-01 |
| GOBP MALATE METABOLIC PROCESS | 6 | 1.93e-01 | 3.07e-01 | 6.06e-01 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 21 | 1.51e-02 | 3.06e-01 | 1.89e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 14 | 4.72e-02 | 3.06e-01 | 3.41e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 15 | 4.00e-02 | -3.06e-01 | 3.10e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 2.36e-01 | 3.06e-01 | 6.48e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 12 | 6.67e-02 | -3.06e-01 | 3.99e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 283 | 1.10e-18 | 3.05e-01 | 3.06e-15 |
| GOBP MYELIN ASSEMBLY | 11 | 7.95e-02 | -3.05e-01 | 4.31e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 7 | 1.62e-01 | 3.05e-01 | 5.74e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 24 | 9.64e-03 | 3.05e-01 | 1.48e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 20 | 1.82e-02 | 3.05e-01 | 2.06e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 7 | 1.62e-01 | -3.05e-01 | 5.74e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 6 | 1.96e-01 | 3.05e-01 | 6.09e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 1.96e-01 | 3.05e-01 | 6.09e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 26 | 7.15e-03 | 3.05e-01 | 1.23e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 6 | 1.96e-01 | 3.05e-01 | 6.09e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 1.14e-01 | -3.05e-01 | 4.95e-01 |
| GOCC AXONEMAL MICROTUBULE | 20 | 1.84e-02 | -3.05e-01 | 2.07e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 10 | 9.56e-02 | -3.04e-01 | 4.61e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 9 | 1.14e-01 | 3.04e-01 | 4.96e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 1.97e-01 | 3.04e-01 | 6.10e-01 |
| GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 2.39e-01 | 3.04e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 16 | 3.53e-02 | -3.04e-01 | 2.91e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 18 | 2.57e-02 | -3.04e-01 | 2.49e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 7 | 1.64e-01 | -3.04e-01 | 5.75e-01 |
| GOBP MUSCLE ATROPHY | 5 | 2.40e-01 | -3.04e-01 | 6.54e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 8 | 1.37e-01 | -3.03e-01 | 5.35e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 1.15e-01 | 3.03e-01 | 4.97e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 11 | 8.19e-02 | 3.03e-01 | 4.35e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 26 | 7.58e-03 | 3.03e-01 | 1.28e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 7 | 1.66e-01 | 3.02e-01 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 11 | 8.25e-02 | 3.02e-01 | 4.38e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 3.60e-03 | 3.02e-01 | 8.37e-02 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 30 | 4.25e-03 | 3.02e-01 | 9.38e-02 |
| GOBP PROTEASOME ASSEMBLY | 12 | 7.07e-02 | 3.01e-01 | 4.10e-01 |
| GOBP FORELIMB MORPHOGENESIS | 16 | 3.70e-02 | -3.01e-01 | 2.97e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 17 | 3.16e-02 | 3.01e-01 | 2.78e-01 |
| GOCC CORTICAL GRANULE | 5 | 2.44e-01 | 3.01e-01 | 6.58e-01 |
| GOMF U3 SNORNA BINDING | 10 | 9.95e-02 | 3.01e-01 | 4.69e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 5 | 2.44e-01 | -3.01e-01 | 6.59e-01 |
| GOBP RESPONSE TO INACTIVITY | 5 | 2.45e-01 | 3.01e-01 | 6.59e-01 |
| GOCC MIB COMPLEX | 13 | 6.07e-02 | 3.01e-01 | 3.85e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 12 | 7.16e-02 | 3.00e-01 | 4.13e-01 |
| GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY | 6 | 2.03e-01 | 3.00e-01 | 6.16e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 16 | 3.77e-02 | 3.00e-01 | 3.00e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 14 | 5.22e-02 | 3.00e-01 | 3.60e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 1.20e-01 | 2.99e-01 | 5.06e-01 |
| GOMF SELENIUM BINDING | 5 | 2.47e-01 | 2.99e-01 | 6.61e-01 |
| GOBP PROTEIN AUTOPROCESSING | 15 | 4.50e-02 | 2.99e-01 | 3.31e-01 |
| GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY | 5 | 2.47e-01 | 2.99e-01 | 6.61e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 14 | 5.28e-02 | 2.99e-01 | 3.61e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 8.61e-02 | -2.99e-01 | 4.44e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 17 | 3.29e-02 | 2.99e-01 | 2.84e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 2.47e-01 | 2.99e-01 | 6.61e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 25 | 9.77e-03 | 2.99e-01 | 1.49e-01 |
| GOCC AXON HILLOCK | 6 | 2.06e-01 | -2.98e-01 | 6.19e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 10 | 1.02e-01 | 2.98e-01 | 4.77e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 2.49e-01 | 2.98e-01 | 6.62e-01 |
| GOBP RETINAL METABOLIC PROCESS | 10 | 1.03e-01 | -2.98e-01 | 4.79e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 19 | 2.48e-02 | 2.98e-01 | 2.45e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 13 | 6.34e-02 | 2.97e-01 | 3.92e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 5 | 2.50e-01 | 2.97e-01 | 6.63e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 1.23e-01 | 2.97e-01 | 5.12e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 2.09e-01 | 2.96e-01 | 6.22e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 9 | 1.24e-01 | -2.96e-01 | 5.14e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 7 | 1.76e-01 | 2.95e-01 | 5.89e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 6 | 2.10e-01 | 2.95e-01 | 6.24e-01 |
| GOBP AEROBIC RESPIRATION | 171 | 2.91e-11 | 2.95e-01 | 1.52e-08 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 9.01e-02 | 2.95e-01 | 4.54e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 11 | 9.01e-02 | 2.95e-01 | 4.54e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 11 | 9.04e-02 | -2.95e-01 | 4.54e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 16 | 4.12e-02 | 2.95e-01 | 3.14e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 5 | 2.54e-01 | -2.95e-01 | 6.67e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 5 | 2.54e-01 | -2.95e-01 | 6.67e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 5 | 2.54e-01 | 2.95e-01 | 6.67e-01 |
| GOMF FERRIC IRON BINDING | 5 | 2.54e-01 | 2.95e-01 | 6.67e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 7 | 1.77e-01 | -2.94e-01 | 5.91e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 11 | 9.09e-02 | -2.94e-01 | 4.55e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 6 | 2.12e-01 | 2.94e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 34 | 2.99e-03 | 2.94e-01 | 7.38e-02 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 7 | 1.78e-01 | 2.94e-01 | 5.91e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 7 | 1.78e-01 | 2.94e-01 | 5.91e-01 |
| GOMF PRERIBOSOME BINDING | 8 | 1.50e-01 | 2.94e-01 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 5 | 2.55e-01 | -2.94e-01 | 6.69e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 70 | 2.17e-05 | 2.94e-01 | 1.68e-03 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 7 | 1.79e-01 | -2.94e-01 | 5.92e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 6 | 2.13e-01 | 2.94e-01 | 6.27e-01 |
| GOMF GDP BINDING | 53 | 2.20e-04 | 2.94e-01 | 1.20e-02 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 2.56e-01 | -2.93e-01 | 6.69e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 12 | 7.84e-02 | -2.93e-01 | 4.28e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 5 | 2.56e-01 | 2.93e-01 | 6.70e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 6 | 2.14e-01 | -2.93e-01 | 6.28e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 24 | 1.30e-02 | 2.93e-01 | 1.75e-01 |
| GOCC NPBAF COMPLEX | 14 | 5.79e-02 | 2.93e-01 | 3.76e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 1.52e-01 | 2.93e-01 | 5.60e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 18 | 3.16e-02 | 2.93e-01 | 2.78e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 11 | 9.28e-02 | -2.93e-01 | 4.56e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 2.14e-01 | 2.93e-01 | 6.29e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 39 | 1.57e-03 | 2.93e-01 | 4.99e-02 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 9 | 1.29e-01 | -2.93e-01 | 5.20e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 6.79e-02 | 2.92e-01 | 4.02e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 10 | 1.09e-01 | -2.92e-01 | 4.88e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 19 | 2.74e-02 | -2.92e-01 | 2.57e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 23 | 1.53e-02 | 2.92e-01 | 1.89e-01 |
| GOBP NEGATIVE REGULATION OF NEURON MIGRATION | 5 | 2.58e-01 | 2.92e-01 | 6.71e-01 |
| GOBP CELL CYCLE DNA REPLICATION INITIATION | 5 | 2.58e-01 | 2.92e-01 | 6.71e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 5 | 2.59e-01 | 2.92e-01 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 2.17e-01 | 2.91e-01 | 6.31e-01 |
| GOBP RESPONSE TO COPPER ION | 17 | 3.78e-02 | 2.91e-01 | 3.00e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 9.47e-02 | 2.91e-01 | 4.60e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 5 | 2.60e-01 | 2.91e-01 | 6.74e-01 |
| GOMF S100 PROTEIN BINDING | 11 | 9.51e-02 | 2.91e-01 | 4.60e-01 |
| GOMF OXYGEN CARRIER ACTIVITY | 6 | 2.18e-01 | 2.91e-01 | 6.31e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 23 | 1.58e-02 | 2.91e-01 | 1.91e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 19 | 2.84e-02 | 2.91e-01 | 2.62e-01 |
| GOBP VIRAL TRANSLATION | 20 | 2.46e-02 | 2.90e-01 | 2.44e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 11 | 9.56e-02 | 2.90e-01 | 4.61e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 1.84e-01 | -2.90e-01 | 5.98e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 5 | 2.61e-01 | 2.90e-01 | 6.75e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 1.75e-04 | 2.90e-01 | 9.97e-03 |
| GOCC DESMOSOME | 11 | 9.64e-02 | -2.90e-01 | 4.62e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 12 | 8.26e-02 | -2.89e-01 | 4.38e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 11 | 9.67e-02 | 2.89e-01 | 4.62e-01 |
| GOBP URETER DEVELOPMENT | 5 | 2.63e-01 | 2.89e-01 | 6.77e-01 |
| GOMF MYOSIN V BINDING | 11 | 9.70e-02 | 2.89e-01 | 4.62e-01 |
| GOBP MICROVILLUS ORGANIZATION | 21 | 2.20e-02 | 2.89e-01 | 2.29e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 9 | 1.34e-01 | -2.89e-01 | 5.30e-01 |
| GOMF EPHRIN RECEPTOR ACTIVITY | 6 | 2.21e-01 | -2.89e-01 | 6.34e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 8 | 1.58e-01 | -2.88e-01 | 5.68e-01 |
| GOMF FERROUS IRON BINDING | 20 | 2.55e-02 | 2.88e-01 | 2.49e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 16 | 4.59e-02 | 2.88e-01 | 3.35e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 18 | 3.43e-02 | 2.88e-01 | 2.87e-01 |
| GOMF CGMP BINDING | 9 | 1.34e-01 | -2.88e-01 | 5.31e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 11 | 9.80e-02 | 2.88e-01 | 4.65e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 19 | 2.97e-02 | -2.88e-01 | 2.69e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 10 | 1.15e-01 | -2.88e-01 | 4.97e-01 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 2.65e-01 | 2.88e-01 | 6.79e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 6 | 2.22e-01 | -2.88e-01 | 6.35e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 2.22e-01 | 2.88e-01 | 6.35e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 10 | 1.15e-01 | -2.88e-01 | 4.97e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 6 | 2.23e-01 | -2.88e-01 | 6.35e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 25 | 1.29e-02 | 2.87e-01 | 1.74e-01 |
| GOCC PRP19 COMPLEX | 12 | 8.49e-02 | 2.87e-01 | 4.43e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.23e-01 | -2.87e-01 | 6.36e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 6 | 2.23e-01 | -2.87e-01 | 6.36e-01 |
| GOBP CHROMATIN LOOPING | 11 | 9.95e-02 | 2.87e-01 | 4.69e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 11 | 9.96e-02 | -2.87e-01 | 4.70e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 2.68e-01 | 2.86e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 16 | 4.78e-02 | 2.86e-01 | 3.44e-01 |
| GOBP RENAL WATER TRANSPORT | 5 | 2.69e-01 | -2.86e-01 | 6.82e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 2.69e-01 | -2.86e-01 | 6.82e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 12 | 8.67e-02 | 2.86e-01 | 4.45e-01 |
| GOBP CELL FATE DETERMINATION | 15 | 5.55e-02 | -2.86e-01 | 3.70e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 2.26e-01 | -2.86e-01 | 6.39e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 2.26e-01 | 2.85e-01 | 6.39e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 13 | 7.53e-02 | 2.85e-01 | 4.22e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 2.27e-01 | -2.85e-01 | 6.39e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 7 | 1.92e-01 | 2.85e-01 | 6.04e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 8 | 1.63e-01 | 2.85e-01 | 5.75e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 12 | 8.79e-02 | 2.85e-01 | 4.49e-01 |
| GOMF LEUCINE BINDING | 6 | 2.28e-01 | 2.84e-01 | 6.40e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 2.71e-01 | 2.84e-01 | 6.85e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 73 | 2.73e-05 | 2.84e-01 | 2.06e-03 |
| GOMF PROTEIN KINASE C ACTIVITY | 14 | 6.58e-02 | 2.84e-01 | 3.98e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 2.28e-01 | -2.84e-01 | 6.40e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 113 | 1.92e-07 | 2.84e-01 | 3.08e-05 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 38 | 2.49e-03 | 2.84e-01 | 6.65e-02 |
| GOCC AP 3 ADAPTOR COMPLEX | 8 | 1.65e-01 | 2.83e-01 | 5.77e-01 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 2.73e-01 | 2.83e-01 | 6.87e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 8 | 1.66e-01 | 2.83e-01 | 5.77e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 13 | 7.78e-02 | -2.83e-01 | 4.27e-01 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 108 | 4.09e-07 | 2.82e-01 | 6.00e-05 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 6 | 2.32e-01 | 2.82e-01 | 6.43e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 11 | 1.06e-01 | 2.82e-01 | 4.81e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 18 | 3.85e-02 | 2.82e-01 | 3.04e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 7 | 1.98e-01 | 2.81e-01 | 6.10e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 5 | 2.76e-01 | -2.81e-01 | 6.91e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 10 | 1.24e-01 | 2.81e-01 | 5.14e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 10 | 1.24e-01 | 2.81e-01 | 5.14e-01 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 1.69e-01 | -2.81e-01 | 5.80e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 9 | 1.44e-01 | 2.81e-01 | 5.47e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 11 | 1.07e-01 | 2.81e-01 | 4.83e-01 |
| GOBP RRNA MODIFICATION | 31 | 6.82e-03 | 2.81e-01 | 1.19e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 11 | 1.07e-01 | 2.81e-01 | 4.84e-01 |
| GOBP GAS TRANSPORT | 7 | 1.99e-01 | 2.80e-01 | 6.11e-01 |
| GOBP OXYGEN TRANSPORT | 7 | 1.99e-01 | 2.80e-01 | 6.11e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 10 | 1.25e-01 | -2.80e-01 | 5.15e-01 |
| GOCC SYMMETRIC SYNAPSE | 5 | 2.78e-01 | 2.80e-01 | 6.93e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 24 | 1.75e-02 | 2.80e-01 | 2.01e-01 |
| GOCC SPINDLE POLE CENTROSOME | 10 | 1.25e-01 | -2.80e-01 | 5.15e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 161 | 9.25e-10 | 2.80e-01 | 2.67e-07 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 8 | 1.70e-01 | 2.80e-01 | 5.82e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 2.36e-01 | 2.80e-01 | 6.48e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 3.49e-02 | 2.80e-01 | 2.89e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 12 | 9.37e-02 | 2.80e-01 | 4.58e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.80e-01 | 2.79e-01 | 6.94e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 7 | 2.01e-01 | 2.79e-01 | 6.14e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 6 | 2.37e-01 | 2.79e-01 | 6.49e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 10 | 1.27e-01 | 2.79e-01 | 5.17e-01 |
| GOBP GERMINAL CENTER FORMATION | 12 | 9.46e-02 | -2.79e-01 | 4.60e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.02e-01 | 2.79e-01 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 11 | 1.10e-01 | 2.78e-01 | 4.89e-01 |
| GOCC CYTOCHROME COMPLEX | 31 | 7.34e-03 | 2.78e-01 | 1.25e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 6 | 2.38e-01 | -2.78e-01 | 6.52e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 5 | 2.81e-01 | 2.78e-01 | 6.96e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 8 | 1.73e-01 | 2.78e-01 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 5 | 2.82e-01 | 2.78e-01 | 6.97e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 13 | 8.27e-02 | -2.78e-01 | 4.38e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 5 | 2.82e-01 | -2.78e-01 | 6.97e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 1.28e-01 | 2.78e-01 | 5.20e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 10 | 1.28e-01 | -2.78e-01 | 5.20e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 15 | 6.28e-02 | 2.78e-01 | 3.89e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 2.83e-01 | 2.77e-01 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 14 | 7.24e-02 | -2.77e-01 | 4.16e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 5 | 2.83e-01 | 2.77e-01 | 6.97e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 6 | 2.40e-01 | 2.77e-01 | 6.54e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 10 | 1.29e-01 | -2.77e-01 | 5.21e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 2.40e-01 | 2.77e-01 | 6.54e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 17 | 4.82e-02 | -2.77e-01 | 3.46e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 9 | 1.51e-01 | -2.77e-01 | 5.58e-01 |
| GOBP RESPONSE TO UV C | 12 | 9.72e-02 | 2.77e-01 | 4.62e-01 |
| GOBP LYMPHOCYTE ANERGY | 5 | 2.85e-01 | 2.76e-01 | 7.00e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 8 | 1.77e-01 | -2.76e-01 | 5.90e-01 |
| GOCC U4 SNRNP | 10 | 1.31e-01 | 2.76e-01 | 5.25e-01 |
| GOBP N GLYCAN PROCESSING | 14 | 7.41e-02 | 2.76e-01 | 4.20e-01 |
| GOBP L LYSINE TRANSPORT | 5 | 2.86e-01 | -2.76e-01 | 7.00e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.86e-01 | -2.76e-01 | 7.00e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 9 | 1.52e-01 | 2.76e-01 | 5.61e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 2.07e-01 | 2.75e-01 | 6.21e-01 |
| GOMF 5S RRNA BINDING | 9 | 1.53e-01 | 2.75e-01 | 5.62e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 8 | 1.78e-01 | 2.75e-01 | 5.92e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 33 | 6.28e-03 | 2.75e-01 | 1.16e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 16 | 5.71e-02 | 2.75e-01 | 3.74e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 5 | 2.87e-01 | -2.75e-01 | 7.02e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 37 | 3.86e-03 | 2.75e-01 | 8.81e-02 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 10 | 1.33e-01 | 2.74e-01 | 5.28e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 10 | 1.33e-01 | 2.74e-01 | 5.29e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 6 | 2.45e-01 | -2.74e-01 | 6.59e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 6 | 2.45e-01 | 2.74e-01 | 6.59e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 6 | 2.45e-01 | 2.74e-01 | 6.59e-01 |
| GOBP TELOMERE CAPPING | 36 | 4.43e-03 | 2.74e-01 | 9.59e-02 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 8 | 1.79e-01 | 2.74e-01 | 5.94e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 3.16e-06 | 2.74e-01 | 3.38e-04 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 48 | 1.03e-03 | 2.74e-01 | 3.83e-02 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 36 | 4.47e-03 | 2.74e-01 | 9.61e-02 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 11 | 1.16e-01 | 2.74e-01 | 4.98e-01 |
| GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 5 | 2.89e-01 | -2.74e-01 | 7.02e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 5 | 2.89e-01 | -2.74e-01 | 7.02e-01 |
| GOCC PLATELET DENSE GRANULE | 11 | 1.16e-01 | 2.74e-01 | 4.99e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 7 | 2.10e-01 | -2.74e-01 | 6.24e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 7 | 2.10e-01 | 2.73e-01 | 6.24e-01 |
| GOBP COCHLEA MORPHOGENESIS | 7 | 2.10e-01 | -2.73e-01 | 6.24e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 2.90e-01 | -2.73e-01 | 7.02e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 3.92e-02 | 2.73e-01 | 3.06e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 15 | 6.69e-02 | 2.73e-01 | 3.99e-01 |
| GOCC AXOLEMMA | 10 | 1.35e-01 | -2.73e-01 | 5.32e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 2.90e-01 | -2.73e-01 | 7.02e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 5 | 2.91e-01 | 2.73e-01 | 7.02e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 8 | 1.81e-01 | -2.73e-01 | 5.96e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 98 | 3.11e-06 | 2.73e-01 | 3.37e-04 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 7 | 2.11e-01 | 2.73e-01 | 6.25e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 1.57e-01 | 2.73e-01 | 5.66e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 8 | 1.82e-01 | 2.73e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 16 | 5.94e-02 | 2.72e-01 | 3.80e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 8 | 1.82e-01 | -2.72e-01 | 5.97e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 1.82e-01 | 2.72e-01 | 5.97e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 1.57e-01 | 2.72e-01 | 5.68e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 22 | 2.73e-02 | 2.72e-01 | 2.57e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 2.93e-01 | 2.72e-01 | 7.03e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 2.49e-01 | -2.72e-01 | 6.63e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 7 | 2.14e-01 | 2.71e-01 | 6.28e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 10 | 1.38e-01 | 2.71e-01 | 5.36e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 7 | 2.14e-01 | -2.71e-01 | 6.29e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 16 | 6.06e-02 | -2.71e-01 | 3.85e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 18 | 4.66e-02 | 2.71e-01 | 3.39e-01 |
| GOBP RESPONSE TO COLD | 30 | 1.03e-02 | -2.71e-01 | 1.54e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 6 | 2.51e-01 | -2.71e-01 | 6.65e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 1.85e-01 | 2.71e-01 | 5.99e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 8 | 1.85e-01 | -2.71e-01 | 5.99e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 71 | 8.22e-05 | 2.70e-01 | 5.24e-03 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 2.15e-01 | 2.70e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 21 | 3.20e-02 | 2.70e-01 | 2.79e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 2.95e-01 | -2.70e-01 | 7.05e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 10 | 1.39e-01 | -2.70e-01 | 5.40e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 13 | 9.18e-02 | -2.70e-01 | 4.56e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 16 | 6.15e-02 | 2.70e-01 | 3.87e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 7 | 2.16e-01 | 2.70e-01 | 6.30e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 9 | 1.61e-01 | -2.70e-01 | 5.73e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 10 | 1.40e-01 | -2.70e-01 | 5.41e-01 |
| GOCC SPERM HEAD | 6 | 2.52e-01 | 2.70e-01 | 6.66e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 5 | 2.96e-01 | -2.70e-01 | 7.06e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 16 | 6.19e-02 | 2.70e-01 | 3.87e-01 |
| GOBP HEART VALVE FORMATION | 5 | 2.97e-01 | 2.69e-01 | 7.06e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 20 | 3.70e-02 | 2.69e-01 | 2.97e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 2.17e-01 | 2.69e-01 | 6.31e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 11 | 1.22e-01 | 2.69e-01 | 5.10e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 12 | 1.06e-01 | 2.69e-01 | 4.82e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 2.97e-01 | -2.69e-01 | 7.07e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 9 | 1.62e-01 | -2.69e-01 | 5.74e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 5 | 2.98e-01 | 2.69e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 1.88e-01 | 2.69e-01 | 6.03e-01 |
| GOBP NK T CELL DIFFERENTIATION | 11 | 1.23e-01 | 2.69e-01 | 5.13e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 6 | 2.55e-01 | 2.69e-01 | 6.68e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 13 | 9.36e-02 | 2.69e-01 | 4.58e-01 |
| GOBP SPHINGOLIPID TRANSLOCATION | 5 | 2.99e-01 | 2.68e-01 | 7.08e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 9 | 1.63e-01 | 2.68e-01 | 5.75e-01 |
| GOBP AMP METABOLIC PROCESS | 16 | 6.33e-02 | 2.68e-01 | 3.92e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 6 | 2.56e-01 | 2.68e-01 | 6.69e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 5 | 3.00e-01 | -2.68e-01 | 7.09e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.65e-01 | -2.67e-01 | 5.76e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 13 | 9.51e-02 | 2.67e-01 | 4.60e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 11 | 1.25e-01 | 2.67e-01 | 5.15e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 11 | 1.25e-01 | 2.67e-01 | 5.15e-01 |
| GOCC PODOSOME | 22 | 3.03e-02 | -2.67e-01 | 2.72e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 21 | 3.44e-02 | -2.67e-01 | 2.88e-01 |
| GOBP SKIN MORPHOGENESIS | 6 | 2.58e-01 | -2.67e-01 | 6.71e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 26 | 1.86e-02 | 2.67e-01 | 2.07e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 13 | 9.61e-02 | -2.67e-01 | 4.61e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 3.02e-01 | 2.66e-01 | 7.10e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 2.22e-01 | 2.66e-01 | 6.35e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 10 | 1.45e-01 | 2.66e-01 | 5.47e-01 |
| GOMF UBIQUINONE BINDING | 6 | 2.59e-01 | 2.66e-01 | 6.72e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 7 | 2.22e-01 | 2.66e-01 | 6.35e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 2.23e-01 | 2.66e-01 | 6.35e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 9 | 1.67e-01 | 2.66e-01 | 5.77e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 5 | 3.03e-01 | 2.66e-01 | 7.10e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 3.03e-01 | -2.66e-01 | 7.10e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 8.49e-02 | 2.66e-01 | 4.43e-01 |
| GOMF SIRNA BINDING | 9 | 1.67e-01 | 2.66e-01 | 5.77e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 11 | 1.27e-01 | -2.66e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 10 | 1.46e-01 | 2.66e-01 | 5.48e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 8 | 1.93e-01 | 2.66e-01 | 6.06e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 3.04e-01 | 2.65e-01 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 8 | 1.94e-01 | 2.65e-01 | 6.06e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 12 | 1.12e-01 | -2.65e-01 | 4.91e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 8 | 1.94e-01 | 2.65e-01 | 6.07e-01 |
| GOCC FILOPODIUM MEMBRANE | 10 | 1.47e-01 | 2.65e-01 | 5.51e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 109 | 1.81e-06 | 2.65e-01 | 2.17e-04 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 13 | 9.83e-02 | 2.65e-01 | 4.66e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 2.25e-01 | 2.65e-01 | 6.38e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 24 | 2.48e-02 | -2.65e-01 | 2.45e-01 |
| GOBP ORGAN INDUCTION | 5 | 3.05e-01 | -2.65e-01 | 7.12e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 3.06e-01 | 2.65e-01 | 7.12e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 1.69e-01 | -2.65e-01 | 5.80e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 16 | 6.71e-02 | -2.64e-01 | 4.00e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 65 | 2.30e-04 | 2.64e-01 | 1.21e-02 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 35 | 6.82e-03 | 2.64e-01 | 1.19e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 1.96e-01 | 2.64e-01 | 6.09e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 8 | 1.96e-01 | -2.64e-01 | 6.09e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 2.62e-01 | 2.64e-01 | 6.77e-01 |
| GOCC CORVET COMPLEX | 7 | 2.26e-01 | 2.64e-01 | 6.39e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 8 | 1.96e-01 | 2.64e-01 | 6.09e-01 |
| GOCC RIBOSOMAL SUBUNIT | 180 | 1.05e-09 | 2.64e-01 | 2.82e-07 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 8 | 1.96e-01 | -2.64e-01 | 6.09e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 6 | 2.63e-01 | 2.64e-01 | 6.77e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 43 | 2.79e-03 | 2.64e-01 | 7.07e-02 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 34 | 7.86e-03 | 2.63e-01 | 1.31e-01 |
| GOBP TONGUE DEVELOPMENT | 9 | 1.71e-01 | -2.63e-01 | 5.83e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 7 | 2.28e-01 | 2.63e-01 | 6.40e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 12 | 1.15e-01 | 2.63e-01 | 4.96e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 26 | 2.03e-02 | 2.63e-01 | 2.19e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 9 | 1.72e-01 | -2.63e-01 | 5.84e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 20 | 4.18e-02 | 2.63e-01 | 3.16e-01 |
| GOBP REGULATION OF GASTRULATION | 7 | 2.28e-01 | -2.63e-01 | 6.40e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 9 | 1.72e-01 | -2.63e-01 | 5.84e-01 |
| GOBP ORGANIC CATION TRANSPORT | 27 | 1.83e-02 | -2.62e-01 | 2.06e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 3.10e-01 | 2.62e-01 | 7.15e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 20 | 4.25e-02 | 2.62e-01 | 3.19e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 1.16e-01 | -2.62e-01 | 4.99e-01 |
| GOCC PEPTIDASE COMPLEX | 103 | 4.48e-06 | 2.62e-01 | 4.58e-04 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 2.67e-01 | 2.62e-01 | 6.82e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 2.67e-01 | 2.62e-01 | 6.82e-01 |
| GOBP PINOCYTOSIS | 16 | 7.01e-02 | 2.62e-01 | 4.09e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 15 | 7.97e-02 | -2.61e-01 | 4.32e-01 |
| GOBP ADP METABOLIC PROCESS | 6 | 2.68e-01 | 2.61e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 24 | 2.68e-02 | 2.61e-01 | 2.54e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 3.12e-01 | 2.61e-01 | 7.15e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 6 | 2.68e-01 | -2.61e-01 | 6.82e-01 |
| GOBP DIAPEDESIS | 6 | 2.69e-01 | -2.61e-01 | 6.82e-01 |
| GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 5 | 3.13e-01 | 2.61e-01 | 7.16e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 13 | 1.04e-01 | 2.61e-01 | 4.80e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 12 | 1.18e-01 | -2.60e-01 | 5.01e-01 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 2.70e-01 | -2.60e-01 | 6.84e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 1.77e-01 | 2.60e-01 | 5.89e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 1.77e-01 | 2.60e-01 | 5.89e-01 |
| GOCC NUCLEAR REPLICATION FORK | 29 | 1.53e-02 | 2.60e-01 | 1.89e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 11 | 1.36e-01 | 2.60e-01 | 5.34e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 15 | 8.16e-02 | -2.60e-01 | 4.34e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 13 | 1.05e-01 | -2.60e-01 | 4.81e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 13 | 1.05e-01 | -2.60e-01 | 4.81e-01 |
| GOCC SUPER ELONGATION COMPLEX | 5 | 3.15e-01 | -2.59e-01 | 7.19e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 8 | 2.04e-01 | -2.59e-01 | 6.17e-01 |
| GOCC BBSOME | 8 | 2.04e-01 | -2.59e-01 | 6.17e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 7 | 2.35e-01 | 2.59e-01 | 6.47e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 8 | 2.04e-01 | -2.59e-01 | 6.17e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 2.71e-01 | 2.59e-01 | 6.85e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 1.06e-01 | 2.59e-01 | 4.81e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 9 | 1.78e-01 | 2.59e-01 | 5.92e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 5 | 3.16e-01 | -2.59e-01 | 7.20e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 2.72e-01 | -2.59e-01 | 6.86e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 14 | 9.35e-02 | 2.59e-01 | 4.58e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 14 | 9.35e-02 | -2.59e-01 | 4.58e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 21 | 4.00e-02 | 2.59e-01 | 3.10e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 18 | 5.76e-02 | 2.59e-01 | 3.76e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 15 | 8.30e-02 | 2.59e-01 | 4.38e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 28 | 1.79e-02 | 2.59e-01 | 2.04e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 18 | 5.78e-02 | 2.58e-01 | 3.76e-01 |
| GOMF AMP BINDING | 13 | 1.07e-01 | -2.58e-01 | 4.84e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 45 | 2.75e-03 | 2.58e-01 | 6.98e-02 |
| GOMF NF KAPPAB BINDING | 28 | 1.81e-02 | 2.58e-01 | 2.05e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 9 | 1.80e-01 | -2.58e-01 | 5.96e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 1.58e-01 | 2.58e-01 | 5.69e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 9 | 1.81e-01 | 2.57e-01 | 5.96e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 23 | 3.27e-02 | 2.57e-01 | 2.84e-01 |
| GOBP CELLULAR RESPIRATION | 207 | 1.89e-10 | 2.57e-01 | 7.53e-08 |
| GOCC RSC TYPE COMPLEX | 14 | 9.59e-02 | 2.57e-01 | 4.61e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 11 | 1.40e-01 | -2.57e-01 | 5.42e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 32 | 1.19e-02 | 2.57e-01 | 1.68e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 5 | 3.20e-01 | -2.57e-01 | 7.23e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 7 | 2.40e-01 | -2.57e-01 | 6.54e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 5 | 3.21e-01 | 2.56e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 14 | 9.67e-02 | 2.56e-01 | 4.62e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 7 | 2.40e-01 | 2.56e-01 | 6.54e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 23 | 3.33e-02 | 2.56e-01 | 2.84e-01 |
| GOCC GOLGI LUMEN | 27 | 2.12e-02 | -2.56e-01 | 2.25e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 13 | 1.10e-01 | 2.56e-01 | 4.89e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 13 | 1.10e-01 | 2.56e-01 | 4.89e-01 |
| GOCC RIBOSOME | 221 | 5.96e-11 | 2.56e-01 | 2.93e-08 |
| GOCC SAGA TYPE COMPLEX | 36 | 7.92e-03 | 2.56e-01 | 1.31e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 7 | 2.41e-01 | -2.56e-01 | 6.56e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 6 | 2.78e-01 | 2.56e-01 | 6.93e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 1.42e-01 | 2.56e-01 | 5.44e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 2.79e-01 | -2.55e-01 | 6.93e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 3.23e-01 | 2.55e-01 | 7.24e-01 |
| GOBP REGULATION OF BONE DEVELOPMENT | 5 | 3.23e-01 | -2.55e-01 | 7.24e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 17 | 6.84e-02 | 2.55e-01 | 4.03e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 14 | 9.83e-02 | 2.55e-01 | 4.66e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 1.43e-01 | 2.55e-01 | 5.45e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 1.75e-02 | 2.55e-01 | 2.01e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 10 | 1.63e-01 | 2.55e-01 | 5.75e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 15 | 8.75e-02 | -2.55e-01 | 4.48e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 2.80e-01 | 2.55e-01 | 6.94e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 3.24e-01 | -2.55e-01 | 7.25e-01 |
| GOBP DOPAMINE SECRETION | 12 | 1.27e-01 | 2.55e-01 | 5.17e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 6 | 2.80e-01 | -2.55e-01 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 9 | 1.86e-01 | -2.54e-01 | 6.00e-01 |
| GOMF CO SMAD BINDING | 6 | 2.81e-01 | 2.54e-01 | 6.96e-01 |
| GOMF MAP KINASE ACTIVITY | 11 | 1.45e-01 | 2.54e-01 | 5.47e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 42 | 4.47e-03 | 2.54e-01 | 9.61e-02 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 1.88e-01 | -2.53e-01 | 6.03e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 13 | 1.14e-01 | -2.53e-01 | 4.96e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 3.27e-01 | 2.53e-01 | 7.28e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 8 | 2.15e-01 | 2.53e-01 | 6.29e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 2.47e-01 | -2.53e-01 | 6.61e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 1.89e-01 | -2.53e-01 | 6.03e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 11 | 1.47e-01 | -2.53e-01 | 5.51e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 7 | 2.47e-01 | -2.53e-01 | 6.61e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 2.47e-01 | 2.52e-01 | 6.61e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 1.90e-01 | -2.52e-01 | 6.03e-01 |
| GOBP RIBOSOME DISASSEMBLY | 13 | 1.15e-01 | 2.52e-01 | 4.97e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 12 | 1.30e-01 | 2.52e-01 | 5.23e-01 |
| GOMF E BOX BINDING | 20 | 5.09e-02 | -2.52e-01 | 3.55e-01 |
| GOCC CORNIFIED ENVELOPE | 12 | 1.31e-01 | 2.52e-01 | 5.24e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 7 | 2.49e-01 | 2.52e-01 | 6.62e-01 |
| GOCC BOX C D RNP COMPLEX | 5 | 3.29e-01 | 2.52e-01 | 7.30e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 9 | 1.91e-01 | 2.52e-01 | 6.04e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 24 | 3.28e-02 | 2.52e-01 | 2.84e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 13 | 1.16e-01 | 2.52e-01 | 4.99e-01 |
| GOCC CALCINEURIN COMPLEX | 5 | 3.30e-01 | 2.52e-01 | 7.31e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 3.30e-01 | 2.52e-01 | 7.31e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 9 | 1.91e-01 | 2.51e-01 | 6.04e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 8 | 2.18e-01 | 2.51e-01 | 6.31e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 26 | 2.66e-02 | 2.51e-01 | 2.54e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 8 | 2.18e-01 | -2.51e-01 | 6.31e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 7 | 2.50e-01 | -2.51e-01 | 6.63e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 9 | 1.92e-01 | 2.51e-01 | 6.04e-01 |
| GOCC ATAC COMPLEX | 13 | 1.17e-01 | 2.51e-01 | 4.99e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 3.31e-01 | 2.51e-01 | 7.31e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 14 | 1.04e-01 | -2.51e-01 | 4.80e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 13 | 1.17e-01 | -2.51e-01 | 4.99e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 2.19e-01 | 2.51e-01 | 6.33e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 15 | 9.26e-02 | -2.51e-01 | 4.56e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 21 | 4.66e-02 | -2.51e-01 | 3.39e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 1.93e-01 | 2.51e-01 | 6.05e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 13 | 1.18e-01 | 2.51e-01 | 5.00e-01 |
| GOMF P53 BINDING | 55 | 1.32e-03 | 2.50e-01 | 4.46e-02 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 2.88e-01 | 2.50e-01 | 7.02e-01 |
| GOCC TRAMP COMPLEX | 5 | 3.32e-01 | -2.50e-01 | 7.33e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 13 | 1.18e-01 | 2.50e-01 | 5.01e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 16 | 8.33e-02 | 2.50e-01 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 3.33e-01 | 2.50e-01 | 7.33e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 7 | 2.53e-01 | 2.50e-01 | 6.66e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 7 | 2.53e-01 | -2.50e-01 | 6.66e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 18 | 6.68e-02 | 2.50e-01 | 3.99e-01 |
| GOCC LAMELLAR BODY | 5 | 3.34e-01 | -2.50e-01 | 7.33e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 2.90e-01 | -2.50e-01 | 7.02e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 8 | 2.22e-01 | 2.49e-01 | 6.35e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 2.91e-01 | 2.49e-01 | 7.02e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 17 | 7.55e-02 | 2.49e-01 | 4.22e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 7.56e-02 | -2.49e-01 | 4.22e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 17 | 7.56e-02 | -2.49e-01 | 4.22e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 36 | 9.82e-03 | 2.49e-01 | 1.49e-01 |
| GOMF TELOMERIC DNA BINDING | 37 | 8.85e-03 | 2.49e-01 | 1.41e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 20 | 5.42e-02 | -2.49e-01 | 3.65e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 8.51e-02 | 2.49e-01 | 4.43e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 8 | 2.24e-01 | 2.48e-01 | 6.36e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 9 | 1.97e-01 | 2.48e-01 | 6.10e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 9 | 1.97e-01 | -2.48e-01 | 6.10e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 18 | 6.83e-02 | 2.48e-01 | 4.03e-01 |
| GOBP POSITIVE T CELL SELECTION | 32 | 1.52e-02 | 2.48e-01 | 1.89e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 2.93e-01 | 2.48e-01 | 7.03e-01 |
| GOCC CHROMATOID BODY | 6 | 2.93e-01 | 2.48e-01 | 7.03e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 20 | 5.50e-02 | -2.48e-01 | 3.68e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 160 | 6.59e-08 | 2.48e-01 | 1.25e-05 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 2.56e-01 | 2.48e-01 | 6.70e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 1.38e-01 | 2.48e-01 | 5.36e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 11 | 1.55e-01 | 2.47e-01 | 5.65e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 41 | 6.18e-03 | 2.47e-01 | 1.15e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 12 | 1.38e-01 | -2.47e-01 | 5.37e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 5 | 3.38e-01 | 2.47e-01 | 7.37e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 98 | 2.41e-05 | 2.47e-01 | 1.83e-03 |
| GOMF CHEMOATTRACTANT ACTIVITY | 10 | 1.76e-01 | 2.47e-01 | 5.89e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 5 | 3.39e-01 | 2.47e-01 | 7.37e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 7 | 2.58e-01 | -2.47e-01 | 6.71e-01 |
| GOCC SYNAPTIC CLEFT | 6 | 2.95e-01 | -2.47e-01 | 7.05e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 8 | 2.27e-01 | -2.47e-01 | 6.39e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 6 | 2.95e-01 | -2.47e-01 | 7.05e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 17 | 7.83e-02 | 2.47e-01 | 4.28e-01 |
| GOCC OUTER DYNEIN ARM | 6 | 2.96e-01 | -2.46e-01 | 7.06e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 3.40e-01 | -2.46e-01 | 7.37e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 1.39e-01 | 2.46e-01 | 5.41e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 21 | 5.07e-02 | -2.46e-01 | 3.55e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 3.40e-01 | -2.46e-01 | 7.37e-01 |
| GOCC MAIN AXON | 35 | 1.17e-02 | -2.46e-01 | 1.67e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 6 | 2.97e-01 | 2.46e-01 | 7.06e-01 |
| GOCC RIBBON SYNAPSE | 9 | 2.01e-01 | -2.46e-01 | 6.14e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 6 | 2.97e-01 | -2.46e-01 | 7.06e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 2.60e-01 | -2.46e-01 | 6.74e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 11 | 1.58e-01 | -2.46e-01 | 5.69e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 23 | 4.14e-02 | 2.46e-01 | 3.15e-01 |
| GOBP POLYAMINE TRANSPORT | 11 | 1.58e-01 | -2.46e-01 | 5.69e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 8 | 2.29e-01 | -2.46e-01 | 6.41e-01 |
| GOBP CDP CHOLINE PATHWAY | 5 | 3.42e-01 | -2.46e-01 | 7.39e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 14 | 1.12e-01 | 2.46e-01 | 4.91e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 27 | 2.73e-02 | -2.46e-01 | 2.57e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 13 | 1.26e-01 | -2.45e-01 | 5.15e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 26 | 3.04e-02 | 2.45e-01 | 2.72e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 2.98e-01 | 2.45e-01 | 7.07e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 5 | 3.43e-01 | 2.45e-01 | 7.39e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 87 | 7.92e-05 | 2.45e-01 | 5.13e-03 |
| GOCC PHAGOLYSOSOME | 5 | 3.43e-01 | 2.45e-01 | 7.39e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 13 | 1.27e-01 | 2.45e-01 | 5.17e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 23 | 4.22e-02 | -2.45e-01 | 3.18e-01 |
| GOCC GBAF COMPLEX | 13 | 1.27e-01 | 2.45e-01 | 5.17e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 26 | 3.09e-02 | -2.45e-01 | 2.74e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 10 | 1.81e-01 | 2.45e-01 | 5.96e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 1.27e-01 | 2.44e-01 | 5.17e-01 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 10 | 1.81e-01 | -2.44e-01 | 5.96e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 8 | 2.32e-01 | 2.44e-01 | 6.43e-01 |
| GOBP RRNA TRANSCRIPTION | 31 | 1.86e-02 | 2.44e-01 | 2.07e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 1.82e-01 | 2.44e-01 | 5.97e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 3.14e-02 | 2.44e-01 | 2.77e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 8 | 2.33e-01 | 2.44e-01 | 6.44e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 12 | 1.44e-01 | 2.44e-01 | 5.47e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 11 | 1.62e-01 | -2.44e-01 | 5.74e-01 |
| GOBP CONVERGENT EXTENSION | 10 | 1.82e-01 | -2.44e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 16 | 9.17e-02 | 2.44e-01 | 4.56e-01 |
| GOBP DNA REPLICATION INITIATION | 29 | 2.33e-02 | 2.43e-01 | 2.36e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 142 | 5.65e-07 | 2.43e-01 | 7.62e-05 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 40 | 7.78e-03 | 2.43e-01 | 1.30e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 9 | 2.06e-01 | -2.43e-01 | 6.20e-01 |
| GOBP MIDBODY ABSCISSION | 14 | 1.15e-01 | 2.43e-01 | 4.97e-01 |
| GOMF PROTEIN KINASE A BINDING | 37 | 1.05e-02 | 2.43e-01 | 1.57e-01 |
| GOBP COBALT ION TRANSPORT | 5 | 3.47e-01 | -2.43e-01 | 7.43e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 2.66e-01 | 2.43e-01 | 6.80e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 18 | 7.47e-02 | 2.43e-01 | 4.20e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 7 | 2.66e-01 | 2.43e-01 | 6.81e-01 |
| GOMF SUMO BINDING | 16 | 9.31e-02 | 2.43e-01 | 4.57e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 2.08e-01 | 2.42e-01 | 6.22e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 7 | 2.67e-01 | 2.42e-01 | 6.82e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 3.04e-01 | 2.42e-01 | 7.11e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 33 | 1.61e-02 | 2.42e-01 | 1.92e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 5 | 3.48e-01 | 2.42e-01 | 7.44e-01 |
| GOCC MCM COMPLEX | 8 | 2.36e-01 | 2.42e-01 | 6.48e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 16 | 9.37e-02 | 2.42e-01 | 4.58e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 87 | 9.65e-05 | 2.42e-01 | 5.93e-03 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 3.49e-01 | 2.42e-01 | 7.44e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 3.05e-01 | 2.42e-01 | 7.12e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 26 | 3.28e-02 | 2.42e-01 | 2.84e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 42 | 6.72e-03 | 2.42e-01 | 1.19e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 5 | 3.49e-01 | 2.42e-01 | 7.44e-01 |
| GOBP FIBRINOLYSIS | 6 | 3.05e-01 | 2.42e-01 | 7.12e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 6 | 3.06e-01 | 2.41e-01 | 7.12e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 1.66e-01 | 2.41e-01 | 5.77e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 15 | 1.06e-01 | -2.41e-01 | 4.81e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 9 | 2.10e-01 | 2.41e-01 | 6.24e-01 |
| GOMF ISOPRENOID BINDING | 11 | 1.66e-01 | -2.41e-01 | 5.77e-01 |
| GOBP REGULATION OF DNA METHYLATION | 14 | 1.19e-01 | 2.41e-01 | 5.02e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 7 | 2.70e-01 | -2.41e-01 | 6.84e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 12 | 1.49e-01 | 2.41e-01 | 5.55e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 3.07e-01 | 2.41e-01 | 7.13e-01 |
| GOBP DEPYRIMIDINATION | 8 | 2.38e-01 | -2.41e-01 | 6.52e-01 |
| GOCC STEREOCILIUM TIP | 8 | 2.38e-01 | -2.41e-01 | 6.52e-01 |
| GOBP AGGREPHAGY | 8 | 2.38e-01 | 2.41e-01 | 6.52e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 32 | 1.85e-02 | 2.41e-01 | 2.07e-01 |
| GOMF GPI ANCHOR BINDING | 5 | 3.52e-01 | 2.40e-01 | 7.47e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 26 | 3.39e-02 | 2.40e-01 | 2.86e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 3.52e-01 | 2.40e-01 | 7.47e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 11 | 1.68e-01 | 2.40e-01 | 5.77e-01 |
| GOCC NUCLEOSOME | 33 | 1.70e-02 | 2.40e-01 | 2.00e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 9 | 2.12e-01 | 2.40e-01 | 6.26e-01 |
| GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 5 | 3.53e-01 | -2.40e-01 | 7.47e-01 |
| GOCC METHYLOSOME | 12 | 1.50e-01 | 2.40e-01 | 5.58e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 3.09e-01 | 2.40e-01 | 7.14e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 5 | 3.53e-01 | -2.40e-01 | 7.47e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 14 | 1.21e-01 | -2.40e-01 | 5.07e-01 |
| GOBP RNA CAPPING | 34 | 1.57e-02 | 2.40e-01 | 1.91e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 6 | 3.10e-01 | -2.40e-01 | 7.15e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 2.14e-01 | 2.39e-01 | 6.28e-01 |
| GOCC BRAHMA COMPLEX | 13 | 1.35e-01 | 2.39e-01 | 5.32e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 3.54e-01 | 2.39e-01 | 7.48e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 12 | 1.51e-01 | -2.39e-01 | 5.60e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 21 | 5.81e-02 | 2.39e-01 | 3.76e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 7 | 2.74e-01 | -2.39e-01 | 6.88e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 11 | 1.70e-01 | 2.39e-01 | 5.82e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 8 | 2.42e-01 | 2.39e-01 | 6.57e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 6.47e-02 | 2.39e-01 | 3.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 2.15e-01 | 2.39e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 13 | 1.37e-01 | -2.38e-01 | 5.35e-01 |
| GOBP MAST CELL CHEMOTAXIS | 6 | 3.12e-01 | -2.38e-01 | 7.16e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 8 | 2.43e-01 | -2.38e-01 | 6.58e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 7 | 2.75e-01 | 2.38e-01 | 6.90e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 15 | 1.10e-01 | -2.38e-01 | 4.90e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 3.57e-01 | -2.38e-01 | 7.50e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 5 | 3.57e-01 | 2.38e-01 | 7.50e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 7 | 2.76e-01 | -2.38e-01 | 6.90e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 15 | 1.11e-01 | 2.38e-01 | 4.90e-01 |
| GOBP ERBB2 ERBB4 SIGNALING PATHWAY | 5 | 3.57e-01 | 2.38e-01 | 7.50e-01 |
| GOBP REGULATION OF RNA BINDING | 8 | 2.44e-01 | 2.38e-01 | 6.59e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 3.58e-01 | -2.38e-01 | 7.50e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 3.16e-07 | 2.38e-01 | 4.90e-05 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 46 | 5.36e-03 | 2.37e-01 | 1.08e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 2.02e-02 | 2.37e-01 | 2.18e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 1.95e-01 | -2.37e-01 | 6.08e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 8 | 2.46e-01 | -2.37e-01 | 6.61e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 2.78e-01 | 2.37e-01 | 6.93e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 39 | 1.06e-02 | 2.37e-01 | 1.57e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 23 | 4.95e-02 | 2.37e-01 | 3.51e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 20 | 6.73e-02 | -2.36e-01 | 4.01e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 9 | 2.20e-01 | -2.36e-01 | 6.33e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 7 | 2.79e-01 | -2.36e-01 | 6.94e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 2.48e-01 | 2.36e-01 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 14 | 1.26e-01 | -2.36e-01 | 5.17e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 11 | 1.76e-01 | -2.36e-01 | 5.89e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 38 | 1.20e-02 | 2.36e-01 | 1.68e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 3.62e-01 | -2.36e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 3.62e-01 | -2.36e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 10 | 1.97e-01 | 2.36e-01 | 6.10e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 8 | 2.49e-01 | 2.36e-01 | 6.62e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 3.62e-01 | -2.36e-01 | 7.52e-01 |
| GOBP PLATELET MORPHOGENESIS | 20 | 6.84e-02 | 2.35e-01 | 4.03e-01 |
| GOBP DNA DEALKYLATION | 32 | 2.14e-02 | 2.35e-01 | 2.26e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 40 | 1.01e-02 | 2.35e-01 | 1.52e-01 |
| GOBP MONOCYTE EXTRAVASATION | 8 | 2.50e-01 | -2.35e-01 | 6.63e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 83 | 2.19e-04 | 2.35e-01 | 1.20e-02 |
| GOBP AORTIC VALVE MORPHOGENESIS | 13 | 1.43e-01 | 2.35e-01 | 5.45e-01 |
| GOBP TONGUE MORPHOGENESIS | 5 | 3.64e-01 | -2.35e-01 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 9 | 2.23e-01 | -2.35e-01 | 6.36e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 6 | 3.20e-01 | 2.34e-01 | 7.23e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 10 | 1.99e-01 | 2.34e-01 | 6.11e-01 |
| GOMF SNORNA BINDING | 32 | 2.18e-02 | 2.34e-01 | 2.29e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 18 | 8.53e-02 | 2.34e-01 | 4.43e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 5 | 3.64e-01 | -2.34e-01 | 7.54e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 11 | 1.79e-01 | 2.34e-01 | 5.92e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 7.73e-02 | 2.34e-01 | 4.26e-01 |
| GOBP DOPAMINE TRANSPORT | 17 | 9.47e-02 | 2.34e-01 | 4.60e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 26 | 3.89e-02 | -2.34e-01 | 3.05e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 12 | 1.60e-01 | 2.34e-01 | 5.73e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 2.00e-01 | -2.34e-01 | 6.12e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 17 | 9.51e-02 | -2.34e-01 | 4.60e-01 |
| GOBP ACTIN NUCLEATION | 46 | 6.09e-03 | 2.34e-01 | 1.15e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 2.25e-01 | 2.34e-01 | 6.38e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 1.17e-01 | 2.34e-01 | 4.99e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 2.25e-01 | 2.34e-01 | 6.38e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 6 | 3.22e-01 | 2.34e-01 | 7.24e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 37 | 1.40e-02 | 2.34e-01 | 1.81e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 6 | 3.22e-01 | 2.33e-01 | 7.24e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 16 | 1.06e-01 | 2.33e-01 | 4.82e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 6 | 3.23e-01 | 2.33e-01 | 7.24e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 60 | 1.85e-03 | 2.33e-01 | 5.54e-02 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 2.87e-01 | 2.33e-01 | 7.01e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 10 | 2.03e-01 | -2.32e-01 | 6.16e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 7 | 2.87e-01 | -2.32e-01 | 7.01e-01 |
| GOBP SHORT TERM MEMORY | 5 | 3.69e-01 | -2.32e-01 | 7.58e-01 |
| GOBP COLLATERAL SPROUTING | 13 | 1.47e-01 | -2.32e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 24 | 4.91e-02 | 2.32e-01 | 3.50e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 5.99e-02 | 2.32e-01 | 3.83e-01 |
| GOBP RESPONSE TO PROGESTERONE | 27 | 3.71e-02 | -2.32e-01 | 2.98e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 7 | 2.88e-01 | -2.32e-01 | 7.02e-01 |
| GOMF PHOSPHOLIPASE BINDING | 16 | 1.09e-01 | -2.32e-01 | 4.87e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 8 | 2.57e-01 | 2.32e-01 | 6.70e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 20 | 7.33e-02 | 2.31e-01 | 4.18e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 6 | 3.26e-01 | 2.31e-01 | 7.27e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 37 | 1.49e-02 | 2.31e-01 | 1.87e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 5 | 3.70e-01 | 2.31e-01 | 7.59e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 6 | 3.27e-01 | -2.31e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 7 | 2.90e-01 | 2.31e-01 | 7.02e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 48 | 5.64e-03 | 2.31e-01 | 1.11e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 64 | 1.40e-03 | 2.31e-01 | 4.61e-02 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 1.38e-02 | 2.31e-01 | 1.80e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 7 | 2.91e-01 | -2.31e-01 | 7.02e-01 |
| GOBP BLOOD VESSEL MATURATION | 5 | 3.72e-01 | 2.31e-01 | 7.60e-01 |
| GOBP MALE SEX DETERMINATION | 5 | 3.72e-01 | 2.31e-01 | 7.60e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 5 | 3.72e-01 | -2.31e-01 | 7.60e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 9 | 2.31e-01 | -2.30e-01 | 6.43e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 86 | 2.24e-04 | 2.30e-01 | 1.20e-02 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 16 | 1.11e-01 | 2.30e-01 | 4.90e-01 |
| GOBP DENDRITIC TRANSPORT | 10 | 2.08e-01 | 2.30e-01 | 6.22e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 66 | 1.23e-03 | 2.30e-01 | 4.35e-02 |
| GOCC CHROMAFFIN GRANULE | 8 | 2.60e-01 | 2.30e-01 | 6.74e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 11 | 1.87e-01 | 2.30e-01 | 6.01e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 26 | 4.25e-02 | 2.30e-01 | 3.19e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 19 | 8.29e-02 | -2.30e-01 | 4.38e-01 |
| GOBP DETECTION OF CELL DENSITY | 6 | 3.30e-01 | 2.30e-01 | 7.31e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 1.37e-01 | 2.30e-01 | 5.35e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 19 | 8.31e-02 | 2.30e-01 | 4.38e-01 |
| GOBP REPLACEMENT OSSIFICATION | 12 | 1.69e-01 | -2.30e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 9 | 2.33e-01 | 2.29e-01 | 6.45e-01 |
| GOBP RRNA METHYLATION | 22 | 6.27e-02 | 2.29e-01 | 3.89e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 7 | 2.94e-01 | 2.29e-01 | 7.04e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 5 | 3.75e-01 | -2.29e-01 | 7.63e-01 |
| GOBP L ALANINE TRANSPORT | 7 | 2.94e-01 | 2.29e-01 | 7.04e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 16 | 1.13e-01 | 2.29e-01 | 4.93e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 9 | 2.34e-01 | -2.29e-01 | 6.46e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 11 | 1.89e-01 | 2.29e-01 | 6.03e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 11 | 1.89e-01 | -2.29e-01 | 6.03e-01 |
| GOMF C X C CHEMOKINE RECEPTOR ACTIVITY | 7 | 2.95e-01 | 2.29e-01 | 7.04e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 11 | 1.89e-01 | 2.29e-01 | 6.03e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 11 | 1.89e-01 | -2.29e-01 | 6.03e-01 |
| GOCC SPINDLE MIDZONE | 27 | 4.01e-02 | -2.28e-01 | 3.10e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 3.34e-02 | 2.28e-01 | 2.84e-01 |
| GOCC SET1C COMPASS COMPLEX | 13 | 1.54e-01 | 2.28e-01 | 5.64e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 16 | 1.14e-01 | 2.28e-01 | 4.96e-01 |
| GOBP ADENOSINE TO INOSINE EDITING | 5 | 3.77e-01 | 2.28e-01 | 7.65e-01 |
| GOCC SCAR COMPLEX | 10 | 2.12e-01 | 2.28e-01 | 6.26e-01 |
| GOBP CELL AGGREGATION | 7 | 2.96e-01 | -2.28e-01 | 7.06e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 12 | 1.72e-01 | 2.28e-01 | 5.83e-01 |
| GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS | 5 | 3.78e-01 | -2.28e-01 | 7.65e-01 |
| GOBP N ACYLETHANOLAMINE METABOLIC PROCESS | 5 | 3.78e-01 | -2.28e-01 | 7.65e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 3.34e-01 | 2.28e-01 | 7.33e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 3.34e-01 | -2.28e-01 | 7.33e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 19 | 8.59e-02 | 2.28e-01 | 4.44e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 23 | 5.89e-02 | 2.28e-01 | 3.79e-01 |
| GOBP RNA 5 END PROCESSING | 20 | 7.84e-02 | 2.27e-01 | 4.28e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 17 | 1.05e-01 | 2.27e-01 | 4.81e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 5 | 3.79e-01 | 2.27e-01 | 7.67e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 11 | 1.92e-01 | 2.27e-01 | 6.04e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 3.35e-01 | 2.27e-01 | 7.34e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 73 | 8.06e-04 | 2.27e-01 | 3.29e-02 |
| GOCC RNA CAP BINDING COMPLEX | 19 | 8.68e-02 | 2.27e-01 | 4.45e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 9.57e-02 | 2.27e-01 | 4.61e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 6 | 3.36e-01 | -2.27e-01 | 7.34e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 18 | 9.58e-02 | -2.27e-01 | 4.61e-01 |
| GOCC CHECKPOINT CLAMP COMPLEX | 5 | 3.80e-01 | -2.27e-01 | 7.67e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 2.99e-01 | 2.27e-01 | 7.08e-01 |
| GOCC ATPASE COMPLEX | 134 | 6.11e-06 | 2.27e-01 | 5.94e-04 |
| GOBP REGULATION OF PROTON TRANSPORT | 13 | 1.57e-01 | 2.26e-01 | 5.68e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 11 | 1.94e-01 | 2.26e-01 | 6.06e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 24 | 5.49e-02 | 2.26e-01 | 3.68e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 10 | 2.15e-01 | -2.26e-01 | 6.29e-01 |
| GOBP PEROXISOMAL TRANSPORT | 22 | 6.62e-02 | 2.26e-01 | 3.99e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 22 | 6.63e-02 | 2.26e-01 | 3.99e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 51 | 5.23e-03 | 2.26e-01 | 1.07e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 8 | 2.69e-01 | 2.26e-01 | 6.82e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 6 | 3.38e-01 | -2.26e-01 | 7.36e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 66 | 1.52e-03 | 2.26e-01 | 4.85e-02 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 12 | 1.76e-01 | -2.26e-01 | 5.89e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 32 | 2.72e-02 | 2.26e-01 | 2.57e-01 |
| GOBP TOOTH MINERALIZATION | 12 | 1.76e-01 | 2.26e-01 | 5.89e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 3.39e-01 | 2.26e-01 | 7.37e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 19 | 8.90e-02 | 2.25e-01 | 4.52e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 2.42e-01 | 2.25e-01 | 6.56e-01 |
| GOBP VIRAL GENOME REPLICATION | 108 | 5.27e-05 | 2.25e-01 | 3.73e-03 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 2.70e-01 | -2.25e-01 | 6.84e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 11 | 1.96e-01 | -2.25e-01 | 6.09e-01 |
| GOMF DENEDDYLASE ACTIVITY | 5 | 3.83e-01 | 2.25e-01 | 7.69e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 3.83e-01 | 2.25e-01 | 7.69e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 25 | 5.13e-02 | 2.25e-01 | 3.56e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 2.70e-01 | 2.25e-01 | 6.85e-01 |
| GOBP SEROTONIN SECRETION | 5 | 3.84e-01 | -2.25e-01 | 7.69e-01 |
| GOCC SIN3 TYPE COMPLEX | 22 | 6.79e-02 | 2.25e-01 | 4.02e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 3.03e-01 | -2.25e-01 | 7.10e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 8 | 2.71e-01 | 2.25e-01 | 6.85e-01 |
| GOMF ADP BINDING | 30 | 3.32e-02 | 2.25e-01 | 2.84e-01 |
| GOMF GAMMA CATENIN BINDING | 6 | 3.41e-01 | 2.25e-01 | 7.38e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 24 | 5.71e-02 | 2.24e-01 | 3.74e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 31 | 3.06e-02 | 2.24e-01 | 2.73e-01 |
| GOBP DECIDUALIZATION | 13 | 1.61e-01 | 2.24e-01 | 5.74e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 41 | 1.30e-02 | 2.24e-01 | 1.75e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 26 | 4.78e-02 | -2.24e-01 | 3.44e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 29 | 3.68e-02 | 2.24e-01 | 2.97e-01 |
| GOBP GOLGI RIBBON FORMATION | 9 | 2.45e-01 | 2.24e-01 | 6.59e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 6 | 3.43e-01 | -2.24e-01 | 7.39e-01 |
| GOMF ATPASE INHIBITOR ACTIVITY | 5 | 3.86e-01 | 2.24e-01 | 7.70e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 13 | 1.63e-01 | -2.24e-01 | 5.75e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 3.43e-01 | -2.24e-01 | 7.39e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 19 | 9.15e-02 | 2.24e-01 | 4.56e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 73 | 9.60e-04 | 2.24e-01 | 3.73e-02 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 38 | 1.72e-02 | 2.24e-01 | 2.00e-01 |
| GOBP ECTODERM DEVELOPMENT | 13 | 1.63e-01 | -2.23e-01 | 5.75e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 3.87e-01 | 2.23e-01 | 7.70e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 6 | 3.44e-01 | 2.23e-01 | 7.39e-01 |
| GOBP RESPONSE TO PAIN | 15 | 1.34e-01 | -2.23e-01 | 5.31e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 3.06e-01 | -2.23e-01 | 7.13e-01 |
| GOMF PEPTIDE HORMONE BINDING | 14 | 1.48e-01 | -2.23e-01 | 5.54e-01 |
| GOCC ENDOSOME LUMEN | 22 | 7.06e-02 | 2.23e-01 | 4.10e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 24 | 5.91e-02 | 2.23e-01 | 3.79e-01 |
| GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 3.89e-01 | -2.23e-01 | 7.71e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 18 | 1.02e-01 | 2.22e-01 | 4.77e-01 |
| GOMF NUCLEOSOME BINDING | 52 | 5.54e-03 | 2.22e-01 | 1.11e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 3.45e-01 | 2.22e-01 | 7.41e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 13 | 1.65e-01 | 2.22e-01 | 5.77e-01 |
| GOCC HOST CELLULAR COMPONENT | 7 | 3.09e-01 | 2.22e-01 | 7.14e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 12 | 1.83e-01 | 2.22e-01 | 5.97e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 6 | 3.46e-01 | 2.22e-01 | 7.42e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 24 | 5.98e-02 | -2.22e-01 | 3.82e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 8 | 2.77e-01 | 2.22e-01 | 6.91e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 3.09e-01 | 2.22e-01 | 7.15e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 11 | 2.02e-01 | -2.22e-01 | 6.15e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 58 | 3.49e-03 | 2.22e-01 | 8.17e-02 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.25e-01 | -2.22e-01 | 6.38e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 13 | 1.66e-01 | 2.22e-01 | 5.77e-01 |
| GOBP MATURATION OF LSU RRNA | 28 | 4.24e-02 | 2.22e-01 | 3.19e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 12 | 1.84e-01 | -2.22e-01 | 5.98e-01 |
| GOBP CHORION DEVELOPMENT | 5 | 3.91e-01 | 2.22e-01 | 7.73e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 3.91e-01 | 2.22e-01 | 7.73e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.78e-01 | 2.21e-01 | 6.93e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 32 | 3.03e-02 | 2.21e-01 | 2.72e-01 |
| GOCC ACROSOMAL MEMBRANE | 11 | 2.04e-01 | 2.21e-01 | 6.17e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 13 | 1.67e-01 | 2.21e-01 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 11 | 2.04e-01 | -2.21e-01 | 6.17e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 10 | 2.26e-01 | 2.21e-01 | 6.39e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 14 | 1.52e-01 | -2.21e-01 | 5.61e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 26 | 5.12e-02 | -2.21e-01 | 3.56e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 2.18e-02 | 2.21e-01 | 2.29e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 7 | 3.12e-01 | 2.21e-01 | 7.15e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 3.49e-01 | -2.21e-01 | 7.44e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 6 | 3.49e-01 | 2.21e-01 | 7.44e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 125 | 2.09e-05 | 2.21e-01 | 1.63e-03 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 39 | 1.72e-02 | 2.21e-01 | 2.00e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 10 | 2.28e-01 | 2.20e-01 | 6.40e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 8 | 2.82e-01 | 2.20e-01 | 6.97e-01 |
| GOBP MAST CELL MIGRATION | 8 | 2.82e-01 | -2.20e-01 | 6.97e-01 |
| GOMF 7S RNA BINDING | 7 | 3.14e-01 | 2.20e-01 | 7.18e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 11 | 2.07e-01 | -2.20e-01 | 6.21e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 17 | 1.17e-01 | -2.20e-01 | 4.99e-01 |
| GOBP TRNA 5 END PROCESSING | 14 | 1.55e-01 | 2.20e-01 | 5.65e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 21 | 8.14e-02 | 2.20e-01 | 4.34e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 3.14e-01 | 2.20e-01 | 7.18e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 5 | 3.95e-01 | -2.20e-01 | 7.75e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 16 | 1.29e-01 | 2.19e-01 | 5.20e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 6 | 3.52e-01 | 2.19e-01 | 7.47e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 17 | 1.18e-01 | 2.19e-01 | 5.00e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 2.55e-01 | 2.19e-01 | 6.69e-01 |
| GOCC KATANIN COMPLEX | 5 | 3.97e-01 | 2.19e-01 | 7.76e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 5 | 3.97e-01 | 2.19e-01 | 7.76e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 8 | 2.84e-01 | 2.19e-01 | 6.99e-01 |
| GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING | 5 | 3.97e-01 | 2.19e-01 | 7.77e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 20 | 9.08e-02 | -2.18e-01 | 4.54e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 5 | 3.98e-01 | -2.18e-01 | 7.77e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 5 | 3.98e-01 | 2.18e-01 | 7.77e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 8 | 2.85e-01 | 2.18e-01 | 7.00e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 10 | 2.32e-01 | 2.18e-01 | 6.44e-01 |
| GOCC LEWY BODY | 7 | 3.18e-01 | -2.18e-01 | 7.21e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 10 | 2.32e-01 | 2.18e-01 | 6.44e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 6 | 3.55e-01 | -2.18e-01 | 7.49e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 3.99e-01 | 2.18e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 3.56e-01 | 2.18e-01 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 1.92e-01 | -2.18e-01 | 6.04e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 15 | 1.45e-01 | -2.17e-01 | 5.47e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 13 | 1.75e-01 | 2.17e-01 | 5.89e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 2.88e-01 | -2.17e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 4.01e-01 | 2.17e-01 | 7.80e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MATURATION | 5 | 4.01e-01 | 2.17e-01 | 7.80e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 6 | 3.58e-01 | 2.17e-01 | 7.50e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 7 | 3.21e-01 | -2.17e-01 | 7.24e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 13 | 1.76e-01 | -2.17e-01 | 5.89e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 8 | 2.89e-01 | 2.17e-01 | 7.02e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 8 | 2.89e-01 | 2.17e-01 | 7.02e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 14 | 1.61e-01 | 2.17e-01 | 5.73e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 9 | 2.61e-01 | -2.17e-01 | 6.74e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 12 | 1.94e-01 | 2.16e-01 | 6.07e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 6 | 3.59e-01 | -2.16e-01 | 7.51e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 7 | 3.22e-01 | 2.16e-01 | 7.24e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 2.90e-01 | -2.16e-01 | 7.02e-01 |
| GOCC COSTAMERE | 10 | 2.37e-01 | -2.16e-01 | 6.49e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 2.90e-01 | 2.16e-01 | 7.02e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 17 | 1.23e-01 | 2.16e-01 | 5.13e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 3.60e-01 | -2.16e-01 | 7.51e-01 |
| GOBP LATE NUCLEOPHAGY | 7 | 3.23e-01 | -2.16e-01 | 7.24e-01 |
| GOMF LAMIN BINDING | 14 | 1.62e-01 | 2.16e-01 | 5.74e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 12 | 1.96e-01 | -2.16e-01 | 6.09e-01 |
| GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 5 | 4.03e-01 | 2.16e-01 | 7.80e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 9 | 2.62e-01 | -2.16e-01 | 6.77e-01 |
| GOBP CATECHOLAMINE SECRETION | 17 | 1.24e-01 | 2.16e-01 | 5.14e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 13 | 1.78e-01 | 2.16e-01 | 5.92e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 4.04e-01 | 2.16e-01 | 7.80e-01 |
| GOCC COMPLEX OF COLLAGEN TRIMERS | 5 | 4.04e-01 | -2.15e-01 | 7.80e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 5 | 4.04e-01 | 2.15e-01 | 7.80e-01 |
| GOMF FLIPPASE ACTIVITY | 12 | 1.97e-01 | 2.15e-01 | 6.09e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 2.63e-01 | -2.15e-01 | 6.77e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 11 | 2.16e-01 | 2.15e-01 | 6.31e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 9 | 2.64e-01 | -2.15e-01 | 6.78e-01 |
| GOMF LIM DOMAIN BINDING | 5 | 4.05e-01 | -2.15e-01 | 7.80e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 3.62e-01 | -2.15e-01 | 7.52e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 7 | 3.24e-01 | 2.15e-01 | 7.25e-01 |
| GOMF CYCLASE ACTIVITY | 10 | 2.39e-01 | -2.15e-01 | 6.53e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 12 | 1.97e-01 | 2.15e-01 | 6.10e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 7 | 3.25e-01 | -2.15e-01 | 7.25e-01 |
| GOBP RETINOL METABOLIC PROCESS | 21 | 8.82e-02 | -2.15e-01 | 4.49e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 38 | 2.19e-02 | 2.15e-01 | 2.29e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 2.17e-01 | 2.15e-01 | 6.31e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 6 | 3.62e-01 | 2.15e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 10 | 2.40e-01 | 2.15e-01 | 6.54e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 7 | 3.25e-01 | 2.15e-01 | 7.26e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 85 | 6.36e-04 | 2.14e-01 | 2.71e-02 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 12 | 1.99e-01 | 2.14e-01 | 6.11e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 12 | 1.99e-01 | -2.14e-01 | 6.11e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 42 | 1.64e-02 | 2.14e-01 | 1.95e-01 |
| GOMF POLY G BINDING | 8 | 2.94e-01 | 2.14e-01 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 43 | 1.52e-02 | 2.14e-01 | 1.89e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 11 | 2.19e-01 | -2.14e-01 | 6.33e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 54 | 6.56e-03 | 2.14e-01 | 1.18e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 2.00e-01 | -2.14e-01 | 6.11e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 1.66e-01 | 2.14e-01 | 5.77e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 7 | 3.27e-01 | -2.14e-01 | 7.28e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 44 | 1.42e-02 | 2.14e-01 | 1.82e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 9.58e-05 | 2.14e-01 | 5.93e-03 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 1.40e-01 | 2.13e-01 | 5.41e-01 |
| GOBP SULFATION | 9 | 2.68e-01 | -2.13e-01 | 6.82e-01 |
| GOBP PRESYNAPTIC MEMBRANE ORGANIZATION | 5 | 4.09e-01 | -2.13e-01 | 7.82e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 6 | 3.66e-01 | -2.13e-01 | 7.55e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 6 | 3.66e-01 | -2.13e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 9 | 2.68e-01 | 2.13e-01 | 6.82e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 38 | 2.30e-02 | 2.13e-01 | 2.35e-01 |
| GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 5 | 4.09e-01 | -2.13e-01 | 7.83e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 11 | 2.21e-01 | 2.13e-01 | 6.35e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 48 | 1.07e-02 | 2.13e-01 | 1.58e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 30 | 4.36e-02 | -2.13e-01 | 3.25e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 17 | 1.29e-01 | -2.13e-01 | 5.20e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 10 | 2.44e-01 | -2.13e-01 | 6.59e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 5 | 4.10e-01 | -2.13e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 11 | 2.22e-01 | -2.13e-01 | 6.35e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 13 | 1.84e-01 | 2.13e-01 | 5.98e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 12 | 2.02e-01 | -2.13e-01 | 6.15e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 12 | 2.02e-01 | -2.13e-01 | 6.15e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.67e-01 | -2.13e-01 | 7.56e-01 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 2.98e-01 | -2.13e-01 | 7.07e-01 |
| GOMF VINCULIN BINDING | 10 | 2.44e-01 | -2.13e-01 | 6.59e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 9 | 2.70e-01 | 2.13e-01 | 6.84e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 22 | 8.45e-02 | 2.13e-01 | 4.42e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 8 | 2.98e-01 | 2.13e-01 | 7.07e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 11 | 2.22e-01 | 2.12e-01 | 6.35e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 1.69e-01 | 2.12e-01 | 5.80e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 4.44e-02 | 2.12e-01 | 3.29e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 22 | 8.53e-02 | 2.12e-01 | 4.43e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 9 | 2.71e-01 | -2.12e-01 | 6.85e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 17 | 1.30e-01 | 2.12e-01 | 5.23e-01 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 5 | 4.12e-01 | 2.12e-01 | 7.84e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 6 | 3.69e-01 | -2.12e-01 | 7.58e-01 |
| GOBP SNRNA MODIFICATION | 7 | 3.32e-01 | 2.12e-01 | 7.33e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 11 | 2.24e-01 | 2.12e-01 | 6.38e-01 |
| GOBP STEROID CATABOLIC PROCESS | 7 | 3.33e-01 | 2.11e-01 | 7.33e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 35 | 3.06e-02 | 2.11e-01 | 2.73e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 10 | 2.47e-01 | 2.11e-01 | 6.61e-01 |
| GOCC NUCLEAR PERIPHERY | 129 | 3.51e-05 | 2.11e-01 | 2.59e-03 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 5 | 4.13e-01 | -2.11e-01 | 7.85e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 52 | 8.46e-03 | 2.11e-01 | 1.37e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 20 | 1.02e-01 | 2.11e-01 | 4.77e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 12 | 2.05e-01 | -2.11e-01 | 6.19e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 19 | 1.11e-01 | 2.11e-01 | 4.90e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 13 | 1.88e-01 | 2.11e-01 | 6.03e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 11 | 2.26e-01 | -2.11e-01 | 6.39e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 2.67e-02 | 2.11e-01 | 2.54e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 9 | 2.74e-01 | -2.11e-01 | 6.88e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 20 | 1.03e-01 | 2.10e-01 | 4.79e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 2.07e-01 | 2.10e-01 | 6.21e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 4.15e-01 | -2.10e-01 | 7.86e-01 |
| GOBP REGULATION OF DNA REPLICATION | 102 | 2.45e-04 | 2.10e-01 | 1.27e-02 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 19 | 1.13e-01 | -2.10e-01 | 4.93e-01 |
| GOBP RRNA BASE METHYLATION | 8 | 3.03e-01 | 2.10e-01 | 7.10e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 4.16e-01 | 2.10e-01 | 7.86e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 2.50e-01 | 2.10e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 6 | 3.73e-01 | -2.10e-01 | 7.61e-01 |
| GOCC NBAF COMPLEX | 14 | 1.74e-01 | 2.10e-01 | 5.87e-01 |
| GOMF RRNA BINDING | 62 | 4.27e-03 | 2.10e-01 | 9.40e-02 |
| GOBP MRNA 3 END PROCESSING | 48 | 1.19e-02 | 2.10e-01 | 1.68e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 7 | 3.36e-01 | 2.10e-01 | 7.34e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 24 | 7.53e-02 | 2.10e-01 | 4.22e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 23 | 8.16e-02 | 2.10e-01 | 4.34e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 12 | 2.09e-01 | 2.10e-01 | 6.22e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 9 | 2.76e-01 | 2.10e-01 | 6.91e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 5 | 4.17e-01 | 2.10e-01 | 7.88e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 15 | 1.60e-01 | -2.09e-01 | 5.72e-01 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 10 | 2.51e-01 | 2.09e-01 | 6.65e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 12 | 2.09e-01 | -2.09e-01 | 6.23e-01 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 4.18e-01 | -2.09e-01 | 7.88e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 11 | 2.30e-01 | 2.09e-01 | 6.42e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.38e-01 | 2.09e-01 | 7.36e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 11 | 2.30e-01 | -2.09e-01 | 6.42e-01 |
| GOMF DYNEIN COMPLEX BINDING | 20 | 1.06e-01 | 2.09e-01 | 4.81e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 24 | 7.65e-02 | 2.09e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 6 | 3.75e-01 | 2.09e-01 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 5 | 4.19e-01 | 2.09e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 3.76e-01 | 2.09e-01 | 7.65e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 24 | 7.71e-02 | 2.09e-01 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 6 | 3.77e-01 | -2.09e-01 | 7.65e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 7 | 3.40e-01 | 2.08e-01 | 7.37e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 3.07e-01 | 2.08e-01 | 7.13e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 3.40e-01 | 2.08e-01 | 7.37e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 29 | 5.22e-02 | 2.08e-01 | 3.60e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 7 | 3.40e-01 | -2.08e-01 | 7.37e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 11 | 2.32e-01 | 2.08e-01 | 6.44e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 43 | 1.83e-02 | 2.08e-01 | 2.06e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 20 | 1.08e-01 | 2.08e-01 | 4.85e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 23 | 8.44e-02 | 2.08e-01 | 4.42e-01 |
| GOMF LAMININ BINDING | 10 | 2.55e-01 | 2.08e-01 | 6.69e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 14 | 1.79e-01 | 2.08e-01 | 5.92e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 3.10e-01 | -2.07e-01 | 7.15e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 5 | 4.22e-01 | -2.07e-01 | 7.90e-01 |
| GOBP RIBOSOME BIOGENESIS | 308 | 4.30e-10 | 2.07e-01 | 1.56e-07 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 7 | 3.42e-01 | 2.07e-01 | 7.39e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 4.22e-01 | -2.07e-01 | 7.90e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 4.95e-02 | 2.07e-01 | 3.51e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 34 | 3.67e-02 | 2.07e-01 | 2.96e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 74 | 2.09e-03 | 2.07e-01 | 5.97e-02 |
| GOMF MUTSALPHA COMPLEX BINDING | 6 | 3.80e-01 | 2.07e-01 | 7.67e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 12 | 2.15e-01 | 2.07e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 2.15e-01 | 2.07e-01 | 6.29e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 3.43e-01 | 2.07e-01 | 7.39e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 6 | 3.80e-01 | -2.07e-01 | 7.67e-01 |
| GOBP MATURATION OF SSU RRNA | 49 | 1.23e-02 | 2.07e-01 | 1.70e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 40 | 2.37e-02 | 2.07e-01 | 2.38e-01 |
| GOCC COMPACT MYELIN | 7 | 3.43e-01 | 2.07e-01 | 7.39e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 13 | 1.97e-01 | -2.07e-01 | 6.10e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 8 | 3.11e-01 | 2.07e-01 | 7.15e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 5 | 4.23e-01 | -2.07e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 2.83e-01 | -2.07e-01 | 6.98e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 4.25e-01 | 2.06e-01 | 7.91e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 50 | 1.17e-02 | 2.06e-01 | 1.67e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 8.74e-02 | 2.06e-01 | 4.47e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 9.47e-02 | 2.06e-01 | 4.60e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 474 | 2.11e-14 | 2.06e-01 | 1.96e-11 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 8 | 3.13e-01 | -2.06e-01 | 7.17e-01 |
| GOCC POLE PLASM | 14 | 1.83e-01 | -2.06e-01 | 5.97e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 50 | 1.19e-02 | 2.06e-01 | 1.68e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 3.83e-01 | 2.06e-01 | 7.69e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 14 | 1.83e-01 | 2.06e-01 | 5.97e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 23 | 8.81e-02 | 2.06e-01 | 4.49e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 2.38e-01 | -2.05e-01 | 6.52e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 13 | 2.00e-01 | -2.05e-01 | 6.11e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 4.26e-01 | 2.05e-01 | 7.92e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 3.14e-01 | 2.05e-01 | 7.18e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 15 | 1.68e-01 | -2.05e-01 | 5.80e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 18 | 1.31e-01 | 2.05e-01 | 5.25e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 6 | 3.84e-01 | -2.05e-01 | 7.69e-01 |
| GOCC NURD COMPLEX | 15 | 1.69e-01 | 2.05e-01 | 5.80e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 6 | 3.84e-01 | 2.05e-01 | 7.69e-01 |
| GOCC PRESPLICEOSOME | 16 | 1.55e-01 | 2.05e-01 | 5.65e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 16 | 1.55e-01 | 2.05e-01 | 5.65e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 127 | 6.68e-05 | 2.05e-01 | 4.51e-03 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 14 | 1.84e-01 | 2.05e-01 | 5.98e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 2.87e-01 | -2.05e-01 | 7.01e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 446 | 1.49e-13 | 2.05e-01 | 1.25e-10 |
| GOBP LIPID IMPORT INTO CELL | 16 | 1.56e-01 | -2.05e-01 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 28 | 6.06e-02 | 2.05e-01 | 3.85e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 16 | 1.56e-01 | 2.05e-01 | 5.65e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 4.28e-01 | 2.05e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 3.48e-01 | 2.05e-01 | 7.44e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 7 | 3.48e-01 | -2.05e-01 | 7.44e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 5 | 4.28e-01 | 2.05e-01 | 7.93e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 7 | 3.49e-01 | 2.05e-01 | 7.44e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 3.86e-01 | 2.05e-01 | 7.70e-01 |
| GOBP HEART FORMATION | 13 | 2.02e-01 | -2.05e-01 | 6.15e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 30 | 5.27e-02 | 2.04e-01 | 3.61e-01 |
| GOMF GABA RECEPTOR BINDING | 12 | 2.20e-01 | 2.04e-01 | 6.33e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 21 | 1.05e-01 | -2.04e-01 | 4.81e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 17 | 1.45e-01 | 2.04e-01 | 5.47e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 14 | 1.86e-01 | -2.04e-01 | 6.00e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 32 | 4.59e-02 | -2.04e-01 | 3.35e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 7 | 3.50e-01 | -2.04e-01 | 7.45e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 9 | 2.90e-01 | -2.04e-01 | 7.02e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 9 | 2.90e-01 | 2.04e-01 | 7.02e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 12 | 2.22e-01 | 2.04e-01 | 6.35e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 79 | 1.77e-03 | 2.04e-01 | 5.41e-02 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 16 | 1.59e-01 | 2.04e-01 | 5.69e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 5 | 4.31e-01 | 2.03e-01 | 7.95e-01 |
| GOMF U1 SNRNA BINDING | 8 | 3.19e-01 | 2.03e-01 | 7.23e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 3.19e-01 | 2.03e-01 | 7.23e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 8 | 3.20e-01 | -2.03e-01 | 7.23e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 9 | 2.92e-01 | 2.03e-01 | 7.02e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 62 | 5.74e-03 | 2.03e-01 | 1.12e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 9 | 2.92e-01 | 2.03e-01 | 7.03e-01 |
| GOBP SEROTONIN TRANSPORT | 10 | 2.67e-01 | -2.03e-01 | 6.81e-01 |
| GOCC BLOC COMPLEX | 14 | 1.89e-01 | 2.03e-01 | 6.03e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 3.90e-01 | -2.03e-01 | 7.72e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 9 | 2.92e-01 | -2.03e-01 | 7.03e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 23 | 9.27e-02 | 2.03e-01 | 4.56e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 9 | 2.93e-01 | 2.02e-01 | 7.04e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 17 | 1.49e-01 | 2.02e-01 | 5.55e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 36 | 3.59e-02 | 2.02e-01 | 2.94e-01 |
| GOBP NUCLEOBASE TRANSPORT | 7 | 3.55e-01 | 2.02e-01 | 7.48e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 12 | 2.26e-01 | 2.02e-01 | 6.39e-01 |
| GOCC WNT SIGNALOSOME | 7 | 3.55e-01 | -2.02e-01 | 7.49e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 28 | 6.48e-02 | 2.02e-01 | 3.95e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 11 | 2.47e-01 | 2.02e-01 | 6.61e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 5 | 4.35e-01 | -2.02e-01 | 7.98e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 14 | 1.92e-01 | 2.02e-01 | 6.04e-01 |
| GOBP PYROPTOSIS | 29 | 6.04e-02 | 2.02e-01 | 3.85e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 69 | 3.86e-03 | -2.01e-01 | 8.81e-02 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 3.94e-01 | 2.01e-01 | 7.74e-01 |
| GOBP RESPONSE TO PH | 16 | 1.64e-01 | -2.01e-01 | 5.75e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 13 | 2.10e-01 | -2.01e-01 | 6.23e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 6 | 3.94e-01 | 2.01e-01 | 7.74e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 23 | 9.55e-02 | 2.01e-01 | 4.61e-01 |
| GOMF SUMO LIGASE ACTIVITY | 12 | 2.28e-01 | 2.01e-01 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 2.97e-01 | 2.01e-01 | 7.07e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 27 | 7.13e-02 | 2.01e-01 | 4.13e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 13 | 2.11e-01 | 2.01e-01 | 6.24e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 60 | 7.31e-03 | 2.00e-01 | 1.25e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 22 | 1.04e-01 | 2.00e-01 | 4.80e-01 |
| GOBP CAMP METABOLIC PROCESS | 12 | 2.30e-01 | -2.00e-01 | 6.42e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 3.59e-01 | 2.00e-01 | 7.51e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 64 | 5.68e-03 | 2.00e-01 | 1.12e-01 |
| GOCC CILIARY MEMBRANE | 39 | 3.07e-02 | -2.00e-01 | 2.73e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 11 | 2.51e-01 | -2.00e-01 | 6.65e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 1.28e-02 | 2.00e-01 | 1.73e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 14 | 1.96e-01 | 2.00e-01 | 6.09e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 261 | 3.05e-08 | 2.00e-01 | 6.55e-06 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 12 | 2.32e-01 | 1.99e-01 | 6.44e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 32 | 5.11e-02 | 1.99e-01 | 3.55e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 5 | 4.41e-01 | 1.99e-01 | 8.00e-01 |
| GOCC DENDRITE CYTOPLASM | 21 | 1.14e-01 | 1.99e-01 | 4.96e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 13 | 2.14e-01 | 1.99e-01 | 6.29e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 5 | 4.41e-01 | -1.99e-01 | 8.00e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 12 | 2.33e-01 | -1.99e-01 | 6.44e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 37 | 3.63e-02 | 1.99e-01 | 2.95e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 1.98e-01 | 1.99e-01 | 6.10e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 23 | 9.88e-02 | 1.99e-01 | 4.68e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 16 | 1.68e-01 | 1.99e-01 | 5.80e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 2.14e-01 | 1.99e-01 | 6.29e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 9 | 3.02e-01 | -1.99e-01 | 7.09e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 862 | 8.82e-23 | -1.99e-01 | 3.69e-19 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 3.62e-01 | 1.99e-01 | 7.53e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 1.56e-01 | 1.99e-01 | 5.65e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 66 | 5.27e-03 | 1.99e-01 | 1.07e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 24 | 9.21e-02 | -1.99e-01 | 4.56e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 6 | 4.00e-01 | -1.99e-01 | 7.79e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 10 | 2.77e-01 | -1.99e-01 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 12 | 2.34e-01 | -1.98e-01 | 6.46e-01 |
| GOCC AP 2 ADAPTOR COMPLEX | 7 | 3.63e-01 | 1.98e-01 | 7.54e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 5 | 4.43e-01 | 1.98e-01 | 8.01e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 30 | 6.03e-02 | 1.98e-01 | 3.84e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 6 | 4.01e-01 | -1.98e-01 | 7.80e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 7 | 3.64e-01 | 1.98e-01 | 7.54e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 4.01e-01 | 1.98e-01 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 10 | 2.78e-01 | -1.98e-01 | 6.93e-01 |
| GOBP RRNA METABOLIC PROCESS | 243 | 1.16e-07 | 1.98e-01 | 2.03e-05 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 28 | 7.01e-02 | -1.98e-01 | 4.09e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 10 | 2.79e-01 | 1.98e-01 | 6.94e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 9 | 3.05e-01 | -1.98e-01 | 7.12e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 4.02e-01 | -1.97e-01 | 7.80e-01 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 5 | 4.45e-01 | 1.97e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 5 | 4.45e-01 | -1.97e-01 | 8.02e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 13 | 2.18e-01 | 1.97e-01 | 6.31e-01 |
| GOBP RESPONSE TO FATTY ACID | 29 | 6.64e-02 | -1.97e-01 | 3.99e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 27 | 7.65e-02 | 1.97e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 10 | 2.81e-01 | -1.97e-01 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 6 | 4.04e-01 | 1.97e-01 | 7.80e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 14 | 2.03e-01 | 1.97e-01 | 6.15e-01 |
| GOCC POLYSOME | 61 | 7.92e-03 | 1.97e-01 | 1.31e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 6 | 4.04e-01 | -1.97e-01 | 7.80e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 22 | 1.11e-01 | 1.97e-01 | 4.90e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 14 | 2.03e-01 | 1.97e-01 | 6.16e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 6 | 4.05e-01 | -1.96e-01 | 7.80e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 9 | 3.08e-01 | -1.96e-01 | 7.13e-01 |
| GOMF BUBBLE DNA BINDING | 6 | 4.05e-01 | -1.96e-01 | 7.80e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 7 | 3.68e-01 | 1.96e-01 | 7.58e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 22 | 1.11e-01 | 1.96e-01 | 4.90e-01 |
| GOMF 7SK SNRNA BINDING | 8 | 3.36e-01 | -1.96e-01 | 7.34e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 23 | 1.03e-01 | 1.96e-01 | 4.79e-01 |
| GOCC FLEMMING BODY | 27 | 7.78e-02 | 1.96e-01 | 4.27e-01 |
| GOCC COPI VESICLE COAT | 13 | 2.21e-01 | 1.96e-01 | 6.34e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 15 | 1.89e-01 | -1.96e-01 | 6.03e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 8 | 3.37e-01 | 1.96e-01 | 7.36e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 15 | 1.89e-01 | -1.96e-01 | 6.03e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 33 | 5.15e-02 | 1.96e-01 | 3.57e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 3.70e-01 | -1.96e-01 | 7.58e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 16 | 1.75e-01 | -1.96e-01 | 5.89e-01 |
| GOBP FIBROBLAST PROLIFERATION | 68 | 5.30e-03 | 1.96e-01 | 1.07e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 15 | 1.90e-01 | 1.96e-01 | 6.03e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 28 | 7.33e-02 | 1.96e-01 | 4.18e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 15 | 1.90e-01 | 1.96e-01 | 6.03e-01 |
| GOBP R LOOP PROCESSING | 6 | 4.07e-01 | 1.96e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 23 | 1.05e-01 | 1.95e-01 | 4.81e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 9 | 3.10e-01 | 1.95e-01 | 7.15e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 1.90e-01 | 1.95e-01 | 6.04e-01 |
| GOMF BETA TUBULIN BINDING | 32 | 5.60e-02 | 1.95e-01 | 3.71e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 38 | 3.74e-02 | -1.95e-01 | 2.99e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 38 | 3.74e-02 | 1.95e-01 | 2.99e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 25 | 9.13e-02 | 1.95e-01 | 4.55e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 7 | 3.71e-01 | -1.95e-01 | 7.60e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 4.08e-01 | -1.95e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 34 | 4.93e-02 | 1.95e-01 | 3.50e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 5 | 4.51e-01 | 1.95e-01 | 8.04e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 12 | 2.43e-01 | 1.95e-01 | 6.58e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 29 | 6.96e-02 | 1.95e-01 | 4.07e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 1.42e-01 | 1.95e-01 | 5.43e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 2.87e-01 | 1.95e-01 | 7.01e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 82 | 2.33e-03 | 1.95e-01 | 6.39e-02 |
| GOCC SARCOPLASMIC RETICULUM | 42 | 2.92e-02 | 1.95e-01 | 2.67e-01 |
| GOBP CYTOPLASM ORGANIZATION | 9 | 3.12e-01 | 1.95e-01 | 7.16e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 7 | 3.73e-01 | -1.95e-01 | 7.61e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 3.41e-01 | 1.95e-01 | 7.38e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 40 | 3.34e-02 | 1.94e-01 | 2.84e-01 |
| GOBP OOCYTE MATURATION | 15 | 1.92e-01 | 1.94e-01 | 6.04e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 7 | 3.73e-01 | 1.94e-01 | 7.61e-01 |
| GOBP SLEEP | 11 | 2.64e-01 | -1.94e-01 | 6.78e-01 |
| GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.52e-01 | 1.94e-01 | 8.06e-01 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 5 | 4.52e-01 | 1.94e-01 | 8.06e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 673 | 1.44e-17 | 1.94e-01 | 3.02e-14 |
| GOBP EXIT FROM MITOSIS | 26 | 8.67e-02 | -1.94e-01 | 4.45e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 2.88e-01 | 1.94e-01 | 7.02e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 22 | 1.15e-01 | -1.94e-01 | 4.97e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 13 | 2.26e-01 | 1.94e-01 | 6.39e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 6 | 4.11e-01 | -1.94e-01 | 7.83e-01 |
| GOMF HSP70 PROTEIN BINDING | 41 | 3.19e-02 | 1.94e-01 | 2.79e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 8 | 3.43e-01 | -1.94e-01 | 7.39e-01 |
| GOBP NEURON MATURATION | 21 | 1.25e-01 | -1.94e-01 | 5.15e-01 |
| GOBP CATECHOLAMINE UPTAKE | 6 | 4.11e-01 | 1.94e-01 | 7.83e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 38 | 3.91e-02 | 1.94e-01 | 3.06e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 28 | 7.66e-02 | -1.93e-01 | 4.24e-01 |
| GOBP MELANOSOME ASSEMBLY | 18 | 1.56e-01 | 1.93e-01 | 5.65e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 10 | 2.90e-01 | 1.93e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 2.91e-01 | 1.93e-01 | 7.02e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 9 | 3.16e-01 | -1.93e-01 | 7.20e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 7 | 3.77e-01 | -1.93e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 20 | 1.36e-01 | 1.93e-01 | 5.34e-01 |
| GOBP OSTEOCLAST FUSION | 5 | 4.56e-01 | -1.92e-01 | 8.08e-01 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 3.46e-01 | -1.92e-01 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 4.56e-01 | -1.92e-01 | 8.08e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.56e-01 | -1.92e-01 | 8.08e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 6 | 4.15e-01 | -1.92e-01 | 7.86e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 23 | 1.11e-01 | -1.92e-01 | 4.90e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 23 | 1.12e-01 | -1.92e-01 | 4.91e-01 |
| GOBP GROOMING BEHAVIOR | 6 | 4.16e-01 | -1.92e-01 | 7.87e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.71e-01 | 1.92e-01 | 6.85e-01 |
| GOCC POLYSOMAL RIBOSOME | 29 | 7.43e-02 | 1.92e-01 | 4.20e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 3.80e-01 | 1.92e-01 | 7.67e-01 |
| GOBP MICROTUBULE SEVERING | 7 | 3.80e-01 | 1.92e-01 | 7.67e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 15 | 1.99e-01 | -1.91e-01 | 6.11e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 10 | 2.95e-01 | -1.91e-01 | 7.04e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 10 | 2.95e-01 | 1.91e-01 | 7.04e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 8 | 3.49e-01 | 1.91e-01 | 7.44e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 7 | 3.81e-01 | 1.91e-01 | 7.68e-01 |
| GOCC SWR1 COMPLEX | 13 | 2.33e-01 | 1.91e-01 | 6.44e-01 |
| GOBP CELLULAR RESPONSE TO UV | 68 | 6.43e-03 | 1.91e-01 | 1.17e-01 |
| GOCC AXON CYTOPLASM | 49 | 2.07e-02 | 1.91e-01 | 2.21e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 34 | 5.39e-02 | 1.91e-01 | 3.64e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 57 | 1.27e-02 | 1.91e-01 | 1.72e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 3.50e-01 | 1.91e-01 | 7.44e-01 |
| GOCC CONDENSIN COMPLEX | 8 | 3.50e-01 | 1.91e-01 | 7.44e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 24 | 1.06e-01 | 1.91e-01 | 4.81e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 23 | 1.13e-01 | 1.91e-01 | 4.94e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 6 | 4.18e-01 | 1.91e-01 | 7.88e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 19 | 1.50e-01 | 1.91e-01 | 5.58e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 3.22e-01 | 1.91e-01 | 7.24e-01 |
| GOBP HYPERSENSITIVITY | 10 | 2.97e-01 | 1.91e-01 | 7.06e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 48 | 2.24e-02 | 1.91e-01 | 2.31e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 7 | 3.83e-01 | 1.90e-01 | 7.69e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 23 | 1.14e-01 | -1.90e-01 | 4.96e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 2.54e-01 | 1.90e-01 | 6.67e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 69 | 6.29e-03 | 1.90e-01 | 1.16e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 10 | 2.98e-01 | -1.90e-01 | 7.07e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 4.61e-01 | 1.90e-01 | 8.12e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 5 | 4.61e-01 | 1.90e-01 | 8.12e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 9 | 3.23e-01 | -1.90e-01 | 7.25e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 5 | 4.62e-01 | 1.90e-01 | 8.12e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 12 | 2.54e-01 | 1.90e-01 | 6.68e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 5 | 4.62e-01 | -1.90e-01 | 8.12e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 2.75e-01 | 1.90e-01 | 6.89e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 2.55e-01 | 1.90e-01 | 6.69e-01 |
| GOBP TOLL SIGNALING PATHWAY | 8 | 3.53e-01 | -1.90e-01 | 7.47e-01 |
| GOCC U5 SNRNP | 19 | 1.52e-01 | 1.90e-01 | 5.61e-01 |
| GOMF ACTIN MONOMER BINDING | 20 | 1.42e-01 | 1.90e-01 | 5.43e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 8 | 3.53e-01 | -1.90e-01 | 7.47e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 16 | 1.89e-01 | -1.90e-01 | 6.03e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 18 | 1.64e-01 | 1.90e-01 | 5.75e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 6 | 4.21e-01 | 1.90e-01 | 7.90e-01 |
| GOBP RETICULOPHAGY | 16 | 1.89e-01 | -1.90e-01 | 6.03e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 39 | 4.06e-02 | 1.90e-01 | 3.13e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 21 | 1.33e-01 | 1.89e-01 | 5.28e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 7 | 3.85e-01 | 1.89e-01 | 7.70e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 9 | 3.25e-01 | -1.89e-01 | 7.26e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 4.64e-01 | -1.89e-01 | 8.12e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 15 | 2.04e-01 | -1.89e-01 | 6.18e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 8 | 3.54e-01 | 1.89e-01 | 7.48e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 8 | 3.54e-01 | -1.89e-01 | 7.48e-01 |
| GOCC KINESIN COMPLEX | 32 | 6.43e-02 | 1.89e-01 | 3.94e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 4.23e-01 | -1.89e-01 | 7.91e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 48 | 2.36e-02 | 1.89e-01 | 2.38e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 18 | 1.65e-01 | 1.89e-01 | 5.77e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 2.21e-01 | 1.89e-01 | 6.35e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 5.00e-02 | 1.89e-01 | 3.51e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 28 | 8.39e-02 | 1.89e-01 | 4.40e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 6 | 4.23e-01 | 1.89e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 41 | 3.67e-02 | 1.89e-01 | 2.96e-01 |
| GOCC FILAMENTOUS ACTIN | 16 | 1.91e-01 | 1.89e-01 | 6.04e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 29 | 7.88e-02 | -1.89e-01 | 4.30e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 7 | 3.88e-01 | -1.89e-01 | 7.70e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 6.11e-02 | 1.88e-01 | 3.86e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 8 | 3.56e-01 | 1.88e-01 | 7.49e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 14 | 2.22e-01 | 1.88e-01 | 6.35e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 15 | 2.07e-01 | -1.88e-01 | 6.20e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 21 | 1.35e-01 | 1.88e-01 | 5.32e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 15 | 2.07e-01 | 1.88e-01 | 6.21e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 17 | 1.79e-01 | 1.88e-01 | 5.93e-01 |
| GOBP PRE MIRNA PROCESSING | 15 | 2.07e-01 | 1.88e-01 | 6.21e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 1.46e-01 | 1.88e-01 | 5.48e-01 |
| GOBP HISTONE MODIFICATION | 108 | 7.51e-04 | 1.88e-01 | 3.11e-02 |
| GOMF KINASE INHIBITOR ACTIVITY | 61 | 1.12e-02 | 1.88e-01 | 1.63e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 11 | 2.81e-01 | 1.88e-01 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 7 | 3.89e-01 | 1.88e-01 | 7.72e-01 |
| GOBP PLATELET DEGRANULATION | 7 | 3.89e-01 | -1.88e-01 | 7.72e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 6.61e-03 | 1.88e-01 | 1.18e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 6.60e-02 | 1.88e-01 | 3.99e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 3.04e-01 | 1.88e-01 | 7.11e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 28 | 8.55e-02 | 1.88e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 149 | 7.84e-05 | 1.88e-01 | 5.12e-03 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 5 | 4.68e-01 | -1.88e-01 | 8.14e-01 |
| GOMF HISTONE KINASE ACTIVITY | 15 | 2.09e-01 | 1.88e-01 | 6.22e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 3.59e-01 | -1.87e-01 | 7.51e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 9 | 3.30e-01 | -1.87e-01 | 7.31e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 33 | 6.28e-02 | 1.87e-01 | 3.89e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 4.27e-01 | -1.87e-01 | 7.93e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 1.82e-01 | 1.87e-01 | 5.97e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 5 | 4.69e-01 | 1.87e-01 | 8.15e-01 |
| GOBP GLUTAMINE TRANSPORT | 8 | 3.60e-01 | -1.87e-01 | 7.51e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.60e-01 | -1.87e-01 | 7.51e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 1.58e-01 | 1.87e-01 | 5.69e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 12 | 2.62e-01 | -1.87e-01 | 6.77e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 2.43e-01 | 1.87e-01 | 6.58e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 98 | 1.41e-03 | 1.87e-01 | 4.61e-02 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 12 | 2.63e-01 | -1.87e-01 | 6.77e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 9 | 3.32e-01 | -1.87e-01 | 7.33e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 37 | 4.98e-02 | 1.86e-01 | 3.51e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 53 | 1.89e-02 | 1.86e-01 | 2.09e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 55 | 1.69e-02 | -1.86e-01 | 1.98e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 17 | 1.84e-01 | 1.86e-01 | 5.98e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 12 | 2.64e-01 | 1.86e-01 | 6.78e-01 |
| GOCC CILIARY TRANSITION FIBER | 7 | 3.94e-01 | 1.86e-01 | 7.74e-01 |
| GOMF FMN BINDING | 9 | 3.33e-01 | 1.86e-01 | 7.33e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 194 | 8.18e-06 | 1.86e-01 | 7.69e-04 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 16 | 1.98e-01 | 1.86e-01 | 6.10e-01 |
| GOBP RESPONSE TO VITAMIN | 39 | 4.46e-02 | -1.86e-01 | 3.30e-01 |
| GOMF DNA TRANSLOCASE ACTIVITY | 5 | 4.72e-01 | -1.86e-01 | 8.16e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 23 | 1.23e-01 | -1.86e-01 | 5.13e-01 |
| GOCC MKS COMPLEX | 12 | 2.65e-01 | -1.86e-01 | 6.79e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 24 | 1.15e-01 | -1.86e-01 | 4.97e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 10 | 3.09e-01 | 1.86e-01 | 7.15e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 12 | 2.65e-01 | -1.86e-01 | 6.79e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 3.35e-01 | 1.86e-01 | 7.34e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 3.35e-01 | 1.86e-01 | 7.34e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 3.10e-01 | 1.86e-01 | 7.15e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 9 | 3.35e-01 | 1.86e-01 | 7.34e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 10 | 3.10e-01 | -1.85e-01 | 7.15e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 4.32e-01 | -1.85e-01 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 17 | 1.86e-01 | -1.85e-01 | 6.00e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 5.87e-03 | 1.85e-01 | 1.13e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 24 | 1.16e-01 | -1.85e-01 | 4.99e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 16 | 2.00e-01 | 1.85e-01 | 6.11e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 2.10e-02 | 1.85e-01 | 2.23e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 4.74e-01 | 1.85e-01 | 8.17e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 20 | 1.52e-01 | 1.85e-01 | 5.61e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 12 | 2.67e-01 | 1.85e-01 | 6.82e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 3.97e-01 | -1.85e-01 | 7.76e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 4.74e-01 | 1.85e-01 | 8.17e-01 |
| GOBP DETECTION OF BACTERIUM | 11 | 2.88e-01 | 1.85e-01 | 7.02e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 4.74e-01 | 1.85e-01 | 8.17e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 3.97e-01 | 1.85e-01 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 6 | 4.33e-01 | 1.85e-01 | 7.98e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 132 | 2.52e-04 | -1.85e-01 | 1.30e-02 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 6 | 4.34e-01 | -1.85e-01 | 7.98e-01 |
| GOBP CHOLESTEROL EFFLUX | 33 | 6.65e-02 | -1.85e-01 | 3.99e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 46 | 3.04e-02 | 1.85e-01 | 2.72e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 13 | 2.49e-01 | 1.85e-01 | 6.63e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 676 | 4.61e-16 | 1.84e-01 | 7.72e-13 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 33 | 6.68e-02 | 1.84e-01 | 3.99e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 3.98e-01 | -1.84e-01 | 7.77e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 11 | 2.90e-01 | 1.84e-01 | 7.02e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 18 | 1.76e-01 | 1.84e-01 | 5.89e-01 |
| GOBP HAIR FOLLICLE MATURATION | 9 | 3.39e-01 | 1.84e-01 | 7.37e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 21 | 1.44e-01 | 1.84e-01 | 5.47e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 59 | 1.45e-02 | 1.84e-01 | 1.84e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 4.76e-01 | 1.84e-01 | 8.17e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 18 | 1.77e-01 | 1.84e-01 | 5.89e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 6 | 4.36e-01 | 1.84e-01 | 7.98e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 3.68e-01 | -1.84e-01 | 7.58e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 19 | 1.65e-01 | 1.84e-01 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 71 | 7.47e-03 | 1.84e-01 | 1.26e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 6 | 4.36e-01 | -1.84e-01 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 28 | 9.29e-02 | -1.83e-01 | 4.56e-01 |
| GOBP CARDIAC CONDUCTION | 38 | 5.05e-02 | 1.83e-01 | 3.54e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 5 | 4.78e-01 | 1.83e-01 | 8.18e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 2.92e-01 | 1.83e-01 | 7.03e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 33 | 6.84e-02 | 1.83e-01 | 4.03e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 55 | 1.87e-02 | 1.83e-01 | 2.08e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 4.37e-01 | -1.83e-01 | 7.98e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 8 | 3.69e-01 | 1.83e-01 | 7.58e-01 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 5 | 4.78e-01 | -1.83e-01 | 8.18e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 13 | 2.53e-01 | 1.83e-01 | 6.66e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 58 | 1.59e-02 | 1.83e-01 | 1.91e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 89 | 2.84e-03 | 1.83e-01 | 7.15e-02 |
| GOBP REGULATION OF HISTONE MODIFICATION | 35 | 6.09e-02 | 1.83e-01 | 3.85e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 22 | 1.37e-01 | 1.83e-01 | 5.35e-01 |
| GOMF FATTY ACID BINDING | 23 | 1.29e-01 | -1.83e-01 | 5.20e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 192 | 1.27e-05 | 1.83e-01 | 1.15e-03 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 4.02e-01 | 1.83e-01 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 8 | 3.70e-01 | -1.83e-01 | 7.59e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 4.38e-01 | 1.83e-01 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 6 | 4.38e-01 | -1.83e-01 | 7.98e-01 |
| GOCC CIA COMPLEX | 5 | 4.79e-01 | 1.83e-01 | 8.18e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 15 | 2.20e-01 | -1.83e-01 | 6.33e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 16 | 2.05e-01 | 1.83e-01 | 6.19e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 31 | 7.82e-02 | 1.83e-01 | 4.28e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 2.36e-01 | 1.83e-01 | 6.49e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 2.37e-01 | 1.83e-01 | 6.50e-01 |
| GOBP T CELL SELECTION | 41 | 4.35e-02 | 1.82e-01 | 3.24e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 8 | 3.72e-01 | 1.82e-01 | 7.60e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 21 | 1.48e-01 | 1.82e-01 | 5.54e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 11 | 2.95e-01 | -1.82e-01 | 7.05e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 6 | 4.40e-01 | 1.82e-01 | 8.00e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 6 | 4.40e-01 | 1.82e-01 | 8.00e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 8 | 3.73e-01 | 1.82e-01 | 7.61e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 9 | 3.45e-01 | 1.82e-01 | 7.40e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 70 | 8.53e-03 | 1.82e-01 | 1.37e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 47 | 3.12e-02 | 1.82e-01 | 2.75e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 4.82e-01 | -1.82e-01 | 8.20e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 4.82e-01 | 1.82e-01 | 8.20e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 27 | 1.02e-01 | 1.82e-01 | 4.77e-01 |
| GOBP ANIMAL ORGAN FORMATION | 24 | 1.24e-01 | -1.82e-01 | 5.14e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 37 | 5.62e-02 | 1.81e-01 | 3.71e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 27 | 1.03e-01 | 1.81e-01 | 4.78e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 10 | 3.21e-01 | 1.81e-01 | 7.24e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 23 | 1.32e-01 | 1.81e-01 | 5.27e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 63 | 1.29e-02 | 1.81e-01 | 1.74e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 4.06e-01 | 1.81e-01 | 7.81e-01 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 4.83e-01 | 1.81e-01 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 19 | 1.72e-01 | -1.81e-01 | 5.83e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 38 | 5.38e-02 | 1.81e-01 | 3.64e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 15 | 2.25e-01 | -1.81e-01 | 6.39e-01 |
| GOCC SITE OF DNA DAMAGE | 104 | 1.47e-03 | 1.81e-01 | 4.76e-02 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 3.00e-01 | 1.81e-01 | 7.09e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 8 | 3.77e-01 | 1.81e-01 | 7.65e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 69 | 9.58e-03 | 1.80e-01 | 1.47e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 4.08e-01 | 1.80e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 1.26e-01 | 1.80e-01 | 5.16e-01 |
| GOBP RRNA TRANSPORT | 5 | 4.85e-01 | 1.80e-01 | 8.22e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 3.24e-01 | 1.80e-01 | 7.25e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 19 | 1.74e-01 | -1.80e-01 | 5.88e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 10 | 3.24e-01 | -1.80e-01 | 7.25e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 6 | 4.45e-01 | -1.80e-01 | 8.02e-01 |
| GOBP LIPID DIGESTION | 6 | 4.45e-01 | -1.80e-01 | 8.02e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 19 | 1.75e-01 | 1.80e-01 | 5.88e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 32 | 7.85e-02 | -1.80e-01 | 4.28e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 22 | 1.45e-01 | 1.80e-01 | 5.47e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 3.25e-01 | 1.80e-01 | 7.26e-01 |
| GOMF FILAMIN BINDING | 7 | 4.11e-01 | -1.80e-01 | 7.83e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 15 | 2.29e-01 | -1.80e-01 | 6.41e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 22 | 1.46e-01 | -1.79e-01 | 5.48e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 6 | 4.47e-01 | 1.79e-01 | 8.04e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 25 | 1.21e-01 | 1.79e-01 | 5.09e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 2.30e-01 | 1.79e-01 | 6.42e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 9 | 3.53e-01 | 1.79e-01 | 7.47e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 12 | 2.83e-01 | 1.79e-01 | 6.98e-01 |
| GOBP CELLULAR PIGMENTATION | 51 | 2.72e-02 | 1.79e-01 | 2.57e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 27 | 1.08e-01 | 1.79e-01 | 4.85e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 3.05e-01 | 1.79e-01 | 7.12e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 7 | 4.14e-01 | 1.78e-01 | 7.85e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.14e-01 | 1.78e-01 | 7.85e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 7 | 4.14e-01 | 1.78e-01 | 7.86e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 48 | 3.28e-02 | 1.78e-01 | 2.84e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 5 | 4.90e-01 | 1.78e-01 | 8.26e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 19 | 1.79e-01 | -1.78e-01 | 5.93e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 28 | 1.03e-01 | 1.78e-01 | 4.78e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 3.83e-01 | -1.78e-01 | 7.69e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 15 | 2.33e-01 | -1.78e-01 | 6.44e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 11 | 3.07e-01 | -1.78e-01 | 7.13e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 4.91e-01 | -1.78e-01 | 8.27e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 16 | 2.18e-01 | -1.78e-01 | 6.31e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 11 | 3.07e-01 | -1.78e-01 | 7.13e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 4.51e-01 | 1.78e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 6 | 4.51e-01 | 1.78e-01 | 8.04e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 4.51e-01 | 1.78e-01 | 8.04e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 88 | 3.99e-03 | 1.78e-01 | 8.98e-02 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 24 | 1.32e-01 | -1.78e-01 | 5.26e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 4.51e-01 | 1.78e-01 | 8.04e-01 |
| GOBP MICROTUBULE ANCHORING | 21 | 1.59e-01 | 1.78e-01 | 5.70e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 51 | 2.83e-02 | 1.78e-01 | 2.62e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 11 | 3.08e-01 | 1.77e-01 | 7.14e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 23 | 1.41e-01 | -1.77e-01 | 5.43e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 3.57e-01 | 1.77e-01 | 7.50e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 11 | 3.09e-01 | 1.77e-01 | 7.14e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 4.92e-01 | 1.77e-01 | 8.27e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 24 | 1.33e-01 | 1.77e-01 | 5.29e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 13 | 2.69e-01 | -1.77e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 6 | 4.53e-01 | 1.77e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 20 | 1.71e-01 | 1.77e-01 | 5.82e-01 |
| GOBP PIGMENT ACCUMULATION | 10 | 3.32e-01 | 1.77e-01 | 7.33e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 3.32e-01 | 1.77e-01 | 7.33e-01 |
| GOMF RNA POLYMERASE BINDING | 56 | 2.21e-02 | 1.77e-01 | 2.29e-01 |
| GOBP NEPHRON MORPHOGENESIS | 29 | 9.93e-02 | -1.77e-01 | 4.69e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 28 | 1.05e-01 | 1.77e-01 | 4.81e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 64 | 1.45e-02 | 1.77e-01 | 1.84e-01 |
| GOBP ALANINE TRANSPORT | 11 | 3.10e-01 | 1.77e-01 | 7.15e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 1.94e-01 | 1.77e-01 | 6.07e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 4.18e-01 | -1.77e-01 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 40 | 5.31e-02 | 1.77e-01 | 3.63e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 3.59e-01 | -1.77e-01 | 7.51e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 8 | 3.87e-01 | -1.77e-01 | 7.70e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 4.54e-01 | 1.77e-01 | 8.06e-01 |
| GOBP SPINDLE ELONGATION | 8 | 3.87e-01 | -1.77e-01 | 7.70e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 6 | 4.54e-01 | -1.77e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 4.94e-01 | 1.77e-01 | 8.28e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 9 | 3.59e-01 | -1.76e-01 | 7.51e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 30 | 9.46e-02 | -1.76e-01 | 4.60e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 4.54e-01 | 1.76e-01 | 8.06e-01 |
| GOMF WNT PROTEIN BINDING | 9 | 3.60e-01 | 1.76e-01 | 7.52e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 12 | 2.91e-01 | 1.76e-01 | 7.02e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 15 | 2.38e-01 | 1.76e-01 | 6.52e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 33 | 8.03e-02 | -1.76e-01 | 4.32e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 12 | 2.91e-01 | -1.76e-01 | 7.02e-01 |
| GOCC SAGA COMPLEX | 23 | 1.44e-01 | 1.76e-01 | 5.47e-01 |
| GOCC PRERIBOSOME | 103 | 2.08e-03 | 1.76e-01 | 5.95e-02 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 9 | 3.62e-01 | -1.76e-01 | 7.52e-01 |
| GOBP P BODY ASSEMBLY | 21 | 1.64e-01 | 1.76e-01 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 17 | 2.10e-01 | 1.76e-01 | 6.24e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 7 | 4.21e-01 | -1.75e-01 | 7.90e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 18 | 1.98e-01 | 1.75e-01 | 6.10e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 22 | 1.54e-01 | 1.75e-01 | 5.64e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 11 | 3.14e-01 | -1.75e-01 | 7.18e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 13 | 2.74e-01 | 1.75e-01 | 6.88e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 4.22e-01 | 1.75e-01 | 7.90e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 7 | 4.22e-01 | -1.75e-01 | 7.90e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 7 | 4.22e-01 | 1.75e-01 | 7.90e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 8 | 3.91e-01 | 1.75e-01 | 7.73e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 19 | 1.86e-01 | -1.75e-01 | 6.00e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 9 | 3.63e-01 | -1.75e-01 | 7.53e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 68 | 1.25e-02 | 1.75e-01 | 1.72e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 4.22e-01 | 1.75e-01 | 7.90e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 5 | 4.98e-01 | 1.75e-01 | 8.32e-01 |
| GOCC SWI SNF COMPLEX | 29 | 1.03e-01 | 1.75e-01 | 4.78e-01 |
| GOBP INNERVATION | 11 | 3.15e-01 | -1.75e-01 | 7.19e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 27 | 1.16e-01 | 1.75e-01 | 4.98e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 8 | 3.92e-01 | 1.75e-01 | 7.73e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 3.38e-01 | 1.75e-01 | 7.36e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 14 | 2.57e-01 | 1.75e-01 | 6.71e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 4.59e-01 | 1.75e-01 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 10 | 3.39e-01 | -1.75e-01 | 7.37e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 3.39e-01 | 1.75e-01 | 7.37e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 2.42e-01 | -1.75e-01 | 6.56e-01 |
| GOBP INTEGRIN ACTIVATION | 14 | 2.58e-01 | 1.75e-01 | 6.71e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 11 | 3.16e-01 | 1.75e-01 | 7.20e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 11 | 3.17e-01 | 1.74e-01 | 7.20e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 5.00e-01 | 1.74e-01 | 8.32e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 13 | 2.77e-01 | -1.74e-01 | 6.91e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 1.89e-01 | 1.74e-01 | 6.03e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 3.94e-01 | 1.74e-01 | 7.74e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 24 | 1.40e-01 | 1.74e-01 | 5.41e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.60e-01 | 1.74e-01 | 8.11e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 39 | 6.01e-02 | 1.74e-01 | 3.84e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 14 | 2.60e-01 | -1.74e-01 | 6.74e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 2.60e-01 | -1.74e-01 | 6.74e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 28 | 1.12e-01 | -1.74e-01 | 4.91e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 5 | 5.01e-01 | -1.74e-01 | 8.32e-01 |
| GOBP REGULATION OF MICROVILLUS LENGTH | 5 | 5.01e-01 | -1.74e-01 | 8.32e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 2.15e-01 | 1.74e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 3.95e-01 | 1.74e-01 | 7.75e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 168 | 1.06e-04 | 1.74e-01 | 6.50e-03 |
| GOCC AUTOLYSOSOME | 12 | 2.98e-01 | -1.74e-01 | 7.07e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 6 | 4.62e-01 | 1.74e-01 | 8.12e-01 |
| GOBP AMINE CATABOLIC PROCESS | 10 | 3.42e-01 | 1.74e-01 | 7.39e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 9 | 3.68e-01 | -1.73e-01 | 7.57e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 24 | 1.41e-01 | -1.73e-01 | 5.43e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 19 | 1.91e-01 | 1.73e-01 | 6.04e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 8 | 3.96e-01 | 1.73e-01 | 7.76e-01 |
| GOBP PEROXISOME ORGANIZATION | 32 | 8.98e-02 | 1.73e-01 | 4.54e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION | 6 | 4.62e-01 | -1.73e-01 | 8.12e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 5 | 5.02e-01 | 1.73e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 45 | 4.45e-02 | 1.73e-01 | 3.29e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 56 | 2.51e-02 | 1.73e-01 | 2.45e-01 |
| GOBP CILIUM DISASSEMBLY | 6 | 4.63e-01 | 1.73e-01 | 8.12e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 76 | 9.11e-03 | 1.73e-01 | 1.43e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 19 | 1.91e-01 | 1.73e-01 | 6.04e-01 |
| GOBP DNA PROTECTION | 5 | 5.03e-01 | 1.73e-01 | 8.33e-01 |
| GOBP ISOLEUCINE TRANSPORT | 5 | 5.03e-01 | 1.73e-01 | 8.33e-01 |
| GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY | 5 | 5.03e-01 | -1.73e-01 | 8.33e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 11 | 3.21e-01 | -1.73e-01 | 7.24e-01 |
| GOCC DENDRITIC GROWTH CONE | 7 | 4.28e-01 | -1.73e-01 | 7.93e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 31 | 9.58e-02 | 1.73e-01 | 4.61e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 13 | 2.81e-01 | -1.73e-01 | 6.96e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 6 | 4.64e-01 | 1.73e-01 | 8.12e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 12 | 3.00e-01 | -1.73e-01 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 27 | 1.20e-01 | 1.73e-01 | 5.06e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 29 | 1.08e-01 | -1.73e-01 | 4.85e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 16 | 2.32e-01 | 1.73e-01 | 6.43e-01 |
| GOBP MAST CELL PROLIFERATION | 5 | 5.04e-01 | -1.73e-01 | 8.33e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 25 | 1.35e-01 | -1.73e-01 | 5.32e-01 |
| GOBP GLUTATHIONE TRANSPORT | 6 | 4.64e-01 | 1.72e-01 | 8.13e-01 |
| GOBP RESPONSE TO LEUCINE | 12 | 3.01e-01 | 1.72e-01 | 7.09e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 18 | 2.05e-01 | 1.72e-01 | 6.19e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 103 | 2.53e-03 | 1.72e-01 | 6.72e-02 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 8 | 3.99e-01 | -1.72e-01 | 7.78e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 6 | 4.65e-01 | 1.72e-01 | 8.13e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.65e-01 | 1.72e-01 | 8.13e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 79 | 8.20e-03 | 1.72e-01 | 1.34e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 18 | 2.06e-01 | 1.72e-01 | 6.20e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 4.30e-01 | 1.72e-01 | 7.95e-01 |
| GOBP SPERM CAPACITATION | 9 | 3.71e-01 | -1.72e-01 | 7.60e-01 |
| GOCC ESC E Z COMPLEX | 9 | 3.71e-01 | 1.72e-01 | 7.60e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 17 | 2.19e-01 | 1.72e-01 | 6.33e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 37 | 7.02e-02 | 1.72e-01 | 4.09e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 24 | 1.45e-01 | 1.72e-01 | 5.47e-01 |
| GOCC INO80 COMPLEX | 15 | 2.49e-01 | 1.72e-01 | 6.62e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 23 | 1.54e-01 | 1.72e-01 | 5.63e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 38 | 6.68e-02 | 1.72e-01 | 3.99e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 29 | 1.09e-01 | 1.72e-01 | 4.88e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 30 | 1.03e-01 | 1.72e-01 | 4.79e-01 |
| GOBP RIBOSOME ASSEMBLY | 57 | 2.49e-02 | 1.72e-01 | 2.45e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 13 | 2.84e-01 | 1.72e-01 | 6.98e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 12 | 3.03e-01 | -1.72e-01 | 7.10e-01 |
| GOBP PANCREATIC JUICE SECRETION | 5 | 5.06e-01 | 1.72e-01 | 8.35e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 15 | 2.50e-01 | 1.72e-01 | 6.63e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 4.01e-01 | 1.71e-01 | 7.80e-01 |
| GOCC CELL TRAILING EDGE | 13 | 2.85e-01 | 1.71e-01 | 7.00e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 19 | 1.97e-01 | -1.71e-01 | 6.09e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 60 | 2.19e-02 | 1.71e-01 | 2.29e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 5.08e-01 | 1.71e-01 | 8.36e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 5 | 5.08e-01 | 1.71e-01 | 8.36e-01 |
| GOBP CHROMOSOME CONDENSATION | 25 | 1.39e-01 | 1.71e-01 | 5.39e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 15 | 2.52e-01 | 1.71e-01 | 6.65e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 6 | 4.69e-01 | 1.71e-01 | 8.15e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 5 | 5.08e-01 | -1.71e-01 | 8.36e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 4.03e-01 | 1.71e-01 | 7.80e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 8 | 4.03e-01 | 1.71e-01 | 7.80e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 7 | 4.34e-01 | -1.71e-01 | 7.98e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 30 | 1.06e-01 | 1.71e-01 | 4.81e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 33 | 8.99e-02 | 1.71e-01 | 4.54e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 12 | 3.06e-01 | 1.71e-01 | 7.12e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 29 | 1.12e-01 | 1.71e-01 | 4.91e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 5 | 5.09e-01 | 1.71e-01 | 8.36e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 59 | 2.36e-02 | -1.70e-01 | 2.38e-01 |
| GOMF SIALIC ACID BINDING | 7 | 4.35e-01 | -1.70e-01 | 7.98e-01 |
| GOCC HOPS COMPLEX | 9 | 3.77e-01 | 1.70e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 5.10e-01 | 1.70e-01 | 8.37e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 6 | 4.71e-01 | -1.70e-01 | 8.16e-01 |
| GOBP TRANSFERRIN TRANSPORT | 8 | 4.05e-01 | 1.70e-01 | 7.80e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 65 | 1.78e-02 | 1.70e-01 | 2.03e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 103 | 2.90e-03 | 1.70e-01 | 7.21e-02 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 46 | 4.62e-02 | 1.70e-01 | 3.36e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 27 | 1.27e-01 | 1.70e-01 | 5.17e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 5.11e-01 | -1.70e-01 | 8.37e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 7 | 4.36e-01 | 1.70e-01 | 7.98e-01 |
| GOBP SEX DETERMINATION | 7 | 4.36e-01 | 1.70e-01 | 7.98e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 4.72e-01 | 1.70e-01 | 8.16e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 8 | 4.06e-01 | 1.70e-01 | 7.81e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 14 | 2.72e-01 | 1.70e-01 | 6.85e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 14 | 2.72e-01 | 1.70e-01 | 6.85e-01 |
| GOBP MYELIN MAINTENANCE | 15 | 2.55e-01 | 1.70e-01 | 6.69e-01 |
| GOBP VASOCONSTRICTION | 32 | 9.69e-02 | -1.70e-01 | 4.62e-01 |
| GOBP RESPONSE TO ATP | 18 | 2.13e-01 | -1.70e-01 | 6.27e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 5 | 5.11e-01 | -1.70e-01 | 8.37e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 78 | 9.67e-03 | 1.70e-01 | 1.48e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 10 | 3.53e-01 | 1.70e-01 | 7.47e-01 |
| GOBP ZYMOGEN INHIBITION | 6 | 4.72e-01 | 1.70e-01 | 8.16e-01 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 5 | 5.12e-01 | 1.70e-01 | 8.37e-01 |
| GOMF HISTONE BINDING | 219 | 1.61e-05 | 1.69e-01 | 1.39e-03 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 2.41e-01 | 1.69e-01 | 6.55e-01 |
| GOBP MOLTING CYCLE PROCESS | 43 | 5.48e-02 | 1.69e-01 | 3.67e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 4.73e-01 | 1.69e-01 | 8.16e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 6 | 4.73e-01 | 1.69e-01 | 8.16e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 2.01e-01 | 1.69e-01 | 6.14e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 5.12e-01 | 1.69e-01 | 8.37e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 22 | 1.70e-01 | -1.69e-01 | 5.81e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 13 | 2.91e-01 | -1.69e-01 | 7.02e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 11 | 3.32e-01 | -1.69e-01 | 7.33e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 57 | 2.74e-02 | 1.69e-01 | 2.57e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 9 | 3.80e-01 | -1.69e-01 | 7.67e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 10 | 3.55e-01 | 1.69e-01 | 7.49e-01 |
| GOBP ASTROCYTE ACTIVATION | 17 | 2.28e-01 | -1.69e-01 | 6.40e-01 |
| GOCC ENDONUCLEASE COMPLEX | 35 | 8.39e-02 | 1.69e-01 | 4.40e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 8 | 4.08e-01 | 1.69e-01 | 7.82e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 730 | 1.26e-14 | -1.69e-01 | 1.34e-11 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 8 | 4.08e-01 | 1.69e-01 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 4.39e-01 | 1.69e-01 | 8.00e-01 |
| GOBP PROLINE METABOLIC PROCESS | 6 | 4.74e-01 | -1.69e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 19 | 2.03e-01 | 1.69e-01 | 6.16e-01 |
| GOBP MONOCYTE ACTIVATION | 7 | 4.40e-01 | 1.69e-01 | 8.00e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 3.81e-01 | -1.69e-01 | 7.68e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 6 | 4.74e-01 | -1.69e-01 | 8.17e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 5.14e-01 | -1.69e-01 | 8.37e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 6 | 4.75e-01 | -1.69e-01 | 8.17e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 220 | 1.72e-05 | -1.69e-01 | 1.42e-03 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 11 | 3.34e-01 | 1.68e-01 | 7.33e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 22 | 1.72e-01 | 1.68e-01 | 5.83e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 56 | 2.94e-02 | 1.68e-01 | 2.68e-01 |
| GOBP OOCYTE DIFFERENTIATION | 29 | 1.17e-01 | 1.68e-01 | 4.99e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 35 | 8.49e-02 | 1.68e-01 | 4.43e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 4.10e-01 | 1.68e-01 | 7.83e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 10 | 3.57e-01 | -1.68e-01 | 7.50e-01 |
| GOCC HETEROCHROMATIN | 63 | 2.10e-02 | 1.68e-01 | 2.24e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 10 | 3.58e-01 | -1.68e-01 | 7.50e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 3.58e-01 | -1.68e-01 | 7.50e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 18 | 2.17e-01 | -1.68e-01 | 6.31e-01 |
| GOCC MMXD COMPLEX | 5 | 5.16e-01 | -1.68e-01 | 8.38e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 16 | 2.45e-01 | -1.68e-01 | 6.59e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 12 | 3.14e-01 | -1.68e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 65 | 1.94e-02 | 1.68e-01 | 2.12e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 15 | 2.61e-01 | 1.68e-01 | 6.74e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 24 | 1.56e-01 | -1.67e-01 | 5.65e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 37 | 7.82e-02 | 1.67e-01 | 4.28e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 3.85e-01 | 1.67e-01 | 7.70e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 34 | 9.13e-02 | 1.67e-01 | 4.55e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 20 | 1.95e-01 | 1.67e-01 | 6.09e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 6 | 4.78e-01 | 1.67e-01 | 8.18e-01 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.17e-01 | 1.67e-01 | 8.39e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 24 | 1.56e-01 | -1.67e-01 | 5.65e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 2.62e-01 | -1.67e-01 | 6.77e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 21 | 1.85e-01 | 1.67e-01 | 5.99e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 4.13e-01 | 1.67e-01 | 7.85e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 9 | 3.85e-01 | 1.67e-01 | 7.70e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 4.13e-01 | 1.67e-01 | 7.85e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 12 | 3.16e-01 | -1.67e-01 | 7.20e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 7 | 4.44e-01 | 1.67e-01 | 8.02e-01 |
| GOBP ER OVERLOAD RESPONSE | 10 | 3.61e-01 | -1.67e-01 | 7.52e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 59 | 2.66e-02 | 1.67e-01 | 2.54e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 146 | 5.08e-04 | 1.67e-01 | 2.30e-02 |
| GOMF CYTOKINE ACTIVITY | 74 | 1.31e-02 | -1.67e-01 | 1.76e-01 |
| GOCC MICROTUBULE END | 23 | 1.66e-01 | 1.67e-01 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 2.98e-01 | 1.67e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 44 | 5.59e-02 | 1.67e-01 | 3.71e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 22 | 1.76e-01 | 1.67e-01 | 5.89e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 3.39e-01 | 1.66e-01 | 7.37e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 19 | 2.09e-01 | 1.66e-01 | 6.23e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 7 | 4.46e-01 | 1.66e-01 | 8.02e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 5 | 5.20e-01 | -1.66e-01 | 8.40e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 26 | 1.42e-01 | 1.66e-01 | 5.44e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 16 | 2.50e-01 | -1.66e-01 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 31 | 1.09e-01 | 1.66e-01 | 4.88e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 11 | 3.40e-01 | -1.66e-01 | 7.37e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 12 | 3.19e-01 | 1.66e-01 | 7.23e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 22 | 1.77e-01 | 1.66e-01 | 5.91e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 11 | 3.40e-01 | 1.66e-01 | 7.37e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 116 | 2.02e-03 | 1.66e-01 | 5.94e-02 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 5.20e-01 | 1.66e-01 | 8.40e-01 |
| GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX | 5 | 5.20e-01 | 1.66e-01 | 8.40e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 43 | 5.98e-02 | 1.66e-01 | 3.82e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 6 | 4.82e-01 | -1.66e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 24 | 1.60e-01 | 1.66e-01 | 5.71e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 29 | 1.22e-01 | 1.66e-01 | 5.12e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 23 | 1.69e-01 | 1.66e-01 | 5.80e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 4.48e-01 | 1.66e-01 | 8.04e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 30 | 1.16e-01 | 1.66e-01 | 4.99e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 66 | 2.00e-02 | 1.66e-01 | 2.17e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 82 | 9.58e-03 | 1.66e-01 | 1.47e-01 |
| GOBP LIPID PHOSPHORYLATION | 9 | 3.90e-01 | 1.66e-01 | 7.72e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 9 | 3.90e-01 | 1.66e-01 | 7.72e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 5.21e-01 | 1.66e-01 | 8.41e-01 |
| GOMF MHC CLASS IB RECEPTOR ACTIVITY | 7 | 4.48e-01 | 1.66e-01 | 8.04e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 23 | 1.69e-01 | -1.66e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 6 | 4.83e-01 | -1.66e-01 | 8.20e-01 |
| GOBP AXONEME ASSEMBLY | 43 | 6.05e-02 | -1.66e-01 | 3.85e-01 |
| GOCC RNA POLYMERASE COMPLEX | 96 | 5.11e-03 | 1.66e-01 | 1.05e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 39 | 7.39e-02 | 1.65e-01 | 4.19e-01 |
| GOCC 90S PRERIBOSOME | 25 | 1.53e-01 | 1.65e-01 | 5.61e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 3.65e-01 | 1.65e-01 | 7.55e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 55 | 3.40e-02 | 1.65e-01 | 2.86e-01 |
| GOBP TRANSLATIONAL INITIATION | 112 | 2.54e-03 | 1.65e-01 | 6.72e-02 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 27 | 1.37e-01 | -1.65e-01 | 5.35e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 3.22e-01 | 1.65e-01 | 7.24e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 17 | 2.38e-01 | -1.65e-01 | 6.52e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 5.22e-01 | 1.65e-01 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 13 | 3.03e-01 | 1.65e-01 | 7.10e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 385 | 3.02e-08 | 1.65e-01 | 6.55e-06 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 21 | 1.90e-01 | 1.65e-01 | 6.04e-01 |
| GOMF CHEMOKINE ACTIVITY | 15 | 2.68e-01 | -1.65e-01 | 6.82e-01 |
| GOBP RESPONSE TO X RAY | 24 | 1.62e-01 | 1.65e-01 | 5.74e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 5 | 5.23e-01 | -1.65e-01 | 8.41e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 110 | 2.83e-03 | 1.65e-01 | 7.15e-02 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 13 | 3.03e-01 | -1.65e-01 | 7.11e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 81 | 1.04e-02 | 1.65e-01 | 1.55e-01 |
| GOCC RECYCLING ENDOSOME | 150 | 5.06e-04 | 1.65e-01 | 2.30e-02 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 4.20e-01 | 1.65e-01 | 7.89e-01 |
| GOBP MRNA TRANSCRIPTION | 46 | 5.33e-02 | 1.65e-01 | 3.64e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 12 | 3.23e-01 | 1.65e-01 | 7.25e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 70 | 1.73e-02 | -1.65e-01 | 2.00e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 14 | 2.86e-01 | 1.65e-01 | 7.01e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 51 | 4.22e-02 | 1.65e-01 | 3.18e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 24 | 1.63e-01 | 1.65e-01 | 5.75e-01 |
| GOBP TRNA CATABOLIC PROCESS | 15 | 2.71e-01 | 1.64e-01 | 6.85e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 40 | 7.22e-02 | 1.64e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 20 | 2.03e-01 | -1.64e-01 | 6.16e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 19 | 2.15e-01 | -1.64e-01 | 6.29e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 5.25e-01 | 1.64e-01 | 8.42e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 10 | 3.69e-01 | 1.64e-01 | 7.58e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 76 | 1.34e-02 | 1.64e-01 | 1.78e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 85 | 9.04e-03 | 1.64e-01 | 1.42e-01 |
| GOMF CADHERIN BINDING | 264 | 4.86e-06 | 1.64e-01 | 4.89e-04 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 28 | 1.34e-01 | 1.64e-01 | 5.30e-01 |
| GOBP REGULATION OF HAIR CYCLE | 12 | 3.26e-01 | 1.64e-01 | 7.27e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 5 | 5.26e-01 | -1.64e-01 | 8.43e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 13 | 3.07e-01 | 1.64e-01 | 7.13e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 5 | 5.26e-01 | 1.64e-01 | 8.43e-01 |
| GOBP KINETOCHORE ASSEMBLY | 16 | 2.57e-01 | 1.64e-01 | 6.71e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 54 | 3.78e-02 | 1.64e-01 | 3.00e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 61 | 2.75e-02 | 1.63e-01 | 2.57e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 3.96e-01 | 1.63e-01 | 7.76e-01 |
| GOMF ANTIGEN BINDING | 57 | 3.31e-02 | 1.63e-01 | 2.84e-01 |
| GOCC CLATHRIN COATED VESICLE | 146 | 6.76e-04 | 1.63e-01 | 2.84e-02 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 7 | 4.55e-01 | 1.63e-01 | 8.07e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 6 | 4.89e-01 | -1.63e-01 | 8.25e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 66 | 2.21e-02 | 1.63e-01 | 2.30e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 35 | 9.54e-02 | 1.63e-01 | 4.61e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 8 | 4.25e-01 | -1.63e-01 | 7.91e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 10 | 3.72e-01 | 1.63e-01 | 7.60e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 23 | 1.76e-01 | 1.63e-01 | 5.89e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 7 | 4.56e-01 | -1.63e-01 | 8.08e-01 |
| GOCC CLATHRIN COAT | 39 | 7.86e-02 | 1.63e-01 | 4.29e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 1.59e-01 | 1.63e-01 | 5.70e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 8 | 4.26e-01 | -1.63e-01 | 7.92e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 5.29e-01 | 1.63e-01 | 8.44e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 30 | 1.23e-01 | 1.63e-01 | 5.14e-01 |
| GOBP LEUCINE TRANSPORT | 7 | 4.57e-01 | -1.63e-01 | 8.08e-01 |
| GOBP PREPULSE INHIBITION | 7 | 4.57e-01 | -1.62e-01 | 8.08e-01 |
| GOMF TROPOMYOSIN BINDING | 10 | 3.74e-01 | 1.62e-01 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 7 | 4.57e-01 | 1.62e-01 | 8.08e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 13 | 3.11e-01 | 1.62e-01 | 7.15e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 29 | 1.31e-01 | -1.62e-01 | 5.24e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 2.47e-01 | 1.62e-01 | 6.61e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 36 | 9.24e-02 | -1.62e-01 | 4.56e-01 |
| GOBP GLIAL CELL PROLIFERATION | 36 | 9.24e-02 | 1.62e-01 | 4.56e-01 |
| GOBP PLASMINOGEN ACTIVATION | 12 | 3.31e-01 | 1.62e-01 | 7.32e-01 |
| GOBP HEME TRANSPORT | 6 | 4.92e-01 | 1.62e-01 | 8.27e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 6 | 4.92e-01 | 1.62e-01 | 8.27e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.92e-01 | 1.62e-01 | 8.27e-01 |
| GOBP GDP METABOLIC PROCESS | 11 | 3.52e-01 | -1.62e-01 | 7.47e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 59 | 3.15e-02 | 1.62e-01 | 2.78e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 35 | 9.76e-02 | 1.62e-01 | 4.64e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 8 | 4.28e-01 | 1.62e-01 | 7.93e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 2.95e-01 | 1.62e-01 | 7.04e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 8 | 4.28e-01 | -1.62e-01 | 7.93e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 25 | 1.62e-01 | 1.62e-01 | 5.74e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 13 | 3.13e-01 | 1.62e-01 | 7.17e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 26 | 1.54e-01 | 1.62e-01 | 5.64e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 12 | 3.33e-01 | 1.62e-01 | 7.33e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 5.32e-01 | 1.62e-01 | 8.46e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 81 | 1.20e-02 | 1.62e-01 | 1.69e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 15 | 2.79e-01 | 1.62e-01 | 6.94e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 6 | 4.93e-01 | -1.61e-01 | 8.27e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 4.29e-01 | 1.61e-01 | 7.94e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 75 | 1.58e-02 | 1.61e-01 | 1.91e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 8 | 4.30e-01 | -1.61e-01 | 7.94e-01 |
| GOMF LBD DOMAIN BINDING | 5 | 5.32e-01 | -1.61e-01 | 8.46e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 20 | 2.12e-01 | -1.61e-01 | 6.26e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 2.64e-01 | 1.61e-01 | 6.78e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 39 | 8.17e-02 | 1.61e-01 | 4.34e-01 |
| GOBP HEART VALVE DEVELOPMENT | 35 | 9.95e-02 | 1.61e-01 | 4.69e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 5.33e-01 | -1.61e-01 | 8.46e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 22 | 1.91e-01 | -1.61e-01 | 6.04e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 37 | 9.04e-02 | 1.61e-01 | 4.54e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 29 | 1.34e-01 | 1.61e-01 | 5.30e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 25 | 1.64e-01 | 1.61e-01 | 5.75e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 84 | 1.09e-02 | 1.61e-01 | 1.59e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 25 | 1.64e-01 | 1.61e-01 | 5.76e-01 |
| GOBP BONE MARROW DEVELOPMENT | 7 | 4.62e-01 | 1.61e-01 | 8.12e-01 |
| GOBP ENDOSOMAL TRANSPORT | 209 | 6.64e-05 | 1.60e-01 | 4.51e-03 |
| GOBP MRNA SPLICE SITE RECOGNITION | 28 | 1.42e-01 | 1.60e-01 | 5.43e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 4.05e-01 | 1.60e-01 | 7.80e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 5 | 5.35e-01 | -1.60e-01 | 8.47e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 13 | 3.17e-01 | -1.60e-01 | 7.20e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 19 | 2.26e-01 | -1.60e-01 | 6.39e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 24 | 1.74e-01 | 1.60e-01 | 5.88e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 5.35e-01 | 1.60e-01 | 8.47e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 23 | 1.84e-01 | -1.60e-01 | 5.98e-01 |
| GOBP MALE MEIOSIS I | 14 | 2.99e-01 | -1.60e-01 | 7.08e-01 |
| GOMF MHC PROTEIN BINDING | 29 | 1.36e-01 | 1.60e-01 | 5.34e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 19 | 2.27e-01 | -1.60e-01 | 6.40e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 9 | 4.06e-01 | -1.60e-01 | 7.81e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 47 | 5.79e-02 | -1.60e-01 | 3.76e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 19 | 2.28e-01 | 1.60e-01 | 6.40e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 44 | 6.67e-02 | -1.60e-01 | 3.99e-01 |
| GOCC MYELIN SHEATH | 32 | 1.18e-01 | 1.60e-01 | 5.00e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 34 | 1.07e-01 | 1.60e-01 | 4.85e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 3.01e-01 | 1.60e-01 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 6 | 4.99e-01 | 1.60e-01 | 8.32e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 5.37e-01 | 1.59e-01 | 8.47e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 8 | 4.35e-01 | 1.59e-01 | 7.98e-01 |
| GOBP PLATELET AGGREGATION | 49 | 5.37e-02 | 1.59e-01 | 3.64e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 123 | 2.31e-03 | 1.59e-01 | 6.36e-02 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 19 | 2.30e-01 | -1.59e-01 | 6.42e-01 |
| GOBP SEQUESTERING OF METAL ION | 9 | 4.08e-01 | 1.59e-01 | 7.82e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 14 | 3.02e-01 | -1.59e-01 | 7.10e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 19 | 2.30e-01 | -1.59e-01 | 6.42e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 97 | 6.81e-03 | 1.59e-01 | 1.19e-01 |
| GOMF INTEGRIN BINDING | 71 | 2.06e-02 | -1.59e-01 | 2.21e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 7 | 4.66e-01 | 1.59e-01 | 8.13e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 5 | 5.38e-01 | 1.59e-01 | 8.48e-01 |
| GOBP MANGANESE ION TRANSPORT | 9 | 4.09e-01 | -1.59e-01 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 41 | 7.83e-02 | 1.59e-01 | 4.28e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 9 | 4.09e-01 | 1.59e-01 | 7.82e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 6 | 5.00e-01 | 1.59e-01 | 8.32e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 32 | 1.20e-01 | -1.59e-01 | 5.06e-01 |
| GOMF DYNACTIN BINDING | 12 | 3.41e-01 | 1.59e-01 | 7.38e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 76 | 1.68e-02 | 1.59e-01 | 1.98e-01 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 5.01e-01 | -1.59e-01 | 8.32e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 2.08e-01 | 1.59e-01 | 6.22e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 62 | 3.08e-02 | 1.59e-01 | 2.74e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 5.01e-01 | -1.59e-01 | 8.32e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 10 | 3.86e-01 | -1.58e-01 | 7.70e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 4.10e-01 | 1.58e-01 | 7.83e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 20 | 2.20e-01 | 1.58e-01 | 6.33e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 4.68e-01 | -1.58e-01 | 8.15e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 20 | 2.20e-01 | 1.58e-01 | 6.33e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 118 | 3.00e-03 | 1.58e-01 | 7.38e-02 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 14 | 3.05e-01 | -1.58e-01 | 7.12e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 12 | 3.43e-01 | 1.58e-01 | 7.39e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 16 | 2.73e-01 | 1.58e-01 | 6.88e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 5.40e-01 | -1.58e-01 | 8.49e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 5.02e-01 | 1.58e-01 | 8.33e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 4.39e-01 | 1.58e-01 | 7.99e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 6 | 5.03e-01 | 1.58e-01 | 8.33e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 3.64e-01 | 1.58e-01 | 7.54e-01 |
| GOMF VITAMIN B6 BINDING | 30 | 1.34e-01 | 1.58e-01 | 5.31e-01 |
| GOBP SPINAL CORD PATTERNING | 5 | 5.41e-01 | -1.58e-01 | 8.49e-01 |
| GOBP SEQUESTERING OF IRON ION | 5 | 5.41e-01 | 1.58e-01 | 8.49e-01 |
| GOCC CELL POLE | 5 | 5.41e-01 | 1.58e-01 | 8.49e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 15 | 2.90e-01 | -1.58e-01 | 7.02e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 29 | 1.42e-01 | -1.58e-01 | 5.43e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 9 | 4.13e-01 | 1.58e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 11 | 3.65e-01 | -1.58e-01 | 7.55e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 12 | 3.44e-01 | 1.58e-01 | 7.40e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 91 | 9.41e-03 | 1.58e-01 | 1.46e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 2.91e-01 | 1.58e-01 | 7.02e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 8 | 4.40e-01 | -1.58e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 17 | 2.61e-01 | 1.57e-01 | 6.75e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 7 | 4.71e-01 | -1.57e-01 | 8.16e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 57 | 4.00e-02 | 1.57e-01 | 3.10e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 3.89e-01 | 1.57e-01 | 7.71e-01 |
| GOCC TERMINAL BOUTON | 18 | 2.48e-01 | -1.57e-01 | 6.62e-01 |
| GOBP NERVE DEVELOPMENT | 39 | 8.92e-02 | -1.57e-01 | 4.53e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 25 | 1.74e-01 | 1.57e-01 | 5.87e-01 |
| GOBP MUCUS SECRETION | 9 | 4.15e-01 | 1.57e-01 | 7.86e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 11 | 3.68e-01 | 1.57e-01 | 7.57e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 6 | 5.06e-01 | 1.57e-01 | 8.35e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 13 | 3.28e-01 | 1.57e-01 | 7.28e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 8 | 4.42e-01 | -1.57e-01 | 8.01e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 92 | 9.42e-03 | 1.57e-01 | 1.46e-01 |
| GOCC P BODY | 85 | 1.26e-02 | 1.57e-01 | 1.72e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 11 | 3.68e-01 | 1.57e-01 | 7.58e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 6 | 5.07e-01 | 1.57e-01 | 8.36e-01 |
| GOBP NUCLEAR EXPORT | 151 | 9.13e-04 | 1.57e-01 | 3.62e-02 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 7 | 4.73e-01 | -1.56e-01 | 8.17e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 5 | 5.45e-01 | -1.56e-01 | 8.51e-01 |
| GOCC CATALYTIC COMPLEX | 1479 | 4.28e-23 | 1.56e-01 | 3.58e-19 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 9 | 4.17e-01 | 1.56e-01 | 7.87e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 10 | 3.92e-01 | -1.56e-01 | 7.73e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 21 | 2.15e-01 | -1.56e-01 | 6.29e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 21 | 2.15e-01 | -1.56e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION | 5 | 5.45e-01 | -1.56e-01 | 8.52e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 23 | 1.95e-01 | 1.56e-01 | 6.08e-01 |
| GOBP AMELOGENESIS | 12 | 3.49e-01 | 1.56e-01 | 7.44e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 3.92e-01 | 1.56e-01 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 14 | 3.12e-01 | -1.56e-01 | 7.15e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 2.65e-01 | 1.56e-01 | 6.79e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 7 | 4.75e-01 | -1.56e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 61 | 3.52e-02 | -1.56e-01 | 2.91e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 9 | 4.18e-01 | 1.56e-01 | 7.88e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 46 | 6.74e-02 | 1.56e-01 | 4.01e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 8 | 4.45e-01 | -1.56e-01 | 8.02e-01 |
| GOCC BRISC COMPLEX | 6 | 5.09e-01 | 1.56e-01 | 8.36e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 16 | 2.81e-01 | -1.56e-01 | 6.96e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 136 | 1.75e-03 | 1.56e-01 | 5.37e-02 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 5 | 5.47e-01 | 1.56e-01 | 8.53e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 31 | 1.34e-01 | 1.56e-01 | 5.30e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 7 | 4.76e-01 | 1.56e-01 | 8.17e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 7 | 4.76e-01 | 1.56e-01 | 8.17e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 4.76e-01 | -1.56e-01 | 8.17e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 4.19e-01 | 1.56e-01 | 7.89e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 17 | 2.67e-01 | -1.56e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 21 | 2.18e-01 | 1.55e-01 | 6.31e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 5.10e-01 | 1.55e-01 | 8.37e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 27 | 1.62e-01 | 1.55e-01 | 5.74e-01 |
| GOCC CHROMOSOMAL REGION | 330 | 1.32e-06 | 1.55e-01 | 1.70e-04 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 5 | 5.48e-01 | -1.55e-01 | 8.53e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 5 | 5.48e-01 | -1.55e-01 | 8.53e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 3.96e-01 | 1.55e-01 | 7.76e-01 |
| GOMF LRR DOMAIN BINDING | 14 | 3.15e-01 | 1.55e-01 | 7.19e-01 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 5 | 5.48e-01 | 1.55e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 32 | 1.29e-01 | 1.55e-01 | 5.22e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 141 | 1.51e-03 | 1.55e-01 | 4.85e-02 |
| GOCC PML BODY | 99 | 7.78e-03 | 1.55e-01 | 1.30e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 23 | 1.99e-01 | 1.55e-01 | 6.11e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 9.88e-02 | 1.55e-01 | 4.68e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 19 | 2.43e-01 | -1.55e-01 | 6.58e-01 |
| GOBP DNA METHYLATION | 40 | 9.05e-02 | 1.55e-01 | 4.54e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 8 | 4.49e-01 | -1.55e-01 | 8.04e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 7 | 4.79e-01 | -1.55e-01 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 11 | 3.75e-01 | -1.55e-01 | 7.63e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 25 | 1.81e-01 | 1.55e-01 | 5.96e-01 |
| GOBP SISTER CHROMATID COHESION | 43 | 7.96e-02 | 1.55e-01 | 4.31e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 70 | 2.55e-02 | 1.55e-01 | 2.48e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 26 | 1.73e-01 | 1.55e-01 | 5.85e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 5.50e-01 | -1.55e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 10 | 3.97e-01 | 1.55e-01 | 7.77e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 23 | 2.00e-01 | -1.55e-01 | 6.11e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 60 | 3.86e-02 | 1.54e-01 | 3.04e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 5.12e-01 | -1.54e-01 | 8.37e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 8 | 4.50e-01 | -1.54e-01 | 8.04e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 8 | 4.50e-01 | 1.54e-01 | 8.04e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 60 | 3.89e-02 | 1.54e-01 | 3.05e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 3.98e-01 | -1.54e-01 | 7.78e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 6 | 5.13e-01 | 1.54e-01 | 8.37e-01 |
| GOCC U6 SNRNP | 8 | 4.51e-01 | 1.54e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 28 | 1.59e-01 | 1.54e-01 | 5.69e-01 |
| GOBP FRUCTOSE 2 6 BISPHOSPHATE METABOLIC PROCESS | 5 | 5.51e-01 | -1.54e-01 | 8.54e-01 |
| GOMF FRUCTOSE 2 6 BISPHOSPHATE 2 PHOSPHATASE ACTIVITY | 5 | 5.51e-01 | -1.54e-01 | 8.54e-01 |
| GOCC COLLAGEN TRIMER | 20 | 2.33e-01 | -1.54e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 15 | 3.02e-01 | 1.54e-01 | 7.10e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 22 | 2.12e-01 | -1.54e-01 | 6.26e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 9 | 4.24e-01 | 1.54e-01 | 7.91e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 78 | 1.90e-02 | 1.54e-01 | 2.09e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 6 | 5.14e-01 | 1.54e-01 | 8.37e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 2.12e-01 | 1.54e-01 | 6.26e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 3.03e-01 | 1.54e-01 | 7.10e-01 |
| GOCC FILOPODIUM TIP | 15 | 3.03e-01 | 1.54e-01 | 7.11e-01 |
| GOBP IRON IMPORT INTO CELL | 7 | 4.82e-01 | -1.53e-01 | 8.20e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 29 | 1.53e-01 | 1.53e-01 | 5.61e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 1.25e-02 | 1.53e-01 | 1.72e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 230 | 6.40e-05 | 1.53e-01 | 4.40e-03 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 29 | 1.53e-01 | 1.53e-01 | 5.61e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 5.53e-01 | 1.53e-01 | 8.54e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 11 | 3.79e-01 | 1.53e-01 | 7.66e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 39 | 9.77e-02 | 1.53e-01 | 4.64e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 6 | 5.16e-01 | -1.53e-01 | 8.38e-01 |
| GOBP RESPONSE TO ACIDIC PH | 11 | 3.79e-01 | -1.53e-01 | 7.67e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 7 | 4.83e-01 | -1.53e-01 | 8.20e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 9 | 4.26e-01 | -1.53e-01 | 7.92e-01 |
| GOBP FIBROBLAST MIGRATION | 41 | 8.98e-02 | 1.53e-01 | 4.54e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 4.54e-01 | 1.53e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 17 | 2.75e-01 | 1.53e-01 | 6.90e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 49 | 6.43e-02 | 1.53e-01 | 3.94e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 112 | 5.26e-03 | 1.53e-01 | 1.07e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 13 | 3.40e-01 | 1.53e-01 | 7.37e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 21 | 2.26e-01 | -1.53e-01 | 6.39e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 331 | 1.97e-06 | 1.53e-01 | 2.29e-04 |
| GOCC U1 SNRNP | 19 | 2.50e-01 | 1.53e-01 | 6.63e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 24 | 1.96e-01 | 1.53e-01 | 6.09e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 17 | 2.77e-01 | 1.52e-01 | 6.91e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 12 | 3.61e-01 | -1.52e-01 | 7.52e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 5.55e-01 | 1.52e-01 | 8.56e-01 |
| GOBP MEMBRANE FISSION | 40 | 9.55e-02 | 1.52e-01 | 4.61e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 215 | 1.23e-04 | 1.52e-01 | 7.30e-03 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 98 | 9.27e-03 | 1.52e-01 | 1.45e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 10 | 4.05e-01 | -1.52e-01 | 7.80e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 44 | 8.10e-02 | 1.52e-01 | 4.34e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 34 | 1.25e-01 | 1.52e-01 | 5.15e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 72 | 2.59e-02 | 1.52e-01 | 2.50e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 6 | 5.19e-01 | -1.52e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 33 | 1.31e-01 | 1.52e-01 | 5.25e-01 |
| GOBP MATURATION OF 5 8S RRNA | 35 | 1.20e-01 | 1.52e-01 | 5.06e-01 |
| GOCC FILOPODIUM | 70 | 2.82e-02 | 1.52e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 11 | 3.83e-01 | -1.52e-01 | 7.69e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 64 | 3.59e-02 | 1.52e-01 | 2.94e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 4.87e-01 | 1.52e-01 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 29 | 1.58e-01 | 1.52e-01 | 5.68e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 6 | 5.20e-01 | -1.52e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 27 | 1.73e-01 | 1.52e-01 | 5.86e-01 |
| GOMF U6 SNRNA BINDING | 14 | 3.27e-01 | 1.51e-01 | 7.27e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX CIRCULATING | 5 | 5.58e-01 | -1.51e-01 | 8.56e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 18 | 2.67e-01 | -1.51e-01 | 6.82e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 4.89e-01 | 1.51e-01 | 8.25e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 22 | 2.20e-01 | -1.51e-01 | 6.33e-01 |
| GOBP RNA LOCALIZATION | 182 | 4.49e-04 | 1.51e-01 | 2.11e-02 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 8 | 4.59e-01 | -1.51e-01 | 8.10e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 39 | 1.03e-01 | 1.51e-01 | 4.78e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 94 | 1.15e-02 | 1.51e-01 | 1.66e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 55 | 5.30e-02 | 1.51e-01 | 3.62e-01 |
| GOBP RESPONSE TO FRUCTOSE | 5 | 5.59e-01 | -1.51e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 31 | 1.46e-01 | 1.51e-01 | 5.50e-01 |
| GOCC INCLUSION BODY | 56 | 5.11e-02 | 1.51e-01 | 3.55e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 6 | 5.23e-01 | 1.51e-01 | 8.41e-01 |
| GOBP AMYLOID BETA CLEARANCE | 25 | 1.92e-01 | -1.51e-01 | 6.04e-01 |
| GOCC CYTOSOLIC RIBOSOME | 109 | 6.67e-03 | 1.51e-01 | 1.18e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 5 | 5.60e-01 | 1.51e-01 | 8.56e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 9 | 4.34e-01 | -1.51e-01 | 7.98e-01 |
| GOBP ERYTHROCYTE MATURATION | 13 | 3.47e-01 | 1.51e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 3.88e-01 | 1.50e-01 | 7.70e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 802 | 6.84e-13 | 1.50e-01 | 5.20e-10 |
| GOBP DNA LIGATION | 16 | 2.98e-01 | -1.50e-01 | 7.07e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 18 | 2.70e-01 | 1.50e-01 | 6.84e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 34 | 1.30e-01 | -1.50e-01 | 5.23e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 17 | 2.84e-01 | -1.50e-01 | 6.98e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 51 | 6.38e-02 | 1.50e-01 | 3.92e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 10 | 4.11e-01 | 1.50e-01 | 7.83e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 10 | 4.12e-01 | 1.50e-01 | 7.83e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 52 | 6.16e-02 | 1.50e-01 | 3.87e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 12 | 3.69e-01 | -1.50e-01 | 7.58e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 30 | 1.56e-01 | 1.50e-01 | 5.65e-01 |
| GOMF FAD BINDING | 26 | 1.87e-01 | -1.50e-01 | 6.00e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 8 | 4.64e-01 | 1.50e-01 | 8.12e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 14 | 3.32e-01 | -1.50e-01 | 7.33e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 5 | 5.62e-01 | 1.50e-01 | 8.57e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 31 | 1.50e-01 | -1.50e-01 | 5.57e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 22 | 2.25e-01 | 1.50e-01 | 6.38e-01 |
| GOMF ACYL COA BINDING | 16 | 3.00e-01 | 1.50e-01 | 7.09e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 16 | 3.01e-01 | 1.50e-01 | 7.09e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 12 | 3.70e-01 | 1.49e-01 | 7.59e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 15 | 3.17e-01 | -1.49e-01 | 7.20e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 9 | 4.38e-01 | 1.49e-01 | 7.98e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 43 | 9.05e-02 | 1.49e-01 | 4.54e-01 |
| GOCC MITOTIC COHESIN COMPLEX | 6 | 5.27e-01 | 1.49e-01 | 8.43e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 5.27e-01 | 1.49e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 37 | 1.17e-01 | 1.49e-01 | 4.99e-01 |
| GOBP RESPONSE TO MERCURY ION | 5 | 5.64e-01 | -1.49e-01 | 8.57e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 3.72e-01 | 1.49e-01 | 7.60e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 16 | 3.03e-01 | 1.49e-01 | 7.10e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 207 | 2.33e-04 | 1.49e-01 | 1.22e-02 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 9 | 4.40e-01 | 1.49e-01 | 8.00e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 31 | 1.52e-01 | 1.49e-01 | 5.61e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 2.17e-01 | -1.49e-01 | 6.31e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 5.29e-01 | 1.49e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 12 | 3.73e-01 | 1.49e-01 | 7.61e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 29 | 1.66e-01 | 1.49e-01 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 10 | 4.16e-01 | 1.48e-01 | 7.87e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 31 | 1.53e-01 | 1.48e-01 | 5.61e-01 |
| GOCC POLAR MICROTUBULE | 5 | 5.66e-01 | 1.48e-01 | 8.58e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 11 | 3.94e-01 | 1.48e-01 | 7.74e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 23 | 2.18e-01 | 1.48e-01 | 6.31e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 2.18e-01 | 1.48e-01 | 6.31e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 7 | 4.97e-01 | -1.48e-01 | 8.31e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 28 | 1.75e-01 | 1.48e-01 | 5.88e-01 |
| GOBP OOGENESIS | 47 | 7.89e-02 | 1.48e-01 | 4.30e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 21 | 2.40e-01 | 1.48e-01 | 6.54e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 91 | 1.47e-02 | 1.48e-01 | 1.86e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 11 | 3.95e-01 | -1.48e-01 | 7.75e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 18 | 2.77e-01 | 1.48e-01 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 5.30e-01 | -1.48e-01 | 8.45e-01 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 7 | 4.98e-01 | -1.48e-01 | 8.32e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX | 5 | 5.67e-01 | 1.48e-01 | 8.58e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 5.30e-01 | 1.48e-01 | 8.45e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 27 | 1.83e-01 | -1.48e-01 | 5.98e-01 |
| GOBP STARTLE RESPONSE | 13 | 3.56e-01 | -1.48e-01 | 7.49e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 25 | 2.01e-01 | -1.48e-01 | 6.13e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 91 | 1.49e-02 | 1.48e-01 | 1.87e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 12 | 3.75e-01 | 1.48e-01 | 7.64e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 7 | 4.98e-01 | 1.48e-01 | 8.32e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 70 | 3.27e-02 | 1.48e-01 | 2.84e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 31 | 1.55e-01 | 1.48e-01 | 5.65e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 15 | 3.22e-01 | 1.48e-01 | 7.24e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 67 | 3.69e-02 | 1.48e-01 | 2.97e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 26 | 1.93e-01 | -1.47e-01 | 6.06e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 18 | 2.79e-01 | 1.47e-01 | 6.94e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 9 | 4.44e-01 | 1.47e-01 | 8.02e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 20 | 2.54e-01 | -1.47e-01 | 6.68e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 33 | 1.43e-01 | 1.47e-01 | 5.46e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 7 | 5.00e-01 | -1.47e-01 | 8.32e-01 |
| GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 5.69e-01 | -1.47e-01 | 8.59e-01 |
| GOCC LAMELLIPODIUM | 150 | 1.89e-03 | 1.47e-01 | 5.60e-02 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 13 | 3.59e-01 | -1.47e-01 | 7.51e-01 |
| GOBP AXONAL TRANSPORT | 51 | 6.96e-02 | 1.47e-01 | 4.07e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 8.15e-02 | 1.47e-01 | 4.34e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 20 | 2.56e-01 | 1.47e-01 | 6.69e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 23 | 2.23e-01 | 1.47e-01 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 15 | 3.25e-01 | -1.47e-01 | 7.26e-01 |
| GOMF PROTEIN KINASE B BINDING | 9 | 4.46e-01 | 1.47e-01 | 8.02e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 5.70e-01 | 1.47e-01 | 8.59e-01 |
| GOMF HSP90 PROTEIN BINDING | 33 | 1.45e-01 | 1.47e-01 | 5.47e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 50 | 7.29e-02 | -1.47e-01 | 4.17e-01 |
| GOCC CHITOSOME | 12 | 3.79e-01 | -1.47e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 36 | 1.28e-01 | -1.47e-01 | 5.20e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 43 | 9.67e-02 | 1.46e-01 | 4.62e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 67 | 3.83e-02 | 1.46e-01 | 3.02e-01 |
| GOBP RENAL FILTRATION | 8 | 4.73e-01 | -1.46e-01 | 8.17e-01 |
| GOCC PRC1 COMPLEX | 14 | 3.43e-01 | 1.46e-01 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 6 | 5.35e-01 | -1.46e-01 | 8.47e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 10 | 4.23e-01 | -1.46e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 15 | 3.27e-01 | 1.46e-01 | 7.27e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 4.74e-01 | 1.46e-01 | 8.17e-01 |
| GOBP RNA 3 END PROCESSING | 89 | 1.73e-02 | 1.46e-01 | 2.00e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 5 | 5.72e-01 | -1.46e-01 | 8.60e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 4.24e-01 | 1.46e-01 | 7.91e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 7 | 5.04e-01 | -1.46e-01 | 8.33e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 11 | 4.02e-01 | 1.46e-01 | 7.80e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 677 | 1.29e-10 | 1.46e-01 | 5.64e-08 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 2.98e-01 | 1.46e-01 | 7.07e-01 |
| GOMF TRNA BINDING | 66 | 4.05e-02 | 1.46e-01 | 3.12e-01 |
| GOBP RESPONSE TO UV B | 14 | 3.45e-01 | 1.46e-01 | 7.40e-01 |
| GOBP CYTOKINETIC PROCESS | 35 | 1.35e-01 | 1.46e-01 | 5.32e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 30 | 1.67e-01 | 1.46e-01 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 4.02e-01 | -1.46e-01 | 7.80e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 31 | 1.60e-01 | 1.46e-01 | 5.72e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 18 | 2.84e-01 | 1.46e-01 | 6.99e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 4.25e-01 | 1.46e-01 | 7.91e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 133 | 3.75e-03 | 1.46e-01 | 8.61e-02 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 26 | 1.98e-01 | 1.46e-01 | 6.11e-01 |
| GOBP B CELL HOMEOSTASIS | 29 | 1.75e-01 | 1.46e-01 | 5.88e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 30 | 1.67e-01 | 1.46e-01 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 51 | 7.23e-02 | 1.46e-01 | 4.16e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 17 | 2.99e-01 | 1.46e-01 | 7.08e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 5 | 5.73e-01 | -1.46e-01 | 8.60e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 8 | 4.76e-01 | -1.46e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 19 | 2.72e-01 | 1.45e-01 | 6.86e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 3.46e-01 | 1.45e-01 | 7.42e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 12 | 3.83e-01 | -1.45e-01 | 7.69e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 25 | 2.09e-01 | -1.45e-01 | 6.22e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 10 | 4.26e-01 | 1.45e-01 | 7.92e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 18 | 2.86e-01 | 1.45e-01 | 7.00e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 12 | 3.83e-01 | 1.45e-01 | 7.69e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 19 | 2.73e-01 | 1.45e-01 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 9 | 4.50e-01 | -1.45e-01 | 8.04e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 59 | 5.37e-02 | 1.45e-01 | 3.64e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 29 | 1.76e-01 | 1.45e-01 | 5.89e-01 |
| GOCC MALE PRONUCLEUS | 7 | 5.06e-01 | -1.45e-01 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 10 | 4.27e-01 | -1.45e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 26 | 2.00e-01 | 1.45e-01 | 6.12e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 32 | 1.56e-01 | 1.45e-01 | 5.65e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 13 | 3.65e-01 | 1.45e-01 | 7.55e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 49 | 7.92e-02 | -1.45e-01 | 4.30e-01 |
| GOCC CHROMOCENTER | 10 | 4.27e-01 | -1.45e-01 | 7.93e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 6 | 5.39e-01 | 1.45e-01 | 8.48e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 19 | 2.74e-01 | 1.45e-01 | 6.88e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 20 | 2.62e-01 | 1.45e-01 | 6.77e-01 |
| GOMF DYSTROGLYCAN BINDING | 7 | 5.07e-01 | -1.45e-01 | 8.36e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 27 | 1.93e-01 | 1.45e-01 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 257 | 6.75e-05 | 1.45e-01 | 4.52e-03 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 16 | 3.16e-01 | 1.45e-01 | 7.20e-01 |
| GOBP T CELL MIGRATION | 51 | 7.40e-02 | 1.45e-01 | 4.19e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 3.86e-01 | 1.45e-01 | 7.70e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 8 | 4.79e-01 | 1.45e-01 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 6 | 5.40e-01 | 1.45e-01 | 8.49e-01 |
| GOBP REGULATION OF DNA REPAIR | 194 | 5.26e-04 | 1.45e-01 | 2.35e-02 |
| GOBP DNA STRAND ELONGATION | 36 | 1.33e-01 | 1.45e-01 | 5.29e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 20 | 2.63e-01 | 1.45e-01 | 6.77e-01 |
| GOCC DENDRITIC SHAFT | 24 | 2.20e-01 | -1.45e-01 | 6.33e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 26 | 2.02e-01 | -1.45e-01 | 6.15e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 153 | 2.06e-03 | 1.45e-01 | 5.94e-02 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 22 | 2.41e-01 | 1.45e-01 | 6.55e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 50 | 7.73e-02 | -1.45e-01 | 4.26e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 5.40e-01 | -1.44e-01 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 42 | 1.06e-01 | 1.44e-01 | 4.81e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 15 | 3.33e-01 | 1.44e-01 | 7.33e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 192 | 5.79e-04 | 1.44e-01 | 2.55e-02 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 20 | 2.64e-01 | 1.44e-01 | 6.78e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 16 | 3.18e-01 | 1.44e-01 | 7.21e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 8 | 4.80e-01 | -1.44e-01 | 8.19e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 31 | 1.65e-01 | -1.44e-01 | 5.77e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 6 | 5.41e-01 | -1.44e-01 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 11 | 4.09e-01 | 1.44e-01 | 7.82e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 5 | 5.78e-01 | -1.44e-01 | 8.64e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 35 | 1.41e-01 | -1.44e-01 | 5.43e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 4.82e-01 | -1.44e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 8 | 4.82e-01 | 1.44e-01 | 8.20e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 4.82e-01 | -1.43e-01 | 8.20e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 36 | 1.37e-01 | 1.43e-01 | 5.35e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 14 | 3.53e-01 | 1.43e-01 | 7.47e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 3.21e-01 | 1.43e-01 | 7.24e-01 |
| GOCC MITOCHONDRIAL MATRIX | 433 | 3.61e-07 | 1.43e-01 | 5.45e-05 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 68 | 4.13e-02 | 1.43e-01 | 3.15e-01 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 4.83e-01 | -1.43e-01 | 8.20e-01 |
| GOBP RESPONSE TO UV | 120 | 6.84e-03 | 1.43e-01 | 1.19e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 32 | 1.62e-01 | 1.43e-01 | 5.74e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 7 | 5.12e-01 | -1.43e-01 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 8 | 4.84e-01 | 1.43e-01 | 8.21e-01 |
| GOBP PIGMENTATION | 73 | 3.48e-02 | 1.43e-01 | 2.89e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 148 | 2.72e-03 | 1.43e-01 | 6.98e-02 |
| GOBP PROTEIN FOLDING | 176 | 1.09e-03 | 1.43e-01 | 3.95e-02 |
| GOCC CHLORIDE CHANNEL COMPLEX | 16 | 3.22e-01 | 1.43e-01 | 7.24e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 17 | 3.08e-01 | 1.43e-01 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 8 | 4.84e-01 | 1.43e-01 | 8.21e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 8 | 4.84e-01 | -1.43e-01 | 8.21e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 38 | 1.28e-01 | 1.43e-01 | 5.19e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 13 | 3.73e-01 | 1.43e-01 | 7.61e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 21 | 2.58e-01 | -1.43e-01 | 6.71e-01 |
| GOBP AMINO ACID ACTIVATION | 25 | 2.17e-01 | 1.43e-01 | 6.31e-01 |
| GOBP SUCKLING BEHAVIOR | 7 | 5.14e-01 | 1.43e-01 | 8.37e-01 |
| GOCC ENVELOPE | 1049 | 1.28e-14 | 1.42e-01 | 1.34e-11 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 7 | 5.14e-01 | 1.42e-01 | 8.37e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 6 | 5.46e-01 | -1.42e-01 | 8.52e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 63 | 5.08e-02 | 1.42e-01 | 3.55e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 7 | 5.14e-01 | 1.42e-01 | 8.37e-01 |
| GOBP PROTEIN DEMETHYLATION | 12 | 3.93e-01 | -1.42e-01 | 7.74e-01 |
| GOBP INSULIN METABOLIC PROCESS | 10 | 4.36e-01 | -1.42e-01 | 7.98e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 8 | 4.86e-01 | -1.42e-01 | 8.23e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 8 | 4.86e-01 | 1.42e-01 | 8.23e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 30 | 1.78e-01 | 1.42e-01 | 5.91e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 34 | 1.51e-01 | 1.42e-01 | 5.60e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 19 | 2.83e-01 | 1.42e-01 | 6.98e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 34 | 1.51e-01 | 1.42e-01 | 5.60e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 380 | 2.13e-06 | 1.42e-01 | 2.44e-04 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 796 | 1.36e-11 | 1.42e-01 | 7.56e-09 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 17 | 3.10e-01 | -1.42e-01 | 7.15e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 8 | 4.87e-01 | -1.42e-01 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 5 | 5.83e-01 | 1.42e-01 | 8.67e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 27 | 2.02e-01 | -1.42e-01 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 5 | 5.83e-01 | 1.42e-01 | 8.67e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 9 | 4.61e-01 | 1.42e-01 | 8.12e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 13 | 3.76e-01 | 1.42e-01 | 7.65e-01 |
| GOBP MITOTIC CYTOKINESIS | 71 | 3.91e-02 | 1.42e-01 | 3.06e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 15 | 3.42e-01 | 1.42e-01 | 7.39e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 10 | 4.38e-01 | 1.42e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 9 | 4.62e-01 | -1.42e-01 | 8.12e-01 |
| GOBP LUTEINIZATION | 5 | 5.84e-01 | 1.42e-01 | 8.68e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 12 | 3.96e-01 | 1.42e-01 | 7.76e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 17 | 3.13e-01 | 1.42e-01 | 7.16e-01 |
| GOBP TELOMERE MAINTENANCE | 144 | 3.43e-03 | 1.41e-01 | 8.12e-02 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 19 | 2.86e-01 | -1.41e-01 | 7.00e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 29 | 1.87e-01 | -1.41e-01 | 6.02e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 6 | 5.49e-01 | 1.41e-01 | 8.53e-01 |
| GOBP RNA PROCESSING | 858 | 3.20e-12 | 1.41e-01 | 2.06e-09 |
| GOCC POSTSYNAPTIC ENDOSOME | 12 | 3.96e-01 | 1.41e-01 | 7.76e-01 |
| GOCC KINOCILIUM | 6 | 5.49e-01 | -1.41e-01 | 8.53e-01 |
| GOMF HORMONE RECEPTOR BINDING | 10 | 4.39e-01 | 1.41e-01 | 7.99e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 7 | 5.17e-01 | 1.41e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 6 | 5.49e-01 | 1.41e-01 | 8.53e-01 |
| GOCC IGM IMMUNOGLOBULIN COMPLEX | 5 | 5.84e-01 | 1.41e-01 | 8.68e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 9 | 4.63e-01 | -1.41e-01 | 8.12e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 7 | 5.18e-01 | -1.41e-01 | 8.39e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 28 | 1.96e-01 | 1.41e-01 | 6.09e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 155 | 2.48e-03 | 1.41e-01 | 6.63e-02 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 45 | 1.02e-01 | -1.41e-01 | 4.76e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 3.29e-01 | -1.41e-01 | 7.30e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 11 | 4.18e-01 | -1.41e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 36 | 1.44e-01 | -1.41e-01 | 5.47e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 7 | 5.19e-01 | 1.41e-01 | 8.40e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 4.19e-01 | 1.41e-01 | 7.89e-01 |
| GOMF UBIQUITIN BINDING | 98 | 1.62e-02 | 1.41e-01 | 1.93e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 65 | 5.00e-02 | 1.41e-01 | 3.51e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 7 | 5.19e-01 | -1.41e-01 | 8.40e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 13 | 3.80e-01 | 1.41e-01 | 7.67e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 28 | 1.98e-01 | -1.41e-01 | 6.11e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 7 | 5.20e-01 | 1.40e-01 | 8.40e-01 |
| GOMF FOLIC ACID BINDING | 5 | 5.87e-01 | 1.40e-01 | 8.69e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 14 | 3.63e-01 | 1.40e-01 | 7.53e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 33 | 1.63e-01 | -1.40e-01 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 19 | 2.90e-01 | 1.40e-01 | 7.02e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 9 | 4.66e-01 | -1.40e-01 | 8.13e-01 |
| GOCC PAR POLARITY COMPLEX | 6 | 5.52e-01 | 1.40e-01 | 8.54e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 17 | 3.17e-01 | -1.40e-01 | 7.20e-01 |
| GOCC BRCA1 A COMPLEX | 8 | 4.93e-01 | 1.40e-01 | 8.27e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 19 | 2.91e-01 | 1.40e-01 | 7.02e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 3.64e-01 | 1.40e-01 | 7.54e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 10 | 4.43e-01 | -1.40e-01 | 8.02e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 40 | 1.26e-01 | -1.40e-01 | 5.16e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 5.88e-01 | 1.40e-01 | 8.70e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 5.22e-01 | 1.40e-01 | 8.41e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 4.44e-01 | 1.40e-01 | 8.02e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 8 | 4.94e-01 | 1.40e-01 | 8.27e-01 |
| GOBP PROTEIN NITROSYLATION | 10 | 4.44e-01 | 1.40e-01 | 8.02e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 14 | 3.65e-01 | -1.40e-01 | 7.55e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 20 | 2.79e-01 | 1.40e-01 | 6.94e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 22 | 2.57e-01 | -1.40e-01 | 6.70e-01 |
| GOMF SH2 DOMAIN BINDING | 29 | 1.93e-01 | 1.40e-01 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 20 | 2.79e-01 | -1.40e-01 | 6.94e-01 |
| GOBP HISTAMINE SECRETION | 10 | 4.44e-01 | 1.40e-01 | 8.02e-01 |
| GOBP HISTAMINE TRANSPORT | 10 | 4.44e-01 | 1.40e-01 | 8.02e-01 |
| GOBP RESPONSE TO VITAMIN E | 5 | 5.89e-01 | -1.40e-01 | 8.70e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 10 | 4.45e-01 | -1.40e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 11 | 4.23e-01 | 1.40e-01 | 7.91e-01 |
| GOBP ENAMEL MINERALIZATION | 9 | 4.68e-01 | 1.40e-01 | 8.15e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 5.54e-01 | -1.40e-01 | 8.55e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 15 | 3.49e-01 | 1.40e-01 | 7.44e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 5.23e-01 | 1.40e-01 | 8.41e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 15 | 3.50e-01 | 1.40e-01 | 7.44e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 22 | 2.57e-01 | -1.39e-01 | 6.71e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 9 | 4.69e-01 | 1.39e-01 | 8.15e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 12 | 4.03e-01 | 1.39e-01 | 7.80e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 12 | 4.03e-01 | 1.39e-01 | 7.80e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 6 | 5.54e-01 | -1.39e-01 | 8.56e-01 |
| GOCC BLOC 1 COMPLEX | 9 | 4.69e-01 | 1.39e-01 | 8.15e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 27 | 2.11e-01 | 1.39e-01 | 6.24e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 11 | 4.24e-01 | -1.39e-01 | 7.91e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 104 | 1.43e-02 | 1.39e-01 | 1.84e-01 |
| GOCC COATED VESICLE | 234 | 2.55e-04 | 1.39e-01 | 1.31e-02 |
| GOBP T CELL CYTOKINE PRODUCTION | 25 | 2.29e-01 | 1.39e-01 | 6.41e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 5.90e-01 | 1.39e-01 | 8.70e-01 |
| GOBP L GLUTAMATE IMPORT | 23 | 2.49e-01 | 1.39e-01 | 6.62e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 7 | 5.24e-01 | -1.39e-01 | 8.42e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 19 | 2.95e-01 | 1.39e-01 | 7.04e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 6 | 5.56e-01 | -1.39e-01 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 6 | 5.56e-01 | -1.39e-01 | 8.56e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 21 | 2.71e-01 | 1.39e-01 | 6.85e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 6 | 5.56e-01 | -1.39e-01 | 8.56e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 8 | 4.97e-01 | -1.39e-01 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 17 | 3.22e-01 | 1.39e-01 | 7.24e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 50 | 8.97e-02 | 1.39e-01 | 4.54e-01 |
| GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE | 6 | 5.56e-01 | -1.39e-01 | 8.56e-01 |
| GOBP HEAD MORPHOGENESIS | 22 | 2.60e-01 | 1.39e-01 | 6.74e-01 |
| GOBP CHROMOSOME SEPARATION | 61 | 6.12e-02 | 1.39e-01 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 31 | 1.82e-01 | 1.39e-01 | 5.97e-01 |
| GOBP VIRAL LIFE CYCLE | 231 | 2.92e-04 | 1.39e-01 | 1.43e-02 |
| GOCC TRANSPORTER COMPLEX | 208 | 5.86e-04 | 1.39e-01 | 2.55e-02 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 51 | 8.73e-02 | 1.38e-01 | 4.47e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 61 | 6.16e-02 | 1.38e-01 | 3.87e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 9 | 4.72e-01 | 1.38e-01 | 8.16e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 11 | 4.27e-01 | 1.38e-01 | 7.93e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 4.48e-01 | 1.38e-01 | 8.04e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 3.38e-01 | 1.38e-01 | 7.36e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 121 | 8.65e-03 | 1.38e-01 | 1.39e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 6 | 5.57e-01 | -1.38e-01 | 8.56e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 145 | 4.10e-03 | 1.38e-01 | 9.14e-02 |
| GOBP PRIMITIVE HEMOPOIESIS | 6 | 5.58e-01 | -1.38e-01 | 8.56e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 26 | 2.23e-01 | 1.38e-01 | 6.35e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 54 | 7.92e-02 | 1.38e-01 | 4.30e-01 |
| GOCC ENDOCYTIC VESICLE | 235 | 2.75e-04 | 1.38e-01 | 1.38e-02 |
| GOMF RNA POLYMERASE II ACTIVITY | 11 | 4.28e-01 | 1.38e-01 | 7.93e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 3.89e-01 | -1.38e-01 | 7.71e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 2.42e-01 | 1.38e-01 | 6.56e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 76 | 3.77e-02 | 1.38e-01 | 3.00e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 10 | 4.50e-01 | 1.38e-01 | 8.04e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 19 | 2.98e-01 | -1.38e-01 | 7.07e-01 |
| GOBP SERINE TRANSPORT | 9 | 4.74e-01 | -1.38e-01 | 8.17e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.74e-01 | -1.38e-01 | 8.17e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 12 | 4.09e-01 | 1.38e-01 | 7.82e-01 |
| GOBP HISTONE H4 ACETYLATION | 12 | 4.09e-01 | 1.38e-01 | 7.82e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 430 | 1.08e-06 | 1.38e-01 | 1.41e-04 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 5.94e-01 | -1.38e-01 | 8.72e-01 |
| GOBP VIRAL BUDDING | 23 | 2.53e-01 | 1.38e-01 | 6.66e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 6 | 5.59e-01 | 1.38e-01 | 8.56e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 69 | 4.81e-02 | 1.38e-01 | 3.46e-01 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 5 | 5.94e-01 | -1.38e-01 | 8.72e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 613 | 7.62e-09 | 1.38e-01 | 1.82e-06 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 5 | 5.94e-01 | -1.38e-01 | 8.72e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 6 | 5.60e-01 | 1.37e-01 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 26 | 2.25e-01 | -1.37e-01 | 6.39e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 24 | 2.44e-01 | 1.37e-01 | 6.59e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 34 | 1.66e-01 | -1.37e-01 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 28 | 2.09e-01 | -1.37e-01 | 6.22e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 5 | 5.95e-01 | -1.37e-01 | 8.72e-01 |
| GOBP PROTEIN ACETYLATION | 88 | 2.63e-02 | 1.37e-01 | 2.53e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 5 | 5.95e-01 | -1.37e-01 | 8.72e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 30 | 1.94e-01 | 1.37e-01 | 6.06e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 19 | 3.01e-01 | 1.37e-01 | 7.09e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 12 | 4.12e-01 | 1.37e-01 | 7.83e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 6 | 5.61e-01 | -1.37e-01 | 8.56e-01 |
| GOBP VIRAL PROCESS | 330 | 2.07e-05 | 1.37e-01 | 1.63e-03 |
| GOBP REGULATION OF CENTROSOME CYCLE | 48 | 1.01e-01 | 1.37e-01 | 4.74e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 11 | 4.32e-01 | -1.37e-01 | 7.97e-01 |
| GOMF DEAMINASE ACTIVITY | 25 | 2.37e-01 | 1.37e-01 | 6.49e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 17 | 3.29e-01 | 1.37e-01 | 7.30e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 31 | 1.88e-01 | -1.37e-01 | 6.03e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 25 | 2.37e-01 | -1.37e-01 | 6.50e-01 |
| GOBP BILE ACID SECRETION | 6 | 5.62e-01 | 1.37e-01 | 8.57e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 20 | 2.91e-01 | -1.37e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 7 | 5.32e-01 | -1.37e-01 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 80 | 3.49e-02 | 1.37e-01 | 2.89e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 146 | 4.47e-03 | 1.37e-01 | 9.61e-02 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.33e-01 | 1.36e-01 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 14 | 3.77e-01 | 1.36e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 27 | 2.20e-01 | 1.36e-01 | 6.33e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 22 | 2.69e-01 | 1.36e-01 | 6.82e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 5.98e-01 | 1.36e-01 | 8.73e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 10 | 4.56e-01 | -1.36e-01 | 8.08e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 5.33e-01 | 1.36e-01 | 8.46e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 5.64e-01 | -1.36e-01 | 8.57e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 5.33e-01 | 1.36e-01 | 8.46e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 10 | 4.56e-01 | 1.36e-01 | 8.08e-01 |
| GOCC NUCLEAR PORE | 88 | 2.75e-02 | 1.36e-01 | 2.57e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 44 | 1.19e-01 | -1.36e-01 | 5.02e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 63 | 6.24e-02 | 1.36e-01 | 3.89e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 18 | 3.19e-01 | -1.36e-01 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 66 | 5.66e-02 | 1.36e-01 | 3.73e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 5.65e-01 | 1.36e-01 | 8.58e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 24 | 2.50e-01 | 1.36e-01 | 6.63e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 5.65e-01 | -1.36e-01 | 8.58e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 78 | 3.86e-02 | -1.36e-01 | 3.04e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 47 | 1.08e-01 | 1.36e-01 | 4.85e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 10 | 4.58e-01 | 1.36e-01 | 8.09e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 5 | 6.00e-01 | -1.36e-01 | 8.74e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 68 | 5.36e-02 | 1.35e-01 | 3.64e-01 |
| GOMF QUINONE BINDING | 13 | 3.98e-01 | 1.35e-01 | 7.77e-01 |
| GOBP NODAL SIGNALING PATHWAY | 7 | 5.35e-01 | -1.35e-01 | 8.47e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 43 | 1.25e-01 | 1.35e-01 | 5.15e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 6 | 5.66e-01 | 1.35e-01 | 8.58e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 140 | 5.79e-03 | 1.35e-01 | 1.13e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 180 | 1.78e-03 | 1.35e-01 | 5.41e-02 |
| GOBP REGULATION OF METAL ION TRANSPORT | 192 | 1.26e-03 | 1.35e-01 | 4.35e-02 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 8 | 5.08e-01 | 1.35e-01 | 8.36e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 98 | 2.09e-02 | 1.35e-01 | 2.23e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 5 | 6.01e-01 | -1.35e-01 | 8.74e-01 |
| GOBP MRNA PROCESSING | 432 | 1.66e-06 | 1.35e-01 | 2.04e-04 |
| GOMF COBALAMIN BINDING | 6 | 5.67e-01 | 1.35e-01 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 6.01e-01 | -1.35e-01 | 8.74e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 44 | 1.21e-01 | 1.35e-01 | 5.09e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 9 | 4.83e-01 | 1.35e-01 | 8.20e-01 |
| GOMF INSULIN RECEPTOR BINDING | 14 | 3.82e-01 | 1.35e-01 | 7.69e-01 |
| GOCC MRNA EDITING COMPLEX | 13 | 4.00e-01 | 1.35e-01 | 7.79e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 52 | 9.29e-02 | -1.35e-01 | 4.56e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 17 | 3.36e-01 | -1.35e-01 | 7.34e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 12 | 4.19e-01 | 1.35e-01 | 7.89e-01 |
| GOBP PROSTAGLANDIN SECRETION | 10 | 4.61e-01 | -1.35e-01 | 8.12e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 10 | 4.61e-01 | -1.35e-01 | 8.12e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 76 | 4.26e-02 | 1.35e-01 | 3.20e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 89 | 2.84e-02 | 1.35e-01 | 2.62e-01 |
| GOMF CHOLESTEROL BINDING | 36 | 1.63e-01 | 1.34e-01 | 5.75e-01 |
| GOMF MYOSIN BINDING | 43 | 1.28e-01 | 1.34e-01 | 5.18e-01 |
| GOCC ADHERENS JUNCTION | 117 | 1.22e-02 | 1.34e-01 | 1.70e-01 |
| GOBP FAT PAD DEVELOPMENT | 6 | 5.69e-01 | -1.34e-01 | 8.59e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 6 | 5.69e-01 | 1.34e-01 | 8.59e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 55 | 8.54e-02 | 1.34e-01 | 4.43e-01 |
| GOBP MITOCHONDRIAL FISSION | 35 | 1.70e-01 | 1.34e-01 | 5.81e-01 |
| GOBP CYTOKINESIS | 141 | 6.08e-03 | 1.34e-01 | 1.15e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 23 | 2.66e-01 | -1.34e-01 | 6.80e-01 |
| GOBP NEURON CELL CELL ADHESION | 8 | 5.12e-01 | -1.34e-01 | 8.37e-01 |
| GOBP PROTEIN SUMOYLATION | 59 | 7.55e-02 | 1.34e-01 | 4.22e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 32 | 1.90e-01 | 1.34e-01 | 6.03e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 5.70e-01 | -1.34e-01 | 8.59e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 20 | 3.00e-01 | -1.34e-01 | 7.09e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 7 | 5.40e-01 | -1.34e-01 | 8.49e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 16 | 3.54e-01 | -1.34e-01 | 7.48e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 16 | 3.55e-01 | 1.34e-01 | 7.48e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 119 | 1.20e-02 | 1.34e-01 | 1.68e-01 |
| GOMF COMPLEMENT BINDING | 9 | 4.88e-01 | -1.34e-01 | 8.24e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 4.23e-01 | 1.33e-01 | 7.91e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 11 | 4.44e-01 | 1.33e-01 | 8.02e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 5.41e-01 | 1.33e-01 | 8.49e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 1.67e-01 | 1.33e-01 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 11 | 4.44e-01 | 1.33e-01 | 8.02e-01 |
| GOCC MYOSIN COMPLEX | 29 | 2.15e-01 | 1.33e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 8 | 5.14e-01 | 1.33e-01 | 8.37e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 21 | 2.91e-01 | 1.33e-01 | 7.02e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 4.25e-01 | -1.33e-01 | 7.91e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 5.15e-01 | 1.33e-01 | 8.37e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 6.06e-01 | -1.33e-01 | 8.77e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 7 | 5.42e-01 | -1.33e-01 | 8.50e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 11 | 4.45e-01 | -1.33e-01 | 8.02e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 219 | 7.26e-04 | 1.33e-01 | 3.02e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 86 | 3.34e-02 | -1.33e-01 | 2.84e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 21 | 2.92e-01 | -1.33e-01 | 7.03e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 10 | 4.67e-01 | 1.33e-01 | 8.14e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 6 | 5.74e-01 | -1.33e-01 | 8.61e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 19 | 3.17e-01 | 1.33e-01 | 7.20e-01 |
| GOCC SPERM MIDPIECE | 25 | 2.51e-01 | 1.33e-01 | 6.65e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 5.44e-01 | 1.32e-01 | 8.51e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 52 | 9.86e-02 | 1.32e-01 | 4.67e-01 |
| GOMF OPSONIN BINDING | 8 | 5.16e-01 | -1.32e-01 | 8.39e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 5 | 6.08e-01 | -1.32e-01 | 8.79e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 45 | 1.24e-01 | 1.32e-01 | 5.15e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 30 | 2.10e-01 | -1.32e-01 | 6.23e-01 |
| GOBP NCRNA PROCESSING | 395 | 6.89e-06 | 1.32e-01 | 6.55e-04 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 40 | 1.48e-01 | 1.32e-01 | 5.53e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 29 | 2.18e-01 | 1.32e-01 | 6.31e-01 |
| GOMF PHOSPHATASE BINDING | 150 | 5.24e-03 | 1.32e-01 | 1.07e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 45 | 1.25e-01 | 1.32e-01 | 5.15e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 61 | 7.43e-02 | 1.32e-01 | 4.20e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 17 | 3.46e-01 | 1.32e-01 | 7.41e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 47 | 1.17e-01 | 1.32e-01 | 4.99e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 14 | 3.92e-01 | 1.32e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 11 | 4.48e-01 | -1.32e-01 | 8.04e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 60 | 7.69e-02 | -1.32e-01 | 4.24e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 84 | 3.66e-02 | 1.32e-01 | 2.96e-01 |
| GOCC MICROBODY LUMEN | 38 | 1.59e-01 | 1.32e-01 | 5.70e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 448 | 1.87e-06 | 1.32e-01 | 2.21e-04 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 36 | 1.71e-01 | -1.32e-01 | 5.83e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 4.10e-01 | 1.32e-01 | 7.83e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 190 | 1.75e-03 | 1.32e-01 | 5.37e-02 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 11 | 4.49e-01 | 1.32e-01 | 8.04e-01 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 18 | 3.33e-01 | 1.32e-01 | 7.33e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 16 | 3.61e-01 | 1.32e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 17 | 3.47e-01 | -1.32e-01 | 7.42e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 274 | 1.81e-04 | 1.32e-01 | 1.02e-02 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 20 | 3.08e-01 | 1.32e-01 | 7.13e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 60 | 7.79e-02 | 1.32e-01 | 4.27e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 35 | 1.78e-01 | -1.32e-01 | 5.91e-01 |
| GOBP ENDOCRINE PROCESS | 33 | 1.91e-01 | -1.32e-01 | 6.04e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 47 | 1.19e-01 | 1.32e-01 | 5.02e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 5.77e-01 | 1.32e-01 | 8.63e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 181 | 2.31e-03 | 1.32e-01 | 6.36e-02 |
| GOBP RESPONSE TO SALT STRESS | 15 | 3.78e-01 | 1.32e-01 | 7.65e-01 |
| GOBP PROTEIN POLYMERIZATION | 210 | 1.04e-03 | 1.32e-01 | 3.85e-02 |
| GOBP MACROPHAGE DIFFERENTIATION | 42 | 1.41e-01 | 1.31e-01 | 5.43e-01 |
| GOCC LATERAL ELEMENT | 11 | 4.50e-01 | -1.31e-01 | 8.04e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 7 | 5.47e-01 | -1.31e-01 | 8.53e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 30 | 2.13e-01 | -1.31e-01 | 6.27e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 5.77e-01 | 1.31e-01 | 8.64e-01 |
| GOCC MITOCHONDRION | 1365 | 1.09e-15 | 1.31e-01 | 1.52e-12 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 62 | 7.39e-02 | 1.31e-01 | 4.19e-01 |
| GOMF CERAMIDE BINDING | 14 | 3.95e-01 | -1.31e-01 | 7.75e-01 |
| GOBP CENTROSOME SEPARATION | 13 | 4.12e-01 | -1.31e-01 | 7.84e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 31 | 2.06e-01 | -1.31e-01 | 6.20e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 3.36e-01 | 1.31e-01 | 7.34e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 217 | 8.97e-04 | 1.31e-01 | 3.57e-02 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 6 | 5.78e-01 | 1.31e-01 | 8.64e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 26 | 2.48e-01 | 1.31e-01 | 6.61e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 34 | 1.86e-01 | 1.31e-01 | 6.00e-01 |
| GOCC BRUSH BORDER MEMBRANE | 25 | 2.57e-01 | -1.31e-01 | 6.71e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 12 | 4.32e-01 | -1.31e-01 | 7.97e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 27 | 2.39e-01 | 1.31e-01 | 6.53e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 14 | 3.96e-01 | -1.31e-01 | 7.76e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 10 | 4.74e-01 | 1.31e-01 | 8.17e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 5.79e-01 | -1.31e-01 | 8.64e-01 |
| GOBP BICARBONATE TRANSPORT | 19 | 3.24e-01 | 1.31e-01 | 7.25e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 7 | 5.49e-01 | -1.31e-01 | 8.53e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 13 | 4.14e-01 | 1.31e-01 | 7.86e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 3.65e-01 | 1.31e-01 | 7.55e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 5 | 6.13e-01 | -1.31e-01 | 8.82e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 46 | 1.25e-01 | 1.31e-01 | 5.15e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 46 | 1.26e-01 | 1.31e-01 | 5.15e-01 |
| GOBP FAT CELL PROLIFERATION | 9 | 4.98e-01 | -1.31e-01 | 8.32e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 10 | 4.75e-01 | -1.30e-01 | 8.17e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 5.23e-01 | 1.30e-01 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 13 | 4.16e-01 | 1.30e-01 | 7.86e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 9.45e-02 | 1.30e-01 | 4.60e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 8 | 5.23e-01 | -1.30e-01 | 8.41e-01 |
| GOCC ACTOMYOSIN | 46 | 1.26e-01 | 1.30e-01 | 5.16e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 6 | 5.80e-01 | 1.30e-01 | 8.66e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 8 | 5.23e-01 | -1.30e-01 | 8.41e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 43 | 1.40e-01 | -1.30e-01 | 5.41e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 3.82e-01 | 1.30e-01 | 7.69e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 14 | 3.99e-01 | 1.30e-01 | 7.78e-01 |
| GOCC CAJAL BODY | 57 | 8.94e-02 | 1.30e-01 | 4.53e-01 |
| GOBP REGULATION OF VESICLE FUSION | 12 | 4.35e-01 | 1.30e-01 | 7.98e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 10 | 4.76e-01 | 1.30e-01 | 8.17e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 163 | 4.24e-03 | 1.30e-01 | 9.38e-02 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 102 | 2.34e-02 | 1.30e-01 | 2.37e-01 |
| GOBP SPERM DNA CONDENSATION | 7 | 5.51e-01 | -1.30e-01 | 8.54e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 8 | 5.25e-01 | -1.30e-01 | 8.42e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 11 | 4.56e-01 | 1.30e-01 | 8.08e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 22 | 2.92e-01 | -1.30e-01 | 7.02e-01 |
| GOMF PORIN ACTIVITY | 6 | 5.82e-01 | 1.30e-01 | 8.67e-01 |
| GOMF HEPARIN BINDING | 61 | 7.98e-02 | -1.30e-01 | 4.32e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 9 | 5.00e-01 | 1.30e-01 | 8.32e-01 |
| GOBP CELLULAR RESPONSE TO MAGNESIUM ION | 5 | 6.15e-01 | -1.30e-01 | 8.83e-01 |
| GOBP RESPONSE TO HEAT | 74 | 5.39e-02 | 1.30e-01 | 3.64e-01 |
| GOBP TRANSLATIONAL ELONGATION | 61 | 8.00e-02 | 1.30e-01 | 4.32e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 29 | 2.27e-01 | 1.30e-01 | 6.39e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 10 | 4.78e-01 | 1.30e-01 | 8.18e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 76 | 5.09e-02 | -1.30e-01 | 3.55e-01 |
| GOCC CELL CORTEX REGION | 22 | 2.93e-01 | -1.30e-01 | 7.03e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 27 | 2.44e-01 | 1.30e-01 | 6.59e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 21 | 3.04e-01 | -1.29e-01 | 7.11e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 73 | 5.61e-02 | 1.29e-01 | 3.71e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 5 | 6.17e-01 | -1.29e-01 | 8.83e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 5 | 6.17e-01 | -1.29e-01 | 8.83e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 28 | 2.36e-01 | 1.29e-01 | 6.49e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 47 | 1.26e-01 | -1.29e-01 | 5.15e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 9 | 5.02e-01 | 1.29e-01 | 8.33e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 5 | 6.17e-01 | -1.29e-01 | 8.83e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 14 | 4.03e-01 | 1.29e-01 | 7.80e-01 |
| GOCC MEMBRANE COAT | 84 | 4.12e-02 | 1.29e-01 | 3.14e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 104 | 2.32e-02 | 1.29e-01 | 2.36e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 153 | 6.00e-03 | 1.29e-01 | 1.14e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 13 | 4.21e-01 | -1.29e-01 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 24 | 2.75e-01 | 1.29e-01 | 6.89e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 44 | 1.40e-01 | 1.29e-01 | 5.41e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 14 | 4.04e-01 | -1.29e-01 | 7.80e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 6 | 5.85e-01 | 1.29e-01 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 6 | 5.85e-01 | 1.29e-01 | 8.68e-01 |
| GOBP MACROPHAGE MIGRATION | 33 | 2.01e-01 | 1.29e-01 | 6.14e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 8 | 5.29e-01 | 1.29e-01 | 8.44e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 27 | 2.47e-01 | 1.29e-01 | 6.61e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 7 | 5.56e-01 | 1.29e-01 | 8.56e-01 |
| GOBP MRNA TRANSPORT | 115 | 1.74e-02 | 1.29e-01 | 2.01e-01 |
| GOBP MEMBRANE REPOLARIZATION | 15 | 3.89e-01 | 1.28e-01 | 7.72e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 105 | 2.31e-02 | 1.28e-01 | 2.35e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 79 | 4.86e-02 | 1.28e-01 | 3.47e-01 |
| GOCC CONTRACTILE FIBER | 136 | 9.86e-03 | 1.28e-01 | 1.50e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 65 | 7.37e-02 | 1.28e-01 | 4.19e-01 |
| GOMF POLYSACCHARIDE BINDING | 9 | 5.05e-01 | -1.28e-01 | 8.35e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 104 | 2.39e-02 | 1.28e-01 | 2.40e-01 |
| GOBP G1 TO G0 TRANSITION | 13 | 4.23e-01 | -1.28e-01 | 7.91e-01 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 5.05e-01 | 1.28e-01 | 8.35e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 9 | 5.05e-01 | 1.28e-01 | 8.35e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 12 | 4.42e-01 | -1.28e-01 | 8.01e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 6 | 5.87e-01 | 1.28e-01 | 8.69e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 631 | 4.83e-08 | 1.28e-01 | 9.62e-06 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 9 | 5.06e-01 | 1.28e-01 | 8.35e-01 |
| GOBP PLASMA MEMBRANE FUSION | 5 | 6.20e-01 | -1.28e-01 | 8.84e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 31 | 2.17e-01 | -1.28e-01 | 6.31e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 21 | 3.10e-01 | -1.28e-01 | 7.15e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 76 | 5.38e-02 | -1.28e-01 | 3.64e-01 |
| GOCC SARCOLEMMA | 73 | 5.89e-02 | 1.28e-01 | 3.79e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 41 | 1.57e-01 | 1.28e-01 | 5.66e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 13 | 4.25e-01 | 1.28e-01 | 7.91e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 85 | 4.18e-02 | 1.28e-01 | 3.16e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 17 | 3.62e-01 | 1.28e-01 | 7.52e-01 |
| GOMF GLUCOSE BINDING | 9 | 5.07e-01 | 1.28e-01 | 8.36e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.58e-01 | 1.28e-01 | 8.56e-01 |
| GOBP KETONE CATABOLIC PROCESS | 10 | 4.84e-01 | 1.28e-01 | 8.21e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 5.88e-01 | 1.28e-01 | 8.70e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 7 | 5.58e-01 | -1.28e-01 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 2.26e-01 | 1.28e-01 | 6.39e-01 |
| GOBP CHROMATIN REMODELING | 484 | 1.72e-06 | 1.28e-01 | 2.08e-04 |
| GOCC ORGANELLE ENVELOPE LUMEN | 75 | 5.62e-02 | 1.28e-01 | 3.71e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 122 | 1.51e-02 | 1.28e-01 | 1.89e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 38 | 1.74e-01 | 1.28e-01 | 5.87e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 55 | 1.02e-01 | 1.28e-01 | 4.77e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 24 | 2.80e-01 | -1.27e-01 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 19 | 3.36e-01 | 1.27e-01 | 7.34e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 5.08e-01 | -1.27e-01 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 7 | 5.59e-01 | -1.27e-01 | 8.56e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 62 | 8.31e-02 | 1.27e-01 | 4.38e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 28 | 2.44e-01 | 1.27e-01 | 6.58e-01 |
| GOBP INTESTINAL ABSORPTION | 17 | 3.63e-01 | -1.27e-01 | 7.54e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 8 | 5.33e-01 | 1.27e-01 | 8.46e-01 |
| GOMF RIBOSOME BINDING | 103 | 2.57e-02 | 1.27e-01 | 2.49e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 87 | 4.03e-02 | 1.27e-01 | 3.11e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 39 | 1.69e-01 | -1.27e-01 | 5.80e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 7 | 5.60e-01 | 1.27e-01 | 8.56e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 9 | 5.09e-01 | -1.27e-01 | 8.36e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 14 | 4.10e-01 | -1.27e-01 | 7.83e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 6.23e-01 | 1.27e-01 | 8.85e-01 |
| GOBP PROTEIN OXIDATION | 7 | 5.60e-01 | 1.27e-01 | 8.56e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 17 | 3.65e-01 | -1.27e-01 | 7.54e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 77 | 5.41e-02 | 1.27e-01 | 3.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 74 | 5.91e-02 | 1.27e-01 | 3.79e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 11 | 4.66e-01 | -1.27e-01 | 8.13e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 24 | 2.82e-01 | -1.27e-01 | 6.97e-01 |
| GOBP RECEPTOR INTERNALIZATION | 82 | 4.71e-02 | 1.27e-01 | 3.41e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 66 | 7.50e-02 | 1.27e-01 | 4.21e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 17 | 3.66e-01 | -1.27e-01 | 7.55e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 52 | 1.15e-01 | 1.26e-01 | 4.97e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 5.92e-01 | 1.26e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 115 | 1.93e-02 | 1.26e-01 | 2.11e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 9 | 5.12e-01 | 1.26e-01 | 8.37e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 6.25e-01 | -1.26e-01 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 6.25e-01 | 1.26e-01 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 6.26e-01 | -1.26e-01 | 8.86e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 64 | 8.15e-02 | 1.26e-01 | 4.34e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 55 | 1.06e-01 | -1.26e-01 | 4.82e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 6 | 5.93e-01 | 1.26e-01 | 8.71e-01 |
| GOCC NUCLEOLUS | 881 | 3.36e-10 | 1.26e-01 | 1.28e-07 |
| GOBP TRNA METABOLIC PROCESS | 170 | 4.70e-03 | 1.26e-01 | 9.96e-02 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 18 | 3.55e-01 | -1.26e-01 | 7.49e-01 |
| GOBP MRNA METABOLIC PROCESS | 644 | 6.38e-08 | 1.26e-01 | 1.24e-05 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 9 | 5.14e-01 | -1.26e-01 | 8.37e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 12 | 4.51e-01 | -1.26e-01 | 8.04e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 5.38e-01 | 1.26e-01 | 8.48e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 34 | 2.05e-01 | 1.26e-01 | 6.19e-01 |
| GOCC FIBRILLAR CENTER | 129 | 1.39e-02 | 1.26e-01 | 1.80e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 25 | 2.77e-01 | -1.26e-01 | 6.91e-01 |
| GOBP NUCLEUS ORGANIZATION | 118 | 1.86e-02 | 1.26e-01 | 2.07e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 108 | 2.44e-02 | 1.26e-01 | 2.43e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 163 | 5.78e-03 | 1.26e-01 | 1.13e-01 |
| GOCC MICROBODY MEMBRANE | 57 | 1.02e-01 | 1.25e-01 | 4.76e-01 |
| GOBP CARTILAGE CONDENSATION | 6 | 5.95e-01 | -1.25e-01 | 8.72e-01 |
| GOBP PROTEIN TETRAMERIZATION | 60 | 9.34e-02 | 1.25e-01 | 4.58e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 6.28e-01 | -1.25e-01 | 8.87e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 20 | 3.32e-01 | -1.25e-01 | 7.33e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 14 | 4.17e-01 | 1.25e-01 | 7.88e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 7 | 5.66e-01 | 1.25e-01 | 8.58e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 18 | 3.58e-01 | 1.25e-01 | 7.50e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 70 | 7.04e-02 | 1.25e-01 | 4.10e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 4.72e-01 | 1.25e-01 | 8.16e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 5.40e-01 | 1.25e-01 | 8.49e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 15 | 4.02e-01 | 1.25e-01 | 7.80e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 38 | 1.82e-01 | -1.25e-01 | 5.97e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 150 | 8.33e-03 | 1.25e-01 | 1.36e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 13 | 4.35e-01 | -1.25e-01 | 7.98e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 82 | 5.08e-02 | 1.25e-01 | 3.55e-01 |
| GOBP HISTIDINE CATABOLIC PROCESS | 5 | 6.29e-01 | -1.25e-01 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 57 | 1.03e-01 | 1.25e-01 | 4.79e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 6.29e-01 | 1.25e-01 | 8.88e-01 |
| GOBP VIRAL GENE EXPRESSION | 94 | 3.67e-02 | 1.25e-01 | 2.96e-01 |
| GOBP INTRACELLULAR PH ELEVATION | 5 | 6.29e-01 | -1.25e-01 | 8.88e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 15 | 4.03e-01 | 1.25e-01 | 7.80e-01 |
| GOBP CENTROSOME DUPLICATION | 68 | 7.59e-02 | 1.25e-01 | 4.23e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1064 | 1.22e-11 | -1.24e-01 | 7.28e-09 |
| GOCC REPLISOME | 14 | 4.20e-01 | 1.24e-01 | 7.89e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 5.18e-01 | 1.24e-01 | 8.39e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 55 | 1.11e-01 | -1.24e-01 | 4.90e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 16 | 3.89e-01 | 1.24e-01 | 7.71e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 6.30e-01 | 1.24e-01 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 34 | 2.10e-01 | -1.24e-01 | 6.23e-01 |
| GOBP DENDRITE EXTENSION | 21 | 3.24e-01 | 1.24e-01 | 7.25e-01 |
| GOBP RNA SPLICING | 406 | 1.87e-05 | 1.24e-01 | 1.51e-03 |
| GOCC U2 SNRNP | 25 | 2.82e-01 | 1.24e-01 | 6.97e-01 |
| GOMF PROLINE RICH REGION BINDING | 13 | 4.38e-01 | 1.24e-01 | 7.98e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 6 | 5.98e-01 | -1.24e-01 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 6 | 5.98e-01 | 1.24e-01 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 90 | 4.18e-02 | 1.24e-01 | 3.16e-01 |
| GOMF MAGNESIUM ION BINDING | 175 | 4.66e-03 | 1.24e-01 | 9.91e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 51 | 1.25e-01 | 1.24e-01 | 5.15e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 13 | 4.38e-01 | -1.24e-01 | 7.99e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 76 | 6.15e-02 | 1.24e-01 | 3.87e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 37 | 1.92e-01 | 1.24e-01 | 6.04e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 84 | 4.96e-02 | 1.24e-01 | 3.51e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 8 | 5.44e-01 | 1.24e-01 | 8.51e-01 |
| GOMF ALCOHOL BINDING | 57 | 1.06e-01 | 1.24e-01 | 4.81e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 2.40e-01 | 1.24e-01 | 6.54e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 248 | 8.06e-04 | 1.24e-01 | 3.29e-02 |
| GOCC NADPH OXIDASE COMPLEX | 9 | 5.20e-01 | 1.24e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 6 | 6.00e-01 | -1.24e-01 | 8.74e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1190 | 1.29e-12 | 1.24e-01 | 9.00e-10 |
| GOBP SNORNA LOCALIZATION | 6 | 6.00e-01 | 1.24e-01 | 8.74e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 10 | 4.98e-01 | -1.24e-01 | 8.32e-01 |
| GOMF HELICASE ACTIVITY | 141 | 1.14e-02 | 1.24e-01 | 1.65e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 25 | 2.85e-01 | -1.24e-01 | 6.99e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 10 | 4.99e-01 | 1.24e-01 | 8.32e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 69 | 7.61e-02 | 1.24e-01 | 4.23e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 51 | 1.27e-01 | -1.23e-01 | 5.18e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 18 | 3.65e-01 | 1.23e-01 | 7.54e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 176 | 4.81e-03 | 1.23e-01 | 1.02e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 22 | 3.17e-01 | 1.23e-01 | 7.20e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 107 | 2.77e-02 | 1.23e-01 | 2.58e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 8 | 5.46e-01 | 1.23e-01 | 8.52e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 77 | 6.19e-02 | 1.23e-01 | 3.87e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 93 | 4.03e-02 | 1.23e-01 | 3.11e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 76 | 6.37e-02 | 1.23e-01 | 3.92e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 5.00e-01 | 1.23e-01 | 8.32e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 17 | 3.80e-01 | -1.23e-01 | 7.67e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 19 | 3.54e-01 | 1.23e-01 | 7.48e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 19 | 3.54e-01 | 1.23e-01 | 7.48e-01 |
| GOCC DYNEIN COMPLEX | 35 | 2.09e-01 | 1.23e-01 | 6.22e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 9 | 5.24e-01 | -1.23e-01 | 8.41e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 113 | 2.44e-02 | 1.23e-01 | 2.43e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 66 | 8.50e-02 | 1.23e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 48 | 1.42e-01 | 1.23e-01 | 5.43e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 38 | 1.91e-01 | 1.23e-01 | 6.04e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 5.48e-01 | 1.23e-01 | 8.53e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 6.35e-01 | 1.23e-01 | 8.90e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 6.35e-01 | 1.23e-01 | 8.90e-01 |
| GOBP TELOMERE ORGANIZATION | 149 | 9.96e-03 | 1.23e-01 | 1.50e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 12 | 4.63e-01 | -1.22e-01 | 8.12e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 3.97e-01 | -1.22e-01 | 7.76e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 108 | 2.82e-02 | 1.22e-01 | 2.62e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 300 | 2.81e-04 | 1.22e-01 | 1.39e-02 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 22 | 3.21e-01 | 1.22e-01 | 7.24e-01 |
| GOBP EATING BEHAVIOR | 13 | 4.45e-01 | -1.22e-01 | 8.02e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 50 | 1.35e-01 | 1.22e-01 | 5.32e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 9 | 5.25e-01 | 1.22e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 12 | 4.64e-01 | 1.22e-01 | 8.12e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 9 | 5.26e-01 | -1.22e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 34 | 2.18e-01 | 1.22e-01 | 6.31e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 16 | 3.98e-01 | 1.22e-01 | 7.77e-01 |
| GOMF VIRION BINDING | 5 | 6.37e-01 | 1.22e-01 | 8.91e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 7 | 5.76e-01 | 1.22e-01 | 8.63e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 22 | 3.22e-01 | 1.22e-01 | 7.24e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 45 | 1.57e-01 | 1.22e-01 | 5.67e-01 |
| GOCC MICROVILLUS | 51 | 1.32e-01 | -1.22e-01 | 5.27e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 12 | 4.65e-01 | -1.22e-01 | 8.13e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 8 | 5.51e-01 | -1.22e-01 | 8.54e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 8 | 5.51e-01 | 1.22e-01 | 8.54e-01 |
| GOCC COATED VESICLE MEMBRANE | 152 | 9.66e-03 | 1.22e-01 | 1.48e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 46 | 1.53e-01 | -1.22e-01 | 5.62e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 3.34e-01 | 1.22e-01 | 7.34e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 21 | 3.35e-01 | 1.22e-01 | 7.34e-01 |
| GOBP ACROSOME ASSEMBLY | 13 | 4.48e-01 | 1.22e-01 | 8.04e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 23 | 3.13e-01 | 1.22e-01 | 7.17e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 33 | 2.27e-01 | -1.22e-01 | 6.39e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 4.48e-01 | -1.22e-01 | 8.04e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 10 | 5.06e-01 | -1.21e-01 | 8.35e-01 |
| GOMF APOLIPOPROTEIN BINDING | 7 | 5.78e-01 | 1.21e-01 | 8.64e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 142 | 1.26e-02 | 1.21e-01 | 1.72e-01 |
| GOCC EXOCYST | 11 | 4.86e-01 | 1.21e-01 | 8.23e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 17 | 3.87e-01 | -1.21e-01 | 7.70e-01 |
| GOBP CHOLINE TRANSPORT | 5 | 6.39e-01 | -1.21e-01 | 8.92e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 122 | 2.11e-02 | -1.21e-01 | 2.24e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 15 | 4.17e-01 | 1.21e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 5 | 6.40e-01 | -1.21e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 47 | 1.52e-01 | 1.21e-01 | 5.60e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 16 | 4.03e-01 | -1.21e-01 | 7.80e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 9 | 5.30e-01 | 1.21e-01 | 8.45e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 4.69e-01 | 1.21e-01 | 8.15e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 12 | 4.69e-01 | 1.21e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 20 | 3.50e-01 | 1.21e-01 | 7.44e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 70 | 8.08e-02 | -1.21e-01 | 4.34e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 23 | 3.16e-01 | -1.21e-01 | 7.20e-01 |
| GOCC GRANULAR COMPONENT | 6 | 6.09e-01 | 1.21e-01 | 8.79e-01 |
| GOBP RNA CATABOLIC PROCESS | 260 | 8.42e-04 | 1.21e-01 | 3.38e-02 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 33 | 2.31e-01 | 1.21e-01 | 6.42e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 8 | 5.55e-01 | -1.21e-01 | 8.56e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY | 5 | 6.41e-01 | -1.21e-01 | 8.93e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 73 | 7.53e-02 | 1.20e-01 | 4.22e-01 |
| GOMF SNRNA BINDING | 45 | 1.62e-01 | 1.20e-01 | 5.74e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 186 | 4.73e-03 | 1.20e-01 | 1.00e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 128 | 1.89e-02 | 1.20e-01 | 2.09e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 5 | 6.41e-01 | -1.20e-01 | 8.93e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 79 | 6.48e-02 | 1.20e-01 | 3.95e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 24 | 3.08e-01 | 1.20e-01 | 7.13e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 85 | 5.55e-02 | 1.20e-01 | 3.70e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 21 | 3.40e-01 | 1.20e-01 | 7.37e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 61 | 1.05e-01 | 1.20e-01 | 4.81e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 3.52e-01 | 1.20e-01 | 7.47e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 117 | 2.50e-02 | 1.20e-01 | 2.45e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 11 | 4.90e-01 | -1.20e-01 | 8.26e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 6.42e-01 | 1.20e-01 | 8.93e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 4.54e-01 | -1.20e-01 | 8.06e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 9 | 5.33e-01 | 1.20e-01 | 8.46e-01 |
| GOCC OUTER MEMBRANE | 201 | 3.44e-03 | 1.20e-01 | 8.12e-02 |
| GOCC MICROVILLUS MEMBRANE | 17 | 3.92e-01 | -1.20e-01 | 7.73e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 6.11e-01 | 1.20e-01 | 8.80e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 18 | 3.79e-01 | 1.20e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 8 | 5.57e-01 | -1.20e-01 | 8.56e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 5.83e-01 | 1.20e-01 | 8.67e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 5 | 6.43e-01 | 1.20e-01 | 8.93e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 116 | 2.60e-02 | 1.20e-01 | 2.51e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 82 | 6.11e-02 | 1.20e-01 | 3.86e-01 |
| GOBP T CELL HOMEOSTASIS | 35 | 2.21e-01 | 1.20e-01 | 6.34e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 5.12e-01 | -1.20e-01 | 8.37e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 248 | 1.22e-03 | 1.20e-01 | 4.31e-02 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 38 | 2.02e-01 | -1.20e-01 | 6.15e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 714 | 6.71e-08 | 1.20e-01 | 1.25e-05 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 141 | 1.44e-02 | 1.20e-01 | 1.84e-01 |
| GOMF CORECEPTOR ACTIVITY | 25 | 3.01e-01 | -1.19e-01 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 56 | 1.23e-01 | -1.19e-01 | 5.12e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 159 | 9.54e-03 | 1.19e-01 | 1.47e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 781 | 1.88e-08 | 1.19e-01 | 4.25e-06 |
| GOMF LIPID KINASE ACTIVITY | 36 | 2.16e-01 | 1.19e-01 | 6.29e-01 |
| GOCC VESICLE TETHERING COMPLEX | 52 | 1.37e-01 | 1.19e-01 | 5.35e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 9 | 5.36e-01 | 1.19e-01 | 8.47e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 8 | 5.59e-01 | -1.19e-01 | 8.56e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 91 | 4.95e-02 | 1.19e-01 | 3.51e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 89 | 5.21e-02 | 1.19e-01 | 3.60e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 22 | 3.33e-01 | -1.19e-01 | 7.33e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 19 | 3.69e-01 | 1.19e-01 | 7.58e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 9 | 5.36e-01 | 1.19e-01 | 8.47e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 9 | 5.36e-01 | 1.19e-01 | 8.47e-01 |
| GOBP INORGANIC ANION TRANSPORT | 79 | 6.76e-02 | 1.19e-01 | 4.01e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 12 | 4.75e-01 | 1.19e-01 | 8.17e-01 |
| GOMF NADPLUS BINDING | 17 | 3.96e-01 | 1.19e-01 | 7.76e-01 |
| GOBP FAT CELL DIFFERENTIATION | 145 | 1.36e-02 | -1.19e-01 | 1.79e-01 |
| GOBP MYOBLAST FUSION | 23 | 3.24e-01 | 1.19e-01 | 7.25e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 6.15e-01 | -1.19e-01 | 8.83e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 9 | 5.38e-01 | 1.19e-01 | 8.48e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 23 | 3.25e-01 | -1.19e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 5 | 6.46e-01 | -1.19e-01 | 8.94e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 42 | 1.84e-01 | 1.19e-01 | 5.98e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 69 | 8.87e-02 | 1.19e-01 | 4.51e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 6.15e-01 | -1.19e-01 | 8.83e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 6 | 6.15e-01 | -1.19e-01 | 8.83e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 273 | 7.79e-04 | 1.19e-01 | 3.21e-02 |
| GOBP V D J RECOMBINATION | 18 | 3.85e-01 | 1.18e-01 | 7.70e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 11 | 4.97e-01 | -1.18e-01 | 8.31e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 18 | 3.85e-01 | -1.18e-01 | 7.70e-01 |
| GOBP RNA MODIFICATION | 165 | 8.95e-03 | 1.18e-01 | 1.42e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 8 | 5.63e-01 | -1.18e-01 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 125 | 2.28e-02 | 1.18e-01 | 2.34e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 104 | 3.77e-02 | 1.18e-01 | 3.00e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 116 | 2.84e-02 | 1.18e-01 | 2.62e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 52 | 1.41e-01 | 1.18e-01 | 5.43e-01 |
| GOMF GAMMA TUBULIN BINDING | 29 | 2.72e-01 | 1.18e-01 | 6.85e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 70 | 8.82e-02 | 1.18e-01 | 4.49e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 14 | 4.45e-01 | -1.18e-01 | 8.02e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 84 | 6.24e-02 | -1.18e-01 | 3.89e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 305 | 4.24e-04 | 1.18e-01 | 2.01e-02 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 53 | 1.38e-01 | 1.18e-01 | 5.38e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 5.64e-01 | 1.18e-01 | 8.58e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 21 | 3.51e-01 | -1.18e-01 | 7.46e-01 |
| GOBP PROTEIN REPAIR | 6 | 6.18e-01 | 1.18e-01 | 8.83e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 7 | 5.90e-01 | 1.18e-01 | 8.70e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 67 | 9.65e-02 | -1.18e-01 | 4.62e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 16 | 4.16e-01 | -1.17e-01 | 7.87e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 12 | 4.81e-01 | 1.17e-01 | 8.20e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 3.89e-01 | 1.17e-01 | 7.71e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 5.91e-01 | -1.17e-01 | 8.70e-01 |
| GOBP MANCHETTE ASSEMBLY | 7 | 5.91e-01 | -1.17e-01 | 8.70e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 39 | 2.05e-01 | 1.17e-01 | 6.19e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 13 | 4.64e-01 | -1.17e-01 | 8.12e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 6 | 6.19e-01 | 1.17e-01 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 65 | 1.02e-01 | -1.17e-01 | 4.77e-01 |
| GOCC TOR COMPLEX | 11 | 5.01e-01 | 1.17e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 5 | 6.50e-01 | 1.17e-01 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 5 | 6.50e-01 | 1.17e-01 | 8.95e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 8 | 5.66e-01 | 1.17e-01 | 8.58e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 45 | 1.74e-01 | 1.17e-01 | 5.88e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 11 | 5.02e-01 | 1.17e-01 | 8.33e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 18 | 3.90e-01 | 1.17e-01 | 7.72e-01 |
| GOMF SMAD BINDING | 56 | 1.30e-01 | 1.17e-01 | 5.23e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 130 | 2.15e-02 | 1.17e-01 | 2.26e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 6.20e-01 | 1.17e-01 | 8.84e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 112 | 3.29e-02 | 1.17e-01 | 2.84e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 90 | 5.56e-02 | 1.17e-01 | 3.70e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 89 | 5.71e-02 | 1.17e-01 | 3.74e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 7 | 5.93e-01 | -1.17e-01 | 8.71e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 7 | 5.93e-01 | 1.17e-01 | 8.71e-01 |
| GOBP THYMUS DEVELOPMENT | 33 | 2.47e-01 | 1.17e-01 | 6.61e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 11 | 5.03e-01 | -1.17e-01 | 8.33e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 45 | 1.76e-01 | 1.17e-01 | 5.89e-01 |
| GOBP MISMATCH REPAIR | 26 | 3.04e-01 | 1.16e-01 | 7.11e-01 |
| GOMF HYDRO LYASE ACTIVITY | 39 | 2.09e-01 | 1.16e-01 | 6.22e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 160 | 1.12e-02 | 1.16e-01 | 1.63e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 32 | 2.55e-01 | 1.16e-01 | 6.69e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 26 | 3.05e-01 | 1.16e-01 | 7.12e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 7 | 5.95e-01 | 1.16e-01 | 8.72e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 3.25e-01 | 1.16e-01 | 7.25e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 6.22e-01 | -1.16e-01 | 8.85e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 6.53e-01 | -1.16e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 7 | 5.95e-01 | 1.16e-01 | 8.72e-01 |
| GOCC TORC2 COMPLEX | 9 | 5.47e-01 | 1.16e-01 | 8.53e-01 |
| GOBP DNA REPLICATION | 242 | 1.94e-03 | 1.16e-01 | 5.74e-02 |
| GOCC DNA POLYMERASE COMPLEX | 19 | 3.82e-01 | 1.16e-01 | 7.68e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 14 | 4.53e-01 | -1.16e-01 | 8.06e-01 |
| GOCC REPLICATION FORK | 61 | 1.18e-01 | 1.16e-01 | 5.00e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 6 | 6.23e-01 | 1.16e-01 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 83 | 6.85e-02 | 1.16e-01 | 4.03e-01 |
| GOBP CELLULAR SENESCENCE | 82 | 7.02e-02 | 1.16e-01 | 4.09e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 26 | 3.07e-01 | -1.16e-01 | 7.13e-01 |
| GOCC PCG PROTEIN COMPLEX | 32 | 2.57e-01 | 1.16e-01 | 6.71e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 92 | 5.54e-02 | 1.16e-01 | 3.70e-01 |
| GOCC EARLY PHAGOSOME | 9 | 5.48e-01 | 1.16e-01 | 8.53e-01 |
| GOBP NCRNA METABOLIC PROCESS | 528 | 6.25e-06 | 1.16e-01 | 6.01e-04 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 29 | 2.82e-01 | 1.15e-01 | 6.97e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 79 | 7.64e-02 | 1.15e-01 | 4.24e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 11 | 5.08e-01 | -1.15e-01 | 8.36e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 9 | 5.49e-01 | -1.15e-01 | 8.53e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 36 | 2.31e-01 | -1.15e-01 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 29 | 2.83e-01 | 1.15e-01 | 6.97e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 15 | 4.40e-01 | 1.15e-01 | 8.00e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 62 | 1.17e-01 | -1.15e-01 | 4.99e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 11 | 5.08e-01 | 1.15e-01 | 8.36e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 21 | 3.61e-01 | -1.15e-01 | 7.52e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 340 | 2.77e-04 | 1.15e-01 | 1.39e-02 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 54 | 1.44e-01 | 1.15e-01 | 5.47e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 5.98e-01 | 1.15e-01 | 8.73e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 56 | 1.37e-01 | 1.15e-01 | 5.35e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 77 | 8.11e-02 | 1.15e-01 | 4.34e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 6 | 6.26e-01 | 1.15e-01 | 8.86e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 150 | 1.52e-02 | 1.15e-01 | 1.89e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 310 | 5.20e-04 | 1.15e-01 | 2.34e-02 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 104 | 4.30e-02 | 1.15e-01 | 3.21e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 10 | 5.29e-01 | -1.15e-01 | 8.44e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 27 | 3.01e-01 | -1.15e-01 | 7.09e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 109 | 3.83e-02 | 1.15e-01 | 3.03e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 53 | 1.48e-01 | 1.15e-01 | 5.54e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 50 | 1.60e-01 | 1.15e-01 | 5.72e-01 |
| GOCC GROWTH CONE MEMBRANE | 5 | 6.57e-01 | 1.15e-01 | 8.99e-01 |
| GOMF POLY PURINE TRACT BINDING | 25 | 3.20e-01 | 1.15e-01 | 7.24e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 12 | 4.91e-01 | -1.15e-01 | 8.27e-01 |
| GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY | 5 | 6.57e-01 | 1.15e-01 | 8.99e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 263 | 1.40e-03 | -1.15e-01 | 4.61e-02 |
| GOBP RETINA LAYER FORMATION | 12 | 4.92e-01 | -1.15e-01 | 8.27e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 9 | 5.52e-01 | 1.15e-01 | 8.54e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 3.87e-01 | 1.15e-01 | 7.70e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 16 | 4.28e-01 | -1.15e-01 | 7.93e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.00e-01 | 1.15e-01 | 8.74e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 13 | 4.75e-01 | -1.15e-01 | 8.17e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 482 | 1.85e-05 | 1.14e-01 | 1.50e-03 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 9 | 5.52e-01 | -1.14e-01 | 8.54e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 9 | 5.53e-01 | -1.14e-01 | 8.54e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 377 | 1.48e-04 | 1.14e-01 | 8.58e-03 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 9 | 5.53e-01 | -1.14e-01 | 8.54e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 9 | 5.53e-01 | 1.14e-01 | 8.54e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 17 | 4.15e-01 | 1.14e-01 | 7.86e-01 |
| GOMF GTPASE ACTIVITY | 234 | 2.68e-03 | 1.14e-01 | 6.93e-02 |
| GOMF DEUBIQUITINASE ACTIVITY | 89 | 6.29e-02 | 1.14e-01 | 3.89e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 6 | 6.28e-01 | -1.14e-01 | 8.88e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 10 | 5.32e-01 | 1.14e-01 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 17 | 4.16e-01 | -1.14e-01 | 7.86e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 35 | 2.44e-01 | 1.14e-01 | 6.58e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 5 | 6.59e-01 | -1.14e-01 | 9.00e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 10 | 5.33e-01 | -1.14e-01 | 8.46e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 198 | 5.87e-03 | 1.14e-01 | 1.13e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 10 | 5.34e-01 | -1.14e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 43 | 1.97e-01 | 1.14e-01 | 6.10e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 5.14e-01 | -1.14e-01 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 34 | 2.52e-01 | -1.14e-01 | 6.65e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 19 | 3.92e-01 | 1.14e-01 | 7.73e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 10 | 5.34e-01 | 1.14e-01 | 8.46e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 19 | 3.92e-01 | -1.14e-01 | 7.73e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 18 | 4.05e-01 | 1.13e-01 | 7.80e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 6.03e-01 | 1.13e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 30 | 2.83e-01 | -1.13e-01 | 6.97e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 15 | 4.47e-01 | -1.13e-01 | 8.04e-01 |
| GOMF IRON ION BINDING | 74 | 9.22e-02 | 1.13e-01 | 4.56e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 8 | 5.79e-01 | 1.13e-01 | 8.64e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 67 | 1.09e-01 | 1.13e-01 | 4.88e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 15 | 4.48e-01 | -1.13e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 9 | 5.57e-01 | 1.13e-01 | 8.56e-01 |
| GOBP NUCLEAR TRANSPORT | 283 | 1.10e-03 | 1.13e-01 | 3.97e-02 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 30 | 2.84e-01 | -1.13e-01 | 6.98e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 6.32e-01 | -1.13e-01 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 5.80e-01 | -1.13e-01 | 8.66e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 42 | 2.06e-01 | 1.13e-01 | 6.19e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 10 | 5.37e-01 | -1.13e-01 | 8.47e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 202 | 5.83e-03 | 1.13e-01 | 1.13e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 36 | 2.42e-01 | 1.13e-01 | 6.56e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 6 | 6.33e-01 | 1.13e-01 | 8.90e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 7 | 6.06e-01 | 1.13e-01 | 8.76e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 5.17e-01 | 1.13e-01 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 5.58e-01 | -1.13e-01 | 8.56e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 21 | 3.72e-01 | 1.13e-01 | 7.60e-01 |
| GOCC PHOSPHATASE COMPLEX | 47 | 1.82e-01 | 1.13e-01 | 5.97e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 22 | 3.61e-01 | -1.13e-01 | 7.52e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 8 | 5.82e-01 | -1.13e-01 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 11 | 5.18e-01 | -1.12e-01 | 8.40e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 52 | 1.61e-01 | 1.12e-01 | 5.73e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 8 | 5.82e-01 | 1.12e-01 | 8.67e-01 |
| GOBP NK T CELL ACTIVATION | 11 | 5.19e-01 | 1.12e-01 | 8.40e-01 |
| GOCC MEIOTIC SPINDLE | 8 | 5.82e-01 | 1.12e-01 | 8.67e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 5 | 6.64e-01 | -1.12e-01 | 9.03e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 22 | 3.62e-01 | -1.12e-01 | 7.52e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 28 | 3.04e-01 | -1.12e-01 | 7.11e-01 |
| GOMF SPHINGOLIPID BINDING | 20 | 3.85e-01 | -1.12e-01 | 7.70e-01 |
| GOBP ODONTOGENESIS | 46 | 1.88e-01 | 1.12e-01 | 6.03e-01 |
| GOBP RESPONSE TO LECTIN | 20 | 3.85e-01 | 1.12e-01 | 7.70e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1077 | 8.28e-10 | 1.12e-01 | 2.47e-07 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 15 | 4.52e-01 | 1.12e-01 | 8.06e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 6 | 6.34e-01 | -1.12e-01 | 8.90e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 6 | 6.35e-01 | 1.12e-01 | 8.90e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 24 | 3.42e-01 | 1.12e-01 | 7.39e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 20 | 3.86e-01 | -1.12e-01 | 7.70e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 13 | 4.85e-01 | 1.12e-01 | 8.22e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 35 | 2.52e-01 | 1.12e-01 | 6.65e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 50 | 1.71e-01 | -1.12e-01 | 5.83e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 47 | 1.85e-01 | 1.12e-01 | 5.98e-01 |
| GOBP CHROMOSOME ORGANIZATION | 491 | 2.41e-05 | 1.12e-01 | 1.83e-03 |
| GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 5 | 6.65e-01 | -1.12e-01 | 9.03e-01 |
| GOBP CENTRIOLE ASSEMBLY | 42 | 2.10e-01 | 1.12e-01 | 6.23e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 15 | 4.53e-01 | 1.12e-01 | 8.06e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 15 | 4.54e-01 | -1.12e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 28 | 3.06e-01 | 1.12e-01 | 7.12e-01 |
| GOBP EXCRETION | 8 | 5.85e-01 | -1.12e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 28 | 3.07e-01 | 1.12e-01 | 7.13e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 7 | 6.09e-01 | 1.12e-01 | 8.79e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 11 | 5.22e-01 | -1.12e-01 | 8.41e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 5 | 6.66e-01 | 1.12e-01 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 232 | 3.48e-03 | 1.12e-01 | 8.17e-02 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 12 | 5.03e-01 | -1.12e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 13 | 4.86e-01 | 1.12e-01 | 8.23e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 20 | 3.88e-01 | -1.11e-01 | 7.71e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 6.10e-01 | -1.11e-01 | 8.79e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 266 | 1.81e-03 | 1.11e-01 | 5.49e-02 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 11 | 5.22e-01 | 1.11e-01 | 8.41e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 4.87e-01 | 1.11e-01 | 8.23e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 7 | 6.10e-01 | -1.11e-01 | 8.79e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 16 | 4.41e-01 | 1.11e-01 | 8.00e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 84 | 7.80e-02 | -1.11e-01 | 4.28e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 16 | 4.41e-01 | 1.11e-01 | 8.00e-01 |
| GOBP SPERM MOTILITY | 52 | 1.65e-01 | -1.11e-01 | 5.77e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 21 | 3.78e-01 | -1.11e-01 | 7.65e-01 |
| GOCC EXCITATORY SYNAPSE | 27 | 3.17e-01 | 1.11e-01 | 7.20e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 36 | 2.48e-01 | 1.11e-01 | 6.62e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 15 | 4.56e-01 | -1.11e-01 | 8.08e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 15 | 4.56e-01 | -1.11e-01 | 8.08e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 20 | 3.90e-01 | 1.11e-01 | 7.72e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 99 | 5.63e-02 | 1.11e-01 | 3.71e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 5.64e-01 | -1.11e-01 | 8.57e-01 |
| GOBP IMP METABOLIC PROCESS | 13 | 4.88e-01 | 1.11e-01 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 68 | 1.14e-01 | -1.11e-01 | 4.95e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 253 | 2.42e-03 | 1.11e-01 | 6.52e-02 |
| GOCC MANCHETTE | 14 | 4.72e-01 | -1.11e-01 | 8.16e-01 |
| GOCC GLIAL CELL PROJECTION | 20 | 3.90e-01 | 1.11e-01 | 7.72e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 30 | 2.93e-01 | 1.11e-01 | 7.04e-01 |
| GOBP DNA REPAIR | 526 | 1.54e-05 | 1.11e-01 | 1.35e-03 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 6.38e-01 | -1.11e-01 | 8.92e-01 |
| GOBP THALAMUS DEVELOPMENT | 5 | 6.68e-01 | 1.11e-01 | 9.04e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 325 | 6.25e-04 | 1.11e-01 | 2.68e-02 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 55 | 1.56e-01 | 1.11e-01 | 5.65e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 5 | 6.68e-01 | -1.11e-01 | 9.04e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 5 | 6.68e-01 | 1.11e-01 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 9 | 5.65e-01 | -1.11e-01 | 8.58e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 9 | 5.65e-01 | 1.11e-01 | 8.58e-01 |
| GOBP CYTOSOLIC TRANSPORT | 160 | 1.59e-02 | 1.11e-01 | 1.91e-01 |
| GOBP CALCIUM ION TRANSPORT | 229 | 4.01e-03 | 1.11e-01 | 9.00e-02 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 16 | 4.44e-01 | 1.11e-01 | 8.02e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 8 | 5.88e-01 | -1.11e-01 | 8.70e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 8 | 5.88e-01 | 1.11e-01 | 8.70e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 77 | 9.37e-02 | -1.11e-01 | 4.58e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 5.88e-01 | -1.11e-01 | 8.70e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 17 | 4.30e-01 | -1.11e-01 | 7.95e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 26 | 3.29e-01 | 1.11e-01 | 7.30e-01 |
| GOMF LIGASE ACTIVITY | 123 | 3.45e-02 | 1.11e-01 | 2.88e-01 |
| GOBP DNA INTEGRATION | 6 | 6.39e-01 | -1.11e-01 | 8.92e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 20 | 3.92e-01 | 1.11e-01 | 7.73e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 9 | 5.66e-01 | 1.10e-01 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 5.66e-01 | 1.10e-01 | 8.58e-01 |
| GOMF C X C CHEMOKINE BINDING | 5 | 6.69e-01 | -1.10e-01 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 32 | 2.80e-01 | -1.10e-01 | 6.94e-01 |
| GOBP NECROPTOTIC PROCESS | 37 | 2.45e-01 | 1.10e-01 | 6.60e-01 |
| GOBP PROTEIN PALMITOYLATION | 24 | 3.50e-01 | -1.10e-01 | 7.44e-01 |
| GOBP TRNA PROCESSING | 126 | 3.27e-02 | 1.10e-01 | 2.84e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 45 | 2.01e-01 | 1.10e-01 | 6.13e-01 |
| GOBP FEMALE GAMETE GENERATION | 76 | 9.67e-02 | 1.10e-01 | 4.62e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 81 | 8.65e-02 | 1.10e-01 | 4.45e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 6.70e-01 | 1.10e-01 | 9.04e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 6.40e-01 | -1.10e-01 | 8.93e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 16 | 4.46e-01 | 1.10e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 16 | 4.46e-01 | 1.10e-01 | 8.02e-01 |
| GOBP TELOMERE LOCALIZATION | 7 | 6.14e-01 | 1.10e-01 | 8.83e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 6.41e-01 | -1.10e-01 | 8.93e-01 |
| GOMF SH3 DOMAIN BINDING | 88 | 7.46e-02 | 1.10e-01 | 4.20e-01 |
| GOCC CONDENSED CHROMOSOME | 234 | 3.83e-03 | 1.10e-01 | 8.76e-02 |
| GOBP DNA MODIFICATION | 85 | 7.99e-02 | 1.10e-01 | 4.32e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 5 | 6.70e-01 | -1.10e-01 | 9.05e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 247 | 3.00e-03 | 1.10e-01 | 7.38e-02 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 6.15e-01 | -1.10e-01 | 8.83e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 52 | 1.71e-01 | 1.10e-01 | 5.82e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 34 | 2.68e-01 | 1.10e-01 | 6.82e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 731 | 5.23e-07 | 1.10e-01 | 7.33e-05 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 5.28e-01 | -1.10e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 28 | 3.15e-01 | 1.10e-01 | 7.19e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 55 | 1.59e-01 | 1.10e-01 | 5.71e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 13 | 4.93e-01 | -1.10e-01 | 8.27e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 16 | 4.47e-01 | 1.10e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 12 | 5.11e-01 | -1.10e-01 | 8.37e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 29 | 3.07e-01 | 1.10e-01 | 7.13e-01 |
| GOCC TRANSFERASE COMPLEX | 745 | 4.44e-07 | 1.10e-01 | 6.40e-05 |
| GOBP BONE GROWTH | 15 | 4.63e-01 | -1.10e-01 | 8.12e-01 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 6.71e-01 | 1.10e-01 | 9.05e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 2.91e-01 | 1.10e-01 | 7.02e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 17 | 4.35e-01 | 1.09e-01 | 7.98e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 57 | 1.54e-01 | 1.09e-01 | 5.63e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 109 | 4.89e-02 | -1.09e-01 | 3.49e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 30 | 3.00e-01 | 1.09e-01 | 7.09e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 15 | 4.64e-01 | 1.09e-01 | 8.12e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 26 | 3.35e-01 | 1.09e-01 | 7.34e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 76 | 1.00e-01 | -1.09e-01 | 4.72e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 9 | 5.71e-01 | 1.09e-01 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 267 | 2.20e-03 | 1.09e-01 | 6.23e-02 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 29 | 3.09e-01 | -1.09e-01 | 7.15e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 34 | 2.71e-01 | 1.09e-01 | 6.85e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 7 | 6.17e-01 | -1.09e-01 | 8.83e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 9 | 5.71e-01 | 1.09e-01 | 8.59e-01 |
| GOCC AXONAL GROWTH CONE | 19 | 4.11e-01 | -1.09e-01 | 7.83e-01 |
| GOBP RESPONSE TO AMINE | 25 | 3.45e-01 | -1.09e-01 | 7.41e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 9 | 5.71e-01 | -1.09e-01 | 8.59e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 9 | 5.71e-01 | -1.09e-01 | 8.59e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 15 | 4.65e-01 | 1.09e-01 | 8.13e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 10 | 5.51e-01 | 1.09e-01 | 8.54e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 158 | 1.84e-02 | 1.09e-01 | 2.06e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 19 | 4.11e-01 | -1.09e-01 | 7.83e-01 |
| GOBP SARCOMERE ORGANIZATION | 21 | 3.88e-01 | -1.09e-01 | 7.70e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 121 | 3.89e-02 | 1.09e-01 | 3.05e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 165 | 1.61e-02 | 1.09e-01 | 1.92e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 17 | 4.37e-01 | 1.09e-01 | 7.98e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 282 | 1.73e-03 | 1.09e-01 | 5.34e-02 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 6 | 6.45e-01 | 1.09e-01 | 8.93e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 15 | 4.66e-01 | -1.09e-01 | 8.13e-01 |
| GOBP DIOL METABOLIC PROCESS | 22 | 3.78e-01 | 1.09e-01 | 7.65e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 6 | 6.45e-01 | -1.09e-01 | 8.93e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 82 | 8.93e-02 | 1.09e-01 | 4.53e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 44 | 2.13e-01 | 1.09e-01 | 6.27e-01 |
| GOBP FEAR RESPONSE | 20 | 4.01e-01 | 1.09e-01 | 7.80e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 179 | 1.24e-02 | 1.09e-01 | 1.72e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 27 | 3.29e-01 | -1.09e-01 | 7.30e-01 |
| GOBP DNA CONFORMATION CHANGE | 84 | 8.60e-02 | 1.08e-01 | 4.44e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 7 | 6.19e-01 | 1.08e-01 | 8.84e-01 |
| GOBP AMINE METABOLIC PROCESS | 59 | 1.50e-01 | -1.08e-01 | 5.58e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 28 | 3.21e-01 | 1.08e-01 | 7.24e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 5.74e-01 | 1.08e-01 | 8.61e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 6.20e-01 | 1.08e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 6 | 6.46e-01 | -1.08e-01 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 21 | 3.90e-01 | 1.08e-01 | 7.72e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 42 | 2.25e-01 | 1.08e-01 | 6.38e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 6 | 6.46e-01 | -1.08e-01 | 8.94e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 5.96e-01 | -1.08e-01 | 8.72e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 15 | 4.68e-01 | 1.08e-01 | 8.15e-01 |
| GOBP AXONAL FASCICULATION | 7 | 6.20e-01 | 1.08e-01 | 8.84e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 6 | 6.46e-01 | -1.08e-01 | 8.94e-01 |
| GOBP CELL CELL RECOGNITION | 32 | 2.90e-01 | 1.08e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 21 | 3.91e-01 | 1.08e-01 | 7.73e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 43 | 2.20e-01 | 1.08e-01 | 6.33e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 86 | 8.37e-02 | 1.08e-01 | 4.40e-01 |
| GOBP COMPLEMENT ACTIVATION | 24 | 3.60e-01 | -1.08e-01 | 7.51e-01 |
| GOBP UTP METABOLIC PROCESS | 10 | 5.54e-01 | 1.08e-01 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 65 | 1.33e-01 | 1.08e-01 | 5.28e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 5.01e-01 | -1.08e-01 | 8.32e-01 |
| GOBP NUCLEUS LOCALIZATION | 28 | 3.23e-01 | 1.08e-01 | 7.25e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 15 | 4.70e-01 | 1.08e-01 | 8.15e-01 |
| GOBP MOLTING CYCLE | 51 | 1.83e-01 | 1.08e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 15 | 4.70e-01 | 1.08e-01 | 8.16e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 342 | 6.45e-04 | 1.08e-01 | 2.73e-02 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 267 | 2.51e-03 | 1.08e-01 | 6.69e-02 |
| GOBP HORMONE METABOLIC PROCESS | 98 | 6.56e-02 | -1.08e-01 | 3.97e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 7 | 6.22e-01 | 1.08e-01 | 8.85e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 10 | 5.56e-01 | 1.08e-01 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 6.48e-01 | 1.07e-01 | 8.95e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 17 | 4.44e-01 | 1.07e-01 | 8.02e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 13 | 5.03e-01 | 1.07e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 9 | 5.77e-01 | 1.07e-01 | 8.64e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 12 | 5.20e-01 | 1.07e-01 | 8.40e-01 |
| GOBP SPINDLE ORGANIZATION | 171 | 1.58e-02 | 1.07e-01 | 1.91e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 22 | 3.84e-01 | -1.07e-01 | 7.70e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 6 | 6.50e-01 | 1.07e-01 | 8.95e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 6 | 6.50e-01 | 1.07e-01 | 8.95e-01 |
| GOBP G0 TO G1 TRANSITION | 33 | 2.87e-01 | 1.07e-01 | 7.01e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 35 | 2.73e-01 | -1.07e-01 | 6.87e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 21 | 3.96e-01 | -1.07e-01 | 7.76e-01 |
| GOBP PROTEIN MATURATION | 389 | 3.11e-04 | 1.07e-01 | 1.51e-02 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 9 | 5.79e-01 | -1.07e-01 | 8.64e-01 |
| GOCC CILIARY BASAL BODY | 131 | 3.49e-02 | -1.07e-01 | 2.89e-01 |
| GOBP TRANSPORT OF VIRUS | 14 | 4.89e-01 | -1.07e-01 | 8.25e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 29 | 3.19e-01 | 1.07e-01 | 7.23e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 9 | 5.79e-01 | 1.07e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 12 | 5.22e-01 | 1.07e-01 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 12 | 5.22e-01 | 1.07e-01 | 8.41e-01 |
| GOBP RESPONSE TO REDOX STATE | 11 | 5.40e-01 | -1.07e-01 | 8.49e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 35 | 2.75e-01 | 1.07e-01 | 6.89e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 26 | 3.47e-01 | -1.07e-01 | 7.42e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 157 | 2.13e-02 | 1.07e-01 | 2.26e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 24 | 3.66e-01 | -1.07e-01 | 7.55e-01 |
| GOBP DNA METABOLIC PROCESS | 854 | 1.64e-07 | 1.07e-01 | 2.75e-05 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 10 | 5.60e-01 | -1.07e-01 | 8.56e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 454 | 1.09e-04 | 1.07e-01 | 6.59e-03 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 11 | 5.41e-01 | 1.07e-01 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 76 | 1.10e-01 | 1.06e-01 | 4.88e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 6 | 6.52e-01 | 1.06e-01 | 8.97e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 41 | 2.39e-01 | -1.06e-01 | 6.54e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 6 | 6.52e-01 | -1.06e-01 | 8.97e-01 |
| GOMF TAT PROTEIN BINDING | 10 | 5.61e-01 | 1.06e-01 | 8.56e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 30 | 3.14e-01 | 1.06e-01 | 7.18e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 4.11e-01 | 1.06e-01 | 7.83e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 23 | 3.78e-01 | -1.06e-01 | 7.66e-01 |
| GOBP PROTEIN REFOLDING | 21 | 4.00e-01 | 1.06e-01 | 7.79e-01 |
| GOBP COPPER ION HOMEOSTASIS | 16 | 4.62e-01 | -1.06e-01 | 8.12e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 85 | 9.11e-02 | 1.06e-01 | 4.55e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 4.92e-01 | 1.06e-01 | 8.27e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 4.36e-01 | 1.06e-01 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 9 | 5.82e-01 | 1.06e-01 | 8.67e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 8 | 6.04e-01 | -1.06e-01 | 8.76e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 23 | 3.79e-01 | -1.06e-01 | 7.67e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 13 | 5.09e-01 | -1.06e-01 | 8.36e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 129 | 3.82e-02 | 1.06e-01 | 3.02e-01 |
| GOMF CENTROMERIC DNA BINDING | 5 | 6.82e-01 | -1.06e-01 | 9.11e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 58 | 1.64e-01 | -1.06e-01 | 5.75e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 25 | 3.60e-01 | 1.06e-01 | 7.52e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 30 | 3.16e-01 | 1.06e-01 | 7.20e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 15 | 4.79e-01 | 1.06e-01 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 112 | 5.40e-02 | 1.06e-01 | 3.65e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 7 | 6.29e-01 | 1.05e-01 | 8.88e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 5.64e-01 | 1.05e-01 | 8.57e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 21 | 4.03e-01 | 1.05e-01 | 7.80e-01 |
| GOBP MRNA METHYLATION | 18 | 4.39e-01 | 1.05e-01 | 8.00e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 13 | 5.11e-01 | -1.05e-01 | 8.37e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 28 | 3.35e-01 | 1.05e-01 | 7.34e-01 |
| GOMF GTPASE BINDING | 254 | 3.98e-03 | 1.05e-01 | 8.98e-02 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 4.96e-01 | -1.05e-01 | 8.30e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 27 | 3.44e-01 | -1.05e-01 | 7.40e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 44 | 2.28e-01 | 1.05e-01 | 6.40e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 2.18e-01 | -1.05e-01 | 6.31e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 2.34e-01 | 1.05e-01 | 6.45e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 93 | 8.05e-02 | -1.05e-01 | 4.33e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 13 | 5.12e-01 | 1.05e-01 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 14 | 4.97e-01 | -1.05e-01 | 8.31e-01 |
| GOBP MALE SEX DIFFERENTIATION | 87 | 9.11e-02 | 1.05e-01 | 4.55e-01 |
| GOBP ARTERY MORPHOGENESIS | 32 | 3.05e-01 | 1.05e-01 | 7.12e-01 |
| GOMF NAD BINDING | 49 | 2.05e-01 | 1.05e-01 | 6.19e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 38 | 2.64e-01 | 1.05e-01 | 6.78e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 5.48e-01 | -1.05e-01 | 8.53e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 62 | 1.54e-01 | -1.05e-01 | 5.64e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 8 | 6.08e-01 | 1.05e-01 | 8.79e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 3.47e-01 | 1.05e-01 | 7.43e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 8 | 6.09e-01 | -1.05e-01 | 8.79e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 6.86e-01 | -1.04e-01 | 9.13e-01 |
| GOBP LYMPHOCYTE MIGRATION | 70 | 1.31e-01 | 1.04e-01 | 5.25e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 26 | 3.57e-01 | -1.04e-01 | 7.50e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 10 | 5.68e-01 | 1.04e-01 | 8.59e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 10 | 5.68e-01 | -1.04e-01 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 209 | 9.50e-03 | 1.04e-01 | 1.47e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 7 | 6.33e-01 | -1.04e-01 | 8.90e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 78 | 1.12e-01 | 1.04e-01 | 4.91e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1283 | 6.43e-10 | -1.04e-01 | 2.15e-07 |
| GOBP MRNA CATABOLIC PROCESS | 212 | 9.12e-03 | 1.04e-01 | 1.43e-01 |
| GOBP CELLULAR RESPONSE TO PH | 10 | 5.69e-01 | -1.04e-01 | 8.59e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 900 | 1.62e-07 | 1.04e-01 | 2.75e-05 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 55 | 1.82e-01 | 1.04e-01 | 5.97e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 21 | 4.10e-01 | -1.04e-01 | 7.83e-01 |
| GOBP REGULATION OF RNA SPLICING | 154 | 2.64e-02 | 1.04e-01 | 2.53e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 53 | 1.92e-01 | -1.04e-01 | 6.04e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 94 | 8.24e-02 | -1.04e-01 | 4.37e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 13 | 5.17e-01 | 1.04e-01 | 8.39e-01 |
| GOBP PEXOPHAGY | 5 | 6.88e-01 | -1.04e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 36 | 2.82e-01 | 1.04e-01 | 6.97e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 7 | 6.35e-01 | -1.04e-01 | 8.90e-01 |
| GOCC PIGMENT GRANULE | 96 | 7.96e-02 | 1.04e-01 | 4.31e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 295 | 2.27e-03 | 1.04e-01 | 6.36e-02 |
| GOCC NUCLEAR CHROMOSOME | 190 | 1.40e-02 | 1.04e-01 | 1.81e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 14 | 5.02e-01 | 1.04e-01 | 8.33e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 5.91e-01 | -1.04e-01 | 8.70e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 239 | 5.96e-03 | 1.04e-01 | 1.14e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 6.89e-01 | 1.03e-01 | 9.13e-01 |
| GOBP DEPHOSPHORYLATION | 235 | 6.43e-03 | 1.03e-01 | 1.17e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 45 | 2.30e-01 | 1.03e-01 | 6.42e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 6 | 6.61e-01 | 1.03e-01 | 9.01e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 6 | 6.61e-01 | -1.03e-01 | 9.01e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 6 | 6.61e-01 | -1.03e-01 | 9.01e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 4.48e-01 | 1.03e-01 | 8.04e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 5.03e-01 | 1.03e-01 | 8.33e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 5 | 6.89e-01 | 1.03e-01 | 9.13e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 30 | 3.27e-01 | -1.03e-01 | 7.28e-01 |
| GOBP CHROMOSOME SEGREGATION | 343 | 1.06e-03 | 1.03e-01 | 3.85e-02 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 39 | 2.65e-01 | 1.03e-01 | 6.79e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 15 | 4.89e-01 | -1.03e-01 | 8.25e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 143 | 3.35e-02 | 1.03e-01 | 2.84e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 5.72e-01 | -1.03e-01 | 8.60e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 186 | 1.55e-02 | 1.03e-01 | 1.90e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 22 | 4.03e-01 | 1.03e-01 | 7.80e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 6.90e-01 | -1.03e-01 | 9.13e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 19 | 4.37e-01 | 1.03e-01 | 7.98e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 63 | 1.58e-01 | 1.03e-01 | 5.68e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 19 | 4.37e-01 | -1.03e-01 | 7.98e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 23 | 3.93e-01 | -1.03e-01 | 7.74e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 192 | 1.42e-02 | 1.03e-01 | 1.82e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 18 | 4.50e-01 | -1.03e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 4.77e-01 | 1.03e-01 | 8.17e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 6 | 6.63e-01 | 1.03e-01 | 9.02e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 333 | 1.35e-03 | 1.03e-01 | 4.53e-02 |
| GOMF PRE MRNA BINDING | 31 | 3.23e-01 | 1.02e-01 | 7.25e-01 |
| GOBP TOR SIGNALING | 139 | 3.74e-02 | 1.02e-01 | 2.99e-01 |
| GOBP ENDOCYTIC RECYCLING | 70 | 1.39e-01 | 1.02e-01 | 5.40e-01 |
| GOMF GROWTH FACTOR BINDING | 65 | 1.54e-01 | -1.02e-01 | 5.64e-01 |
| GOBP METHYLATION | 235 | 7.07e-03 | 1.02e-01 | 1.23e-01 |
| GOMF EXONUCLEASE ACTIVITY | 75 | 1.26e-01 | 1.02e-01 | 5.16e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 25 | 3.76e-01 | 1.02e-01 | 7.65e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 43 | 2.46e-01 | 1.02e-01 | 6.61e-01 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 5 | 6.92e-01 | -1.02e-01 | 9.14e-01 |
| GOCC CELL CELL CONTACT ZONE | 41 | 2.58e-01 | 1.02e-01 | 6.71e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 5.96e-01 | 1.02e-01 | 8.72e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 16 | 4.80e-01 | 1.02e-01 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 12 | 5.41e-01 | -1.02e-01 | 8.49e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 6.93e-01 | 1.02e-01 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 59 | 1.76e-01 | 1.02e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 6.93e-01 | -1.02e-01 | 9.14e-01 |
| GOMF CALMODULIN BINDING | 113 | 6.16e-02 | 1.02e-01 | 3.87e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 11 | 5.59e-01 | 1.02e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 19 | 4.42e-01 | 1.02e-01 | 8.01e-01 |
| GOBP IRON ION TRANSPORT | 33 | 3.11e-01 | 1.02e-01 | 7.15e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 12 | 5.41e-01 | 1.02e-01 | 8.49e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 27 | 3.60e-01 | -1.02e-01 | 7.51e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 14 | 5.10e-01 | 1.02e-01 | 8.37e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 5.42e-01 | 1.02e-01 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 26 | 3.69e-01 | 1.02e-01 | 7.58e-01 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 5 | 6.94e-01 | 1.02e-01 | 9.15e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 9 | 5.97e-01 | -1.02e-01 | 8.73e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 75 | 1.28e-01 | 1.02e-01 | 5.19e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 21 | 4.20e-01 | 1.02e-01 | 7.89e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 11 | 5.59e-01 | 1.02e-01 | 8.56e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 120 | 5.49e-02 | 1.02e-01 | 3.68e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 10 | 5.78e-01 | -1.02e-01 | 8.64e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1226 | 3.66e-09 | 1.02e-01 | 9.01e-07 |
| GOBP TRANSLATIONAL TERMINATION | 16 | 4.82e-01 | 1.02e-01 | 8.20e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 5.43e-01 | 1.01e-01 | 8.50e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 5.60e-01 | 1.01e-01 | 8.56e-01 |
| GOMF ATPASE BINDING | 61 | 1.71e-01 | 1.01e-01 | 5.83e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 59 | 1.79e-01 | 1.01e-01 | 5.92e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 6.43e-01 | 1.01e-01 | 8.93e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 14 | 5.12e-01 | -1.01e-01 | 8.37e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 300 | 2.64e-03 | 1.01e-01 | 6.91e-02 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 6.20e-01 | 1.01e-01 | 8.84e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 4.57e-01 | 1.01e-01 | 8.08e-01 |
| GOBP MONOAMINE TRANSPORT | 30 | 3.38e-01 | 1.01e-01 | 7.36e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 78 | 1.23e-01 | -1.01e-01 | 5.13e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 25 | 3.82e-01 | -1.01e-01 | 7.68e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 61 | 1.73e-01 | 1.01e-01 | 5.85e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 42 | 2.57e-01 | 1.01e-01 | 6.71e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 6.44e-01 | 1.01e-01 | 8.93e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 11 | 5.62e-01 | -1.01e-01 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 9 | 6.00e-01 | -1.01e-01 | 8.74e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 4.71e-01 | 1.01e-01 | 8.16e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 15 | 4.99e-01 | 1.01e-01 | 8.32e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 4.99e-01 | 1.01e-01 | 8.32e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 117 | 5.99e-02 | 1.01e-01 | 3.83e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 6.96e-01 | -1.01e-01 | 9.16e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 34 | 3.09e-01 | 1.01e-01 | 7.15e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 248 | 6.44e-03 | 1.01e-01 | 1.17e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 262 | 5.13e-03 | 1.01e-01 | 1.05e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 207 | 1.27e-02 | 1.01e-01 | 1.73e-01 |
| GOMF KINESIN BINDING | 33 | 3.17e-01 | 1.01e-01 | 7.20e-01 |
| GOBP CILIUM MOVEMENT | 88 | 1.03e-01 | -1.01e-01 | 4.79e-01 |
| GOBP CELL FATE COMMITMENT | 110 | 6.87e-02 | 1.01e-01 | 4.04e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 286 | 3.54e-03 | 1.01e-01 | 8.26e-02 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 6 | 6.70e-01 | 1.01e-01 | 9.04e-01 |
| GOCC CILIARY PLASM | 94 | 9.25e-02 | -1.01e-01 | 4.56e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 20 | 4.37e-01 | -1.01e-01 | 7.98e-01 |
| GOCC INTEGRIN COMPLEX | 15 | 5.01e-01 | -1.00e-01 | 8.32e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 6 | 6.70e-01 | 1.00e-01 | 9.05e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 5 | 6.98e-01 | 1.00e-01 | 9.16e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 6 | 6.70e-01 | -1.00e-01 | 9.05e-01 |
| GOBP SOMITE DEVELOPMENT | 37 | 2.91e-01 | -1.00e-01 | 7.02e-01 |
| GOCC GTPASE COMPLEX | 23 | 4.05e-01 | 1.00e-01 | 7.81e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 6 | 6.71e-01 | 1.00e-01 | 9.05e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 17 | 4.75e-01 | 1.00e-01 | 8.17e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 4.50e-01 | 1.00e-01 | 8.04e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 23 | 4.06e-01 | -1.00e-01 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 129 | 4.98e-02 | 1.00e-01 | 3.51e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 31 | 3.35e-01 | -1.00e-01 | 7.34e-01 |
| GOBP POSITIVE CHEMOTAXIS | 21 | 4.27e-01 | 1.00e-01 | 7.93e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 167 | 2.59e-02 | 1.00e-01 | 2.50e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 8 | 6.24e-01 | -1.00e-01 | 8.86e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 32 | 3.28e-01 | -9.99e-02 | 7.29e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 5.84e-01 | 9.99e-02 | 8.68e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 121 | 5.81e-02 | 9.99e-02 | 3.76e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 78 | 1.28e-01 | 9.99e-02 | 5.19e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 176 | 2.26e-02 | 9.98e-02 | 2.33e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 28 | 3.61e-01 | 9.98e-02 | 7.52e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 50 | 2.22e-01 | 9.98e-02 | 6.35e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 136 | 4.49e-02 | 9.98e-02 | 3.31e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 541 | 7.97e-05 | 9.98e-02 | 5.13e-03 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 6.48e-01 | -9.98e-02 | 8.94e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 10 | 5.85e-01 | 9.97e-02 | 8.68e-01 |
| GOCC VESICLE LUMEN | 230 | 9.36e-03 | 9.97e-02 | 1.46e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 12 | 5.50e-01 | 9.97e-02 | 8.54e-01 |
| GOBP T CELL PROLIFERATION | 147 | 3.74e-02 | 9.96e-02 | 2.99e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 49 | 2.28e-01 | 9.96e-02 | 6.40e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 8 | 6.26e-01 | 9.96e-02 | 8.86e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 36 | 3.01e-01 | -9.96e-02 | 7.09e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 12 | 5.51e-01 | -9.95e-02 | 8.54e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 4.53e-01 | 9.95e-02 | 8.06e-01 |
| GOCC MYOSIN II COMPLEX | 11 | 5.68e-01 | 9.95e-02 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 20 | 4.41e-01 | 9.95e-02 | 8.00e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 26 | 3.80e-01 | 9.95e-02 | 7.67e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 25 | 3.89e-01 | 9.95e-02 | 7.72e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 6.49e-01 | 9.95e-02 | 8.95e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 28 | 3.63e-01 | 9.94e-02 | 7.53e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 11 | 5.68e-01 | 9.93e-02 | 8.59e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 18 | 4.66e-01 | -9.92e-02 | 8.14e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 217 | 1.20e-02 | 9.91e-02 | 1.69e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 7.01e-01 | 9.91e-02 | 9.17e-01 |
| GOBP HEART TRABECULA FORMATION | 8 | 6.27e-01 | -9.91e-02 | 8.87e-01 |
| GOBP CELL KILLING | 132 | 4.96e-02 | 9.91e-02 | 3.51e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 28 | 3.64e-01 | -9.91e-02 | 7.54e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 7 | 6.50e-01 | -9.90e-02 | 8.95e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 11 | 5.70e-01 | -9.90e-02 | 8.59e-01 |
| GOCC OUTER KINETOCHORE | 12 | 5.53e-01 | 9.90e-02 | 8.54e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.28e-01 | -9.90e-02 | 8.88e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 6 | 6.75e-01 | -9.90e-02 | 9.07e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 5.22e-01 | 9.89e-02 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 6.28e-01 | 9.89e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 43 | 2.62e-01 | 9.89e-02 | 6.77e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 204 | 1.52e-02 | 9.88e-02 | 1.89e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 29 | 3.57e-01 | 9.88e-02 | 7.50e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 5 | 7.02e-01 | 9.88e-02 | 9.18e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 267 | 5.62e-03 | 9.87e-02 | 1.11e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 7 | 6.51e-01 | -9.87e-02 | 8.96e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 8 | 6.29e-01 | -9.87e-02 | 8.88e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 19 | 4.57e-01 | -9.86e-02 | 8.08e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 529 | 1.14e-04 | 9.86e-02 | 6.86e-03 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 382 | 9.83e-04 | 9.86e-02 | 3.77e-02 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 8 | 6.29e-01 | -9.86e-02 | 8.88e-01 |
| GOCC ENDOSOME MEMBRANE | 433 | 4.63e-04 | 9.86e-02 | 2.15e-02 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 5.54e-01 | 9.86e-02 | 8.56e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 32 | 3.35e-01 | -9.86e-02 | 7.34e-01 |
| GOMF METHYL CPG BINDING | 22 | 4.24e-01 | 9.86e-02 | 7.91e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 17 | 4.82e-01 | -9.86e-02 | 8.20e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 19 | 4.57e-01 | 9.85e-02 | 8.08e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 205 | 1.53e-02 | 9.85e-02 | 1.89e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 256 | 6.84e-03 | 9.84e-02 | 1.19e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 96 | 9.61e-02 | 9.84e-02 | 4.61e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 18 | 4.70e-01 | 9.84e-02 | 8.16e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 78 | 1.34e-01 | 9.83e-02 | 5.30e-01 |
| GOBP METANEPHROS DEVELOPMENT | 31 | 3.44e-01 | -9.83e-02 | 7.39e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 15 | 5.10e-01 | -9.83e-02 | 8.37e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 6.53e-01 | 9.83e-02 | 8.97e-01 |
| GOBP RESPONSE TO COBALT ION | 10 | 5.91e-01 | -9.83e-02 | 8.70e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 5.91e-01 | 9.82e-02 | 8.70e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 7 | 6.53e-01 | -9.82e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 7.04e-01 | 9.82e-02 | 9.18e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 605 | 4.22e-05 | 9.82e-02 | 3.04e-03 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 5.73e-01 | -9.81e-02 | 8.60e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 6 | 6.77e-01 | 9.81e-02 | 9.08e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 237 | 9.46e-03 | 9.81e-02 | 1.46e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 53 | 2.17e-01 | 9.81e-02 | 6.31e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 100 | 9.06e-02 | 9.80e-02 | 4.54e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 20 | 4.48e-01 | 9.80e-02 | 8.04e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 72 | 1.51e-01 | 9.79e-02 | 5.60e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 29 | 3.62e-01 | 9.79e-02 | 7.52e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 6.11e-01 | 9.79e-02 | 8.80e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 50 | 2.32e-01 | 9.78e-02 | 6.43e-01 |
| GOBP BASE EXCISION REPAIR | 41 | 2.79e-01 | -9.78e-02 | 6.94e-01 |
| GOBP MUSCLE CELL MIGRATION | 50 | 2.32e-01 | -9.77e-02 | 6.44e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 86 | 1.17e-01 | 9.77e-02 | 5.00e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 17 | 4.85e-01 | 9.77e-02 | 8.23e-01 |
| GOBP TRNA MODIFICATION | 91 | 1.08e-01 | 9.77e-02 | 4.85e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 14 | 5.27e-01 | 9.77e-02 | 8.43e-01 |
| GOMF GLYCOLIPID BINDING | 18 | 4.74e-01 | -9.76e-02 | 8.17e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 15 | 5.13e-01 | 9.76e-02 | 8.37e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 36 | 3.12e-01 | 9.75e-02 | 7.15e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 6 | 6.79e-01 | 9.74e-02 | 9.09e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 160 | 3.38e-02 | 9.74e-02 | 2.86e-01 |
| GOBP CHLORIDE TRANSPORT | 51 | 2.29e-01 | 9.74e-02 | 6.42e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 9 | 6.13e-01 | -9.73e-02 | 8.82e-01 |
| GOCC MYOFILAMENT | 13 | 5.44e-01 | 9.73e-02 | 8.51e-01 |
| GOBP QUINONE METABOLIC PROCESS | 30 | 3.57e-01 | 9.73e-02 | 7.50e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 40 | 2.88e-01 | 9.72e-02 | 7.02e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 13 | 5.44e-01 | 9.72e-02 | 8.51e-01 |
| GOBP DNA DAMAGE RESPONSE | 767 | 5.60e-06 | 9.72e-02 | 5.50e-04 |
| GOCC I BAND | 79 | 1.36e-01 | 9.71e-02 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 61 | 1.90e-01 | 9.71e-02 | 6.03e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 17 | 4.88e-01 | 9.71e-02 | 8.25e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 7 | 6.57e-01 | 9.69e-02 | 8.99e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 89 | 1.14e-01 | -9.69e-02 | 4.96e-01 |
| GOBP TORC2 SIGNALING | 15 | 5.16e-01 | 9.69e-02 | 8.38e-01 |
| GOCC EARLY ENDOSOME | 312 | 3.36e-03 | 9.69e-02 | 8.06e-02 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 6.81e-01 | 9.69e-02 | 9.11e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 23 | 4.21e-01 | -9.69e-02 | 7.90e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 185 | 2.34e-02 | 9.68e-02 | 2.37e-01 |
| GOCC LYSOSOMAL LUMEN | 63 | 1.84e-01 | -9.68e-02 | 5.98e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1475 | 9.96e-10 | 9.68e-02 | 2.78e-07 |
| GOBP BONE MORPHOGENESIS | 41 | 2.84e-01 | -9.68e-02 | 6.98e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 645 | 3.16e-05 | 9.67e-02 | 2.36e-03 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 27 | 3.84e-01 | -9.67e-02 | 7.70e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 12 | 5.62e-01 | -9.66e-02 | 8.57e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 62 | 1.89e-01 | 9.66e-02 | 6.03e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 8 | 6.36e-01 | 9.66e-02 | 8.91e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 5 | 7.09e-01 | 9.65e-02 | 9.20e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 15 | 5.17e-01 | -9.65e-02 | 8.39e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 18 | 4.78e-01 | -9.65e-02 | 8.18e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 6.37e-01 | 9.65e-02 | 8.91e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 23 | 4.24e-01 | 9.64e-02 | 7.91e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 49 | 2.43e-01 | 9.64e-02 | 6.58e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 94 | 1.07e-01 | -9.64e-02 | 4.83e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 27 | 3.86e-01 | 9.64e-02 | 7.70e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 6 | 6.83e-01 | 9.64e-02 | 9.11e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 7 | 6.59e-01 | 9.64e-02 | 9.00e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 7 | 6.59e-01 | 9.64e-02 | 9.00e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 6.83e-01 | 9.63e-02 | 9.11e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 63 | 1.86e-01 | 9.63e-02 | 6.00e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 27 | 3.87e-01 | -9.63e-02 | 7.70e-01 |
| GOCC BASAL PART OF CELL | 149 | 4.29e-02 | 9.63e-02 | 3.21e-01 |
| GOMF DIOXYGENASE ACTIVITY | 69 | 1.67e-01 | 9.62e-02 | 5.77e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 332 | 2.69e-03 | 9.62e-02 | 6.93e-02 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 6.83e-01 | -9.62e-02 | 9.11e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 34 | 3.32e-01 | -9.62e-02 | 7.33e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 79 | 1.40e-01 | 9.62e-02 | 5.41e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 4.15e-01 | 9.62e-02 | 7.86e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 40 | 2.93e-01 | -9.61e-02 | 7.03e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 10 | 5.99e-01 | 9.61e-02 | 8.73e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 509 | 2.26e-04 | 9.60e-02 | 1.20e-02 |
| GOBP RECEPTOR CATABOLIC PROCESS | 25 | 4.06e-01 | -9.60e-02 | 7.81e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 7.10e-01 | -9.60e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 5 | 7.10e-01 | 9.60e-02 | 9.20e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 15 | 5.20e-01 | 9.60e-02 | 8.40e-01 |
| GOBP SPINDLE ASSEMBLY | 116 | 7.46e-02 | 9.59e-02 | 4.20e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 31 | 3.55e-01 | 9.59e-02 | 7.49e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 40 | 2.94e-01 | 9.59e-02 | 7.04e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 5.50e-01 | 9.58e-02 | 8.53e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 191 | 2.27e-02 | 9.58e-02 | 2.33e-01 |
| GOBP RNA DESTABILIZATION | 96 | 1.05e-01 | 9.57e-02 | 4.81e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 18 | 4.82e-01 | 9.57e-02 | 8.20e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 48 | 2.52e-01 | -9.57e-02 | 6.65e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 404 | 1.02e-03 | 9.57e-02 | 3.82e-02 |
| GOBP NEURON PROJECTION REGENERATION | 28 | 3.81e-01 | 9.56e-02 | 7.68e-01 |
| GOBP REGULATION OF MITOPHAGY | 14 | 5.36e-01 | 9.56e-02 | 8.47e-01 |
| GOMF CHROMATIN BINDING | 443 | 6.03e-04 | 9.55e-02 | 2.61e-02 |
| GOCC CHROMOSOME | 1279 | 1.56e-08 | 9.55e-02 | 3.63e-06 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 81 | 1.38e-01 | -9.54e-02 | 5.37e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 132 | 5.87e-02 | 9.54e-02 | 3.79e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 6.62e-01 | 9.54e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 5 | 7.12e-01 | -9.54e-02 | 9.20e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 30 | 3.66e-01 | 9.54e-02 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 158 | 3.91e-02 | 9.53e-02 | 3.06e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 6.41e-01 | 9.52e-02 | 8.93e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 56 | 2.18e-01 | 9.52e-02 | 6.31e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 15 | 5.23e-01 | 9.52e-02 | 8.41e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 59 | 2.07e-01 | 9.51e-02 | 6.20e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 59 | 2.07e-01 | 9.51e-02 | 6.20e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 35 | 3.30e-01 | 9.51e-02 | 7.31e-01 |
| GOBP CARTILAGE DEVELOPMENT | 96 | 1.08e-01 | -9.51e-02 | 4.85e-01 |
| GOCC NUCLEAR BODY | 720 | 1.63e-05 | 9.51e-02 | 1.39e-03 |
| GOBP MITOTIC NUCLEAR DIVISION | 210 | 1.79e-02 | 9.50e-02 | 2.04e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 58 | 2.11e-01 | 9.49e-02 | 6.25e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 34 | 3.38e-01 | -9.49e-02 | 7.36e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 244 | 1.09e-02 | 9.49e-02 | 1.59e-01 |
| GOBP O GLYCAN PROCESSING | 29 | 3.77e-01 | 9.49e-02 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 8 | 6.42e-01 | 9.49e-02 | 8.93e-01 |
| GOCC GOLGI CIS CISTERNA | 16 | 5.11e-01 | -9.49e-02 | 8.37e-01 |
| GOMF DEMETHYLASE ACTIVITY | 34 | 3.39e-01 | 9.48e-02 | 7.37e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 43 | 2.82e-01 | 9.48e-02 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 22 | 4.42e-01 | -9.48e-02 | 8.01e-01 |
| GOBP HEAT ACCLIMATION | 6 | 6.88e-01 | -9.47e-02 | 9.13e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 20 | 4.64e-01 | -9.47e-02 | 8.12e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 26 | 4.04e-01 | 9.47e-02 | 7.80e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 5.12e-01 | 9.46e-02 | 8.37e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 101 | 1.01e-01 | 9.46e-02 | 4.73e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 21 | 4.53e-01 | 9.46e-02 | 8.06e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 10 | 6.05e-01 | -9.46e-02 | 8.76e-01 |
| GOBP KIDNEY MORPHOGENESIS | 40 | 3.01e-01 | -9.46e-02 | 7.09e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 5 | 7.14e-01 | 9.46e-02 | 9.21e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 363 | 2.06e-03 | 9.45e-02 | 5.94e-02 |
| GOBP PYRUVATE TRANSPORT | 6 | 6.89e-01 | 9.43e-02 | 9.13e-01 |
| GOCC SARCOPLASM | 56 | 2.22e-01 | 9.43e-02 | 6.35e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 121 | 7.35e-02 | 9.43e-02 | 4.18e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 6 | 6.89e-01 | -9.43e-02 | 9.13e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 6.44e-01 | 9.42e-02 | 8.93e-01 |
| GOBP NOSE DEVELOPMENT | 6 | 6.89e-01 | -9.42e-02 | 9.13e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 143 | 5.22e-02 | 9.42e-02 | 3.60e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 10 | 6.06e-01 | -9.42e-02 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 8 | 6.45e-01 | 9.42e-02 | 8.93e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 482 | 4.29e-04 | 9.42e-02 | 2.02e-02 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 5 | 7.15e-01 | -9.41e-02 | 9.21e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 33 | 3.50e-01 | 9.41e-02 | 7.44e-01 |
| GOBP CELL FATE SPECIFICATION | 37 | 3.22e-01 | 9.41e-02 | 7.24e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 26 | 4.06e-01 | -9.41e-02 | 7.81e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 2.37e-01 | 9.40e-02 | 6.49e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 9 | 6.25e-01 | -9.40e-02 | 8.86e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 20 | 4.67e-01 | -9.40e-02 | 8.14e-01 |
| GOBP AMIDE METABOLIC PROCESS | 924 | 1.64e-06 | 9.40e-02 | 2.04e-04 |
| GOBP RESPONSE TO DOPAMINE | 31 | 3.65e-01 | 9.40e-02 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 35 | 3.36e-01 | 9.40e-02 | 7.34e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 23 | 4.35e-01 | 9.40e-02 | 7.98e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 162 | 3.94e-02 | 9.40e-02 | 3.07e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.67e-01 | 9.40e-02 | 9.04e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 4.26e-01 | 9.39e-02 | 7.92e-01 |
| GOCC ENDOSOME | 760 | 1.27e-05 | 9.39e-02 | 1.15e-03 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 61 | 2.05e-01 | -9.38e-02 | 6.19e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 4.27e-01 | 9.37e-02 | 7.93e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 59 | 2.13e-01 | 9.37e-02 | 6.28e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1238 | 4.62e-08 | 9.37e-02 | 9.43e-06 |
| GOBP MITOCHONDRIAL TRANSPORT | 169 | 3.60e-02 | 9.37e-02 | 2.94e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 39 | 3.12e-01 | -9.37e-02 | 7.15e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 12 | 5.75e-01 | -9.36e-02 | 8.61e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 7.17e-01 | 9.36e-02 | 9.22e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 8 | 6.47e-01 | -9.36e-02 | 8.94e-01 |
| GOCC CILIARY TRANSITION ZONE | 53 | 2.39e-01 | -9.35e-02 | 6.53e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 41 | 3.00e-01 | -9.35e-02 | 7.09e-01 |
| GOBP ADP TRANSPORT | 10 | 6.09e-01 | -9.34e-02 | 8.79e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 9 | 6.28e-01 | -9.34e-02 | 8.87e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 18 | 4.93e-01 | -9.34e-02 | 8.27e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 46 | 2.74e-01 | -9.33e-02 | 6.88e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 7 | 6.69e-01 | 9.33e-02 | 9.04e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 7 | 6.69e-01 | 9.33e-02 | 9.04e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 11 | 5.92e-01 | 9.33e-02 | 8.71e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 5.61e-01 | -9.32e-02 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 93 | 1.21e-01 | 9.32e-02 | 5.07e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 16 | 5.19e-01 | -9.32e-02 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 82 | 1.45e-01 | 9.31e-02 | 5.48e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.93e-01 | -9.31e-02 | 8.71e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 30 | 3.78e-01 | 9.31e-02 | 7.65e-01 |
| GOBP ETHER METABOLIC PROCESS | 19 | 4.82e-01 | -9.31e-02 | 8.20e-01 |
| GOMF DIACYLGLYCEROL BINDING | 9 | 6.29e-01 | 9.31e-02 | 8.88e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 860 | 4.49e-06 | 9.31e-02 | 4.58e-04 |
| GOBP PHOSPHATE ION TRANSPORT | 15 | 5.33e-01 | 9.30e-02 | 8.46e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 134 | 6.36e-02 | 9.29e-02 | 3.92e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 10 | 6.11e-01 | -9.29e-02 | 8.80e-01 |
| GOBP HISTONE DEACETYLATION | 22 | 4.51e-01 | 9.29e-02 | 8.04e-01 |
| GOBP AMINE TRANSPORT | 38 | 3.22e-01 | 9.29e-02 | 7.24e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 152 | 4.86e-02 | 9.29e-02 | 3.47e-01 |
| GOBP OTIC VESICLE DEVELOPMENT | 5 | 7.19e-01 | -9.28e-02 | 9.23e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 19 | 4.84e-01 | 9.28e-02 | 8.21e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 13 | 5.63e-01 | 9.27e-02 | 8.57e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 339 | 3.50e-03 | 9.26e-02 | 8.17e-02 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 5.09e-01 | 9.26e-02 | 8.36e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 23 | 4.42e-01 | 9.26e-02 | 8.01e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 87 | 1.36e-01 | 9.26e-02 | 5.34e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 43 | 2.94e-01 | 9.26e-02 | 7.04e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 85 | 1.41e-01 | 9.26e-02 | 5.43e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 80 | 1.53e-01 | 9.26e-02 | 5.61e-01 |
| GOBP DUMP METABOLIC PROCESS | 6 | 6.95e-01 | 9.26e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 174 | 3.56e-02 | 9.25e-02 | 2.93e-01 |
| GOBP VESICLE CARGO LOADING | 27 | 4.06e-01 | 9.25e-02 | 7.81e-01 |
| GOCC BLOOD MICROPARTICLE | 52 | 2.49e-01 | 9.25e-02 | 6.63e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 13 | 5.64e-01 | -9.24e-02 | 8.57e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 46 | 2.79e-01 | -9.24e-02 | 6.93e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 10 | 6.13e-01 | 9.24e-02 | 8.82e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 178 | 3.40e-02 | 9.23e-02 | 2.86e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 120 | 8.13e-02 | 9.23e-02 | 4.34e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 80 | 1.54e-01 | 9.23e-02 | 5.64e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 84 | 1.44e-01 | 9.22e-02 | 5.47e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 53 | 2.46e-01 | -9.22e-02 | 6.61e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 6 | 6.96e-01 | -9.22e-02 | 9.16e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 434 | 1.05e-03 | 9.22e-02 | 3.85e-02 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 125 | 7.57e-02 | 9.21e-02 | 4.22e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 19 | 4.87e-01 | 9.21e-02 | 8.24e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 31 | 3.75e-01 | 9.21e-02 | 7.63e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 7 | 6.73e-01 | 9.20e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 12 | 5.81e-01 | -9.20e-02 | 8.66e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 15 | 5.37e-01 | -9.20e-02 | 8.48e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 11 | 5.97e-01 | -9.20e-02 | 8.73e-01 |
| GOCC MYOSIN FILAMENT | 8 | 6.53e-01 | 9.19e-02 | 8.97e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 29 | 3.92e-01 | 9.18e-02 | 7.73e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 20 | 4.78e-01 | -9.17e-02 | 8.18e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 13 | 5.67e-01 | -9.17e-02 | 8.58e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 17 | 5.13e-01 | -9.16e-02 | 8.37e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 18 | 5.01e-01 | -9.15e-02 | 8.33e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 170 | 3.99e-02 | 9.15e-02 | 3.10e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 780 | 1.66e-05 | 9.15e-02 | 1.41e-03 |
| GOMF BETA CATENIN BINDING | 59 | 2.25e-01 | -9.14e-02 | 6.38e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 207 | 2.37e-02 | 9.14e-02 | 2.38e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 6.55e-01 | 9.13e-02 | 8.98e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 6.17e-01 | -9.12e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 13 | 5.69e-01 | -9.12e-02 | 8.59e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 11 | 6.01e-01 | 9.12e-02 | 8.74e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 70 | 1.88e-01 | -9.12e-02 | 6.02e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 101 | 1.14e-01 | -9.11e-02 | 4.96e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 15 | 5.41e-01 | 9.11e-02 | 8.49e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 6 | 6.99e-01 | -9.11e-02 | 9.17e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 35 | 3.52e-01 | -9.10e-02 | 7.46e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 464 | 8.33e-04 | 9.10e-02 | 3.36e-02 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 23 | 4.50e-01 | -9.10e-02 | 8.04e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 7 | 6.77e-01 | -9.10e-02 | 9.08e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 40 | 3.20e-01 | 9.09e-02 | 7.23e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 23 | 4.51e-01 | 9.09e-02 | 8.04e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 6.56e-01 | 9.09e-02 | 8.99e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 38 | 3.33e-01 | -9.09e-02 | 7.33e-01 |
| GOBP UREA TRANSPORT | 5 | 7.25e-01 | 9.09e-02 | 9.27e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 6.02e-01 | 9.08e-02 | 8.75e-01 |
| GOBP INNATE IMMUNE RESPONSE | 626 | 1.19e-04 | 9.07e-02 | 7.10e-03 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 6.78e-01 | 9.07e-02 | 9.08e-01 |
| GOBP MITOTIC CELL CYCLE | 711 | 4.40e-05 | 9.07e-02 | 3.14e-03 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 50 | 2.68e-01 | -9.06e-02 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 14 | 5.57e-01 | -9.06e-02 | 8.56e-01 |
| GOBP SPINDLE LOCALIZATION | 42 | 3.10e-01 | 9.05e-02 | 7.15e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 6.58e-01 | 9.05e-02 | 8.99e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 23 | 4.53e-01 | -9.05e-02 | 8.06e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 428 | 1.42e-03 | 9.04e-02 | 4.64e-02 |
| GOBP RESPONSE TO CATECHOLAMINE | 42 | 3.11e-01 | 9.03e-02 | 7.15e-01 |
| GOMF MRNA BINDING | 267 | 1.13e-02 | 9.03e-02 | 1.65e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 215 | 2.30e-02 | 9.02e-02 | 2.35e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 17 | 5.20e-01 | -9.02e-02 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 32 | 3.78e-01 | -9.02e-02 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 21 | 4.75e-01 | 9.02e-02 | 8.17e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 38 | 3.36e-01 | 9.02e-02 | 7.34e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 4.96e-01 | 9.01e-02 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 18 | 5.08e-01 | 9.01e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 37 | 3.43e-01 | 9.01e-02 | 7.39e-01 |
| GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY | 5 | 7.27e-01 | -9.01e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 24 | 4.45e-01 | 9.00e-02 | 8.02e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 94 | 1.32e-01 | -9.00e-02 | 5.26e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 830 | 1.28e-05 | 9.00e-02 | 1.15e-03 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 6 | 7.03e-01 | 9.00e-02 | 9.18e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.03e-01 | 9.00e-02 | 9.18e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 423 | 1.58e-03 | 9.00e-02 | 4.99e-02 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 7.03e-01 | -8.99e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 100 | 1.21e-01 | 8.98e-02 | 5.08e-01 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.03e-01 | -8.98e-02 | 9.18e-01 |
| GOBP EYE MORPHOGENESIS | 74 | 1.82e-01 | -8.97e-02 | 5.97e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 55 | 2.50e-01 | 8.97e-02 | 6.63e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 34 | 3.66e-01 | -8.96e-02 | 7.55e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 89 | 1.44e-01 | 8.96e-02 | 5.47e-01 |
| GOCC APICAL DENDRITE | 13 | 5.76e-01 | -8.96e-02 | 8.63e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 39 | 3.33e-01 | -8.96e-02 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 100 | 1.22e-01 | 8.96e-02 | 5.11e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 13 | 5.76e-01 | 8.95e-02 | 8.63e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 21 | 4.78e-01 | 8.95e-02 | 8.18e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 9 | 6.42e-01 | -8.95e-02 | 8.93e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 36 | 3.53e-01 | -8.95e-02 | 7.47e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 8 | 6.61e-01 | 8.94e-02 | 9.01e-01 |
| GOMF CHEMOKINE BINDING | 18 | 5.11e-01 | 8.94e-02 | 8.37e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 17 | 5.23e-01 | 8.94e-02 | 8.41e-01 |
| GOBP REFLEX | 6 | 7.04e-01 | 8.94e-02 | 9.18e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 192 | 3.32e-02 | 8.93e-02 | 2.84e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 32 | 3.82e-01 | 8.93e-02 | 7.69e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 749 | 3.79e-05 | 8.92e-02 | 2.76e-03 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 10 | 6.25e-01 | -8.92e-02 | 8.86e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 8 | 6.63e-01 | 8.91e-02 | 9.02e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 7 | 6.83e-01 | -8.90e-02 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 6 | 7.06e-01 | -8.90e-02 | 9.19e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 202 | 2.96e-02 | 8.90e-02 | 2.69e-01 |
| GOBP SYNAPSE PRUNING | 5 | 7.30e-01 | 8.90e-02 | 9.30e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 21 | 4.80e-01 | 8.90e-02 | 8.19e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 16 | 5.38e-01 | -8.90e-02 | 8.48e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 79 | 1.72e-01 | 8.89e-02 | 5.84e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 30 | 4.00e-01 | -8.89e-02 | 7.79e-01 |
| GOBP PLATELET ACTIVATION | 83 | 1.62e-01 | 8.89e-02 | 5.74e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 12 | 5.94e-01 | 8.89e-02 | 8.72e-01 |
| GOMF CUPROUS ION BINDING | 6 | 7.06e-01 | -8.89e-02 | 9.19e-01 |
| GOBP VESICLE TETHERING | 32 | 3.85e-01 | 8.88e-02 | 7.70e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 366 | 3.68e-03 | 8.88e-02 | 8.52e-02 |
| GOBP SYNAPSE MATURATION | 14 | 5.65e-01 | 8.87e-02 | 8.58e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1353 | 7.07e-08 | 8.87e-02 | 1.29e-05 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 987 | 3.09e-06 | 8.87e-02 | 3.37e-04 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 17 | 5.27e-01 | -8.87e-02 | 8.43e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 9 | 6.45e-01 | 8.87e-02 | 8.93e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 96 | 1.34e-01 | 8.87e-02 | 5.30e-01 |
| GOBP NEPHRON DEVELOPMENT | 66 | 2.13e-01 | -8.87e-02 | 6.28e-01 |
| GOBP FLUID TRANSPORT | 14 | 5.66e-01 | -8.86e-02 | 8.58e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 10 | 6.27e-01 | -8.86e-02 | 8.87e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 8 | 6.64e-01 | -8.86e-02 | 9.03e-01 |
| GOMF FK506 BINDING | 8 | 6.64e-01 | 8.86e-02 | 9.03e-01 |
| GOMF MACROLIDE BINDING | 8 | 6.64e-01 | 8.86e-02 | 9.03e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 388 | 2.88e-03 | 8.85e-02 | 7.19e-02 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 6 | 7.07e-01 | 8.85e-02 | 9.20e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 78 | 1.77e-01 | 8.85e-02 | 5.90e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 95 | 1.37e-01 | -8.85e-02 | 5.35e-01 |
| GOCC MICROTUBULE PLUS END | 18 | 5.16e-01 | 8.84e-02 | 8.38e-01 |
| GOBP RESPONSE TO CHEMOKINE | 42 | 3.22e-01 | 8.84e-02 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 611 | 2.12e-04 | 8.84e-02 | 1.17e-02 |
| GOBP DENDRITIC SPINE MAINTENANCE | 14 | 5.67e-01 | -8.84e-02 | 8.58e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 28 | 4.19e-01 | 8.84e-02 | 7.88e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 17 | 5.28e-01 | 8.83e-02 | 8.44e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 385 | 3.05e-03 | 8.83e-02 | 7.49e-02 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 7 | 6.86e-01 | -8.83e-02 | 9.13e-01 |
| GOMF PROTEOGLYCAN BINDING | 12 | 5.97e-01 | 8.83e-02 | 8.73e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 267 | 1.33e-02 | 8.82e-02 | 1.77e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 326 | 6.38e-03 | 8.82e-02 | 1.17e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 6 | 7.08e-01 | 8.82e-02 | 9.20e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 50 | 2.81e-01 | 8.82e-02 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 16 | 5.42e-01 | 8.81e-02 | 8.49e-01 |
| GOBP RNA METHYLATION | 86 | 1.59e-01 | 8.80e-02 | 5.69e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 36 | 3.61e-01 | 8.80e-02 | 7.52e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 33 | 3.82e-01 | -8.80e-02 | 7.68e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 7.09e-01 | -8.80e-02 | 9.20e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 359 | 4.36e-03 | 8.79e-02 | 9.55e-02 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 7.33e-01 | 8.79e-02 | 9.31e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 16 | 5.43e-01 | 8.79e-02 | 8.50e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 6 | 7.09e-01 | 8.79e-02 | 9.20e-01 |
| GOBP RESPONSE TO VITAMIN D | 16 | 5.43e-01 | -8.79e-02 | 8.50e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 213 | 2.74e-02 | 8.79e-02 | 2.57e-01 |
| GOBP COPPER ION TRANSPORT | 12 | 5.98e-01 | 8.79e-02 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 121 | 9.58e-02 | 8.78e-02 | 4.61e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 17 | 5.31e-01 | 8.78e-02 | 8.46e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 86 | 1.60e-01 | 8.77e-02 | 5.72e-01 |
| GOBP MAINTENANCE OF LOCATION | 238 | 2.01e-02 | 8.77e-02 | 2.17e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 6.88e-01 | -8.76e-02 | 9.13e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 19 | 5.09e-01 | 8.76e-02 | 8.36e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 20 | 4.98e-01 | -8.76e-02 | 8.32e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 7.35e-01 | -8.76e-02 | 9.31e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 37 | 3.57e-01 | -8.75e-02 | 7.50e-01 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 7.35e-01 | -8.75e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 95 | 1.41e-01 | 8.75e-02 | 5.43e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 30 | 4.07e-01 | 8.75e-02 | 7.82e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 9 | 6.50e-01 | -8.74e-02 | 8.95e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 10 | 6.32e-01 | 8.74e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 187 | 3.99e-02 | 8.73e-02 | 3.10e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 10 | 6.33e-01 | -8.73e-02 | 8.90e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 9 | 6.50e-01 | 8.73e-02 | 8.95e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 44 | 3.17e-01 | -8.73e-02 | 7.20e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 17 | 5.34e-01 | 8.72e-02 | 8.46e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 54 | 2.68e-01 | 8.72e-02 | 6.82e-01 |
| GOBP VASCULAR WOUND HEALING | 9 | 6.51e-01 | 8.71e-02 | 8.96e-01 |
| GOBP DETOXIFICATION | 86 | 1.63e-01 | 8.71e-02 | 5.75e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 12 | 6.02e-01 | 8.70e-02 | 8.75e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 6.51e-01 | 8.70e-02 | 8.96e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 11 | 6.18e-01 | 8.69e-02 | 8.83e-01 |
| GOCC M BAND | 14 | 5.74e-01 | -8.69e-02 | 8.61e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 25 | 4.52e-01 | -8.69e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 44 | 3.19e-01 | 8.68e-02 | 7.23e-01 |
| GOBP DIGESTION | 42 | 3.31e-01 | -8.68e-02 | 7.31e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 10 | 6.35e-01 | 8.68e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 13 | 5.88e-01 | -8.68e-02 | 8.70e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 6 | 7.13e-01 | -8.67e-02 | 9.21e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 360 | 4.89e-03 | 8.67e-02 | 1.02e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1322 | 1.89e-07 | 8.67e-02 | 3.08e-05 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 6.35e-01 | 8.67e-02 | 8.90e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 27 | 4.36e-01 | -8.67e-02 | 7.98e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 21 | 4.92e-01 | -8.67e-02 | 8.27e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 229 | 2.42e-02 | 8.67e-02 | 2.41e-01 |
| GOBP UREA CYCLE | 7 | 6.92e-01 | 8.66e-02 | 9.14e-01 |
| GOBP UREA METABOLIC PROCESS | 7 | 6.92e-01 | 8.66e-02 | 9.14e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 39 | 3.50e-01 | -8.66e-02 | 7.44e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 59 | 2.51e-01 | 8.65e-02 | 6.64e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 454 | 1.67e-03 | 8.65e-02 | 5.22e-02 |
| GOBP SKELETAL MUSCLE ADAPTATION | 6 | 7.14e-01 | -8.65e-02 | 9.21e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 99 | 1.38e-01 | 8.65e-02 | 5.36e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 48 | 3.00e-01 | 8.64e-02 | 7.09e-01 |
| GOBP RECEPTOR CLUSTERING | 34 | 3.83e-01 | -8.64e-02 | 7.69e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 23 | 4.73e-01 | -8.64e-02 | 8.17e-01 |
| GOCC AMPHISOME | 12 | 6.05e-01 | -8.64e-02 | 8.76e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 21 | 4.93e-01 | -8.64e-02 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 6.36e-01 | 8.63e-02 | 8.91e-01 |
| GOBP MACROMOLECULE METHYLATION | 182 | 4.51e-02 | 8.63e-02 | 3.31e-01 |
| GOBP HEMOSTASIS | 129 | 9.10e-02 | 8.63e-02 | 4.55e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 7 | 6.93e-01 | -8.62e-02 | 9.14e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 6.20e-01 | 8.62e-02 | 8.84e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 38 | 3.58e-01 | -8.62e-02 | 7.50e-01 |
| GOBP VACUOLAR ACIDIFICATION | 31 | 4.06e-01 | -8.62e-02 | 7.81e-01 |
| GOCC VESICLE COAT | 54 | 2.74e-01 | 8.62e-02 | 6.88e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 6 | 7.15e-01 | 8.62e-02 | 9.21e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 72 | 2.07e-01 | 8.61e-02 | 6.20e-01 |
| GOBP HIPPO SIGNALING | 30 | 4.14e-01 | -8.61e-02 | 7.86e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 6.73e-01 | 8.61e-02 | 9.06e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 6.73e-01 | 8.61e-02 | 9.06e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 31 | 4.07e-01 | -8.60e-02 | 7.82e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 13 | 5.91e-01 | -8.60e-02 | 8.70e-01 |
| GOCC MITOTIC SPINDLE | 148 | 7.13e-02 | 8.60e-02 | 4.13e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 8 | 6.74e-01 | 8.59e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 11 | 6.22e-01 | -8.59e-02 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 10 | 6.38e-01 | -8.59e-02 | 8.92e-01 |
| GOMF R SMAD BINDING | 19 | 5.17e-01 | -8.59e-02 | 8.39e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 271 | 1.53e-02 | 8.59e-02 | 1.89e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 42 | 3.36e-01 | 8.58e-02 | 7.34e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 9 | 6.56e-01 | -8.58e-02 | 8.98e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 144 | 7.59e-02 | 8.58e-02 | 4.23e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 361 | 5.28e-03 | 8.58e-02 | 1.07e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 764 | 6.35e-05 | 8.58e-02 | 4.40e-03 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 292 | 1.20e-02 | 8.58e-02 | 1.68e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 40 | 3.49e-01 | 8.57e-02 | 7.44e-01 |
| GOCC CELL LEADING EDGE | 304 | 1.06e-02 | 8.56e-02 | 1.57e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 221 | 2.88e-02 | 8.56e-02 | 2.65e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 272 | 1.55e-02 | 8.56e-02 | 1.90e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 7 | 6.95e-01 | 8.55e-02 | 9.16e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 36 | 3.75e-01 | 8.55e-02 | 7.63e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 660 | 2.02e-04 | 8.55e-02 | 1.12e-02 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 141 | 8.03e-02 | 8.55e-02 | 4.32e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 131 | 9.18e-02 | -8.54e-02 | 4.56e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 435 | 2.37e-03 | 8.54e-02 | 6.45e-02 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 11 | 6.24e-01 | 8.54e-02 | 8.86e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 17 | 5.42e-01 | -8.54e-02 | 8.50e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 47 | 3.12e-01 | 8.53e-02 | 7.15e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 5 | 7.41e-01 | 8.53e-02 | 9.34e-01 |
| GOBP DNA DEAMINATION | 11 | 6.24e-01 | 8.53e-02 | 8.86e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 28 | 4.35e-01 | -8.53e-02 | 7.98e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 14 | 5.81e-01 | -8.53e-02 | 8.66e-01 |
| GOBP WATER TRANSPORT | 9 | 6.58e-01 | -8.52e-02 | 8.99e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 13 | 5.95e-01 | 8.52e-02 | 8.72e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 6 | 7.18e-01 | -8.52e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 23 | 4.79e-01 | 8.52e-02 | 8.18e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 22 | 4.89e-01 | 8.52e-02 | 8.25e-01 |
| GOMF AMINO ACID BINDING | 22 | 4.89e-01 | 8.52e-02 | 8.25e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 25 | 4.61e-01 | -8.52e-02 | 8.12e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 16 | 5.55e-01 | -8.52e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 28 | 4.36e-01 | -8.51e-02 | 7.98e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 11 | 6.25e-01 | 8.51e-02 | 8.86e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 55 | 2.76e-01 | 8.50e-02 | 6.90e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 7 | 6.97e-01 | -8.49e-02 | 9.16e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 16 | 5.57e-01 | 8.49e-02 | 8.56e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1079 | 3.33e-06 | 8.49e-02 | 3.48e-04 |
| GOBP GRANULOCYTE MIGRATION | 89 | 1.67e-01 | 8.48e-02 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 6.98e-01 | 8.48e-02 | 9.16e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 5.33e-01 | -8.48e-02 | 8.46e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 30 | 4.22e-01 | -8.48e-02 | 7.90e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 6.78e-01 | 8.48e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 56 | 2.73e-01 | 8.47e-02 | 6.87e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 18 | 5.34e-01 | -8.47e-02 | 8.46e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 520 | 1.02e-03 | 8.47e-02 | 3.82e-02 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 5 | 7.43e-01 | 8.47e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 14 | 5.83e-01 | -8.47e-02 | 8.68e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 58 | 2.65e-01 | -8.46e-02 | 6.79e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 33 | 4.00e-01 | 8.46e-02 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 29 | 4.31e-01 | -8.46e-02 | 7.95e-01 |
| GOBP GLYCOLYTIC PROCESS | 67 | 2.32e-01 | 8.46e-02 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 10 | 6.43e-01 | -8.46e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 17 | 5.46e-01 | -8.45e-02 | 8.53e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 628 | 3.33e-04 | 8.45e-02 | 1.61e-02 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 22 | 4.93e-01 | 8.45e-02 | 8.27e-01 |
| GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER | 5 | 7.44e-01 | -8.44e-02 | 9.35e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 5.98e-01 | 8.44e-02 | 8.73e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 13 | 5.98e-01 | 8.44e-02 | 8.73e-01 |
| GOBP INTESTINAL STEM CELL HOMEOSTASIS | 5 | 7.44e-01 | -8.44e-02 | 9.35e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 5.36e-01 | -8.43e-02 | 8.47e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 21 | 5.04e-01 | -8.43e-02 | 8.33e-01 |
| GOCC COP9 SIGNALOSOME | 17 | 5.47e-01 | 8.43e-02 | 8.53e-01 |
| GOCC LIPID DROPLET | 74 | 2.11e-01 | 8.42e-02 | 6.24e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 21 | 5.04e-01 | -8.42e-02 | 8.34e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 17 | 5.48e-01 | -8.42e-02 | 8.53e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 24 | 4.75e-01 | -8.42e-02 | 8.17e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 7 | 7.00e-01 | -8.41e-02 | 9.17e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 29 | 4.33e-01 | 8.41e-02 | 7.98e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 24 | 4.76e-01 | 8.41e-02 | 8.17e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 183 | 5.04e-02 | 8.40e-02 | 3.53e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 251 | 2.23e-02 | 8.40e-02 | 2.30e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 10 | 6.46e-01 | -8.40e-02 | 8.94e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 89 | 1.71e-01 | 8.39e-02 | 5.83e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 54 | 2.87e-01 | 8.38e-02 | 7.01e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 61 | 2.58e-01 | -8.38e-02 | 6.71e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 7 | 7.01e-01 | 8.38e-02 | 9.17e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 184 | 5.04e-02 | 8.38e-02 | 3.53e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 179 | 5.37e-02 | 8.38e-02 | 3.64e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 5.27e-01 | 8.38e-02 | 8.44e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1116 | 3.20e-06 | 8.37e-02 | 3.38e-04 |
| GOBP DEDIFFERENTIATION | 5 | 7.46e-01 | -8.37e-02 | 9.35e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 12 | 6.16e-01 | 8.37e-02 | 8.83e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 15 | 5.75e-01 | -8.36e-02 | 8.62e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 22 | 4.97e-01 | 8.36e-02 | 8.31e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 11 | 6.31e-01 | -8.36e-02 | 8.89e-01 |
| GOCC SMAD PROTEIN COMPLEX | 5 | 7.46e-01 | 8.36e-02 | 9.35e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 79 | 1.99e-01 | -8.36e-02 | 6.11e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1319 | 5.26e-07 | 8.36e-02 | 7.33e-05 |
| GOBP RESPONSE TO ESTROGEN | 36 | 3.86e-01 | 8.36e-02 | 7.70e-01 |
| GOBP ICOSANOID SECRETION | 16 | 5.63e-01 | -8.34e-02 | 8.57e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 16 | 5.63e-01 | 8.34e-02 | 8.57e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 74 | 2.15e-01 | 8.34e-02 | 6.29e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 37 | 3.80e-01 | 8.34e-02 | 7.67e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 534 | 1.05e-03 | 8.34e-02 | 3.85e-02 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 45 | 3.34e-01 | -8.34e-02 | 7.33e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 68 | 2.35e-01 | 8.33e-02 | 6.47e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 14 | 5.90e-01 | -8.33e-02 | 8.70e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 5 | 7.47e-01 | -8.32e-02 | 9.35e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 13 | 6.04e-01 | 8.31e-02 | 8.76e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 531 | 1.12e-03 | 8.31e-02 | 4.04e-02 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 348 | 7.99e-03 | 8.31e-02 | 1.31e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 17 | 5.53e-01 | -8.30e-02 | 8.55e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 7 | 7.04e-01 | -8.30e-02 | 9.18e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 106 | 1.40e-01 | -8.30e-02 | 5.42e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 6.67e-01 | 8.29e-02 | 9.04e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 23 | 4.91e-01 | 8.29e-02 | 8.27e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 84 | 1.89e-01 | 8.29e-02 | 6.03e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 245 | 2.60e-02 | 8.28e-02 | 2.51e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 82 | 1.96e-01 | 8.28e-02 | 6.09e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 50 | 3.12e-01 | 8.27e-02 | 7.15e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 29 | 4.41e-01 | 8.27e-02 | 8.00e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 55 | 2.89e-01 | -8.27e-02 | 7.02e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 4.93e-01 | 8.27e-02 | 8.27e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 19 | 5.33e-01 | 8.27e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 7.05e-01 | -8.27e-02 | 9.18e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 819 | 6.87e-05 | 8.26e-02 | 4.53e-03 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 9 | 6.68e-01 | -8.25e-02 | 9.04e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 191 | 4.98e-02 | 8.25e-02 | 3.51e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 5 | 7.50e-01 | -8.25e-02 | 9.35e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 5 | 7.50e-01 | -8.25e-02 | 9.35e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 6.36e-01 | -8.24e-02 | 8.91e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 17 | 5.56e-01 | 8.24e-02 | 8.56e-01 |
| GOBP EMBRYONIC CLEAVAGE | 8 | 6.87e-01 | 8.24e-02 | 9.13e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 5.24e-01 | -8.24e-02 | 8.41e-01 |
| GOBP PEPTIDE CROSS LINKING | 8 | 6.87e-01 | 8.23e-02 | 9.13e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 50 | 3.15e-01 | -8.23e-02 | 7.19e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 7.06e-01 | 8.22e-02 | 9.19e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 5 | 7.50e-01 | -8.21e-02 | 9.35e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 18 | 5.47e-01 | 8.21e-02 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 6.88e-01 | 8.21e-02 | 9.13e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 21 | 5.15e-01 | 8.21e-02 | 8.38e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 11 | 6.38e-01 | 8.20e-02 | 8.92e-01 |
| GOBP TORC1 SIGNALING | 89 | 1.81e-01 | 8.20e-02 | 5.97e-01 |
| GOMF LNCRNA BINDING | 11 | 6.38e-01 | 8.20e-02 | 8.92e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 14 | 5.95e-01 | 8.20e-02 | 8.72e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 203 | 4.45e-02 | 8.20e-02 | 3.29e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 12 | 6.23e-01 | 8.20e-02 | 8.86e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 5 | 7.51e-01 | -8.20e-02 | 9.35e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 162 | 7.24e-02 | 8.20e-02 | 4.16e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 13 | 6.09e-01 | 8.19e-02 | 8.79e-01 |
| GOCC TRAPP COMPLEX | 15 | 5.83e-01 | 8.19e-02 | 8.67e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 68 | 2.44e-01 | -8.18e-02 | 6.58e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 290 | 1.69e-02 | 8.18e-02 | 1.98e-01 |
| GOMF ALPHA GLUCOSIDASE ACTIVITY | 5 | 7.51e-01 | -8.18e-02 | 9.35e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 127 | 1.12e-01 | 8.18e-02 | 4.91e-01 |
| GOBP CELL CYCLE PROCESS | 981 | 1.80e-05 | 8.18e-02 | 1.48e-03 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 7.51e-01 | 8.18e-02 | 9.35e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 13 | 6.10e-01 | -8.18e-02 | 8.79e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 14 | 5.96e-01 | 8.18e-02 | 8.72e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 6.24e-01 | -8.18e-02 | 8.86e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 6.54e-01 | 8.17e-02 | 8.98e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 6.24e-01 | 8.17e-02 | 8.86e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 15 | 5.84e-01 | -8.17e-02 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 39 | 3.77e-01 | -8.17e-02 | 7.65e-01 |
| GOBP VASCULAR TRANSPORT | 47 | 3.33e-01 | 8.17e-02 | 7.33e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 5.38e-01 | 8.17e-02 | 8.48e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 63 | 2.63e-01 | 8.16e-02 | 6.77e-01 |
| GOBP INSULIN PROCESSING | 5 | 7.52e-01 | 8.16e-02 | 9.35e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 268 | 2.19e-02 | 8.16e-02 | 2.29e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 464 | 2.74e-03 | 8.16e-02 | 6.98e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 8 | 6.90e-01 | -8.16e-02 | 9.13e-01 |
| GOBP RESPONSE TO ETHANOL | 66 | 2.52e-01 | 8.15e-02 | 6.66e-01 |
| GOBP SNRNA PROCESSING | 26 | 4.72e-01 | 8.15e-02 | 8.16e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 6.11e-01 | 8.15e-02 | 8.80e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 5.28e-01 | 8.15e-02 | 8.44e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 17 | 5.61e-01 | 8.15e-02 | 8.56e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 49 | 3.24e-01 | 8.15e-02 | 7.25e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 122 | 1.21e-01 | 8.14e-02 | 5.08e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 48 | 3.29e-01 | -8.14e-02 | 7.30e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 24 | 4.90e-01 | 8.14e-02 | 8.26e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 30 | 4.41e-01 | -8.14e-02 | 8.00e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 241 | 3.01e-02 | 8.13e-02 | 2.71e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 6.73e-01 | 8.13e-02 | 9.06e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 30 | 4.41e-01 | 8.13e-02 | 8.00e-01 |
| GOBP HISTONE UBIQUITINATION | 9 | 6.73e-01 | 8.13e-02 | 9.06e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 7 | 7.10e-01 | -8.12e-02 | 9.20e-01 |
| GOBP DETECTION OF VIRUS | 5 | 7.53e-01 | 8.12e-02 | 9.36e-01 |
| GOBP RESPONSE TO ETHER | 10 | 6.57e-01 | -8.12e-02 | 8.99e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 68 | 2.48e-01 | -8.11e-02 | 6.61e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 8 | 6.91e-01 | 8.11e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 7 | 7.10e-01 | -8.11e-02 | 9.20e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 147 | 9.02e-02 | -8.11e-02 | 4.54e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 37 | 3.94e-01 | -8.10e-02 | 7.74e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 76 | 2.22e-01 | 8.10e-02 | 6.35e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 157 | 8.03e-02 | 8.10e-02 | 4.32e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 22 | 5.11e-01 | 8.10e-02 | 8.37e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 31 | 4.35e-01 | 8.10e-02 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.92e-01 | -8.10e-02 | 9.14e-01 |
| GOBP FUCOSYLATION | 11 | 6.42e-01 | 8.09e-02 | 8.93e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 278 | 2.07e-02 | 8.09e-02 | 2.21e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 5 | 7.54e-01 | -8.09e-02 | 9.37e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 7 | 7.11e-01 | 8.09e-02 | 9.20e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 7 | 7.11e-01 | 8.08e-02 | 9.20e-01 |
| GOBP REGULATION OF AUTOPHAGY | 300 | 1.66e-02 | 8.07e-02 | 1.96e-01 |
| GOCC CELL BODY MEMBRANE | 8 | 6.93e-01 | 8.07e-02 | 9.14e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 163 | 7.62e-02 | -8.06e-02 | 4.23e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 29 | 4.52e-01 | -8.06e-02 | 8.06e-01 |
| GOBP REGULATION OF BINDING | 188 | 5.75e-02 | 8.05e-02 | 3.75e-01 |
| GOBP PODOSOME ASSEMBLY | 16 | 5.78e-01 | -8.04e-02 | 8.64e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 159 | 8.07e-02 | 8.04e-02 | 4.34e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 32 | 4.32e-01 | 8.04e-02 | 7.96e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 55 | 3.03e-01 | 8.03e-02 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 39 | 3.86e-01 | 8.03e-02 | 7.70e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 7.34e-01 | 8.03e-02 | 9.31e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 32 | 4.32e-01 | -8.03e-02 | 7.97e-01 |
| GOBP CHROMOSOME LOCALIZATION | 93 | 1.82e-01 | 8.02e-02 | 5.97e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 10 | 6.61e-01 | -8.02e-02 | 9.01e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 10 | 6.61e-01 | -8.02e-02 | 9.01e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 94 | 1.80e-01 | 8.01e-02 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 96 | 1.75e-01 | 8.01e-02 | 5.89e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 107 | 1.53e-01 | 8.01e-02 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 7.56e-01 | 8.01e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 7.56e-01 | 8.01e-02 | 9.38e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 52 | 3.18e-01 | 8.01e-02 | 7.21e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 7.34e-01 | -8.01e-02 | 9.31e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 17 | 5.68e-01 | -8.00e-02 | 8.59e-01 |
| GOBP MICROTUBULE NUCLEATION | 44 | 3.59e-01 | 8.00e-02 | 7.51e-01 |
| GOCC SECONDARY LYSOSOME | 16 | 5.80e-01 | -7.99e-02 | 8.66e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 38 | 3.94e-01 | 7.99e-02 | 7.74e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 17 | 5.69e-01 | 7.99e-02 | 8.59e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 17 | 5.69e-01 | 7.99e-02 | 8.59e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 6.78e-01 | -7.99e-02 | 9.08e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 7.35e-01 | 7.98e-02 | 9.31e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 59 | 2.89e-01 | 7.98e-02 | 7.02e-01 |
| GOCC CLATHRIN COATED PIT | 57 | 2.98e-01 | 7.98e-02 | 7.07e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 11 | 6.47e-01 | -7.98e-02 | 8.94e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 22 | 5.18e-01 | 7.97e-02 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 57 | 2.98e-01 | -7.97e-02 | 7.07e-01 |
| GOMF SULFATIDE BINDING | 5 | 7.58e-01 | 7.97e-02 | 9.38e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 6 | 7.35e-01 | 7.97e-02 | 9.31e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 34 | 4.21e-01 | -7.97e-02 | 7.90e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 6 | 7.35e-01 | -7.97e-02 | 9.31e-01 |
| GOBP EXPLORATION BEHAVIOR | 12 | 6.33e-01 | -7.96e-02 | 8.90e-01 |
| GOBP POTASSIUM ION TRANSPORT | 78 | 2.25e-01 | 7.96e-02 | 6.38e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 29 | 4.58e-01 | 7.96e-02 | 8.09e-01 |
| GOBP LIPID EXPORT FROM CELL | 23 | 5.09e-01 | -7.96e-02 | 8.36e-01 |
| GOMF NUCLEASE ACTIVITY | 172 | 7.26e-02 | 7.95e-02 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 17 | 5.70e-01 | 7.95e-02 | 8.59e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 329 | 1.36e-02 | 7.95e-02 | 1.79e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 25 | 4.92e-01 | 7.94e-02 | 8.27e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 12 | 6.34e-01 | -7.94e-02 | 8.90e-01 |
| GOMF PDZ DOMAIN BINDING | 48 | 3.42e-01 | 7.93e-02 | 7.39e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 7.59e-01 | 7.92e-02 | 9.39e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 6 | 7.37e-01 | 7.91e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 89 | 1.98e-01 | -7.91e-02 | 6.10e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 9 | 6.81e-01 | -7.91e-02 | 9.11e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 7.59e-01 | 7.91e-02 | 9.39e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 137 | 1.11e-01 | 7.90e-02 | 4.90e-01 |
| GOBP TRANSCYTOSIS | 14 | 6.09e-01 | -7.90e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 91 | 1.93e-01 | 7.90e-02 | 6.06e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 120 | 1.36e-01 | 7.89e-02 | 5.34e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 26 | 4.87e-01 | 7.88e-02 | 8.23e-01 |
| GOBP PROTEIN DESTABILIZATION | 46 | 3.56e-01 | 7.88e-02 | 7.49e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 10 | 6.66e-01 | 7.87e-02 | 9.04e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 268 | 2.71e-02 | 7.87e-02 | 2.57e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 7.61e-01 | 7.87e-02 | 9.40e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 10 | 6.67e-01 | -7.87e-02 | 9.04e-01 |
| GOMF ALPHA TUBULIN BINDING | 33 | 4.34e-01 | -7.87e-02 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 750 | 2.81e-04 | 7.86e-02 | 1.39e-02 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 15 | 5.98e-01 | -7.86e-02 | 8.73e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 8 | 7.00e-01 | 7.86e-02 | 9.17e-01 |
| GOBP NUCLEAR MIGRATION | 21 | 5.33e-01 | 7.86e-02 | 8.46e-01 |
| GOBP REGULATION OF CELL CYCLE | 817 | 1.58e-04 | 7.85e-02 | 9.09e-03 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 49 | 3.42e-01 | 7.85e-02 | 7.39e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 6.38e-01 | -7.85e-02 | 8.92e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 23 | 5.15e-01 | -7.85e-02 | 8.38e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 103 | 1.69e-01 | -7.85e-02 | 5.80e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1091 | 1.57e-05 | 7.84e-02 | 1.37e-03 |
| GOCC MITOTIC SPINDLE MIDZONE | 9 | 6.84e-01 | 7.84e-02 | 9.12e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 6.68e-01 | 7.84e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 12 | 6.38e-01 | -7.84e-02 | 8.92e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 121 | 1.37e-01 | 7.84e-02 | 5.35e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 12 | 6.38e-01 | -7.84e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 63 | 2.82e-01 | 7.84e-02 | 6.97e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 34 | 4.29e-01 | 7.84e-02 | 7.94e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 7.20e-01 | 7.84e-02 | 9.24e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 510 | 2.61e-03 | 7.83e-02 | 6.85e-02 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 50 | 3.38e-01 | 7.83e-02 | 7.36e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 115 | 1.48e-01 | 7.83e-02 | 5.52e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 351 | 1.21e-02 | 7.83e-02 | 1.69e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 8 | 7.02e-01 | 7.82e-02 | 9.18e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 19 | 5.55e-01 | 7.82e-02 | 8.56e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 593 | 1.24e-03 | 7.82e-02 | 4.35e-02 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 123 | 1.35e-01 | -7.82e-02 | 5.32e-01 |
| GOBP T CELL ACTIVATION | 419 | 6.33e-03 | 7.81e-02 | 1.16e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 14 | 6.13e-01 | -7.81e-02 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 15 | 6.01e-01 | -7.81e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 11 | 6.54e-01 | 7.81e-02 | 8.98e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 253 | 3.30e-02 | 7.80e-02 | 2.84e-01 |
| GOBP RETINA HOMEOSTASIS | 39 | 3.99e-01 | -7.80e-02 | 7.79e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 11 | 6.54e-01 | -7.80e-02 | 8.98e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 7.63e-01 | -7.80e-02 | 9.40e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 25 | 5.00e-01 | 7.79e-02 | 8.32e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 894 | 9.19e-05 | 7.79e-02 | 5.78e-03 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 305 | 1.97e-02 | 7.79e-02 | 2.15e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 142 | 1.10e-01 | 7.79e-02 | 4.88e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 154 | 9.62e-02 | -7.78e-02 | 4.61e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 50 | 3.42e-01 | 7.78e-02 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 164 | 8.65e-02 | 7.77e-02 | 4.45e-01 |
| GOBP UBIQUITIN RECYCLING | 11 | 6.55e-01 | 7.77e-02 | 8.98e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 39 | 4.01e-01 | 7.77e-02 | 7.80e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 7 | 7.22e-01 | -7.76e-02 | 9.25e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 5 | 7.64e-01 | -7.76e-02 | 9.40e-01 |
| GOBP B CELL ACTIVATION | 203 | 5.71e-02 | 7.76e-02 | 3.74e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 7.64e-01 | -7.76e-02 | 9.40e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 99 | 1.83e-01 | 7.76e-02 | 5.97e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 49 | 3.48e-01 | 7.75e-02 | 7.44e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 14 | 6.16e-01 | -7.75e-02 | 8.83e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 6.87e-01 | -7.75e-02 | 9.13e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 27 | 4.87e-01 | 7.74e-02 | 8.23e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 17 | 5.81e-01 | -7.74e-02 | 8.66e-01 |
| GOBP REPLICATIVE SENESCENCE | 11 | 6.57e-01 | 7.74e-02 | 8.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 7.23e-01 | -7.73e-02 | 9.25e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 42 | 3.86e-01 | 7.73e-02 | 7.70e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 30 | 4.64e-01 | 7.73e-02 | 8.12e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 77 | 2.42e-01 | 7.72e-02 | 6.56e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 60 | 3.01e-01 | 7.72e-02 | 7.09e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 7.24e-01 | -7.72e-02 | 9.26e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 14 | 6.17e-01 | 7.71e-02 | 8.83e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 93 | 2.00e-01 | 7.70e-02 | 6.11e-01 |
| GOBP BLOOD VESSEL REMODELING | 20 | 5.51e-01 | -7.70e-02 | 8.54e-01 |
| GOMF BH DOMAIN BINDING | 9 | 6.89e-01 | -7.70e-02 | 9.13e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 129 | 1.31e-01 | 7.70e-02 | 5.25e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 811 | 2.22e-04 | 7.70e-02 | 1.20e-02 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 6.59e-01 | -7.69e-02 | 9.00e-01 |
| GOBP GRANULOCYTE ACTIVATION | 36 | 4.25e-01 | -7.69e-02 | 7.91e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 12 | 6.45e-01 | 7.69e-02 | 8.93e-01 |
| GOCC ZYMOGEN GRANULE | 9 | 6.90e-01 | -7.69e-02 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 107 | 1.70e-01 | 7.69e-02 | 5.81e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 30 | 4.66e-01 | 7.69e-02 | 8.13e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 25 | 5.06e-01 | -7.68e-02 | 8.35e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 5.73e-01 | 7.68e-02 | 8.60e-01 |
| GOBP PHOTOPERIODISM | 21 | 5.43e-01 | 7.67e-02 | 8.50e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 10 | 6.75e-01 | 7.67e-02 | 9.07e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 7.45e-01 | 7.67e-02 | 9.35e-01 |
| GOCC TORC1 COMPLEX | 6 | 7.45e-01 | 7.67e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 71 | 2.64e-01 | 7.67e-02 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 22 | 5.34e-01 | 7.67e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 7.07e-01 | 7.66e-02 | 9.20e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 5 | 7.67e-01 | 7.66e-02 | 9.41e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 62 | 2.97e-01 | 7.66e-02 | 7.07e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 184 | 7.38e-02 | 7.66e-02 | 4.19e-01 |
| GOBP ENDOCYTOSIS | 460 | 5.12e-03 | 7.66e-02 | 1.05e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 8 | 7.08e-01 | -7.65e-02 | 9.20e-01 |
| GOCC KERATIN FILAMENT | 8 | 7.08e-01 | -7.65e-02 | 9.20e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 10 | 6.76e-01 | 7.64e-02 | 9.07e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.91e-01 | 7.64e-02 | 9.14e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 15 | 6.08e-01 | 7.64e-02 | 8.79e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 465 | 5.02e-03 | 7.63e-02 | 1.04e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 27 | 4.93e-01 | 7.63e-02 | 8.27e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 31 | 4.63e-01 | 7.62e-02 | 8.12e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 63 | 2.96e-01 | 7.62e-02 | 7.06e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 31 | 4.63e-01 | 7.62e-02 | 8.12e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 125 | 1.42e-01 | 7.62e-02 | 5.44e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 5 | 7.68e-01 | -7.61e-02 | 9.41e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 35 | 4.36e-01 | 7.61e-02 | 7.98e-01 |
| GOBP VASCULOGENESIS | 39 | 4.11e-01 | 7.61e-02 | 7.83e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 75 | 2.56e-01 | 7.59e-02 | 6.69e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 108 | 1.73e-01 | 7.59e-02 | 5.87e-01 |
| GOBP ZYMOGEN ACTIVATION | 32 | 4.58e-01 | 7.59e-02 | 8.08e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 654 | 1.02e-03 | 7.59e-02 | 3.82e-02 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 23 | 5.29e-01 | -7.58e-02 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 55 | 3.31e-01 | -7.58e-02 | 7.32e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 46 | 3.74e-01 | -7.58e-02 | 7.62e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 21 | 5.48e-01 | -7.58e-02 | 8.53e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 24 | 5.21e-01 | 7.58e-02 | 8.40e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 25 | 5.12e-01 | -7.58e-02 | 8.37e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 12 | 6.50e-01 | 7.58e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 563 | 2.26e-03 | 7.58e-02 | 6.35e-02 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 6.78e-01 | 7.57e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 6.64e-01 | 7.56e-02 | 9.03e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 5 | 7.70e-01 | 7.56e-02 | 9.41e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 6 | 7.48e-01 | -7.56e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 13 | 6.37e-01 | 7.55e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 35 | 4.40e-01 | 7.55e-02 | 8.00e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 668 | 9.68e-04 | 7.54e-02 | 3.75e-02 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 29 | 4.82e-01 | 7.54e-02 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 41 | 4.04e-01 | 7.54e-02 | 7.80e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 34 | 4.47e-01 | -7.54e-02 | 8.04e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 7.30e-01 | -7.54e-02 | 9.30e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 11 | 6.65e-01 | -7.54e-02 | 9.03e-01 |
| GOBP RESPONSE TO FOOD | 16 | 6.02e-01 | -7.54e-02 | 8.75e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 415 | 8.78e-03 | 7.53e-02 | 1.40e-01 |
| GOBP SEX DIFFERENTIATION | 134 | 1.33e-01 | 7.53e-02 | 5.28e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 19 | 5.70e-01 | 7.53e-02 | 8.59e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 79 | 2.48e-01 | 7.53e-02 | 6.61e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 104 | 1.85e-01 | 7.53e-02 | 5.99e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 16 | 6.03e-01 | -7.52e-02 | 8.75e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 115 | 1.64e-01 | -7.52e-02 | 5.76e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 491 | 4.58e-03 | 7.51e-02 | 9.76e-02 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 9 | 6.97e-01 | 7.51e-02 | 9.16e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 6.27e-01 | 7.50e-02 | 8.87e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 7 | 7.31e-01 | 7.50e-02 | 9.30e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 5.52e-01 | 7.50e-02 | 8.54e-01 |
| GOBP VIRION ASSEMBLY | 30 | 4.78e-01 | 7.49e-02 | 8.18e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 7.31e-01 | -7.49e-02 | 9.30e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 6 | 7.51e-01 | 7.49e-02 | 9.35e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 25 | 5.17e-01 | 7.49e-02 | 8.39e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 59 | 3.20e-01 | -7.49e-02 | 7.24e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 5.93e-01 | 7.49e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 7 | 7.32e-01 | 7.49e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 15 | 6.16e-01 | 7.48e-02 | 8.83e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 41 | 4.08e-01 | -7.48e-02 | 7.82e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 19 | 5.73e-01 | 7.48e-02 | 8.60e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 7.51e-01 | -7.48e-02 | 9.35e-01 |
| GOBP UV PROTECTION | 9 | 6.98e-01 | -7.48e-02 | 9.16e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 19 | 5.73e-01 | -7.48e-02 | 8.60e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 34 | 4.51e-01 | 7.47e-02 | 8.04e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 24 | 5.27e-01 | 7.47e-02 | 8.43e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 374 | 1.35e-02 | 7.47e-02 | 1.78e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 23 | 5.36e-01 | -7.47e-02 | 8.47e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 8 | 7.15e-01 | 7.46e-02 | 9.21e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 28 | 4.94e-01 | 7.46e-02 | 8.28e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 21 | 5.54e-01 | -7.46e-02 | 8.55e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 67 | 2.91e-01 | -7.46e-02 | 7.02e-01 |
| GOBP PIRNA PROCESSING | 8 | 7.15e-01 | -7.46e-02 | 9.21e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 8 | 7.15e-01 | 7.46e-02 | 9.21e-01 |
| GOMF ALKALI METAL ION BINDING | 12 | 6.55e-01 | 7.46e-02 | 8.98e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 39 | 4.21e-01 | 7.45e-02 | 7.90e-01 |
| GOCC MIDBODY | 174 | 9.05e-02 | 7.45e-02 | 4.54e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 465 | 6.19e-03 | 7.45e-02 | 1.15e-01 |
| GOCC LEADING EDGE MEMBRANE | 112 | 1.74e-01 | 7.45e-02 | 5.87e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 7.33e-01 | 7.44e-02 | 9.31e-01 |
| GOBP ERAD PATHWAY | 94 | 2.13e-01 | 7.44e-02 | 6.27e-01 |
| GOBP CERAMIDE TRANSPORT | 12 | 6.55e-01 | -7.44e-02 | 8.98e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 6 | 7.53e-01 | -7.43e-02 | 9.36e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 12 | 6.56e-01 | -7.43e-02 | 8.98e-01 |
| GOCC MEDIATOR COMPLEX | 37 | 4.34e-01 | 7.43e-02 | 7.98e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 123 | 1.55e-01 | -7.43e-02 | 5.65e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 52 | 3.55e-01 | 7.42e-02 | 7.48e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 15 | 6.19e-01 | 7.42e-02 | 8.84e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 7 | 7.34e-01 | -7.42e-02 | 9.31e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 31 | 4.75e-01 | 7.41e-02 | 8.17e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 11 | 6.71e-01 | 7.41e-02 | 9.05e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 13 | 6.44e-01 | -7.40e-02 | 8.93e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 461 | 6.72e-03 | 7.40e-02 | 1.19e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 21 | 5.57e-01 | 7.40e-02 | 8.56e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 329 | 2.14e-02 | 7.40e-02 | 2.26e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 119 | 1.64e-01 | -7.40e-02 | 5.75e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 27 | 5.06e-01 | 7.40e-02 | 8.35e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 21 | 5.57e-01 | 7.40e-02 | 8.56e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 65 | 3.03e-01 | -7.40e-02 | 7.10e-01 |
| GOCC CLATHRIN VESICLE COAT | 26 | 5.14e-01 | 7.39e-02 | 8.37e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 11 | 6.71e-01 | -7.39e-02 | 9.05e-01 |
| GOBP BRAIN MORPHOGENESIS | 22 | 5.49e-01 | 7.39e-02 | 8.53e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 7.54e-01 | 7.39e-02 | 9.37e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 325 | 2.25e-02 | 7.39e-02 | 2.32e-01 |
| GOMF L ASCORBIC ACID BINDING | 15 | 6.21e-01 | -7.38e-02 | 8.84e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 28 | 4.99e-01 | 7.38e-02 | 8.32e-01 |
| GOBP MEMBRANE INVAGINATION | 45 | 3.93e-01 | 7.37e-02 | 7.73e-01 |
| GOBP HEMOPOIESIS | 665 | 1.30e-03 | 7.37e-02 | 4.43e-02 |
| GOBP FACE MORPHOGENESIS | 18 | 5.89e-01 | 7.36e-02 | 8.70e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 24 | 5.33e-01 | -7.36e-02 | 8.46e-01 |
| GOBP VESICLE ORGANIZATION | 285 | 3.31e-02 | 7.36e-02 | 2.84e-01 |
| GOMF VITAMIN BINDING | 78 | 2.62e-01 | 7.36e-02 | 6.76e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 46 | 3.88e-01 | -7.36e-02 | 7.71e-01 |
| GOMF STEROID BINDING | 59 | 3.29e-01 | 7.35e-02 | 7.30e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 84 | 2.45e-01 | 7.35e-02 | 6.59e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 45 | 3.94e-01 | 7.35e-02 | 7.74e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 283 | 3.39e-02 | 7.35e-02 | 2.86e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 17 | 6.00e-01 | 7.35e-02 | 8.74e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 25 | 5.25e-01 | -7.34e-02 | 8.42e-01 |
| GOCC PHAGOCYTIC VESICLE | 119 | 1.67e-01 | 7.34e-02 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 47 | 3.84e-01 | -7.34e-02 | 7.70e-01 |
| GOCC HEMOGLOBIN COMPLEX | 5 | 7.76e-01 | 7.34e-02 | 9.43e-01 |
| GOBP HEAD DEVELOPMENT | 436 | 8.97e-03 | 7.33e-02 | 1.42e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 158 | 1.12e-01 | 7.33e-02 | 4.92e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 10 | 6.88e-01 | -7.33e-02 | 9.13e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 13 | 6.47e-01 | 7.33e-02 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 8 | 7.20e-01 | 7.33e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 34 | 4.60e-01 | -7.33e-02 | 8.10e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 731 | 8.19e-04 | 7.33e-02 | 3.32e-02 |
| GOCC MICROBODY | 117 | 1.71e-01 | 7.33e-02 | 5.83e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 7.37e-01 | 7.33e-02 | 9.32e-01 |
| GOCC IGA IMMUNOGLOBULIN COMPLEX | 5 | 7.77e-01 | 7.32e-02 | 9.43e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 7.56e-01 | 7.32e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 13 | 6.48e-01 | -7.32e-02 | 8.94e-01 |
| GOMF PROTEASE BINDING | 91 | 2.28e-01 | 7.32e-02 | 6.40e-01 |
| GOBP DAMP METABOLIC PROCESS | 5 | 7.77e-01 | 7.31e-02 | 9.43e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 119 | 1.69e-01 | 7.31e-02 | 5.80e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 11 | 6.75e-01 | 7.30e-02 | 9.07e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 11 | 6.75e-01 | 7.30e-02 | 9.07e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 17 | 6.03e-01 | 7.30e-02 | 8.75e-01 |
| GOCC STEREOCILIUM BUNDLE | 31 | 4.82e-01 | -7.29e-02 | 8.20e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 26 | 5.20e-01 | 7.29e-02 | 8.40e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 40 | 4.25e-01 | -7.29e-02 | 7.92e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 698 | 1.13e-03 | 7.29e-02 | 4.05e-02 |
| GOBP GLOMERULUS DEVELOPMENT | 30 | 4.90e-01 | -7.29e-02 | 8.26e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 10 | 6.90e-01 | -7.28e-02 | 9.13e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 5.93e-01 | 7.28e-02 | 8.71e-01 |
| GOCC APICAL PART OF CELL | 223 | 6.18e-02 | 7.28e-02 | 3.87e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 77 | 2.70e-01 | -7.27e-02 | 6.84e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 107 | 1.94e-01 | 7.27e-02 | 6.07e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 11 | 6.76e-01 | -7.27e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 14 | 6.38e-01 | 7.27e-02 | 8.92e-01 |
| GOBP MICROTUBULE BASED PROCESS | 651 | 1.69e-03 | 7.27e-02 | 5.25e-02 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 10 | 6.91e-01 | 7.26e-02 | 9.14e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 68 | 3.01e-01 | 7.26e-02 | 7.09e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 8 | 7.22e-01 | -7.26e-02 | 9.25e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 7 | 7.39e-01 | -7.26e-02 | 9.33e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 25 | 5.30e-01 | 7.26e-02 | 8.45e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1084 | 6.83e-05 | 7.25e-02 | 4.53e-03 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 14 | 6.38e-01 | 7.25e-02 | 8.92e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 12 | 6.64e-01 | 7.25e-02 | 9.03e-01 |
| GOCC PROTEIN KINASE COMPLEX | 122 | 1.67e-01 | 7.25e-02 | 5.77e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 7.59e-01 | -7.25e-02 | 9.39e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 24 | 5.39e-01 | -7.24e-02 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 274 | 3.98e-02 | 7.24e-02 | 3.10e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 23 | 5.48e-01 | 7.24e-02 | 8.53e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 7.79e-01 | 7.23e-02 | 9.44e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 27 | 5.16e-01 | -7.23e-02 | 8.38e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 6 | 7.59e-01 | 7.23e-02 | 9.39e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 42 | 4.18e-01 | 7.23e-02 | 7.88e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 7.41e-01 | 7.23e-02 | 9.34e-01 |
| GOBP MESODERM DEVELOPMENT | 55 | 3.55e-01 | -7.22e-02 | 7.49e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 10 | 6.93e-01 | 7.22e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 51 | 3.73e-01 | 7.21e-02 | 7.61e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 92 | 2.33e-01 | 7.21e-02 | 6.44e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 7 | 7.41e-01 | -7.21e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 134 | 1.51e-01 | 7.20e-02 | 5.58e-01 |
| GOCC NUCLEAR SPECK | 367 | 1.84e-02 | 7.20e-02 | 2.06e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 12 | 6.66e-01 | -7.20e-02 | 9.04e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 390 | 1.52e-02 | 7.19e-02 | 1.89e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 81 | 2.64e-01 | 7.19e-02 | 6.78e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 9 | 7.09e-01 | 7.19e-02 | 9.20e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 329 | 2.57e-02 | 7.18e-02 | 2.49e-01 |
| GOCC GOLGI STACK | 112 | 1.90e-01 | 7.18e-02 | 6.03e-01 |
| GOCC PHAGOCYTIC CUP | 24 | 5.43e-01 | 7.18e-02 | 8.50e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 257 | 4.84e-02 | 7.17e-02 | 3.47e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 9 | 7.10e-01 | -7.17e-02 | 9.20e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 15 | 6.31e-01 | -7.17e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 6.31e-01 | -7.16e-02 | 8.89e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 17 | 6.10e-01 | -7.15e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 7.82e-01 | -7.14e-02 | 9.45e-01 |
| GOBP AORTA MORPHOGENESIS | 18 | 6.00e-01 | -7.14e-02 | 8.74e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 35 | 4.65e-01 | -7.14e-02 | 8.13e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 336 | 2.50e-02 | 7.14e-02 | 2.45e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 6 | 7.62e-01 | 7.14e-02 | 9.40e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 31 | 4.92e-01 | 7.14e-02 | 8.27e-01 |
| GOBP GLUCOCORTICOID SECRETION | 8 | 7.27e-01 | 7.13e-02 | 9.28e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 13 | 6.56e-01 | 7.13e-02 | 8.99e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 13 | 6.57e-01 | 7.12e-02 | 8.99e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 13 | 6.57e-01 | -7.11e-02 | 8.99e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 12 | 6.70e-01 | -7.11e-02 | 9.04e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 9 | 7.12e-01 | 7.11e-02 | 9.20e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 8 | 7.28e-01 | -7.10e-02 | 9.29e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.45e-01 | -7.10e-02 | 9.35e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 5 | 7.83e-01 | 7.10e-02 | 9.45e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 6 | 7.63e-01 | -7.10e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 147 | 1.38e-01 | 7.10e-02 | 5.37e-01 |
| GOMF MONOSACCHARIDE BINDING | 49 | 3.91e-01 | 7.09e-02 | 7.73e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 188 | 9.44e-02 | 7.09e-02 | 4.60e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 8 | 7.29e-01 | 7.09e-02 | 9.29e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 6.46e-01 | 7.09e-02 | 8.94e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 119 | 1.83e-01 | 7.08e-02 | 5.97e-01 |
| GOBP REGULATION OF TRANSPORT | 1006 | 1.74e-04 | 7.08e-02 | 9.96e-03 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 15 | 6.35e-01 | 7.08e-02 | 8.90e-01 |
| GOBP PROTEIN PROCESSING | 148 | 1.38e-01 | 7.08e-02 | 5.37e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 98 | 2.27e-01 | 7.07e-02 | 6.39e-01 |
| GOCC GOLGI MEMBRANE | 501 | 7.10e-03 | 7.07e-02 | 1.23e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 154 | 1.31e-01 | 7.06e-02 | 5.25e-01 |
| GOCC DENDRITE MEMBRANE | 10 | 6.99e-01 | 7.06e-02 | 9.17e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 204 | 8.29e-02 | 7.06e-02 | 4.38e-01 |
| GOBP CELL CYCLE | 1365 | 1.69e-05 | 7.06e-02 | 1.41e-03 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 35 | 4.70e-01 | 7.05e-02 | 8.16e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 7 | 7.47e-01 | 7.05e-02 | 9.35e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 119 | 1.85e-01 | 7.05e-02 | 5.98e-01 |
| GOBP NEURON MIGRATION | 92 | 2.43e-01 | 7.05e-02 | 6.58e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 148 | 1.40e-01 | 7.04e-02 | 5.41e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 60 | 3.46e-01 | -7.04e-02 | 7.42e-01 |
| GOCC NSL COMPLEX | 11 | 6.86e-01 | 7.04e-02 | 9.13e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 102 | 2.20e-01 | 7.04e-02 | 6.33e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 101 | 2.22e-01 | -7.03e-02 | 6.35e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 7 | 7.47e-01 | 7.03e-02 | 9.35e-01 |
| GOCC PROTEIN DNA COMPLEX | 840 | 6.12e-04 | 7.03e-02 | 2.64e-02 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 7 | 7.48e-01 | -7.02e-02 | 9.35e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 20 | 5.87e-01 | 7.02e-02 | 8.69e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 10 | 7.01e-01 | -7.02e-02 | 9.17e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 17 | 6.16e-01 | -7.02e-02 | 8.83e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 269 | 4.84e-02 | 7.01e-02 | 3.47e-01 |
| GOCC NUCLEAR ENVELOPE | 395 | 1.73e-02 | 7.01e-02 | 2.00e-01 |
| GOBP VIRAL TRANSCRIPTION | 46 | 4.11e-01 | 7.01e-02 | 7.83e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 13 | 6.62e-01 | -7.01e-02 | 9.01e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 227 | 6.98e-02 | 7.00e-02 | 4.08e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 429 | 1.33e-02 | 7.00e-02 | 1.77e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 251 | 5.68e-02 | -7.00e-02 | 3.74e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 7.16e-01 | 7.00e-02 | 9.22e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 25 | 5.45e-01 | -7.00e-02 | 8.51e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 14 | 6.51e-01 | 6.99e-02 | 8.96e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 72 | 3.05e-01 | 6.99e-02 | 7.12e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 20 | 5.88e-01 | -6.99e-02 | 8.70e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 28 | 5.23e-01 | -6.98e-02 | 8.41e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 5 | 7.87e-01 | 6.98e-02 | 9.46e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 13 | 6.63e-01 | 6.98e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 90 | 2.53e-01 | -6.98e-02 | 6.67e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 67 | 3.24e-01 | -6.97e-02 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 10 | 7.03e-01 | -6.97e-02 | 9.18e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 17 | 6.19e-01 | 6.97e-02 | 8.84e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 213 | 8.02e-02 | 6.97e-02 | 4.32e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 198 | 9.16e-02 | 6.97e-02 | 4.56e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 8 | 7.33e-01 | 6.96e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 9 | 7.18e-01 | 6.96e-02 | 9.22e-01 |
| GOBP REGULATION OF CELL SHAPE | 99 | 2.32e-01 | 6.96e-02 | 6.43e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 88 | 2.60e-01 | -6.96e-02 | 6.73e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 8 | 7.33e-01 | 6.96e-02 | 9.31e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 159 | 1.31e-01 | 6.96e-02 | 5.24e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 16 | 6.30e-01 | -6.96e-02 | 8.88e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 72 | 3.08e-01 | -6.96e-02 | 7.13e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 7.88e-01 | -6.95e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 12 | 6.77e-01 | 6.94e-02 | 9.08e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 22 | 5.73e-01 | 6.94e-02 | 8.60e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 13 | 6.65e-01 | 6.94e-02 | 9.03e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 27 | 5.33e-01 | -6.94e-02 | 8.46e-01 |
| GOBP KINETOCHORE ORGANIZATION | 20 | 5.92e-01 | 6.93e-02 | 8.70e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 187 | 1.03e-01 | 6.93e-02 | 4.78e-01 |
| GOBP IMPORT INTO CELL | 557 | 5.52e-03 | 6.92e-02 | 1.10e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 9 | 7.20e-01 | 6.91e-02 | 9.24e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 35 | 4.80e-01 | -6.91e-02 | 8.18e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 123 | 1.87e-01 | 6.90e-02 | 6.01e-01 |
| GOBP GOLGI ORGANIZATION | 132 | 1.71e-01 | 6.90e-02 | 5.83e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 23 | 5.67e-01 | 6.90e-02 | 8.58e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 9 | 7.20e-01 | 6.90e-02 | 9.24e-01 |
| GOBP MACROMOLECULE DEACYLATION | 64 | 3.41e-01 | 6.89e-02 | 7.38e-01 |
| GOBP BLASTODERM SEGMENTATION | 6 | 7.70e-01 | -6.89e-02 | 9.41e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 6 | 7.70e-01 | -6.89e-02 | 9.41e-01 |
| GOBP PANCREAS DEVELOPMENT | 34 | 4.87e-01 | -6.89e-02 | 8.24e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 62 | 3.49e-01 | -6.88e-02 | 7.44e-01 |
| GOCC SPINDLE | 345 | 2.87e-02 | 6.88e-02 | 2.64e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 135 | 1.68e-01 | 6.88e-02 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 142 | 1.58e-01 | 6.88e-02 | 5.68e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 13 | 6.68e-01 | 6.88e-02 | 9.04e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 11 | 6.93e-01 | 6.88e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 22 | 5.77e-01 | 6.86e-02 | 8.64e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 9 | 7.22e-01 | -6.86e-02 | 9.25e-01 |
| GOCC CENTROSOME | 537 | 6.90e-03 | 6.86e-02 | 1.20e-01 |
| GOBP RESPONSE TO COCAINE | 23 | 5.69e-01 | -6.86e-02 | 8.59e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 169 | 1.25e-01 | 6.85e-02 | 5.15e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 25 | 5.53e-01 | 6.85e-02 | 8.54e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 17 | 6.25e-01 | -6.85e-02 | 8.86e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 72 | 3.15e-01 | -6.85e-02 | 7.19e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 264 | 5.63e-02 | 6.84e-02 | 3.71e-01 |
| GOMF HYALURONIC ACID BINDING | 13 | 6.69e-01 | 6.84e-02 | 9.04e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 47 | 4.18e-01 | -6.84e-02 | 7.88e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 118 | 2.00e-01 | 6.84e-02 | 6.12e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 8 | 7.38e-01 | 6.84e-02 | 9.33e-01 |
| GOBP NEUROBLAST PROLIFERATION | 37 | 4.72e-01 | 6.83e-02 | 8.16e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 23 | 5.71e-01 | -6.83e-02 | 8.59e-01 |
| GOCC RUFFLE MEMBRANE | 77 | 3.01e-01 | 6.83e-02 | 7.09e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 119 | 1.99e-01 | 6.83e-02 | 6.11e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 10 | 7.09e-01 | -6.83e-02 | 9.20e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 9 | 7.23e-01 | -6.83e-02 | 9.25e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 121 | 1.96e-01 | 6.82e-02 | 6.09e-01 |
| GOBP PROTEIN METHYLATION | 68 | 3.32e-01 | 6.81e-02 | 7.33e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 17 | 6.27e-01 | 6.81e-02 | 8.87e-01 |
| GOCC A BAND | 18 | 6.17e-01 | 6.81e-02 | 8.83e-01 |
| GOMF ACTININ BINDING | 21 | 5.89e-01 | -6.81e-02 | 8.70e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 13 | 6.71e-01 | -6.81e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 12 | 6.83e-01 | 6.80e-02 | 9.11e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 27 | 5.41e-01 | 6.80e-02 | 8.49e-01 |
| GOCC POSTSYNAPSE | 372 | 2.49e-02 | 6.80e-02 | 2.45e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 6 | 7.73e-01 | -6.80e-02 | 9.42e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 681 | 2.69e-03 | 6.80e-02 | 6.93e-02 |
| GOBP REGULATION OF NUCLEAR DIVISION | 87 | 2.74e-01 | 6.80e-02 | 6.88e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 11 | 6.96e-01 | -6.80e-02 | 9.16e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 13 | 6.71e-01 | 6.80e-02 | 9.05e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 49 | 4.11e-01 | 6.79e-02 | 7.83e-01 |
| GOCC RUFFLE | 147 | 1.56e-01 | 6.79e-02 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 917 | 5.65e-04 | 6.79e-02 | 2.50e-02 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 122 | 1.96e-01 | -6.79e-02 | 6.09e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 487 | 1.08e-02 | 6.79e-02 | 1.58e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 97 | 2.49e-01 | -6.78e-02 | 6.62e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 33 | 5.00e-01 | 6.78e-02 | 8.32e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 5.28e-01 | -6.78e-02 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 6 | 7.74e-01 | 6.78e-02 | 9.42e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 16 | 6.39e-01 | 6.77e-02 | 8.92e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 107 | 2.27e-01 | 6.77e-02 | 6.39e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 66 | 3.42e-01 | -6.77e-02 | 7.39e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1036 | 2.75e-04 | 6.77e-02 | 1.38e-02 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 25 | 5.59e-01 | 6.76e-02 | 8.56e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 11 | 6.98e-01 | 6.76e-02 | 9.16e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 11 | 6.98e-01 | 6.76e-02 | 9.16e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 12 | 6.85e-01 | 6.75e-02 | 9.13e-01 |
| GOCC MOTILE CILIUM | 136 | 1.75e-01 | -6.75e-02 | 5.88e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 31 | 5.15e-01 | 6.75e-02 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 25 | 5.59e-01 | 6.75e-02 | 8.56e-01 |
| GOBP ACID SECRETION | 20 | 6.01e-01 | -6.75e-02 | 8.74e-01 |
| GOCC ESCRT COMPLEX | 25 | 5.60e-01 | 6.74e-02 | 8.56e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 7.12e-01 | 6.74e-02 | 9.20e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 22 | 5.84e-01 | -6.74e-02 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 40 | 4.61e-01 | -6.74e-02 | 8.12e-01 |
| GOCC APICAL JUNCTION COMPLEX | 78 | 3.04e-01 | 6.74e-02 | 7.11e-01 |
| GOBP LIVER MORPHOGENESIS | 17 | 6.31e-01 | -6.72e-02 | 8.89e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 54 | 3.93e-01 | 6.72e-02 | 7.74e-01 |
| GOBP STEM CELL PROLIFERATION | 59 | 3.72e-01 | 6.72e-02 | 7.60e-01 |
| GOMF SYMPORTER ACTIVITY | 76 | 3.12e-01 | -6.72e-02 | 7.15e-01 |
| GOBP RESPONSE TO VIRUS | 321 | 3.92e-02 | 6.72e-02 | 3.06e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 860 | 9.36e-04 | 6.71e-02 | 3.67e-02 |
| GOMF SPECTRIN BINDING | 15 | 6.53e-01 | 6.71e-02 | 8.97e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 44 | 4.42e-01 | -6.71e-02 | 8.01e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 50 | 4.12e-01 | 6.70e-02 | 7.84e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 82 | 2.95e-01 | 6.70e-02 | 7.04e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 11 | 7.01e-01 | 6.69e-02 | 9.17e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 61 | 3.66e-01 | -6.69e-02 | 7.55e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 7 | 7.59e-01 | 6.69e-02 | 9.39e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 20 | 6.05e-01 | 6.69e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 11 | 7.01e-01 | -6.69e-02 | 9.17e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 10 | 7.14e-01 | 6.68e-02 | 9.21e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 6 | 7.77e-01 | -6.68e-02 | 9.43e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 65 | 3.52e-01 | -6.68e-02 | 7.47e-01 |
| GOBP NADP METABOLIC PROCESS | 33 | 5.07e-01 | 6.68e-02 | 8.36e-01 |
| GOBP TRABECULA MORPHOGENESIS | 26 | 5.56e-01 | 6.68e-02 | 8.56e-01 |
| GOCC ANCHORING JUNCTION | 575 | 6.59e-03 | 6.67e-02 | 1.18e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1525 | 1.93e-05 | 6.67e-02 | 1.53e-03 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 7.15e-01 | 6.67e-02 | 9.21e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 7.96e-01 | -6.67e-02 | 9.49e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 44 | 4.45e-01 | -6.66e-02 | 8.02e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 21 | 5.97e-01 | -6.66e-02 | 8.73e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 30 | 5.28e-01 | 6.66e-02 | 8.44e-01 |
| GOMF KINASE ACTIVITY | 553 | 7.90e-03 | 6.65e-02 | 1.31e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 22 | 5.89e-01 | 6.65e-02 | 8.70e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 488 | 1.24e-02 | 6.64e-02 | 1.72e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 9 | 7.30e-01 | -6.64e-02 | 9.30e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 18 | 6.26e-01 | -6.64e-02 | 8.86e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 54 | 3.99e-01 | 6.64e-02 | 7.78e-01 |
| GOBP PROTEIN ACYLATION | 121 | 2.08e-01 | 6.63e-02 | 6.22e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 5 | 7.97e-01 | -6.63e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 84 | 2.94e-01 | -6.63e-02 | 7.04e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 7.97e-01 | 6.63e-02 | 9.49e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 15 | 6.57e-01 | -6.62e-02 | 8.99e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 13 | 6.79e-01 | 6.62e-02 | 9.09e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 7 | 7.62e-01 | 6.62e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 51 | 4.14e-01 | 6.61e-02 | 7.86e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 8 | 7.46e-01 | -6.60e-02 | 9.35e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 977 | 5.58e-04 | 6.60e-02 | 2.48e-02 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 24 | 5.76e-01 | -6.60e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 430 | 1.96e-02 | 6.59e-02 | 2.14e-01 |
| GOMF C C CHEMOKINE BINDING | 12 | 6.93e-01 | 6.59e-02 | 9.14e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 55 | 3.98e-01 | 6.59e-02 | 7.77e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 7.80e-01 | -6.59e-02 | 9.44e-01 |
| GOBP VISUAL BEHAVIOR | 30 | 5.32e-01 | 6.59e-02 | 8.46e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 210 | 1.01e-01 | 6.58e-02 | 4.73e-01 |
| GOBP EPIBOLY | 25 | 5.69e-01 | 6.58e-02 | 8.59e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 17 | 6.39e-01 | 6.57e-02 | 8.92e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 58 | 3.87e-01 | -6.57e-02 | 7.70e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 23 | 5.86e-01 | 6.57e-02 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 143 | 1.76e-01 | 6.57e-02 | 5.89e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 15 | 6.60e-01 | 6.57e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 285 | 5.73e-02 | 6.57e-02 | 3.75e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 19 | 6.21e-01 | 6.56e-02 | 8.84e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 22 | 5.95e-01 | 6.55e-02 | 8.72e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 29 | 5.41e-01 | -6.55e-02 | 8.49e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 116 | 2.24e-01 | -6.55e-02 | 6.36e-01 |
| GOBP OVULATION | 7 | 7.64e-01 | -6.55e-02 | 9.40e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 7 | 7.64e-01 | 6.55e-02 | 9.40e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 30 | 5.35e-01 | 6.55e-02 | 8.47e-01 |
| GOBP CALCIUM ION IMPORT | 23 | 5.87e-01 | 6.55e-02 | 8.69e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 34 | 5.09e-01 | -6.55e-02 | 8.36e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 6 | 7.81e-01 | 6.54e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 96 | 2.69e-01 | 6.54e-02 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 222 | 9.43e-02 | 6.53e-02 | 4.60e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 132 | 1.96e-01 | 6.53e-02 | 6.09e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 6.84e-01 | 6.53e-02 | 9.12e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 24 | 5.80e-01 | -6.53e-02 | 8.66e-01 |
| GOMF COA HYDROLASE ACTIVITY | 15 | 6.62e-01 | 6.53e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 23 | 5.88e-01 | 6.53e-02 | 8.70e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 95 | 2.72e-01 | 6.52e-02 | 6.86e-01 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 8.01e-01 | 6.52e-02 | 9.50e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 24 | 5.80e-01 | 6.52e-02 | 8.66e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 15 | 6.62e-01 | 6.52e-02 | 9.01e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 403 | 2.54e-02 | 6.52e-02 | 2.48e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 39 | 4.82e-01 | 6.51e-02 | 8.20e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 8 | 7.50e-01 | 6.51e-02 | 9.35e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 82 | 3.09e-01 | 6.51e-02 | 7.14e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 19 | 6.23e-01 | -6.51e-02 | 8.86e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 63 | 3.72e-01 | 6.51e-02 | 7.60e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 94 | 2.76e-01 | 6.51e-02 | 6.91e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 373 | 3.17e-02 | 6.51e-02 | 2.78e-01 |
| GOMF PROTEIN KINASE C BINDING | 32 | 5.24e-01 | -6.51e-02 | 8.42e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 61 | 3.80e-01 | 6.51e-02 | 7.67e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 486 | 1.46e-02 | 6.51e-02 | 1.85e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 7 | 7.66e-01 | 6.50e-02 | 9.40e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 821 | 1.72e-03 | 6.50e-02 | 5.33e-02 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 7 | 7.66e-01 | 6.50e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 71 | 3.45e-01 | 6.49e-02 | 7.41e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 44 | 4.57e-01 | 6.49e-02 | 8.08e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 54 | 4.10e-01 | -6.48e-02 | 7.83e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 91 | 2.86e-01 | -6.48e-02 | 7.00e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 876 | 1.27e-03 | 6.48e-02 | 4.38e-02 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 146 | 1.77e-01 | 6.48e-02 | 5.91e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 7 | 7.67e-01 | 6.48e-02 | 9.41e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 8 | 7.51e-01 | -6.48e-02 | 9.35e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 43 | 4.63e-01 | -6.48e-02 | 8.12e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 11 | 7.10e-01 | 6.47e-02 | 9.20e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 48 | 4.39e-01 | 6.47e-02 | 7.99e-01 |
| GOBP XENOBIOTIC TRANSPORT | 26 | 5.68e-01 | 6.46e-02 | 8.59e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 52 | 4.21e-01 | 6.46e-02 | 7.90e-01 |
| GOBP TRNA METHYLATION | 42 | 4.69e-01 | 6.46e-02 | 8.15e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 43 | 4.64e-01 | -6.46e-02 | 8.12e-01 |
| GOMF ZINC ION BINDING | 567 | 9.03e-03 | 6.46e-02 | 1.42e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 7.37e-01 | 6.46e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 11 | 7.11e-01 | -6.45e-02 | 9.20e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 85 | 3.05e-01 | 6.45e-02 | 7.12e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 11 | 7.11e-01 | 6.45e-02 | 9.20e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 41 | 4.75e-01 | -6.45e-02 | 8.17e-01 |
| GOBP DEMETHYLATION | 42 | 4.70e-01 | 6.45e-02 | 8.16e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 84 | 3.08e-01 | 6.44e-02 | 7.13e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 493 | 1.49e-02 | 6.44e-02 | 1.87e-01 |
| GOBP MEMBRANE ORGANIZATION | 605 | 7.24e-03 | 6.44e-02 | 1.24e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 139 | 1.91e-01 | 6.44e-02 | 6.04e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 6 | 7.85e-01 | -6.43e-02 | 9.46e-01 |
| GOMF DEATH RECEPTOR BINDING | 14 | 6.77e-01 | -6.43e-02 | 9.08e-01 |
| GOCC INTERCELLULAR BRIDGE | 62 | 3.81e-01 | 6.43e-02 | 7.68e-01 |
| GOCC NUCLEAR MEMBRANE | 251 | 8.03e-02 | 6.43e-02 | 4.32e-01 |
| GOBP CELL DIVISION | 488 | 1.56e-02 | 6.43e-02 | 1.91e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 221 | 1.01e-01 | 6.42e-02 | 4.73e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 38 | 4.93e-01 | 6.42e-02 | 8.27e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 14 | 6.78e-01 | -6.42e-02 | 9.08e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 7.25e-01 | -6.42e-02 | 9.27e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 703 | 4.03e-03 | 6.42e-02 | 9.00e-02 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 69 | 3.57e-01 | -6.41e-02 | 7.50e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 12 | 7.01e-01 | -6.41e-02 | 9.17e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 51 | 4.29e-01 | 6.41e-02 | 7.93e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 119 | 2.28e-01 | 6.41e-02 | 6.40e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 173 | 1.47e-01 | -6.41e-02 | 5.51e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 433 | 2.30e-02 | 6.40e-02 | 2.35e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 66 | 3.69e-01 | -6.40e-02 | 7.58e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 6 | 7.86e-01 | 6.40e-02 | 9.46e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 385 | 3.20e-02 | 6.40e-02 | 2.79e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 7.40e-01 | 6.39e-02 | 9.34e-01 |
| GOBP WOUND HEALING | 235 | 9.22e-02 | 6.39e-02 | 4.56e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 112 | 2.43e-01 | -6.39e-02 | 6.58e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 161 | 1.63e-01 | 6.39e-02 | 5.75e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 25 | 5.81e-01 | -6.39e-02 | 8.66e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 7.86e-01 | -6.39e-02 | 9.46e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 53 | 4.22e-01 | 6.38e-02 | 7.90e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 11 | 7.14e-01 | 6.37e-02 | 9.21e-01 |
| GOBP PEROXISOME FISSION | 8 | 7.55e-01 | -6.37e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 94 | 2.86e-01 | 6.37e-02 | 7.00e-01 |
| GOBP STRESS FIBER ASSEMBLY | 76 | 3.37e-01 | 6.37e-02 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 12 | 7.02e-01 | 6.37e-02 | 9.18e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 149 | 1.80e-01 | 6.37e-02 | 5.96e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 498 | 1.55e-02 | 6.37e-02 | 1.90e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 18 | 6.40e-01 | 6.36e-02 | 8.93e-01 |
| GOBP RNA STABILIZATION | 55 | 4.15e-01 | 6.36e-02 | 7.86e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 52 | 4.28e-01 | 6.36e-02 | 7.93e-01 |
| GOCC TRANSPORT VESICLE | 279 | 6.85e-02 | 6.36e-02 | 4.03e-01 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 8 | 7.56e-01 | 6.36e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 20 | 6.23e-01 | 6.35e-02 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 110 | 2.51e-01 | 6.34e-02 | 6.65e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 40 | 4.88e-01 | -6.34e-02 | 8.24e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 18 | 6.41e-01 | 6.34e-02 | 8.93e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 9 | 7.42e-01 | -6.34e-02 | 9.34e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 44 | 4.67e-01 | 6.34e-02 | 8.14e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 61 | 3.92e-01 | -6.34e-02 | 7.73e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 290 | 6.50e-02 | 6.32e-02 | 3.96e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 42 | 4.79e-01 | 6.32e-02 | 8.18e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 42 | 4.79e-01 | 6.32e-02 | 8.18e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 128 | 2.18e-01 | -6.32e-02 | 6.31e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 24 | 5.92e-01 | 6.32e-02 | 8.71e-01 |
| GOCC SECRETORY GRANULE | 571 | 1.04e-02 | 6.31e-02 | 1.55e-01 |
| GOCC GERM CELL NUCLEUS | 45 | 4.64e-01 | 6.31e-02 | 8.12e-01 |
| GOBP CELL ACTIVATION | 774 | 3.09e-03 | 6.31e-02 | 7.54e-02 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 51 | 4.37e-01 | 6.30e-02 | 7.98e-01 |
| GOCC ENDOLYSOSOME | 21 | 6.18e-01 | 6.29e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 6 | 7.90e-01 | -6.29e-02 | 9.47e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 6.26e-01 | -6.29e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 746 | 3.75e-03 | 6.29e-02 | 8.61e-02 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 57 | 4.12e-01 | 6.28e-02 | 7.84e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 345 | 4.59e-02 | 6.28e-02 | 3.35e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 5 | 8.08e-01 | -6.28e-02 | 9.52e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 6 | 7.90e-01 | -6.28e-02 | 9.47e-01 |
| GOCC GID COMPLEX | 5 | 8.08e-01 | 6.28e-02 | 9.52e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 14 | 6.85e-01 | 6.27e-02 | 9.12e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 23 | 6.03e-01 | 6.27e-02 | 8.75e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 12 | 7.07e-01 | -6.27e-02 | 9.20e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 7.59e-01 | 6.26e-02 | 9.39e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 12 | 7.08e-01 | -6.25e-02 | 9.20e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 64 | 3.88e-01 | 6.25e-02 | 7.70e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 12 | 7.08e-01 | -6.25e-02 | 9.20e-01 |
| GOMF TRANSPORTER ACTIVITY | 671 | 6.16e-03 | 6.25e-02 | 1.15e-01 |
| GOBP PROTEOLYSIS | 1140 | 4.52e-04 | 6.25e-02 | 2.11e-02 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 60 | 4.03e-01 | 6.24e-02 | 7.80e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 9 | 7.46e-01 | -6.24e-02 | 9.35e-01 |
| GOBP SECRETION BY TISSUE | 18 | 6.47e-01 | 6.23e-02 | 8.94e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 6 | 7.92e-01 | -6.23e-02 | 9.48e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 7 | 7.75e-01 | -6.23e-02 | 9.43e-01 |
| GOCC CILIARY ROOTLET | 9 | 7.47e-01 | -6.21e-02 | 9.35e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 24 | 5.99e-01 | 6.21e-02 | 8.73e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 59 | 4.10e-01 | -6.21e-02 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 392 | 3.58e-02 | 6.21e-02 | 2.94e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 10 | 7.34e-01 | 6.20e-02 | 9.31e-01 |
| GOCC MITOCHONDRIAL CRISTA | 6 | 7.93e-01 | 6.20e-02 | 9.48e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 10 | 7.34e-01 | 6.20e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 28 | 5.71e-01 | -6.20e-02 | 8.59e-01 |
| GOBP B CELL DIFFERENTIATION | 104 | 2.76e-01 | 6.19e-02 | 6.90e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 27 | 5.78e-01 | -6.19e-02 | 8.64e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 49 | 4.54e-01 | -6.19e-02 | 8.06e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 885 | 1.99e-03 | 6.19e-02 | 5.85e-02 |
| GOBP PROTEIN STABILIZATION | 174 | 1.60e-01 | 6.19e-02 | 5.72e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 5.78e-01 | -6.19e-02 | 8.64e-01 |
| GOBP REGULATION OF DNA BINDING | 61 | 4.04e-01 | 6.19e-02 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 5 | 8.11e-01 | 6.19e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 263 | 8.52e-02 | 6.18e-02 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 154 | 1.86e-01 | 6.18e-02 | 6.00e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 12 | 7.11e-01 | 6.18e-02 | 9.20e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 15 | 6.79e-01 | -6.18e-02 | 9.09e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 71 | 3.69e-01 | 6.18e-02 | 7.58e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 117 | 2.49e-01 | 6.18e-02 | 6.63e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 198 | 1.35e-01 | -6.17e-02 | 5.32e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 135 | 2.17e-01 | 6.17e-02 | 6.31e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 10 | 7.36e-01 | 6.17e-02 | 9.31e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 56 | 4.26e-01 | 6.16e-02 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 12 | 7.12e-01 | -6.16e-02 | 9.20e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 22 | 6.18e-01 | 6.15e-02 | 8.83e-01 |
| GOBP MEMORY | 62 | 4.03e-01 | 6.15e-02 | 7.80e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 101 | 2.86e-01 | 6.15e-02 | 7.00e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 14 | 6.91e-01 | -6.14e-02 | 9.14e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 449 | 2.64e-02 | 6.14e-02 | 2.53e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 49 | 4.57e-01 | 6.14e-02 | 8.08e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 365 | 4.50e-02 | 6.13e-02 | 3.31e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 58 | 4.20e-01 | -6.13e-02 | 7.89e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 6 | 7.95e-01 | -6.13e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 14 | 6.92e-01 | 6.13e-02 | 9.14e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1031 | 1.02e-03 | 6.12e-02 | 3.82e-02 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 26 | 5.89e-01 | 6.12e-02 | 8.70e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 106 | 2.77e-01 | -6.12e-02 | 6.91e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 289 | 7.45e-02 | 6.12e-02 | 4.20e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 8 | 7.65e-01 | 6.11e-02 | 9.40e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 54 | 4.37e-01 | 6.11e-02 | 7.98e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 23 | 6.12e-01 | -6.11e-02 | 8.81e-01 |
| GOCC PROTEIN LIPID COMPLEX | 17 | 6.63e-01 | 6.10e-02 | 9.02e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 10 | 7.38e-01 | -6.10e-02 | 9.33e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 42 | 4.94e-01 | 6.10e-02 | 8.28e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 7.66e-01 | 6.09e-02 | 9.40e-01 |
| GOBP LYMPHANGIOGENESIS | 6 | 7.96e-01 | -6.08e-02 | 9.49e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 228 | 1.14e-01 | 6.08e-02 | 4.96e-01 |
| GOBP MUSCLE HYPERTROPHY | 57 | 4.27e-01 | 6.08e-02 | 7.93e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 84 | 3.36e-01 | -6.08e-02 | 7.34e-01 |
| GOCC CELL DIVISION SITE | 59 | 4.20e-01 | 6.07e-02 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 533 | 1.72e-02 | 6.07e-02 | 2.00e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 48 | 4.67e-01 | 6.07e-02 | 8.14e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 7.66e-01 | -6.07e-02 | 9.41e-01 |
| GOBP RESPONSE TO CAFFEINE | 12 | 7.16e-01 | -6.06e-02 | 9.22e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 38 | 5.19e-01 | -6.05e-02 | 8.40e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 303 | 7.10e-02 | 6.05e-02 | 4.11e-01 |
| GOBP RESPONSE TO RADIATION | 302 | 7.14e-02 | 6.05e-02 | 4.13e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 15 | 6.85e-01 | 6.05e-02 | 9.12e-01 |
| GOBP MATING BEHAVIOR | 14 | 6.95e-01 | -6.05e-02 | 9.16e-01 |
| GOBP SPERMATID DIFFERENTIATION | 99 | 2.99e-01 | -6.05e-02 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 51 | 4.56e-01 | -6.04e-02 | 8.08e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 8.15e-01 | 6.04e-02 | 9.54e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 10 | 7.41e-01 | -6.04e-02 | 9.34e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 228 | 1.17e-01 | -6.04e-02 | 4.99e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 31 | 5.61e-01 | -6.03e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 32 | 5.55e-01 | 6.03e-02 | 8.56e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 7.18e-01 | 6.03e-02 | 9.22e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 150 | 2.04e-01 | -6.02e-02 | 6.17e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 43 | 4.95e-01 | 6.02e-02 | 8.28e-01 |
| GOBP ACTIN FILAMENT SEVERING | 15 | 6.87e-01 | 6.02e-02 | 9.13e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 7 | 7.83e-01 | -6.02e-02 | 9.45e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 64 | 4.06e-01 | -6.01e-02 | 7.81e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 5 | 8.16e-01 | 6.01e-02 | 9.54e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 61 | 4.17e-01 | -6.01e-02 | 7.88e-01 |
| GOBP PHOSPHORYLATION | 1076 | 1.02e-03 | 6.01e-02 | 3.82e-02 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 278 | 8.59e-02 | 6.00e-02 | 4.44e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 7.30e-01 | -6.00e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 40 | 5.11e-01 | -6.00e-02 | 8.37e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 472 | 2.64e-02 | 6.00e-02 | 2.53e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 16 | 6.78e-01 | 6.00e-02 | 9.08e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 123 | 2.52e-01 | 5.99e-02 | 6.65e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 8 | 7.69e-01 | 5.99e-02 | 9.41e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 7 | 7.84e-01 | -5.99e-02 | 9.46e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 49 | 4.69e-01 | 5.99e-02 | 8.15e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 8.17e-01 | -5.98e-02 | 9.54e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 6 | 8.00e-01 | -5.98e-02 | 9.50e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 6.98e-01 | -5.98e-02 | 9.17e-01 |
| GOBP AMINO ACID SALVAGE | 5 | 8.17e-01 | 5.98e-02 | 9.54e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 8.17e-01 | 5.98e-02 | 9.54e-01 |
| GOBP ORGANELLE FUSION | 126 | 2.47e-01 | 5.98e-02 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 8 | 7.70e-01 | 5.96e-02 | 9.41e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 12 | 7.21e-01 | 5.96e-02 | 9.24e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 25 | 6.06e-01 | 5.95e-02 | 8.77e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 7.32e-01 | -5.95e-02 | 9.31e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 96 | 3.14e-01 | 5.95e-02 | 7.18e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 19 | 6.53e-01 | -5.95e-02 | 8.97e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 492 | 2.46e-02 | 5.95e-02 | 2.44e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 21 | 6.37e-01 | -5.95e-02 | 8.92e-01 |
| GOBP FATTY ACID BETA OXIDATION | 62 | 4.19e-01 | 5.95e-02 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 7.71e-01 | 5.94e-02 | 9.41e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 58 | 4.34e-01 | -5.94e-02 | 7.98e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 27 | 5.93e-01 | -5.94e-02 | 8.71e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 48 | 4.77e-01 | -5.94e-02 | 8.17e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 5 | 8.18e-01 | -5.94e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 8 | 7.71e-01 | -5.94e-02 | 9.41e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 33 | 5.56e-01 | 5.93e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 26 | 6.01e-01 | 5.93e-02 | 8.74e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 430 | 3.60e-02 | 5.93e-02 | 2.94e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 9 | 7.58e-01 | -5.92e-02 | 9.39e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 16 | 6.82e-01 | -5.92e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 35 | 5.45e-01 | 5.92e-02 | 8.51e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 9 | 7.59e-01 | -5.91e-02 | 9.39e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 24 | 6.16e-01 | 5.91e-02 | 8.83e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 59 | 4.33e-01 | 5.91e-02 | 7.98e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1037 | 1.49e-03 | 5.91e-02 | 4.80e-02 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 8 | 7.72e-01 | -5.91e-02 | 9.41e-01 |
| GOCC GOLGI APPARATUS | 1130 | 9.74e-04 | 5.90e-02 | 3.75e-02 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 263 | 1.01e-01 | 5.89e-02 | 4.73e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 94 | 3.24e-01 | 5.89e-02 | 7.25e-01 |
| GOBP RESPONSE TO ISCHEMIA | 41 | 5.14e-01 | 5.89e-02 | 8.37e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 6 | 8.03e-01 | -5.89e-02 | 9.51e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 65 | 4.12e-01 | -5.89e-02 | 7.84e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 7 | 7.87e-01 | 5.88e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 22 | 6.33e-01 | 5.88e-02 | 8.90e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 86 | 3.46e-01 | -5.88e-02 | 7.42e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 57 | 4.43e-01 | 5.88e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 49 | 4.77e-01 | 5.88e-02 | 8.17e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 17 | 6.75e-01 | -5.88e-02 | 9.07e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 87 | 3.44e-01 | -5.88e-02 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 122 | 2.63e-01 | 5.88e-02 | 6.77e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 256 | 1.07e-01 | 5.87e-02 | 4.83e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 29 | 5.84e-01 | 5.87e-02 | 8.68e-01 |
| GOBP APOPTOTIC PROCESS | 1288 | 4.95e-04 | 5.87e-02 | 2.29e-02 |
| GOBP HEART TRABECULA MORPHOGENESIS | 20 | 6.50e-01 | 5.86e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 14 | 7.04e-01 | 5.86e-02 | 9.18e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 31 | 5.73e-01 | -5.86e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 202 | 1.52e-01 | 5.86e-02 | 5.61e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 694 | 9.13e-03 | 5.85e-02 | 1.43e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 28 | 5.92e-01 | 5.85e-02 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 61 | 4.30e-01 | -5.85e-02 | 7.94e-01 |
| GOCC ACROSOMAL VESICLE | 63 | 4.23e-01 | -5.85e-02 | 7.90e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 72 | 3.91e-01 | -5.85e-02 | 7.73e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 8 | 7.75e-01 | -5.85e-02 | 9.42e-01 |
| GOCC VESICLE MEMBRANE | 863 | 3.92e-03 | 5.84e-02 | 8.88e-02 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 7.75e-01 | -5.84e-02 | 9.42e-01 |
| GOBP RRNA CATABOLIC PROCESS | 19 | 6.60e-01 | 5.84e-02 | 9.01e-01 |
| GOBP VALINE METABOLIC PROCESS | 6 | 8.05e-01 | -5.83e-02 | 9.51e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 16 | 6.86e-01 | -5.83e-02 | 9.13e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 7.62e-01 | 5.83e-02 | 9.40e-01 |
| GOCC CASPASE COMPLEX | 9 | 7.62e-01 | 5.83e-02 | 9.40e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 120 | 2.71e-01 | 5.83e-02 | 6.85e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 20 | 6.52e-01 | 5.83e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 25 | 6.14e-01 | -5.83e-02 | 8.83e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 6 | 8.05e-01 | -5.83e-02 | 9.51e-01 |
| GOMF METAL CLUSTER BINDING | 63 | 4.24e-01 | 5.82e-02 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 110 | 2.92e-01 | 5.82e-02 | 7.03e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 8.22e-01 | -5.82e-02 | 9.57e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 8 | 7.76e-01 | -5.82e-02 | 9.43e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 19 | 6.61e-01 | -5.82e-02 | 9.01e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 495 | 2.76e-02 | 5.81e-02 | 2.58e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 97 | 3.23e-01 | 5.81e-02 | 7.24e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 16 | 6.88e-01 | -5.81e-02 | 9.13e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 68 | 4.08e-01 | 5.81e-02 | 7.82e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 131 | 2.52e-01 | 5.81e-02 | 6.65e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 36 | 5.47e-01 | -5.81e-02 | 8.53e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 985 | 2.30e-03 | 5.80e-02 | 6.36e-02 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 93 | 3.34e-01 | 5.80e-02 | 7.33e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 5 | 8.22e-01 | 5.80e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 272 | 1.01e-01 | 5.80e-02 | 4.73e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 13 | 7.18e-01 | 5.79e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 43 | 5.12e-01 | -5.79e-02 | 8.37e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 60 | 4.38e-01 | 5.79e-02 | 7.99e-01 |
| GOBP L SERINE METABOLIC PROCESS | 8 | 7.77e-01 | 5.79e-02 | 9.43e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 7 | 7.91e-01 | -5.78e-02 | 9.48e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 8.06e-01 | -5.78e-02 | 9.51e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 69 | 4.07e-01 | 5.77e-02 | 7.82e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 32 | 5.72e-01 | 5.77e-02 | 8.60e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 14 | 7.09e-01 | 5.77e-02 | 9.20e-01 |
| GOBP MITOTIC RECOMBINATION | 22 | 6.40e-01 | 5.77e-02 | 8.92e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 9 | 7.65e-01 | 5.76e-02 | 9.40e-01 |
| GOBP REGULATION OF BONE REMODELING | 29 | 5.91e-01 | -5.76e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 371 | 5.77e-02 | 5.76e-02 | 3.76e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 12 | 7.30e-01 | -5.76e-02 | 9.30e-01 |
| GOBP SYNAPSE ASSEMBLY | 85 | 3.59e-01 | -5.76e-02 | 7.51e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 41 | 5.24e-01 | -5.75e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 7.92e-01 | -5.75e-02 | 9.48e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 77 | 3.83e-01 | 5.75e-02 | 7.69e-01 |
| GOBP INSULIN SECRETION | 113 | 2.92e-01 | -5.75e-02 | 7.02e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 9 | 7.65e-01 | -5.75e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 13 | 7.20e-01 | 5.74e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 8.08e-01 | 5.73e-02 | 9.52e-01 |
| GOBP TISSUE REGENERATION | 39 | 5.36e-01 | 5.73e-02 | 8.47e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 15 | 7.01e-01 | 5.73e-02 | 9.17e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 13 | 7.21e-01 | -5.73e-02 | 9.24e-01 |
| GOBP RHYTHMIC BEHAVIOR | 23 | 6.35e-01 | 5.72e-02 | 8.90e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 18 | 6.74e-01 | -5.72e-02 | 9.07e-01 |
| GOCC GOLGI CISTERNA | 86 | 3.60e-01 | 5.72e-02 | 7.51e-01 |
| GOBP REGULATION OF GTP BINDING | 8 | 7.79e-01 | -5.72e-02 | 9.44e-01 |
| GOBP CD40 SIGNALING PATHWAY | 12 | 7.32e-01 | -5.72e-02 | 9.30e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 7.94e-01 | 5.70e-02 | 9.48e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 7.94e-01 | -5.70e-02 | 9.48e-01 |
| GOMF WW DOMAIN BINDING | 12 | 7.33e-01 | 5.70e-02 | 9.31e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 29 | 5.96e-01 | -5.69e-02 | 8.72e-01 |
| GOCC INNER KINETOCHORE | 17 | 6.85e-01 | 5.69e-02 | 9.12e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 7.81e-01 | 5.69e-02 | 9.44e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 11 | 7.44e-01 | 5.69e-02 | 9.35e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 20 | 6.60e-01 | -5.69e-02 | 9.01e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 79 | 3.83e-01 | -5.68e-02 | 7.69e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1056 | 2.05e-03 | 5.68e-02 | 5.94e-02 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 12 | 7.33e-01 | 5.68e-02 | 9.31e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 10 | 7.56e-01 | -5.68e-02 | 9.38e-01 |
| GOMF MIRNA BINDING | 33 | 5.73e-01 | -5.67e-02 | 8.60e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 151 | 2.30e-01 | 5.67e-02 | 6.42e-01 |
| GOBP NEURAL TUBE PATTERNING | 26 | 6.17e-01 | -5.67e-02 | 8.83e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 134 | 2.58e-01 | 5.67e-02 | 6.71e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 61 | 4.45e-01 | -5.66e-02 | 8.02e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 6 | 8.10e-01 | -5.66e-02 | 9.53e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 7.69e-01 | -5.66e-02 | 9.41e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 10 | 7.57e-01 | 5.65e-02 | 9.38e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 79 | 3.86e-01 | -5.65e-02 | 7.70e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 42 | 5.27e-01 | 5.65e-02 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 7 | 7.96e-01 | -5.65e-02 | 9.49e-01 |
| GOBP ANOIKIS | 26 | 6.18e-01 | 5.65e-02 | 8.83e-01 |
| GOBP REGULATION OF URINE VOLUME | 6 | 8.11e-01 | 5.65e-02 | 9.53e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 226 | 1.45e-01 | 5.65e-02 | 5.47e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 8.27e-01 | -5.65e-02 | 9.57e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 12 | 7.35e-01 | 5.65e-02 | 9.31e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 7 | 7.96e-01 | -5.64e-02 | 9.49e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 5 | 8.27e-01 | 5.64e-02 | 9.57e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 7.15e-01 | 5.64e-02 | 9.21e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 10 | 7.58e-01 | -5.64e-02 | 9.38e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 21 | 6.55e-01 | 5.64e-02 | 8.98e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 139 | 2.52e-01 | 5.64e-02 | 6.65e-01 |
| GOMF FLOPPASE ACTIVITY | 16 | 6.96e-01 | 5.64e-02 | 9.16e-01 |
| GOBP OXALATE TRANSPORT | 5 | 8.27e-01 | -5.63e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 7.83e-01 | 5.63e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 5 | 8.27e-01 | 5.63e-02 | 9.57e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 33 | 5.76e-01 | 5.63e-02 | 8.63e-01 |
| GOMF DNA HELICASE ACTIVITY | 55 | 4.71e-01 | 5.62e-02 | 8.16e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 44 | 5.19e-01 | 5.62e-02 | 8.40e-01 |
| GOBP PROTEIN TARGETING | 284 | 1.04e-01 | 5.62e-02 | 4.80e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 138 | 2.55e-01 | 5.62e-02 | 6.69e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 31 | 5.89e-01 | 5.62e-02 | 8.70e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 8.12e-01 | 5.61e-02 | 9.53e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 23 | 6.42e-01 | 5.61e-02 | 8.93e-01 |
| GOBP BODY FLUID SECRETION | 43 | 5.25e-01 | 5.60e-02 | 8.42e-01 |
| GOCC SYNAPSE | 824 | 6.83e-03 | 5.60e-02 | 1.19e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 519 | 3.00e-02 | 5.60e-02 | 2.71e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 45 | 5.16e-01 | 5.59e-02 | 8.39e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 7.48e-01 | -5.59e-02 | 9.35e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 5 | 8.29e-01 | 5.59e-02 | 9.58e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 148 | 2.42e-01 | 5.58e-02 | 6.56e-01 |
| GOCC DENSE CORE GRANULE | 13 | 7.28e-01 | 5.58e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 13 | 7.28e-01 | 5.58e-02 | 9.28e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 7.00e-01 | 5.57e-02 | 9.17e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 13 | 7.28e-01 | -5.56e-02 | 9.29e-01 |
| GOCC TRANS GOLGI NETWORK | 200 | 1.76e-01 | 5.56e-02 | 5.89e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 14 | 7.19e-01 | 5.56e-02 | 9.23e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 120 | 2.94e-01 | 5.56e-02 | 7.04e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 81 | 3.88e-01 | 5.56e-02 | 7.70e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 8 | 7.86e-01 | -5.55e-02 | 9.46e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 150 | 2.41e-01 | 5.55e-02 | 6.56e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 7 | 7.99e-01 | 5.55e-02 | 9.50e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 8 | 7.86e-01 | 5.55e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 530 | 2.98e-02 | 5.55e-02 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 539 | 2.86e-02 | 5.55e-02 | 2.64e-01 |
| GOBP REGULATED EXOCYTOSIS | 139 | 2.60e-01 | 5.54e-02 | 6.74e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 22 | 6.53e-01 | 5.54e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 47 | 5.12e-01 | -5.54e-02 | 8.37e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 220 | 1.58e-01 | 5.54e-02 | 5.69e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 31 | 5.94e-01 | -5.54e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 8 | 7.86e-01 | -5.53e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 33 | 5.83e-01 | 5.53e-02 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 57 | 4.71e-01 | 5.53e-02 | 8.16e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 8 | 7.87e-01 | -5.52e-02 | 9.46e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 8.15e-01 | -5.52e-02 | 9.54e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 39 | 5.51e-01 | -5.52e-02 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 15 | 7.12e-01 | -5.51e-02 | 9.20e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 525 | 3.18e-02 | 5.51e-02 | 2.79e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 24 | 6.41e-01 | -5.51e-02 | 8.93e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 69 | 4.29e-01 | 5.51e-02 | 7.94e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 74 | 4.14e-01 | -5.50e-02 | 7.85e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 25 | 6.34e-01 | -5.50e-02 | 8.90e-01 |
| GOMF U1 SNRNP BINDING | 6 | 8.16e-01 | 5.49e-02 | 9.54e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 543 | 2.96e-02 | 5.49e-02 | 2.69e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 73 | 4.18e-01 | 5.49e-02 | 7.88e-01 |
| GOBP PROTEIN NEDDYLATION | 27 | 6.22e-01 | -5.48e-02 | 8.85e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 33 | 5.86e-01 | -5.48e-02 | 8.69e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 121 | 2.98e-01 | 5.48e-02 | 7.07e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 5 | 8.32e-01 | 5.48e-02 | 9.59e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 7 | 8.02e-01 | 5.48e-02 | 9.51e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 41 | 5.44e-01 | 5.48e-02 | 8.51e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 40 | 5.49e-01 | 5.47e-02 | 8.53e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 41 | 5.44e-01 | -5.47e-02 | 8.51e-01 |
| GOCC FEMALE PRONUCLEUS | 9 | 7.76e-01 | 5.47e-02 | 9.43e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 8.02e-01 | -5.47e-02 | 9.51e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 6.72e-01 | -5.47e-02 | 9.05e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 24 | 6.43e-01 | -5.46e-02 | 8.93e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 608 | 2.24e-02 | 5.46e-02 | 2.31e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 18 | 6.88e-01 | -5.46e-02 | 9.13e-01 |
| GOBP THYROID HORMONE GENERATION | 10 | 7.65e-01 | 5.46e-02 | 9.40e-01 |
| GOBP STEROID METABOLIC PROCESS | 172 | 2.18e-01 | -5.46e-02 | 6.31e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 141 | 2.64e-01 | 5.46e-02 | 6.78e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 69 | 4.33e-01 | -5.46e-02 | 7.98e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 30 | 6.05e-01 | -5.46e-02 | 8.76e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 49 | 5.09e-01 | 5.46e-02 | 8.36e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 8 | 7.89e-01 | -5.46e-02 | 9.47e-01 |
| GOBP TRACHEA DEVELOPMENT | 11 | 7.54e-01 | -5.45e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1277 | 1.25e-03 | 5.45e-02 | 4.35e-02 |
| GOCC MLL3 4 COMPLEX | 12 | 7.44e-01 | 5.45e-02 | 9.35e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 752 | 1.18e-02 | 5.44e-02 | 1.68e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 28 | 6.18e-01 | -5.44e-02 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 15 | 7.15e-01 | -5.44e-02 | 9.21e-01 |
| GOBP IMPORT INTO NUCLEUS | 135 | 2.76e-01 | 5.44e-02 | 6.90e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 63 | 4.56e-01 | 5.44e-02 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 5 | 8.33e-01 | 5.44e-02 | 9.59e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 39 | 5.57e-01 | -5.44e-02 | 8.56e-01 |
| GOBP RECOMBINATIONAL REPAIR | 161 | 2.35e-01 | 5.44e-02 | 6.47e-01 |
| GOBP REGULATION OF LIPID STORAGE | 36 | 5.73e-01 | -5.44e-02 | 8.60e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 17 | 6.98e-01 | 5.44e-02 | 9.16e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 6 | 8.18e-01 | -5.44e-02 | 9.54e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 6 | 8.18e-01 | 5.43e-02 | 9.54e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 44 | 5.34e-01 | -5.43e-02 | 8.46e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 44 | 5.34e-01 | -5.42e-02 | 8.46e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 26 | 6.32e-01 | -5.42e-02 | 8.90e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 6.32e-01 | 5.42e-02 | 8.90e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 8.34e-01 | 5.42e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 16 | 7.08e-01 | 5.41e-02 | 9.20e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 21 | 6.68e-01 | 5.41e-02 | 9.04e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 7 | 8.04e-01 | 5.41e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 39 | 5.59e-01 | 5.41e-02 | 8.56e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 18 | 6.91e-01 | -5.41e-02 | 9.14e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 79 | 4.06e-01 | -5.41e-02 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 44 | 5.35e-01 | 5.41e-02 | 8.47e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 41 | 5.49e-01 | 5.41e-02 | 8.53e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 33 | 5.91e-01 | -5.41e-02 | 8.70e-01 |
| GOBP TRNA 3 END PROCESSING | 7 | 8.05e-01 | 5.40e-02 | 9.51e-01 |
| GOMF STEROL BINDING | 45 | 5.31e-01 | 5.40e-02 | 8.46e-01 |
| GOBP REGULATION OF HEART GROWTH | 32 | 5.98e-01 | 5.40e-02 | 8.73e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 6.61e-01 | 5.40e-02 | 9.01e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 16 | 7.09e-01 | -5.39e-02 | 9.20e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 45 | 5.32e-01 | -5.39e-02 | 8.46e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 7 | 8.05e-01 | 5.39e-02 | 9.51e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 26 | 6.35e-01 | 5.39e-02 | 8.90e-01 |
| GOBP NAD METABOLIC PROCESS | 28 | 6.22e-01 | -5.39e-02 | 8.85e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 50 | 5.10e-01 | -5.38e-02 | 8.37e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 6.16e-01 | 5.38e-02 | 8.83e-01 |
| GOCC AXON INITIAL SEGMENT | 8 | 7.92e-01 | -5.38e-02 | 9.48e-01 |
| GOBP ENTRY INTO HOST | 97 | 3.60e-01 | 5.38e-02 | 7.52e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 67 | 4.47e-01 | 5.38e-02 | 8.03e-01 |
| GOCC NODE OF RANVIER | 7 | 8.05e-01 | 5.38e-02 | 9.51e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 8 | 7.92e-01 | -5.38e-02 | 9.48e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 21 | 6.70e-01 | -5.38e-02 | 9.04e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 133 | 2.86e-01 | 5.37e-02 | 7.00e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 8 | 7.93e-01 | -5.36e-02 | 9.48e-01 |
| GOBP ORGANELLE FISSION | 347 | 8.72e-02 | 5.36e-02 | 4.47e-01 |
| GOMF PHOSPHATASE ACTIVITY | 194 | 1.99e-01 | 5.36e-02 | 6.11e-01 |
| GOCC VACUOLAR MEMBRANE | 399 | 6.75e-02 | 5.36e-02 | 4.01e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 14 | 7.29e-01 | 5.35e-02 | 9.29e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 165 | 2.37e-01 | 5.35e-02 | 6.49e-01 |
| GOBP SIRNA PROCESSING | 8 | 7.93e-01 | 5.35e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 159 | 2.45e-01 | 5.35e-02 | 6.60e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 226 | 1.68e-01 | 5.34e-02 | 5.77e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 32 | 6.01e-01 | -5.34e-02 | 8.74e-01 |
| GOBP REGULATION OF CYTOKINESIS | 66 | 4.54e-01 | 5.34e-02 | 8.06e-01 |
| GOBP CELLULAR HOMEOSTASIS | 486 | 4.51e-02 | 5.34e-02 | 3.31e-01 |
| GOCC ACTIN CYTOSKELETON | 322 | 1.01e-01 | 5.34e-02 | 4.73e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 33 | 5.96e-01 | 5.33e-02 | 8.72e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 35 | 5.85e-01 | 5.33e-02 | 8.68e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 7 | 8.07e-01 | 5.33e-02 | 9.51e-01 |
| GOBP PEPTIDE TRANSPORT | 137 | 2.82e-01 | -5.33e-02 | 6.97e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 8.07e-01 | 5.33e-02 | 9.51e-01 |
| GOBP NEUTROPHIL MIGRATION | 74 | 4.29e-01 | 5.33e-02 | 7.93e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 103 | 3.51e-01 | -5.32e-02 | 7.46e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 128 | 2.99e-01 | 5.32e-02 | 7.08e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 13 | 7.40e-01 | 5.32e-02 | 9.34e-01 |
| GOBP TOLERANCE INDUCTION | 17 | 7.05e-01 | 5.31e-02 | 9.18e-01 |
| GOCC SECRETORY VESICLE | 665 | 2.05e-02 | 5.31e-02 | 2.20e-01 |
| GOCC SMN COMPLEX | 10 | 7.71e-01 | 5.31e-02 | 9.41e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 442 | 5.69e-02 | 5.31e-02 | 3.74e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 19 | 6.89e-01 | -5.31e-02 | 9.13e-01 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 5 | 8.37e-01 | 5.31e-02 | 9.61e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 111 | 3.35e-01 | -5.30e-02 | 7.34e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 55 | 4.97e-01 | 5.30e-02 | 8.31e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 721 | 1.62e-02 | 5.30e-02 | 1.93e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 45 | 5.39e-01 | -5.30e-02 | 8.48e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 7.72e-01 | -5.30e-02 | 9.41e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 82 | 4.08e-01 | 5.29e-02 | 7.82e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 11 | 7.62e-01 | -5.28e-02 | 9.40e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 138 | 2.85e-01 | 5.28e-02 | 6.99e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 14 | 7.32e-01 | 5.28e-02 | 9.31e-01 |
| GOBP VASODILATION | 18 | 6.98e-01 | -5.28e-02 | 9.16e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 61 | 4.77e-01 | 5.27e-02 | 8.17e-01 |
| GOBP ETHANOL CATABOLIC PROCESS | 6 | 8.23e-01 | -5.27e-02 | 9.57e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 26 | 6.42e-01 | 5.27e-02 | 8.93e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 7.33e-01 | -5.27e-02 | 9.31e-01 |
| GOCC CAVEOLA | 43 | 5.51e-01 | 5.26e-02 | 8.54e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 14 | 7.33e-01 | -5.26e-02 | 9.31e-01 |
| GOBP RECEPTOR RECYCLING | 38 | 5.75e-01 | 5.26e-02 | 8.62e-01 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 5 | 8.39e-01 | -5.26e-02 | 9.61e-01 |
| GOBP RESPONSE TO LITHIUM ION | 7 | 8.10e-01 | 5.26e-02 | 9.53e-01 |
| GOMF TRANSITION METAL ION BINDING | 708 | 1.81e-02 | 5.26e-02 | 2.05e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 55 | 5.01e-01 | -5.25e-02 | 8.32e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 7 | 8.10e-01 | -5.25e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 264 | 1.43e-01 | 5.25e-02 | 5.47e-01 |
| GOBP URATE METABOLIC PROCESS | 5 | 8.39e-01 | -5.24e-02 | 9.61e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 60 | 4.83e-01 | 5.24e-02 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 15 | 7.25e-01 | 5.24e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 134 | 2.96e-01 | 5.24e-02 | 7.06e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 200 | 2.03e-01 | 5.23e-02 | 6.16e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 10 | 7.74e-01 | 5.23e-02 | 9.42e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 326 | 1.06e-01 | 5.23e-02 | 4.81e-01 |
| GOBP ASPARAGINE METABOLIC PROCESS | 5 | 8.40e-01 | 5.23e-02 | 9.61e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 78 | 4.26e-01 | -5.22e-02 | 7.92e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 47 | 5.36e-01 | 5.22e-02 | 8.47e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 124 | 3.16e-01 | 5.22e-02 | 7.20e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 10 | 7.75e-01 | 5.22e-02 | 9.42e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 59 | 4.88e-01 | 5.22e-02 | 8.25e-01 |
| GOCC NEURON SPINE | 102 | 3.63e-01 | 5.22e-02 | 7.53e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 165 | 2.49e-01 | 5.21e-02 | 6.62e-01 |
| GOBP REGULATION OF CELL KILLING | 80 | 4.21e-01 | 5.21e-02 | 7.90e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 12 | 7.55e-01 | 5.21e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 19 | 6.94e-01 | 5.21e-02 | 9.15e-01 |
| GOCC CONTRACTILE RING | 10 | 7.76e-01 | -5.20e-02 | 9.43e-01 |
| GOMF GROWTH HORMONE RECEPTOR BINDING | 5 | 8.40e-01 | 5.20e-02 | 9.61e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 17 | 7.11e-01 | -5.18e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 60 | 4.88e-01 | 5.18e-02 | 8.24e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 114 | 3.40e-01 | 5.18e-02 | 7.37e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 33 | 6.07e-01 | 5.18e-02 | 8.77e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 23 | 6.68e-01 | -5.17e-02 | 9.04e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 62 | 4.82e-01 | 5.17e-02 | 8.20e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 82 | 4.19e-01 | 5.17e-02 | 7.89e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 12 | 7.57e-01 | 5.16e-02 | 9.38e-01 |
| GOBP GENITALIA DEVELOPMENT | 15 | 7.29e-01 | 5.16e-02 | 9.29e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 16 | 7.21e-01 | 5.16e-02 | 9.24e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 6 | 8.27e-01 | -5.16e-02 | 9.57e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 379 | 8.61e-02 | 5.16e-02 | 4.44e-01 |
| GOMF LYASE ACTIVITY | 133 | 3.05e-01 | 5.16e-02 | 7.12e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 25 | 6.56e-01 | -5.16e-02 | 8.98e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 18 | 7.05e-01 | 5.15e-02 | 9.19e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 46 | 5.47e-01 | -5.14e-02 | 8.53e-01 |
| GOBP NEUROBLAST DIVISION | 8 | 8.01e-01 | -5.14e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 6 | 8.28e-01 | 5.13e-02 | 9.57e-01 |
| GOBP RESPONSE TO LEAD ION | 16 | 7.22e-01 | 5.13e-02 | 9.25e-01 |
| GOBP SELECTIVE AUTOPHAGY | 87 | 4.09e-01 | 5.13e-02 | 7.82e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 70 | 4.59e-01 | -5.13e-02 | 8.09e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 19 | 6.99e-01 | -5.13e-02 | 9.17e-01 |
| GOBP STEROL METABOLIC PROCESS | 93 | 3.94e-01 | -5.12e-02 | 7.74e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 9 | 7.90e-01 | -5.12e-02 | 9.47e-01 |
| GOBP MEMBRANE FUSION | 118 | 3.37e-01 | 5.12e-02 | 7.36e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 271 | 1.48e-01 | 5.12e-02 | 5.54e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 7 | 8.15e-01 | -5.12e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 277 | 1.44e-01 | 5.11e-02 | 5.47e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 14 | 7.41e-01 | 5.11e-02 | 9.34e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 50 | 5.32e-01 | -5.11e-02 | 8.46e-01 |
| GOMF CARD DOMAIN BINDING | 13 | 7.50e-01 | -5.10e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 319 | 1.19e-01 | 5.10e-02 | 5.02e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 250 | 1.66e-01 | 5.10e-02 | 5.77e-01 |
| GOMF RNA STEM LOOP BINDING | 14 | 7.41e-01 | 5.10e-02 | 9.34e-01 |
| GOBP PHENOTYPIC SWITCHING | 5 | 8.44e-01 | -5.09e-02 | 9.61e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 457 | 6.35e-02 | -5.09e-02 | 3.92e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 81 | 4.29e-01 | -5.09e-02 | 7.94e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1178 | 3.74e-03 | 5.09e-02 | 8.61e-02 |
| GOBP GLIAL CELL DIFFERENTIATION | 136 | 3.07e-01 | -5.08e-02 | 7.13e-01 |
| GOMF OXIDIZED DNA BINDING | 10 | 7.81e-01 | -5.07e-02 | 9.45e-01 |
| GOBP PUTRESCINE BIOSYNTHETIC PROCESS | 5 | 8.44e-01 | 5.07e-02 | 9.62e-01 |
| GOBP ZINC ION TRANSPORT | 21 | 6.87e-01 | -5.07e-02 | 9.13e-01 |
| GOBP CELL MATRIX ADHESION | 134 | 3.11e-01 | 5.07e-02 | 7.15e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.45e-01 | 5.07e-02 | 9.62e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 687 | 2.48e-02 | 5.07e-02 | 2.45e-01 |
| GOCC CELL SURFACE | 407 | 8.11e-02 | 5.06e-02 | 4.34e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 6 | 8.30e-01 | 5.06e-02 | 9.59e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 90 | 4.07e-01 | 5.06e-02 | 7.82e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 39 | 5.85e-01 | -5.06e-02 | 8.68e-01 |
| GOBP HEART PROCESS | 111 | 3.58e-01 | 5.05e-02 | 7.50e-01 |
| GOMF POLY A BINDING | 19 | 7.03e-01 | 5.05e-02 | 9.18e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 75 | 4.50e-01 | 5.05e-02 | 8.04e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 183 | 2.40e-01 | 5.04e-02 | 6.54e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 50 | 5.38e-01 | 5.04e-02 | 8.48e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 11 | 7.72e-01 | -5.04e-02 | 9.41e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 131 | 3.21e-01 | 5.03e-02 | 7.24e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 10 | 7.83e-01 | 5.03e-02 | 9.45e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 9 | 7.94e-01 | -5.03e-02 | 9.48e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 20 | 6.97e-01 | -5.03e-02 | 9.16e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 239 | 1.82e-01 | 5.03e-02 | 5.97e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 140 | 3.06e-01 | 5.02e-02 | 7.12e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 17 | 7.20e-01 | 5.02e-02 | 9.24e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 57 | 5.13e-01 | 5.02e-02 | 8.37e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 23 | 6.77e-01 | 5.02e-02 | 9.08e-01 |
| GOBP REGULATION OF PH | 72 | 4.62e-01 | -5.02e-02 | 8.12e-01 |
| GOMF SNRNP BINDING | 9 | 7.94e-01 | -5.02e-02 | 9.48e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 62 | 4.95e-01 | 5.01e-02 | 8.29e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 9 | 7.95e-01 | 5.01e-02 | 9.48e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 67 | 4.79e-01 | 5.01e-02 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 46 | 5.57e-01 | 5.01e-02 | 8.56e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 177 | 2.52e-01 | 5.00e-02 | 6.65e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 22 | 6.85e-01 | -5.00e-02 | 9.12e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 10 | 7.84e-01 | -5.00e-02 | 9.46e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 17 | 7.21e-01 | -5.00e-02 | 9.24e-01 |
| GOBP RESPONSE TO BMP | 72 | 4.64e-01 | -5.00e-02 | 8.12e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 35 | 6.09e-01 | 5.00e-02 | 8.79e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 37 | 5.99e-01 | 5.00e-02 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 107 | 3.73e-01 | 4.99e-02 | 7.61e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 130 | 3.26e-01 | 4.99e-02 | 7.27e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 12 | 7.65e-01 | -4.99e-02 | 9.40e-01 |
| GOCC SYNAPTIC MEMBRANE | 168 | 2.66e-01 | 4.99e-02 | 6.80e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 5 | 8.47e-01 | -4.98e-02 | 9.63e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 123 | 3.41e-01 | 4.98e-02 | 7.38e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 58 | 5.12e-01 | -4.98e-02 | 8.37e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 32 | 6.26e-01 | 4.98e-02 | 8.87e-01 |
| GOBP DEFENSE RESPONSE | 1078 | 6.47e-03 | 4.97e-02 | 1.17e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 30 | 6.37e-01 | 4.97e-02 | 8.92e-01 |
| GOBP EXOCYTOSIS | 227 | 1.98e-01 | 4.97e-02 | 6.11e-01 |
| GOBP ORGANELLE DISASSEMBLY | 129 | 3.30e-01 | 4.97e-02 | 7.31e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 7.86e-01 | 4.97e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 8.47e-01 | 4.97e-02 | 9.63e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 8.33e-01 | 4.97e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 32 | 6.27e-01 | -4.96e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 6.94e-01 | -4.96e-02 | 9.15e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 60 | 5.06e-01 | 4.96e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 314 | 1.32e-01 | 4.96e-02 | 5.27e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 14 | 7.48e-01 | 4.95e-02 | 9.35e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 29 | 6.45e-01 | 4.95e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 40 | 5.88e-01 | 4.95e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 45 | 5.66e-01 | 4.95e-02 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 69 | 4.78e-01 | 4.94e-02 | 8.18e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 105 | 3.82e-01 | 4.94e-02 | 7.69e-01 |
| GOMF MISMATCHED DNA BINDING | 14 | 7.49e-01 | -4.94e-02 | 9.35e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 22 | 6.89e-01 | -4.94e-02 | 9.13e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 285 | 1.53e-01 | 4.94e-02 | 5.61e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 14 | 7.49e-01 | -4.93e-02 | 9.35e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 24 | 6.76e-01 | -4.93e-02 | 9.07e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 563 | 4.69e-02 | 4.93e-02 | 3.40e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 25 | 6.70e-01 | 4.93e-02 | 9.04e-01 |
| GOBP MITOTIC DNA REPLICATION | 14 | 7.50e-01 | -4.93e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 6 | 8.34e-01 | -4.93e-02 | 9.59e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 242 | 1.89e-01 | 4.92e-02 | 6.03e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 48 | 5.56e-01 | 4.92e-02 | 8.56e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 34 | 6.20e-01 | 4.92e-02 | 8.84e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 5 | 8.49e-01 | -4.91e-02 | 9.63e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 203 | 2.29e-01 | 4.91e-02 | 6.41e-01 |
| GOBP AXON EXTENSION | 73 | 4.69e-01 | 4.91e-02 | 8.15e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 9 | 7.99e-01 | 4.91e-02 | 9.50e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 12 | 7.69e-01 | -4.91e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 66 | 4.91e-01 | 4.90e-02 | 8.27e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 8.35e-01 | 4.90e-02 | 9.60e-01 |
| GOBP SELF PROTEOLYSIS | 8 | 8.11e-01 | 4.89e-02 | 9.53e-01 |
| GOMF PHOSPHOLIPID BINDING | 326 | 1.30e-01 | 4.89e-02 | 5.23e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 23 | 6.85e-01 | -4.88e-02 | 9.13e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 14 | 7.52e-01 | 4.88e-02 | 9.35e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 8 | 8.11e-01 | -4.88e-02 | 9.53e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 33 | 6.28e-01 | -4.87e-02 | 8.88e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 121 | 3.56e-01 | 4.87e-02 | 7.49e-01 |
| GOMF PH DOMAIN BINDING | 8 | 8.12e-01 | -4.87e-02 | 9.53e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 18 | 7.21e-01 | 4.86e-02 | 9.24e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 35 | 6.19e-01 | 4.86e-02 | 8.84e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 22 | 6.93e-01 | 4.86e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 8.51e-01 | 4.86e-02 | 9.63e-01 |
| GOCC RIPOPTOSOME | 6 | 8.37e-01 | 4.85e-02 | 9.61e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 384 | 1.04e-01 | 4.85e-02 | 4.80e-01 |
| GOBP AORTA DEVELOPMENT | 32 | 6.35e-01 | 4.85e-02 | 8.90e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 76 | 4.66e-01 | 4.84e-02 | 8.13e-01 |
| GOCC VACUOLE | 652 | 3.64e-02 | 4.84e-02 | 2.95e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 81 | 4.52e-01 | 4.84e-02 | 8.06e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 7.91e-01 | 4.84e-02 | 9.48e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 81 | 4.52e-01 | 4.84e-02 | 8.06e-01 |
| GOCC EUCHROMATIN | 40 | 5.97e-01 | -4.83e-02 | 8.73e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 11 | 7.82e-01 | 4.83e-02 | 9.45e-01 |
| GOCC SPECIFIC GRANULE | 117 | 3.68e-01 | 4.83e-02 | 7.57e-01 |
| GOBP INTRACILIARY TRANSPORT | 38 | 6.07e-01 | -4.83e-02 | 8.77e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 31 | 6.42e-01 | 4.82e-02 | 8.93e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 40 | 5.98e-01 | 4.82e-02 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 184 | 2.61e-01 | 4.82e-02 | 6.74e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 61 | 5.16e-01 | 4.82e-02 | 8.38e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 16 | 7.39e-01 | -4.82e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 336 | 1.31e-01 | 4.81e-02 | 5.24e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 56 | 5.34e-01 | -4.81e-02 | 8.46e-01 |
| GOBP STEROID HORMONE SECRETION | 11 | 7.82e-01 | -4.81e-02 | 9.45e-01 |
| GOBP RESPONSE TO FUNGUS | 32 | 6.38e-01 | 4.81e-02 | 8.92e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 58 | 5.27e-01 | 4.81e-02 | 8.43e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 14 | 7.56e-01 | -4.80e-02 | 9.38e-01 |
| GOCC CENTRIOLE | 128 | 3.49e-01 | 4.80e-02 | 7.44e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 41 | 5.95e-01 | 4.80e-02 | 8.72e-01 |
| GOBP CELL CELL ADHESION | 526 | 6.14e-02 | 4.80e-02 | 3.86e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 8.39e-01 | -4.79e-02 | 9.61e-01 |
| GOBP AXON GUIDANCE | 102 | 4.04e-01 | -4.78e-02 | 7.80e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 8.53e-01 | 4.78e-02 | 9.64e-01 |
| GOBP REGULATION OF CELL ADHESION | 501 | 6.89e-02 | 4.77e-02 | 4.05e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 14 | 7.57e-01 | -4.77e-02 | 9.38e-01 |
| GOBP CYTOKINE PRODUCTION | 535 | 6.06e-02 | 4.77e-02 | 3.85e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 58 | 5.30e-01 | -4.76e-02 | 8.45e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 36 | 6.21e-01 | -4.76e-02 | 8.85e-01 |
| GOMF ANNEALING ACTIVITY | 9 | 8.05e-01 | -4.76e-02 | 9.51e-01 |
| GOCC THO COMPLEX | 6 | 8.40e-01 | 4.75e-02 | 9.61e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 92 | 4.31e-01 | 4.75e-02 | 7.96e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 8.40e-01 | 4.75e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 646 | 4.09e-02 | 4.75e-02 | 3.14e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 7.95e-01 | 4.75e-02 | 9.48e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 168 | 2.90e-01 | 4.74e-02 | 7.02e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 7 | 8.28e-01 | 4.74e-02 | 9.57e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 12 | 7.76e-01 | -4.74e-02 | 9.43e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 16 | 7.43e-01 | 4.74e-02 | 9.35e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 144 | 3.27e-01 | 4.73e-02 | 7.28e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 8.06e-01 | 4.73e-02 | 9.51e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 10 | 7.96e-01 | -4.73e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 7 | 8.29e-01 | -4.73e-02 | 9.58e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 6 | 8.41e-01 | -4.72e-02 | 9.61e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 39 | 6.10e-01 | -4.72e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 167 | 2.93e-01 | 4.72e-02 | 7.04e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 9 | 8.06e-01 | -4.72e-02 | 9.51e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 193 | 2.60e-01 | 4.72e-02 | 6.73e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 5 | 8.55e-01 | -4.72e-02 | 9.64e-01 |
| GOBP RESPONSE TO NICOTINE | 22 | 7.02e-01 | 4.71e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 6 | 8.42e-01 | 4.71e-02 | 9.61e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 7.97e-01 | 4.71e-02 | 9.49e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 12 | 7.78e-01 | 4.71e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 36 | 6.25e-01 | -4.71e-02 | 8.86e-01 |
| GOCC CATENIN COMPLEX | 12 | 7.78e-01 | 4.69e-02 | 9.43e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 7.04e-01 | 4.69e-02 | 9.18e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 94 | 4.33e-01 | 4.69e-02 | 7.98e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 27 | 6.74e-01 | -4.68e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 224 | 2.28e-01 | 4.68e-02 | 6.40e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 22 | 7.04e-01 | -4.68e-02 | 9.18e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 7.70e-01 | 4.68e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 138 | 3.43e-01 | 4.68e-02 | 7.39e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 23 | 6.98e-01 | -4.68e-02 | 9.16e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 17 | 7.39e-01 | 4.68e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 41 | 6.05e-01 | -4.68e-02 | 8.76e-01 |
| GOCC PLASMA MEMBRANE RAFT | 57 | 5.42e-01 | 4.67e-02 | 8.49e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 283 | 1.78e-01 | 4.67e-02 | 5.91e-01 |
| GOBP REGENERATION | 100 | 4.20e-01 | 4.67e-02 | 7.90e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 7.32e-01 | 4.66e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 5 | 8.57e-01 | -4.66e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 201 | 2.56e-01 | 4.65e-02 | 6.70e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 70 | 5.01e-01 | 4.65e-02 | 8.32e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 8.57e-01 | 4.65e-02 | 9.65e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 100 | 4.22e-01 | -4.65e-02 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 329 | 1.49e-01 | 4.65e-02 | 5.55e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 36 | 6.30e-01 | -4.65e-02 | 8.88e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 12 | 7.81e-01 | -4.64e-02 | 9.44e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 455 | 9.15e-02 | 4.64e-02 | 4.56e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 59 | 5.38e-01 | -4.64e-02 | 8.48e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 46 | 5.87e-01 | 4.63e-02 | 8.69e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 66 | 5.16e-01 | -4.63e-02 | 8.38e-01 |
| GOMF DNA POLYMERASE BINDING | 20 | 7.20e-01 | 4.63e-02 | 9.24e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 54 | 5.56e-01 | 4.63e-02 | 8.56e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 10 | 8.00e-01 | -4.63e-02 | 9.50e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 38 | 6.22e-01 | 4.63e-02 | 8.85e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 45 | 5.91e-01 | 4.63e-02 | 8.70e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 903 | 1.97e-02 | 4.63e-02 | 2.14e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 64 | 5.23e-01 | -4.62e-02 | 8.41e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 8.10e-01 | 4.62e-02 | 9.53e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 81 | 4.73e-01 | 4.62e-02 | 8.17e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 65 | 5.21e-01 | 4.61e-02 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 8.33e-01 | 4.60e-02 | 9.59e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 8.59e-01 | -4.60e-02 | 9.66e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 23 | 7.03e-01 | 4.59e-02 | 9.18e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 7 | 8.33e-01 | 4.59e-02 | 9.59e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 79 | 4.81e-01 | -4.59e-02 | 8.20e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 69 | 5.10e-01 | 4.59e-02 | 8.37e-01 |
| GOBP CELL MATURATION | 83 | 4.71e-01 | -4.58e-02 | 8.16e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 8.59e-01 | -4.58e-02 | 9.66e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 85 | 4.66e-01 | 4.58e-02 | 8.13e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 320 | 1.61e-01 | -4.58e-02 | 5.73e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 800 | 2.93e-02 | 4.57e-02 | 2.68e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 85 | 4.67e-01 | -4.57e-02 | 8.14e-01 |
| GOCC CORTICAL CYTOSKELETON | 66 | 5.21e-01 | -4.57e-02 | 8.40e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 54 | 5.62e-01 | -4.57e-02 | 8.56e-01 |
| GOCC CELL CELL JUNCTION | 286 | 1.85e-01 | 4.57e-02 | 5.99e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 143 | 3.47e-01 | -4.57e-02 | 7.42e-01 |
| GOBP TRACHEA FORMATION | 6 | 8.46e-01 | 4.57e-02 | 9.63e-01 |
| GOBP TRACHEA MORPHOGENESIS | 6 | 8.46e-01 | 4.57e-02 | 9.63e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 9 | 8.14e-01 | 4.54e-02 | 9.54e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 99 | 4.36e-01 | 4.54e-02 | 7.98e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 7.94e-01 | 4.54e-02 | 9.48e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 39 | 6.24e-01 | 4.54e-02 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 84 | 4.73e-01 | 4.54e-02 | 8.17e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 55 | 5.61e-01 | 4.54e-02 | 8.56e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 168 | 3.12e-01 | 4.53e-02 | 7.15e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 34 | 6.48e-01 | -4.53e-02 | 8.94e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 61 | 5.41e-01 | 4.53e-02 | 8.49e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 451 | 1.01e-01 | 4.53e-02 | 4.73e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 124 | 3.85e-01 | 4.53e-02 | 7.70e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 14 | 7.69e-01 | 4.52e-02 | 9.41e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 7.78e-01 | 4.52e-02 | 9.43e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 36 | 6.39e-01 | -4.51e-02 | 8.92e-01 |
| GOBP SULFATE TRANSPORT | 10 | 8.05e-01 | -4.51e-02 | 9.51e-01 |
| GOCC T TUBULE | 26 | 6.91e-01 | 4.51e-02 | 9.14e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 49 | 5.85e-01 | -4.51e-02 | 8.68e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 15 | 7.63e-01 | -4.51e-02 | 9.40e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.37e-01 | -4.50e-02 | 9.61e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 10 | 8.05e-01 | 4.50e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 8 | 8.25e-01 | -4.50e-02 | 9.57e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 40 | 6.22e-01 | 4.50e-02 | 8.85e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 55 | 5.64e-01 | 4.50e-02 | 8.57e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 105 | 4.27e-01 | 4.49e-02 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 72 | 5.10e-01 | 4.49e-02 | 8.37e-01 |
| GOBP L SERINE TRANSPORT | 7 | 8.37e-01 | -4.49e-02 | 9.61e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.37e-01 | -4.49e-02 | 9.61e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 9 | 8.16e-01 | -4.49e-02 | 9.54e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 8.37e-01 | 4.49e-02 | 9.61e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 23 | 7.10e-01 | 4.49e-02 | 9.20e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 15 | 7.64e-01 | 4.48e-02 | 9.40e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 20 | 7.29e-01 | 4.48e-02 | 9.29e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 137 | 3.66e-01 | 4.48e-02 | 7.55e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 9 | 8.16e-01 | -4.47e-02 | 9.54e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 14 | 7.72e-01 | 4.46e-02 | 9.41e-01 |
| GOBP ORGANELLE ASSEMBLY | 761 | 3.79e-02 | 4.46e-02 | 3.00e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 6.73e-01 | -4.46e-02 | 9.06e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 520 | 8.37e-02 | 4.46e-02 | 4.40e-01 |
| GOBP SEGMENTATION | 41 | 6.21e-01 | 4.46e-02 | 8.85e-01 |
| GOBP PHAGOCYTOSIS | 157 | 3.36e-01 | 4.46e-02 | 7.34e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 7.06e-01 | 4.45e-02 | 9.19e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 8.51e-01 | -4.43e-02 | 9.63e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 21 | 7.25e-01 | -4.43e-02 | 9.27e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 17 | 7.52e-01 | -4.43e-02 | 9.35e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 13 | 7.82e-01 | -4.43e-02 | 9.45e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 8.09e-01 | -4.42e-02 | 9.53e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 71 | 5.20e-01 | -4.42e-02 | 8.40e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 246 | 2.34e-01 | 4.42e-02 | 6.46e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 11 | 8.00e-01 | 4.42e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 14 | 7.75e-01 | -4.41e-02 | 9.42e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 14 | 7.75e-01 | 4.41e-02 | 9.42e-01 |
| GOBP GOLGI DISASSEMBLY | 5 | 8.64e-01 | -4.41e-02 | 9.67e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.19e-01 | -4.41e-02 | 9.55e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 16 | 7.60e-01 | 4.41e-02 | 9.40e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 5 | 8.65e-01 | 4.40e-02 | 9.67e-01 |
| GOBP RESPONSE TO PROTOZOAN | 21 | 7.27e-01 | -4.40e-02 | 9.28e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 32 | 6.67e-01 | 4.40e-02 | 9.04e-01 |
| GOCC CATSPER COMPLEX | 6 | 8.52e-01 | -4.40e-02 | 9.63e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 18 | 7.47e-01 | -4.40e-02 | 9.35e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 7 | 8.40e-01 | -4.40e-02 | 9.61e-01 |
| GOCC NON MOTILE CILIUM | 84 | 4.86e-01 | -4.40e-02 | 8.23e-01 |
| GOBP BONE MINERALIZATION | 59 | 5.59e-01 | -4.40e-02 | 8.56e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 15 | 7.68e-01 | -4.40e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 8.65e-01 | -4.39e-02 | 9.67e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 30 | 6.77e-01 | 4.39e-02 | 9.08e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 16 | 7.61e-01 | -4.39e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 72 | 5.20e-01 | 4.39e-02 | 8.40e-01 |
| GOCC KINETOCHORE MICROTUBULE | 18 | 7.47e-01 | 4.39e-02 | 9.35e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 106 | 4.36e-01 | -4.39e-02 | 7.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 8 | 8.30e-01 | -4.38e-02 | 9.59e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 18 | 7.48e-01 | 4.38e-02 | 9.35e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 8.41e-01 | -4.38e-02 | 9.61e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 133 | 3.84e-01 | 4.38e-02 | 7.70e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 348 | 1.62e-01 | 4.38e-02 | 5.74e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 10 | 8.11e-01 | -4.37e-02 | 9.53e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 21 | 7.29e-01 | -4.37e-02 | 9.29e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 9 | 8.20e-01 | 4.37e-02 | 9.56e-01 |
| GOCC PERIKARYON | 66 | 5.40e-01 | -4.37e-02 | 8.49e-01 |
| GOBP EOSINOPHIL MIGRATION | 12 | 7.93e-01 | 4.37e-02 | 9.48e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 250 | 2.36e-01 | 4.36e-02 | 6.49e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 44 | 6.17e-01 | 4.36e-02 | 8.83e-01 |
| GOBP VESICLE COATING | 36 | 6.51e-01 | 4.35e-02 | 8.96e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 179 | 3.16e-01 | -4.35e-02 | 7.20e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 8 | 8.31e-01 | 4.35e-02 | 9.59e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 11 | 8.03e-01 | 4.35e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 884 | 3.02e-02 | 4.34e-02 | 2.71e-01 |
| GOBP T CELL DIFFERENTIATION | 240 | 2.48e-01 | 4.34e-02 | 6.62e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 10 | 8.12e-01 | 4.34e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 5 | 8.67e-01 | -4.34e-02 | 9.67e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 61 | 5.58e-01 | 4.33e-02 | 8.56e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 100 | 4.54e-01 | -4.33e-02 | 8.06e-01 |
| GOBP HORMONE TRANSPORT | 160 | 3.46e-01 | -4.33e-02 | 7.42e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 24 | 7.14e-01 | 4.32e-02 | 9.21e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 18 | 7.51e-01 | -4.32e-02 | 9.35e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 94 | 4.69e-01 | 4.32e-02 | 8.15e-01 |
| GOMF I SMAD BINDING | 11 | 8.04e-01 | 4.32e-02 | 9.51e-01 |
| GOCC SPINDLE MICROTUBULE | 67 | 5.41e-01 | 4.32e-02 | 8.49e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 119 | 4.17e-01 | -4.32e-02 | 7.87e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 149 | 3.64e-01 | 4.32e-02 | 7.54e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 174 | 3.27e-01 | -4.32e-02 | 7.28e-01 |
| GOMF RDNA BINDING | 9 | 8.23e-01 | 4.31e-02 | 9.57e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 7 | 8.44e-01 | -4.31e-02 | 9.61e-01 |
| GOMF MICROTUBULE BINDING | 196 | 3.00e-01 | 4.30e-02 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 110 | 4.36e-01 | 4.30e-02 | 7.98e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 41 | 6.34e-01 | -4.30e-02 | 8.90e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 51 | 5.96e-01 | 4.30e-02 | 8.72e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 9 | 8.23e-01 | -4.29e-02 | 9.57e-01 |
| GOCC MSL COMPLEX | 5 | 8.68e-01 | 4.29e-02 | 9.67e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 376 | 1.55e-01 | 4.29e-02 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 17 | 7.60e-01 | -4.29e-02 | 9.39e-01 |
| GOBP EXOCYTIC PROCESS | 58 | 5.72e-01 | -4.29e-02 | 8.60e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 346 | 1.72e-01 | 4.29e-02 | 5.84e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 24 | 7.16e-01 | 4.29e-02 | 9.22e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 8.68e-01 | 4.29e-02 | 9.67e-01 |
| GOMF ANTIPORTER ACTIVITY | 93 | 4.76e-01 | 4.29e-02 | 8.17e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 189 | 3.11e-01 | 4.29e-02 | 7.15e-01 |
| GOBP TRABECULA FORMATION | 11 | 8.06e-01 | -4.28e-02 | 9.51e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 49 | 6.04e-01 | -4.28e-02 | 8.76e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 8 | 8.34e-01 | 4.28e-02 | 9.59e-01 |
| GOCC AZUROPHIL GRANULE | 125 | 4.10e-01 | 4.28e-02 | 7.83e-01 |
| GOMF KINASE BINDING | 576 | 8.14e-02 | 4.28e-02 | 4.34e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 20 | 7.41e-01 | -4.28e-02 | 9.34e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 27 | 7.01e-01 | 4.27e-02 | 9.17e-01 |
| GOBP MYOBLAST PROLIFERATION | 12 | 7.98e-01 | -4.27e-02 | 9.50e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 86 | 4.94e-01 | 4.27e-02 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 64 | 5.55e-01 | 4.27e-02 | 8.56e-01 |
| GOCC ACTIN FILAMENT | 73 | 5.29e-01 | 4.27e-02 | 8.44e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 5 | 8.69e-01 | 4.26e-02 | 9.67e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 55 | 5.85e-01 | -4.26e-02 | 8.68e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 10 | 8.16e-01 | -4.26e-02 | 9.54e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 8.35e-01 | 4.24e-02 | 9.60e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 66 | 5.52e-01 | -4.24e-02 | 8.54e-01 |
| GOCC MULTIVESICULAR BODY | 39 | 6.48e-01 | -4.23e-02 | 8.94e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 8.26e-01 | -4.23e-02 | 9.57e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 8.26e-01 | -4.23e-02 | 9.57e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 8.70e-01 | -4.23e-02 | 9.68e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 58 | 5.79e-01 | -4.22e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 8.47e-01 | -4.22e-02 | 9.63e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 40 | 6.45e-01 | 4.22e-02 | 8.93e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 28 | 7.00e-01 | 4.22e-02 | 9.17e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 28 | 7.00e-01 | 4.22e-02 | 9.17e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 64 | 5.61e-01 | 4.21e-02 | 8.56e-01 |
| GOCC NUCLEOID | 43 | 6.33e-01 | 4.21e-02 | 8.90e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 13 | 7.93e-01 | 4.21e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 41 | 6.42e-01 | -4.20e-02 | 8.93e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 95 | 4.79e-01 | 4.20e-02 | 8.18e-01 |
| GOBP RESPONSE TO CADMIUM ION | 38 | 6.54e-01 | 4.20e-02 | 8.98e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 134 | 4.03e-01 | 4.19e-02 | 7.80e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 119 | 4.30e-01 | -4.19e-02 | 7.95e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 540 | 9.78e-02 | 4.19e-02 | 4.64e-01 |
| GOBP ERBB SIGNALING PATHWAY | 86 | 5.02e-01 | 4.19e-02 | 8.33e-01 |
| GOMF AMIDE BINDING | 233 | 2.72e-01 | 4.19e-02 | 6.86e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 8.48e-01 | 4.19e-02 | 9.63e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 17 | 7.65e-01 | 4.19e-02 | 9.40e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 35 | 6.68e-01 | 4.19e-02 | 9.04e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 374 | 1.66e-01 | 4.18e-02 | 5.77e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 66 | 5.57e-01 | 4.18e-02 | 8.56e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 236 | 2.70e-01 | 4.18e-02 | 6.84e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 17 | 7.65e-01 | 4.18e-02 | 9.40e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 154 | 3.72e-01 | -4.18e-02 | 7.60e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 6 | 8.59e-01 | -4.18e-02 | 9.66e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 10 | 8.19e-01 | 4.18e-02 | 9.55e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 7.35e-01 | -4.18e-02 | 9.31e-01 |
| GOBP DNA RECOMBINATION | 271 | 2.39e-01 | 4.17e-02 | 6.52e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 8.72e-01 | -4.17e-02 | 9.68e-01 |
| GOBP SIGNAL RELEASE | 246 | 2.62e-01 | -4.17e-02 | 6.76e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 7.73e-01 | 4.16e-02 | 9.42e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 29 | 6.98e-01 | -4.16e-02 | 9.16e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 14 | 7.88e-01 | -4.16e-02 | 9.46e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 6 | 8.60e-01 | 4.16e-02 | 9.66e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 8.49e-01 | -4.16e-02 | 9.63e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 35 | 6.71e-01 | -4.16e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 20 | 7.48e-01 | 4.15e-02 | 9.35e-01 |
| GOBP PALLIUM DEVELOPMENT | 112 | 4.48e-01 | -4.15e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 6 | 8.60e-01 | 4.15e-02 | 9.66e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 44 | 6.34e-01 | -4.15e-02 | 8.90e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 21 | 7.43e-01 | 4.14e-02 | 9.35e-01 |
| GOBP VESICLE LOCALIZATION | 172 | 3.51e-01 | 4.13e-02 | 7.45e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 8.73e-01 | 4.13e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 8 | 8.40e-01 | -4.13e-02 | 9.61e-01 |
| GOBP BLEB ASSEMBLY | 5 | 8.73e-01 | 4.13e-02 | 9.68e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 8 | 8.40e-01 | 4.13e-02 | 9.61e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1256 | 1.54e-02 | 4.13e-02 | 1.89e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 37 | 6.64e-01 | -4.13e-02 | 9.03e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 196 | 3.21e-01 | 4.12e-02 | 7.24e-01 |
| GOBP AMIDE TRANSPORT | 189 | 3.30e-01 | -4.11e-02 | 7.31e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 53 | 6.05e-01 | 4.11e-02 | 8.76e-01 |
| GOBP B CELL PROLIFERATION | 62 | 5.76e-01 | 4.11e-02 | 8.63e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 47 | 6.26e-01 | -4.11e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 57 | 5.92e-01 | 4.11e-02 | 8.71e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 8.31e-01 | 4.11e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 196 | 3.23e-01 | 4.10e-02 | 7.24e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 22 | 7.39e-01 | -4.10e-02 | 9.33e-01 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 6 | 8.62e-01 | -4.10e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 11 | 8.14e-01 | -4.10e-02 | 9.54e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 8.31e-01 | -4.10e-02 | 9.59e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 9 | 8.31e-01 | -4.10e-02 | 9.59e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 44 | 6.38e-01 | -4.10e-02 | 8.92e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 9 | 8.32e-01 | 4.09e-02 | 9.59e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 6 | 8.62e-01 | 4.09e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 167 | 3.63e-01 | -4.09e-02 | 7.53e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 17 | 7.70e-01 | -4.09e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 975 | 3.27e-02 | 4.09e-02 | 2.84e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 35 | 6.76e-01 | 4.08e-02 | 9.08e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 5 | 8.74e-01 | 4.08e-02 | 9.68e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 8.74e-01 | 4.08e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 6 | 8.62e-01 | 4.08e-02 | 9.67e-01 |
| GOMF LIPID BINDING | 514 | 1.15e-01 | 4.08e-02 | 4.97e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 29 | 7.04e-01 | -4.08e-02 | 9.18e-01 |
| GOCC GAP JUNCTION | 6 | 8.63e-01 | 4.08e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 28 | 7.09e-01 | 4.07e-02 | 9.20e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 5 | 8.75e-01 | 4.07e-02 | 9.68e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 12 | 8.07e-01 | -4.07e-02 | 9.51e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 10 | 8.24e-01 | -4.07e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 35 | 6.77e-01 | 4.07e-02 | 9.08e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 16 | 7.78e-01 | 4.07e-02 | 9.43e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 38 | 6.65e-01 | -4.07e-02 | 9.03e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 43 | 6.45e-01 | -4.06e-02 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 37 | 6.70e-01 | 4.05e-02 | 9.04e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 560 | 1.03e-01 | 4.05e-02 | 4.79e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 9 | 8.33e-01 | -4.05e-02 | 9.59e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 434 | 1.50e-01 | 4.05e-02 | 5.58e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 55 | 6.04e-01 | 4.04e-02 | 8.76e-01 |
| GOBP RESPONSE TO MANGANESE ION | 14 | 7.93e-01 | -4.04e-02 | 9.48e-01 |
| GOBP REGULATION OF CELL GROWTH | 254 | 2.69e-01 | 4.04e-02 | 6.83e-01 |
| GOBP LIPID STORAGE | 62 | 5.83e-01 | -4.04e-02 | 8.67e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 265 | 2.60e-01 | 4.04e-02 | 6.73e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 35 | 6.80e-01 | -4.03e-02 | 9.10e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 15 | 7.87e-01 | 4.03e-02 | 9.46e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 29 | 7.08e-01 | -4.03e-02 | 9.20e-01 |
| GOBP RESPONSE TO STEROL | 22 | 7.44e-01 | -4.03e-02 | 9.35e-01 |
| GOBP RESPONSE TO SELENIUM ION | 5 | 8.76e-01 | 4.02e-02 | 9.68e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 12 | 8.10e-01 | 4.02e-02 | 9.53e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 127 | 4.35e-01 | -4.02e-02 | 7.98e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 19 | 7.62e-01 | 4.02e-02 | 9.40e-01 |
| GOBP EPITHELIAL CELL MATURATION | 11 | 8.18e-01 | -4.01e-02 | 9.54e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 18 | 7.68e-01 | 4.01e-02 | 9.41e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 25 | 7.29e-01 | 4.01e-02 | 9.29e-01 |
| GOCC DENDRITIC TREE | 346 | 2.02e-01 | 4.01e-02 | 6.15e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 20 | 7.56e-01 | 4.01e-02 | 9.38e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 11 | 8.19e-01 | 4.00e-02 | 9.54e-01 |
| GOBP MANNOSYLATION | 19 | 7.63e-01 | 4.00e-02 | 9.40e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 19 | 7.63e-01 | 3.99e-02 | 9.40e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 49 | 6.29e-01 | 3.99e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 74 | 5.53e-01 | -3.99e-02 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 81 | 5.35e-01 | 3.99e-02 | 8.47e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 8.19e-01 | 3.99e-02 | 9.55e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 8.55e-01 | -3.99e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 113 | 4.65e-01 | 3.99e-02 | 8.13e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 22 | 7.46e-01 | 3.99e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 10 | 8.27e-01 | 3.98e-02 | 9.57e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 24 | 7.36e-01 | 3.98e-02 | 9.31e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 23 | 7.41e-01 | 3.98e-02 | 9.34e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 7.41e-01 | -3.98e-02 | 9.34e-01 |
| GOCC NEURON PROJECTION TERMINUS | 55 | 6.10e-01 | -3.98e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 289 | 2.47e-01 | 3.97e-02 | 6.61e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 996 | 3.60e-02 | 3.97e-02 | 2.94e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 25 | 7.31e-01 | -3.97e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 39 | 6.68e-01 | 3.97e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 383 | 1.85e-01 | 3.97e-02 | 5.98e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 53 | 6.18e-01 | -3.97e-02 | 8.83e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 71 | 5.64e-01 | 3.96e-02 | 8.57e-01 |
| GOBP EMBRYO DEVELOPMENT | 633 | 9.11e-02 | 3.96e-02 | 4.55e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 511 | 1.28e-01 | 3.96e-02 | 5.18e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 36 | 6.81e-01 | -3.96e-02 | 9.11e-01 |
| GOBP MYOBLAST MIGRATION | 8 | 8.46e-01 | 3.96e-02 | 9.63e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 23 | 7.42e-01 | 3.96e-02 | 9.35e-01 |
| GOBP CMP METABOLIC PROCESS | 7 | 8.56e-01 | 3.96e-02 | 9.65e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 22 | 7.48e-01 | -3.96e-02 | 9.35e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 5 | 8.78e-01 | 3.96e-02 | 9.68e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 33 | 6.94e-01 | -3.96e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 14 | 7.98e-01 | -3.95e-02 | 9.50e-01 |
| GOMF PEPTIDASE ACTIVITY | 331 | 2.19e-01 | 3.95e-02 | 6.32e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 5 | 8.79e-01 | -3.94e-02 | 9.69e-01 |
| GOBP STRIATUM DEVELOPMENT | 14 | 7.98e-01 | 3.94e-02 | 9.50e-01 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 6 | 8.67e-01 | 3.94e-02 | 9.67e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 9 | 8.38e-01 | 3.94e-02 | 9.61e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 373 | 1.93e-01 | 3.94e-02 | 6.06e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 80 | 5.43e-01 | 3.94e-02 | 8.50e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 8.06e-01 | 3.94e-02 | 9.51e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 9 | 8.38e-01 | -3.93e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 19 | 7.67e-01 | -3.93e-02 | 9.41e-01 |
| GOBP FACE DEVELOPMENT | 34 | 6.92e-01 | -3.93e-02 | 9.14e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 8.14e-01 | 3.93e-02 | 9.54e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 8.30e-01 | -3.93e-02 | 9.59e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 6 | 8.68e-01 | 3.92e-02 | 9.67e-01 |
| GOBP RESPONSE TO AXON INJURY | 41 | 6.65e-01 | 3.91e-02 | 9.03e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 12 | 8.15e-01 | -3.91e-02 | 9.54e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 7 | 8.58e-01 | -3.90e-02 | 9.66e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 267 | 2.74e-01 | 3.90e-02 | 6.88e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 51 | 6.30e-01 | -3.90e-02 | 8.88e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 9 | 8.40e-01 | 3.89e-02 | 9.61e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 72 | 5.68e-01 | 3.89e-02 | 8.59e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 12 | 8.16e-01 | -3.89e-02 | 9.54e-01 |
| GOBP NEUROMUSCULAR PROCESS | 80 | 5.48e-01 | -3.89e-02 | 8.53e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 24 | 7.42e-01 | 3.88e-02 | 9.34e-01 |
| GOBP MUSCLE ADAPTATION | 58 | 6.09e-01 | -3.88e-02 | 8.79e-01 |
| GOBP CELL GROWTH | 302 | 2.47e-01 | 3.88e-02 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 8.81e-01 | 3.88e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 24 | 7.42e-01 | -3.88e-02 | 9.35e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 8.81e-01 | -3.88e-02 | 9.69e-01 |
| GOCC CMG COMPLEX | 10 | 8.32e-01 | -3.88e-02 | 9.59e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 5 | 8.81e-01 | 3.87e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 102 | 5.00e-01 | -3.87e-02 | 8.32e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 8 | 8.50e-01 | 3.87e-02 | 9.63e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 19 | 7.70e-01 | 3.87e-02 | 9.41e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 49 | 6.40e-01 | -3.87e-02 | 8.92e-01 |
| GOBP LEUKOCYTE AGGREGATION | 10 | 8.32e-01 | -3.86e-02 | 9.59e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 48 | 6.44e-01 | -3.86e-02 | 8.93e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 11 | 8.25e-01 | 3.86e-02 | 9.57e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 28 | 7.24e-01 | 3.86e-02 | 9.26e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 17 | 7.83e-01 | -3.85e-02 | 9.45e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 24 | 7.44e-01 | -3.85e-02 | 9.35e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 37 | 6.86e-01 | 3.85e-02 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 22 | 7.55e-01 | -3.84e-02 | 9.38e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 33 | 7.03e-01 | 3.84e-02 | 9.18e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 23 | 7.50e-01 | -3.84e-02 | 9.35e-01 |
| GOBP NEURON RECOGNITION | 18 | 7.78e-01 | -3.83e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 24 | 7.45e-01 | -3.83e-02 | 9.35e-01 |
| GOMF BH3 DOMAIN BINDING | 6 | 8.71e-01 | -3.83e-02 | 9.68e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 8 | 8.51e-01 | 3.83e-02 | 9.63e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 324 | 2.38e-01 | 3.83e-02 | 6.52e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 141 | 4.34e-01 | -3.82e-02 | 7.98e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 10 | 8.35e-01 | -3.81e-02 | 9.59e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 8.72e-01 | 3.81e-02 | 9.68e-01 |
| GOMF PEPTIDE BINDING | 178 | 3.81e-01 | 3.81e-02 | 7.68e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 31 | 7.14e-01 | 3.81e-02 | 9.21e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 6 | 8.72e-01 | 3.81e-02 | 9.68e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 8.52e-01 | 3.81e-02 | 9.63e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 32 | 7.09e-01 | -3.81e-02 | 9.20e-01 |
| GOMF SULFUR COMPOUND BINDING | 129 | 4.56e-01 | -3.81e-02 | 8.08e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 10 | 8.35e-01 | 3.81e-02 | 9.60e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 373 | 2.09e-01 | 3.81e-02 | 6.22e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 74 | 5.72e-01 | -3.80e-02 | 8.60e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 9 | 8.44e-01 | 3.80e-02 | 9.61e-01 |
| GOBP TISSUE REMODELING | 89 | 5.36e-01 | -3.80e-02 | 8.47e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 244 | 3.08e-01 | 3.80e-02 | 7.14e-01 |
| GOMF GLUTATHIONE BINDING | 7 | 8.62e-01 | 3.80e-02 | 9.67e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 30 | 7.19e-01 | 3.80e-02 | 9.23e-01 |
| GOBP MUSCLE CONTRACTION | 163 | 4.04e-01 | 3.79e-02 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 13 | 8.13e-01 | 3.79e-02 | 9.54e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 11 | 8.28e-01 | -3.79e-02 | 9.57e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 8.20e-01 | -3.79e-02 | 9.56e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 39 | 6.82e-01 | 3.79e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 5 | 8.83e-01 | 3.79e-02 | 9.70e-01 |
| GOBP NUCLEOTIDE SALVAGE | 16 | 7.93e-01 | 3.79e-02 | 9.48e-01 |
| GOBP RESPONSE TO WOUNDING | 304 | 2.58e-01 | 3.79e-02 | 6.71e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 173 | 3.92e-01 | 3.78e-02 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 11 | 8.28e-01 | 3.78e-02 | 9.57e-01 |
| GOBP GTP METABOLIC PROCESS | 21 | 7.65e-01 | 3.77e-02 | 9.40e-01 |
| GOCC PLASMA MEMBRANE REGION | 666 | 9.96e-02 | 3.77e-02 | 4.70e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 44 | 6.66e-01 | -3.77e-02 | 9.03e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 5 | 8.84e-01 | -3.77e-02 | 9.70e-01 |
| GOBP SPROUTING ANGIOGENESIS | 63 | 6.06e-01 | 3.76e-02 | 8.76e-01 |
| GOCC CLEAVAGE FURROW | 45 | 6.62e-01 | 3.76e-02 | 9.02e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 130 | 4.59e-01 | 3.76e-02 | 8.10e-01 |
| GOBP GMP METABOLIC PROCESS | 25 | 7.45e-01 | 3.76e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 8.73e-01 | 3.76e-02 | 9.68e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 24 | 7.50e-01 | -3.76e-02 | 9.35e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 78 | 5.67e-01 | 3.76e-02 | 8.58e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 7 | 8.63e-01 | -3.76e-02 | 9.67e-01 |
| GOBP GENERATION OF NEURONS | 805 | 7.28e-02 | 3.76e-02 | 4.17e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 97 | 5.24e-01 | -3.75e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 6 | 8.74e-01 | -3.75e-02 | 9.68e-01 |
| GOBP HEART MORPHOGENESIS | 121 | 4.77e-01 | 3.75e-02 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 22 | 7.61e-01 | -3.74e-02 | 9.40e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 34 | 7.06e-01 | 3.74e-02 | 9.19e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 30 | 7.23e-01 | 3.74e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 36 | 6.98e-01 | -3.74e-02 | 9.16e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 8.38e-01 | 3.74e-02 | 9.61e-01 |
| GOBP SOMITOGENESIS | 29 | 7.28e-01 | -3.73e-02 | 9.29e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 11 | 8.30e-01 | -3.73e-02 | 9.59e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 6 | 8.74e-01 | -3.73e-02 | 9.68e-01 |
| GOMF COLLAGEN BINDING | 32 | 7.15e-01 | 3.73e-02 | 9.21e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 21 | 7.68e-01 | 3.72e-02 | 9.41e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 27 | 7.38e-01 | 3.72e-02 | 9.33e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 65 | 6.04e-01 | -3.72e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 19 | 7.79e-01 | 3.72e-02 | 9.44e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 50 | 6.50e-01 | 3.72e-02 | 8.95e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 126 | 4.72e-01 | -3.71e-02 | 8.16e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 34 | 7.08e-01 | 3.71e-02 | 9.20e-01 |
| GOBP SNRNA TRANSCRIPTION | 17 | 7.91e-01 | 3.71e-02 | 9.48e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 21 | 7.68e-01 | -3.71e-02 | 9.41e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 754 | 8.56e-02 | 3.71e-02 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 8.86e-01 | -3.71e-02 | 9.71e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 11 | 8.32e-01 | 3.70e-02 | 9.59e-01 |
| GOBP CELL SUBSTRATE ADHESION | 197 | 3.71e-01 | 3.70e-02 | 7.60e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 36 | 7.01e-01 | 3.70e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 5 | 8.86e-01 | 3.70e-02 | 9.71e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 66 | 6.03e-01 | 3.70e-02 | 8.76e-01 |
| GOBP RESPONSE TO METAL ION | 214 | 3.52e-01 | 3.70e-02 | 7.47e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 5 | 8.86e-01 | -3.70e-02 | 9.71e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 31 | 7.22e-01 | 3.70e-02 | 9.25e-01 |
| GOBP NEURON DEVELOPMENT | 642 | 1.13e-01 | 3.70e-02 | 4.93e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 14 | 8.11e-01 | -3.70e-02 | 9.53e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 5 | 8.87e-01 | 3.68e-02 | 9.71e-01 |
| GOBP RESPONSE TO CAMP | 45 | 6.69e-01 | -3.68e-02 | 9.04e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 51 | 6.50e-01 | -3.68e-02 | 8.95e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 31 | 7.23e-01 | -3.68e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 9 | 8.49e-01 | -3.67e-02 | 9.63e-01 |
| GOBP LACTATION | 24 | 7.55e-01 | 3.67e-02 | 9.38e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 54 | 6.41e-01 | -3.67e-02 | 8.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 8.87e-01 | -3.67e-02 | 9.71e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 41 | 6.85e-01 | -3.66e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 15 | 8.06e-01 | 3.66e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 63 | 6.16e-01 | 3.66e-02 | 8.83e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 58 | 6.30e-01 | -3.66e-02 | 8.88e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 8.49e-01 | 3.66e-02 | 9.63e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 37 | 7.00e-01 | -3.66e-02 | 9.17e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 260 | 3.12e-01 | 3.65e-02 | 7.15e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 6 | 8.77e-01 | 3.65e-02 | 9.68e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 661 | 1.12e-01 | 3.65e-02 | 4.92e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 23 | 7.62e-01 | 3.65e-02 | 9.40e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 23 | 7.62e-01 | -3.65e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 23 | 7.62e-01 | -3.65e-02 | 9.40e-01 |
| GOMF MANGANESE ION BINDING | 53 | 6.46e-01 | -3.65e-02 | 8.94e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 64 | 6.14e-01 | 3.64e-02 | 8.83e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 8.14e-01 | 3.64e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 12 | 8.27e-01 | 3.64e-02 | 9.57e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 8.88e-01 | -3.64e-02 | 9.71e-01 |
| GOCC DYSTROGLYCAN COMPLEX | 5 | 8.88e-01 | 3.64e-02 | 9.71e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 12 | 8.27e-01 | -3.64e-02 | 9.57e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 72 | 5.94e-01 | -3.63e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 16 | 8.02e-01 | -3.63e-02 | 9.51e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 8 | 8.59e-01 | 3.63e-02 | 9.66e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 88 | 5.57e-01 | -3.63e-02 | 8.56e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 145 | 4.52e-01 | 3.62e-02 | 8.06e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 12 | 8.28e-01 | 3.62e-02 | 9.57e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 530 | 1.56e-01 | 3.62e-02 | 5.65e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 8.78e-01 | 3.62e-02 | 9.68e-01 |
| GOBP RESPONSE TO ESTRADIOL | 59 | 6.31e-01 | 3.62e-02 | 8.89e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 50 | 6.59e-01 | 3.61e-02 | 9.00e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 23 | 7.65e-01 | -3.60e-02 | 9.40e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 53 | 6.51e-01 | 3.60e-02 | 8.96e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 32 | 7.25e-01 | 3.59e-02 | 9.27e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 8.69e-01 | 3.59e-02 | 9.67e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 14 | 8.16e-01 | -3.59e-02 | 9.54e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 399 | 2.21e-01 | 3.58e-02 | 6.35e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1186 | 4.10e-02 | 3.57e-02 | 3.14e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 64 | 6.21e-01 | 3.57e-02 | 8.85e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 8.80e-01 | 3.57e-02 | 9.69e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 8.90e-01 | 3.57e-02 | 9.71e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 41 | 6.93e-01 | 3.57e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 622 | 1.32e-01 | 3.56e-02 | 5.26e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 138 | 4.71e-01 | 3.56e-02 | 8.16e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 7 | 8.71e-01 | -3.56e-02 | 9.68e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 8.18e-01 | -3.56e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 29 | 7.41e-01 | -3.55e-02 | 9.34e-01 |
| GOBP MESENCHYME DEVELOPMENT | 153 | 4.49e-01 | -3.55e-02 | 8.04e-01 |
| GOBP CELL RECOGNITION | 64 | 6.24e-01 | 3.54e-02 | 8.86e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 17 | 8.00e-01 | 3.54e-02 | 9.50e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 17 | 8.00e-01 | 3.54e-02 | 9.50e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 87 | 5.68e-01 | -3.54e-02 | 8.59e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 367 | 2.46e-01 | 3.54e-02 | 6.61e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 24 | 7.64e-01 | 3.54e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 91 | 5.60e-01 | 3.54e-02 | 8.56e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 140 | 4.71e-01 | 3.53e-02 | 8.16e-01 |
| GOMF SYNTAXIN 1 BINDING | 12 | 8.32e-01 | -3.53e-02 | 9.59e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 6 | 8.81e-01 | -3.53e-02 | 9.69e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 20 | 7.85e-01 | -3.53e-02 | 9.46e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 137 | 4.77e-01 | -3.53e-02 | 8.17e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 17 | 8.02e-01 | 3.52e-02 | 9.51e-01 |
| GOBP LEUKOCYTE MIGRATION | 232 | 3.57e-01 | 3.52e-02 | 7.50e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 45 | 6.83e-01 | -3.52e-02 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 107 | 5.30e-01 | 3.52e-02 | 8.45e-01 |
| GOBP SYNAPSE ORGANIZATION | 241 | 3.49e-01 | -3.51e-02 | 7.44e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 493 | 1.84e-01 | 3.51e-02 | 5.98e-01 |
| GOBP LIPID CATABOLIC PROCESS | 201 | 3.92e-01 | 3.51e-02 | 7.73e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 149 | 4.61e-01 | 3.51e-02 | 8.12e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 684 | 1.21e-01 | 3.50e-02 | 5.08e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 12 | 8.34e-01 | 3.50e-02 | 9.59e-01 |
| GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 8.92e-01 | -3.50e-02 | 9.72e-01 |
| GOBP INFLAMMATORY RESPONSE | 495 | 1.85e-01 | -3.50e-02 | 5.98e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 10 | 8.48e-01 | -3.50e-02 | 9.63e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 984 | 6.61e-02 | 3.50e-02 | 3.99e-01 |
| GOBP CELL ADHESION | 803 | 9.49e-02 | 3.50e-02 | 4.60e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 8.73e-01 | -3.50e-02 | 9.68e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 45 | 6.85e-01 | 3.50e-02 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 20 | 7.87e-01 | 3.50e-02 | 9.46e-01 |
| GOBP DORSAL SPINAL CORD DEVELOPMENT | 5 | 8.92e-01 | 3.50e-02 | 9.72e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 97 | 5.53e-01 | -3.49e-02 | 8.54e-01 |
| GOBP LIPID OXIDATION | 81 | 5.88e-01 | 3.49e-02 | 8.70e-01 |
| GOBP HEART DEVELOPMENT | 322 | 2.84e-01 | 3.49e-02 | 6.98e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 11 | 8.41e-01 | 3.48e-02 | 9.61e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 31 | 7.37e-01 | -3.48e-02 | 9.32e-01 |
| GOBP RNA DECAPPING | 18 | 7.98e-01 | 3.48e-02 | 9.50e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 24 | 7.68e-01 | -3.48e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 17 | 8.04e-01 | 3.47e-02 | 9.51e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 319 | 2.88e-01 | 3.47e-02 | 7.02e-01 |
| GOCC DENDRITE TERMINUS | 10 | 8.49e-01 | -3.47e-02 | 9.63e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 148 | 4.67e-01 | 3.47e-02 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 15 | 8.16e-01 | -3.46e-02 | 9.54e-01 |
| GOBP REGULATION OF HEART RATE | 41 | 7.01e-01 | -3.46e-02 | 9.17e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 357 | 2.63e-01 | 3.46e-02 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 23 | 7.75e-01 | 3.45e-02 | 9.42e-01 |
| GOBP ATP TRANSPORT | 14 | 8.23e-01 | 3.45e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 22 | 7.80e-01 | -3.45e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 40 | 7.06e-01 | -3.44e-02 | 9.19e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 39 | 7.10e-01 | 3.44e-02 | 9.20e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 96 | 5.61e-01 | -3.44e-02 | 8.56e-01 |
| GOMF LIPASE ACTIVITY | 71 | 6.17e-01 | -3.44e-02 | 8.83e-01 |
| GOBP REGULATION OF CELL SIZE | 117 | 5.21e-01 | 3.44e-02 | 8.41e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 11 | 8.44e-01 | 3.44e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 21 | 7.85e-01 | -3.43e-02 | 9.46e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 8 | 8.66e-01 | -3.43e-02 | 9.67e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 9 | 8.59e-01 | 3.43e-02 | 9.66e-01 |
| GOBP MESENDODERM DEVELOPMENT | 5 | 8.94e-01 | 3.43e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 349 | 2.74e-01 | 3.43e-02 | 6.88e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 29 | 7.50e-01 | -3.42e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 413 | 2.35e-01 | 3.42e-02 | 6.47e-01 |
| GOBP CHEMOKINE PRODUCTION | 61 | 6.44e-01 | -3.42e-02 | 8.93e-01 |
| GOMF TUBULIN BINDING | 277 | 3.29e-01 | 3.42e-02 | 7.30e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 156 | 4.62e-01 | 3.42e-02 | 8.12e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 9 | 8.59e-01 | -3.42e-02 | 9.66e-01 |
| GOMF SYNTAXIN BINDING | 46 | 6.89e-01 | -3.42e-02 | 9.13e-01 |
| GOBP REGULATION OF ANOIKIS | 16 | 8.13e-01 | 3.42e-02 | 9.54e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 95 | 5.66e-01 | -3.41e-02 | 8.58e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 8.85e-01 | 3.41e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 5 | 8.95e-01 | -3.41e-02 | 9.72e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 110 | 5.38e-01 | 3.41e-02 | 8.48e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 22 | 7.82e-01 | -3.40e-02 | 9.45e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 6 | 8.85e-01 | 3.40e-02 | 9.70e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 44 | 6.97e-01 | 3.40e-02 | 9.16e-01 |
| GOBP RENAL SYSTEM PROCESS | 46 | 6.90e-01 | -3.40e-02 | 9.13e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 7.93e-01 | 3.40e-02 | 9.48e-01 |
| GOBP ENERGY HOMEOSTASIS | 42 | 7.03e-01 | -3.40e-02 | 9.18e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 30 | 7.48e-01 | 3.39e-02 | 9.35e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 14 | 8.26e-01 | -3.39e-02 | 9.57e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 21 | 7.88e-01 | -3.39e-02 | 9.47e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1053 | 6.68e-02 | 3.38e-02 | 3.99e-01 |
| GOCC CELL CORTEX | 207 | 4.03e-01 | 3.38e-02 | 7.80e-01 |
| GOCC LATE ENDOSOME | 243 | 3.65e-01 | 3.38e-02 | 7.55e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 196 | 4.16e-01 | 3.38e-02 | 7.86e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 113 | 5.35e-01 | 3.38e-02 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 8.96e-01 | 3.38e-02 | 9.72e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 73 | 6.18e-01 | -3.38e-02 | 8.83e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 5 | 8.96e-01 | 3.38e-02 | 9.72e-01 |
| GOBP POLYOL METABOLIC PROCESS | 68 | 6.31e-01 | -3.37e-02 | 8.89e-01 |
| GOBP COGNITION | 163 | 4.58e-01 | 3.37e-02 | 8.09e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 65 | 6.39e-01 | 3.37e-02 | 8.92e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 134 | 5.01e-01 | 3.37e-02 | 8.32e-01 |
| GOMF ORGANIC ACID BINDING | 96 | 5.69e-01 | -3.37e-02 | 8.59e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 147 | 4.82e-01 | 3.37e-02 | 8.20e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 51 | 6.78e-01 | -3.37e-02 | 9.08e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 41 | 7.09e-01 | 3.37e-02 | 9.20e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 7 | 8.77e-01 | -3.37e-02 | 9.68e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 40 | 7.13e-01 | -3.36e-02 | 9.21e-01 |
| GOBP DUMP CATABOLIC PROCESS | 5 | 8.96e-01 | 3.36e-02 | 9.72e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 75 | 6.15e-01 | 3.36e-02 | 8.83e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 8.11e-01 | -3.35e-02 | 9.53e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 137 | 4.99e-01 | 3.35e-02 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 9 | 8.62e-01 | -3.35e-02 | 9.67e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 22 | 7.86e-01 | -3.35e-02 | 9.46e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 19 | 8.00e-01 | 3.35e-02 | 9.50e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 17 | 8.11e-01 | -3.35e-02 | 9.53e-01 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 5 | 8.97e-01 | 3.34e-02 | 9.72e-01 |
| GOBP GLAND MORPHOGENESIS | 54 | 6.71e-01 | -3.34e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 338 | 2.93e-01 | 3.34e-02 | 7.04e-01 |
| GOBP NEURON PROJECTION EXTENSION | 103 | 5.59e-01 | 3.34e-02 | 8.56e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 37 | 7.26e-01 | 3.33e-02 | 9.27e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 12 | 8.42e-01 | -3.33e-02 | 9.61e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 181 | 4.40e-01 | 3.33e-02 | 8.00e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 7 | 8.79e-01 | 3.33e-02 | 9.69e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 44 | 7.02e-01 | -3.33e-02 | 9.18e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 245 | 3.71e-01 | 3.33e-02 | 7.60e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 247 | 3.69e-01 | 3.33e-02 | 7.58e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 24 | 7.78e-01 | -3.32e-02 | 9.43e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 132 | 5.11e-01 | -3.32e-02 | 8.37e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 8.98e-01 | -3.32e-02 | 9.72e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 19 | 8.02e-01 | 3.32e-02 | 9.51e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 186 | 4.36e-01 | 3.32e-02 | 7.98e-01 |
| GOBP GLIAL CELL MIGRATION | 38 | 7.24e-01 | 3.31e-02 | 9.26e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 77 | 6.16e-01 | 3.31e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 59 | 6.61e-01 | 3.31e-02 | 9.01e-01 |
| GOCC AMPHISOME MEMBRANE | 10 | 8.57e-01 | 3.30e-02 | 9.65e-01 |
| GOBP CELL MORPHOGENESIS | 556 | 1.86e-01 | 3.30e-02 | 6.00e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 77 | 6.17e-01 | -3.30e-02 | 8.83e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 12 | 8.43e-01 | 3.30e-02 | 9.61e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 28 | 7.63e-01 | 3.30e-02 | 9.40e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 21 | 7.94e-01 | 3.29e-02 | 9.48e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 11 | 8.50e-01 | -3.29e-02 | 9.63e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 101 | 5.69e-01 | 3.29e-02 | 8.59e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 5 | 8.99e-01 | 3.28e-02 | 9.73e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 76 | 6.21e-01 | -3.28e-02 | 8.85e-01 |
| GOBP FATTY ACID TRANSPORT | 55 | 6.74e-01 | -3.28e-02 | 9.07e-01 |
| GOBP NUCLEOSIDE SALVAGE | 10 | 8.58e-01 | 3.27e-02 | 9.66e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 84 | 6.05e-01 | -3.27e-02 | 8.76e-01 |
| GOBP MACROPHAGE ACTIVATION | 73 | 6.30e-01 | -3.27e-02 | 8.88e-01 |
| GOCC XY BODY | 11 | 8.51e-01 | -3.26e-02 | 9.63e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.51e-01 | -3.26e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 35 | 7.38e-01 | 3.26e-02 | 9.33e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 11 | 8.51e-01 | 3.26e-02 | 9.63e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 20 | 8.01e-01 | 3.26e-02 | 9.50e-01 |
| GOMF BMP BINDING | 5 | 9.00e-01 | -3.26e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 192 | 4.37e-01 | 3.26e-02 | 7.98e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 8.39e-01 | 3.26e-02 | 9.61e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 13 | 8.39e-01 | 3.25e-02 | 9.61e-01 |
| GOCC TERTIARY GRANULE LUMEN | 37 | 7.32e-01 | 3.25e-02 | 9.31e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 93 | 5.89e-01 | 3.24e-02 | 8.70e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 9 | 8.66e-01 | 3.24e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 17 | 8.17e-01 | -3.24e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 9 | 8.66e-01 | -3.24e-02 | 9.67e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 8 | 8.74e-01 | -3.24e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 7 | 8.82e-01 | 3.24e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 29 | 7.63e-01 | -3.24e-02 | 9.40e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 39 | 7.27e-01 | -3.23e-02 | 9.28e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 57 | 6.73e-01 | 3.23e-02 | 9.06e-01 |
| GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.00e-01 | -3.23e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 27 | 7.71e-01 | 3.23e-02 | 9.41e-01 |
| GOCC BRUSH BORDER | 54 | 6.82e-01 | -3.23e-02 | 9.11e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 81 | 6.16e-01 | 3.23e-02 | 8.83e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 20 | 8.03e-01 | 3.22e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 8 | 8.75e-01 | 3.21e-02 | 9.68e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 8.83e-01 | -3.21e-02 | 9.70e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 8 | 8.75e-01 | 3.21e-02 | 9.68e-01 |
| GOBP NEURON FATE COMMITMENT | 16 | 8.24e-01 | 3.21e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 8.41e-01 | -3.21e-02 | 9.61e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 11 | 8.54e-01 | -3.21e-02 | 9.64e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 10 | 8.61e-01 | -3.21e-02 | 9.66e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 9 | 8.68e-01 | -3.21e-02 | 9.67e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 26 | 7.77e-01 | -3.21e-02 | 9.43e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 21 | 8.00e-01 | -3.20e-02 | 9.50e-01 |
| GOBP MACROAUTOPHAGY | 300 | 3.43e-01 | 3.20e-02 | 7.39e-01 |
| GOBP NEURAL CREST FORMATION | 9 | 8.68e-01 | 3.20e-02 | 9.67e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 10 | 8.61e-01 | -3.20e-02 | 9.67e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 9.02e-01 | 3.19e-02 | 9.73e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.84e-01 | 3.19e-02 | 9.70e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 168 | 4.76e-01 | 3.19e-02 | 8.17e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 13 | 8.42e-01 | -3.19e-02 | 9.61e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 5 | 9.02e-01 | 3.19e-02 | 9.73e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 89 | 6.03e-01 | -3.19e-02 | 8.76e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 28 | 7.70e-01 | -3.19e-02 | 9.41e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 28 | 7.70e-01 | -3.19e-02 | 9.41e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 8 | 8.76e-01 | -3.19e-02 | 9.68e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 35 | 7.45e-01 | -3.18e-02 | 9.35e-01 |
| GOBP FERTILIZATION | 77 | 6.30e-01 | -3.18e-02 | 8.88e-01 |
| GOBP VESICLE DOCKING | 49 | 7.00e-01 | -3.18e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 66 | 6.55e-01 | 3.18e-02 | 8.98e-01 |
| GOBP ESTROUS CYCLE | 10 | 8.62e-01 | -3.18e-02 | 9.67e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 128 | 5.36e-01 | 3.17e-02 | 8.47e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 8 | 8.77e-01 | 3.17e-02 | 9.68e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 36 | 7.42e-01 | 3.17e-02 | 9.35e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 8.77e-01 | -3.17e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 8 | 8.77e-01 | -3.17e-02 | 9.68e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 9 | 8.69e-01 | -3.16e-02 | 9.67e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 303 | 3.45e-01 | 3.16e-02 | 7.41e-01 |
| GOBP TOXIN TRANSPORT | 5 | 9.03e-01 | -3.16e-02 | 9.73e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 52 | 6.93e-01 | -3.16e-02 | 9.15e-01 |
| GOBP RESPONSE TO HORMONE | 508 | 2.26e-01 | 3.16e-02 | 6.39e-01 |
| GOCC SPERM CONNECTING PIECE | 5 | 9.03e-01 | 3.15e-02 | 9.73e-01 |
| GOBP RESPONSE TO STARVATION | 160 | 4.92e-01 | 3.15e-02 | 8.27e-01 |
| GOBP ORGANIC ANION TRANSPORT | 231 | 4.11e-01 | 3.15e-02 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 95 | 5.97e-01 | 3.14e-02 | 8.73e-01 |
| GOBP DENDRITE MORPHOGENESIS | 88 | 6.11e-01 | -3.14e-02 | 8.80e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 65 | 6.62e-01 | 3.14e-02 | 9.01e-01 |
| GOMF INTERLEUKIN 1 BINDING | 6 | 8.94e-01 | -3.14e-02 | 9.72e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 692 | 1.63e-01 | 3.14e-02 | 5.75e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 8.34e-01 | 3.13e-02 | 9.59e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 574 | 2.02e-01 | 3.13e-02 | 6.15e-01 |
| GOBP INTERFERON BETA PRODUCTION | 52 | 6.96e-01 | 3.13e-02 | 9.16e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 73 | 6.44e-01 | -3.13e-02 | 8.93e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 101 | 5.88e-01 | -3.12e-02 | 8.70e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 403 | 2.84e-01 | 3.12e-02 | 6.98e-01 |
| GOCC TERTIARY GRANULE | 122 | 5.52e-01 | 3.12e-02 | 8.54e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 30 | 7.68e-01 | -3.12e-02 | 9.41e-01 |
| GOBP ORGANELLE INHERITANCE | 13 | 8.46e-01 | 3.11e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 12 | 8.52e-01 | -3.11e-02 | 9.63e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 133 | 5.37e-01 | 3.11e-02 | 8.47e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 8.87e-01 | 3.10e-02 | 9.71e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 23 | 7.97e-01 | 3.10e-02 | 9.49e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 24 | 7.93e-01 | 3.10e-02 | 9.48e-01 |
| GOBP RENAL ABSORPTION | 14 | 8.41e-01 | -3.09e-02 | 9.61e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 47 | 7.14e-01 | 3.09e-02 | 9.21e-01 |
| GOCC SEX CHROMOSOME | 24 | 7.93e-01 | 3.09e-02 | 9.48e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 9 | 8.72e-01 | -3.09e-02 | 9.68e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 29 | 7.73e-01 | 3.09e-02 | 9.42e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 44 | 7.23e-01 | -3.09e-02 | 9.25e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 114 | 5.70e-01 | 3.09e-02 | 8.59e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 7 | 8.88e-01 | 3.09e-02 | 9.71e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 9 | 8.73e-01 | 3.08e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 42 | 7.30e-01 | 3.07e-02 | 9.30e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 474 | 2.54e-01 | 3.07e-02 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 96 | 6.04e-01 | -3.07e-02 | 8.76e-01 |
| GOBP GLUTAMATE SECRETION | 13 | 8.48e-01 | -3.06e-02 | 9.63e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 29 | 7.75e-01 | 3.06e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 19 | 8.18e-01 | -3.06e-02 | 9.54e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 10 | 8.67e-01 | -3.05e-02 | 9.67e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 223 | 4.34e-01 | -3.05e-02 | 7.98e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 15 | 8.38e-01 | 3.05e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 485 | 2.54e-01 | 3.04e-02 | 6.67e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 14 | 8.44e-01 | 3.04e-02 | 9.61e-01 |
| GOBP NEUROGENESIS | 947 | 1.17e-01 | 3.04e-02 | 4.99e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 7 | 8.89e-01 | -3.04e-02 | 9.71e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 30 | 7.73e-01 | 3.04e-02 | 9.42e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 48 | 7.16e-01 | 3.04e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 83 | 6.33e-01 | 3.04e-02 | 8.90e-01 |
| GOBP MELANIN METABOLIC PROCESS | 16 | 8.34e-01 | -3.04e-02 | 9.59e-01 |
| GOBP HEART GROWTH | 47 | 7.19e-01 | 3.04e-02 | 9.23e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 11 | 8.62e-01 | -3.04e-02 | 9.67e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 5 | 9.06e-01 | 3.03e-02 | 9.75e-01 |
| GOBP RESPONSE TO BACTERIUM | 368 | 3.20e-01 | 3.03e-02 | 7.23e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 106 | 5.90e-01 | 3.03e-02 | 8.70e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 295 | 3.72e-01 | 3.03e-02 | 7.60e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 6 | 8.98e-01 | 3.03e-02 | 9.72e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 154 | 5.18e-01 | -3.03e-02 | 8.39e-01 |
| GOBP REGULATION OF GROWTH | 359 | 3.27e-01 | 3.03e-02 | 7.27e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 217 | 4.44e-01 | 3.02e-02 | 8.02e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 18 | 8.25e-01 | -3.01e-02 | 9.57e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 31 | 7.72e-01 | -3.01e-02 | 9.41e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 168 | 5.03e-01 | -3.00e-02 | 8.33e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 8.46e-01 | -3.00e-02 | 9.63e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 7 | 8.91e-01 | -2.99e-02 | 9.71e-01 |
| GOMF CHROMATIN DNA BINDING | 81 | 6.42e-01 | 2.99e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 32 | 7.70e-01 | -2.99e-02 | 9.41e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 240 | 4.27e-01 | 2.99e-02 | 7.93e-01 |
| GOBP AMINO ACID TRANSPORT | 79 | 6.47e-01 | -2.98e-02 | 8.94e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 8.99e-01 | -2.98e-02 | 9.73e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 38 | 7.51e-01 | 2.98e-02 | 9.35e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 11 | 8.64e-01 | 2.98e-02 | 9.67e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 129 | 5.60e-01 | 2.98e-02 | 8.56e-01 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 5 | 9.08e-01 | 2.97e-02 | 9.75e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 24 | 8.01e-01 | 2.97e-02 | 9.51e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 438 | 2.89e-01 | 2.97e-02 | 7.02e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 80 | 6.47e-01 | -2.97e-02 | 8.94e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 14 | 8.48e-01 | 2.97e-02 | 9.63e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 8.92e-01 | 2.96e-02 | 9.72e-01 |
| GOBP NADPH REGENERATION | 19 | 8.23e-01 | 2.96e-02 | 9.57e-01 |
| GOCC COPI COATED VESICLE | 24 | 8.02e-01 | 2.96e-02 | 9.51e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 13 | 8.54e-01 | 2.96e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 17 | 8.33e-01 | 2.96e-02 | 9.59e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 53 | 7.10e-01 | -2.95e-02 | 9.20e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 8 | 8.85e-01 | -2.95e-02 | 9.70e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 8.72e-01 | -2.95e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 7 | 8.93e-01 | -2.94e-02 | 9.72e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 136 | 5.55e-01 | -2.93e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 39 | 7.52e-01 | -2.93e-02 | 9.35e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 600 | 2.24e-01 | 2.93e-02 | 6.36e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 5 | 9.10e-01 | -2.93e-02 | 9.76e-01 |
| GOCC GABA ERGIC SYNAPSE | 25 | 8.00e-01 | -2.93e-02 | 9.50e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 455 | 2.89e-01 | 2.91e-02 | 7.02e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 25 | 8.01e-01 | 2.91e-02 | 9.51e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 8.31e-01 | 2.91e-02 | 9.59e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 6 | 9.02e-01 | 2.91e-02 | 9.73e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 28 | 7.90e-01 | -2.91e-02 | 9.47e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 113 | 5.94e-01 | 2.90e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 24 | 8.06e-01 | 2.90e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 9 | 8.80e-01 | -2.89e-02 | 9.69e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 49 | 7.26e-01 | 2.89e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 11 | 8.68e-01 | -2.89e-02 | 9.67e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 8.37e-01 | 2.88e-02 | 9.61e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 7 | 8.95e-01 | 2.88e-02 | 9.72e-01 |
| GOBP TISSUE MORPHOGENESIS | 308 | 3.87e-01 | 2.88e-02 | 7.70e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 8 | 8.88e-01 | 2.88e-02 | 9.71e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 120 | 5.87e-01 | 2.88e-02 | 8.69e-01 |
| GOBP ORGANELLE LOCALIZATION | 469 | 2.89e-01 | 2.88e-02 | 7.02e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 12 | 8.63e-01 | -2.88e-02 | 9.67e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 10 | 8.75e-01 | -2.87e-02 | 9.68e-01 |
| GOMF FRIZZLED BINDING | 13 | 8.58e-01 | -2.87e-02 | 9.66e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 14 | 8.53e-01 | 2.87e-02 | 9.63e-01 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 8.69e-01 | -2.87e-02 | 9.67e-01 |
| GOCC SPINDLE POLE | 146 | 5.51e-01 | 2.86e-02 | 8.54e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 9 | 8.82e-01 | 2.86e-02 | 9.70e-01 |
| GOCC COPII VESICLE COAT | 16 | 8.43e-01 | 2.86e-02 | 9.61e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 14 | 8.53e-01 | 2.86e-02 | 9.64e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 216 | 4.70e-01 | -2.86e-02 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 9.12e-01 | -2.86e-02 | 9.77e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 10 | 8.76e-01 | -2.86e-02 | 9.68e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 35 | 7.70e-01 | -2.86e-02 | 9.41e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 74 | 6.71e-01 | 2.86e-02 | 9.05e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 64 | 6.93e-01 | 2.86e-02 | 9.14e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 14 | 8.54e-01 | 2.85e-02 | 9.64e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 24 | 8.09e-01 | 2.85e-02 | 9.53e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 28 | 7.94e-01 | -2.85e-02 | 9.48e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 31 | 7.84e-01 | 2.85e-02 | 9.46e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.70e-01 | 2.84e-02 | 9.68e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 137 | 5.66e-01 | -2.84e-02 | 8.58e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 8.44e-01 | 2.84e-02 | 9.62e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 7.91e-01 | -2.84e-02 | 9.48e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 123 | 5.88e-01 | 2.84e-02 | 8.70e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 196 | 4.95e-01 | 2.83e-02 | 8.28e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 8.83e-01 | -2.83e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 238 | 4.53e-01 | 2.83e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 12 | 8.65e-01 | -2.83e-02 | 9.67e-01 |
| GOBP AXIS SPECIFICATION | 39 | 7.60e-01 | -2.83e-02 | 9.39e-01 |
| GOCC NEURON PROJECTION | 715 | 2.02e-01 | 2.83e-02 | 6.15e-01 |
| GOBP PLACENTA DEVELOPMENT | 85 | 6.53e-01 | 2.82e-02 | 8.97e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 21 | 8.23e-01 | -2.82e-02 | 9.57e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 45 | 7.44e-01 | 2.82e-02 | 9.35e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 6 | 9.05e-01 | -2.82e-02 | 9.74e-01 |
| GOBP LIPID MODIFICATION | 137 | 5.71e-01 | 2.81e-02 | 8.59e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 8.66e-01 | -2.81e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 56 | 7.18e-01 | 2.80e-02 | 9.22e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 21 | 8.25e-01 | 2.79e-02 | 9.57e-01 |
| GOMF U2 SNRNA BINDING | 6 | 9.06e-01 | 2.79e-02 | 9.75e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 160 | 5.44e-01 | -2.78e-02 | 8.51e-01 |
| GOBP BLASTOCYST GROWTH | 18 | 8.38e-01 | 2.78e-02 | 9.61e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 35 | 7.76e-01 | 2.78e-02 | 9.43e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 6 | 9.06e-01 | 2.78e-02 | 9.75e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 13 | 8.63e-01 | -2.77e-02 | 9.67e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 63 | 7.04e-01 | -2.77e-02 | 9.18e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 10 | 8.80e-01 | 2.77e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 6 | 9.07e-01 | 2.76e-02 | 9.75e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 44 | 7.51e-01 | -2.76e-02 | 9.35e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 50 | 7.36e-01 | -2.76e-02 | 9.31e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 8.86e-01 | 2.76e-02 | 9.71e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 50 | 7.36e-01 | -2.76e-02 | 9.31e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 14 | 8.58e-01 | -2.76e-02 | 9.66e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 8 | 8.93e-01 | 2.76e-02 | 9.72e-01 |
| GOBP PROTEIN DEACETYLATION | 53 | 7.29e-01 | 2.76e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 113 | 6.13e-01 | 2.76e-02 | 8.82e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 21 | 8.27e-01 | 2.75e-02 | 9.57e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 900 | 1.66e-01 | 2.75e-02 | 5.77e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 8.59e-01 | 2.75e-02 | 9.66e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 514 | 2.89e-01 | 2.75e-02 | 7.02e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 48 | 7.42e-01 | -2.75e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 19 | 8.36e-01 | 2.75e-02 | 9.60e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 8.75e-01 | -2.74e-02 | 9.68e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 5 | 9.15e-01 | 2.74e-02 | 9.78e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 276 | 4.35e-01 | 2.74e-02 | 7.98e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 21 | 8.28e-01 | 2.74e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 73 | 6.86e-01 | 2.74e-02 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 95 | 6.46e-01 | 2.73e-02 | 8.94e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 11 | 8.75e-01 | 2.73e-02 | 9.68e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 287 | 4.28e-01 | 2.73e-02 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 14 | 8.60e-01 | -2.73e-02 | 9.66e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 34 | 7.83e-01 | -2.73e-02 | 9.45e-01 |
| GOBP VITAMIN TRANSPORT | 23 | 8.21e-01 | 2.72e-02 | 9.57e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 37 | 7.75e-01 | 2.72e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 5 | 9.16e-01 | 2.72e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 139 | 5.81e-01 | -2.71e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 61 | 7.14e-01 | 2.71e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 54 | 7.31e-01 | 2.71e-02 | 9.30e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 8.15e-01 | -2.71e-02 | 9.54e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 5 | 9.17e-01 | 2.71e-02 | 9.78e-01 |
| GOCC GATOR2 COMPLEX | 5 | 9.17e-01 | 2.71e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 35 | 7.82e-01 | 2.71e-02 | 9.45e-01 |
| GOBP BLASTOCYST FORMATION | 34 | 7.85e-01 | -2.71e-02 | 9.46e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 39 | 7.70e-01 | 2.71e-02 | 9.41e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 113 | 6.20e-01 | 2.71e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 42 | 7.62e-01 | 2.70e-02 | 9.40e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 126 | 6.01e-01 | 2.70e-02 | 8.74e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 76 | 6.84e-01 | -2.70e-02 | 9.12e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 36 | 7.79e-01 | 2.70e-02 | 9.44e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 70 | 6.97e-01 | 2.70e-02 | 9.16e-01 |
| GOBP REGULATION OF XENOPHAGY | 9 | 8.89e-01 | -2.70e-02 | 9.71e-01 |
| GOBP STEM CELL DIVISION | 23 | 8.23e-01 | 2.69e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 79 | 6.79e-01 | 2.69e-02 | 9.09e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 214 | 4.99e-01 | 2.69e-02 | 8.32e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 179 | 5.36e-01 | -2.69e-02 | 8.47e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 171 | 5.46e-01 | 2.68e-02 | 8.53e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 8.83e-01 | 2.68e-02 | 9.70e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 98 | 6.47e-01 | 2.68e-02 | 8.94e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 13 | 8.67e-01 | -2.68e-02 | 9.67e-01 |
| GOBP LOCOMOTOR RHYTHM | 9 | 8.89e-01 | 2.68e-02 | 9.71e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 104 | 6.38e-01 | -2.67e-02 | 8.92e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 40 | 7.70e-01 | -2.67e-02 | 9.41e-01 |
| GOBP MAST CELL ACTIVATION | 52 | 7.39e-01 | 2.67e-02 | 9.33e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 26 | 8.14e-01 | -2.67e-02 | 9.54e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 8.90e-01 | 2.67e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 8.73e-01 | -2.67e-02 | 9.68e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 16 | 8.54e-01 | -2.66e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 82 | 6.77e-01 | -2.66e-02 | 9.08e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 24 | 8.22e-01 | 2.65e-02 | 9.57e-01 |
| GOBP STEROL TRANSPORT | 80 | 6.83e-01 | 2.65e-02 | 9.11e-01 |
| GOBP PROTEIN DENEDDYLATION | 10 | 8.85e-01 | 2.64e-02 | 9.70e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 163 | 5.62e-01 | -2.64e-02 | 8.57e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 30 | 8.03e-01 | 2.63e-02 | 9.51e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 19 | 8.43e-01 | -2.63e-02 | 9.61e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 8.97e-01 | -2.63e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 721 | 2.33e-01 | 2.63e-02 | 6.44e-01 |
| GOBP STEM CELL DIFFERENTIATION | 135 | 5.98e-01 | 2.63e-02 | 8.73e-01 |
| GOMF RAGE RECEPTOR BINDING | 9 | 8.91e-01 | -2.63e-02 | 9.71e-01 |
| GOBP HOMEOSTATIC PROCESS | 1014 | 1.62e-01 | 2.63e-02 | 5.74e-01 |
| GOBP RESPONSE TO PEPTIDE | 321 | 4.20e-01 | -2.63e-02 | 7.89e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 8 | 8.98e-01 | 2.62e-02 | 9.72e-01 |
| GOBP SKIN DEVELOPMENT | 133 | 6.02e-01 | -2.62e-02 | 8.75e-01 |
| GOBP NEURON FATE SPECIFICATION | 7 | 9.04e-01 | -2.62e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 96 | 6.58e-01 | 2.62e-02 | 8.99e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 8.98e-01 | 2.61e-02 | 9.72e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 35 | 7.89e-01 | -2.61e-02 | 9.47e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 76 | 6.95e-01 | -2.60e-02 | 9.16e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 208 | 5.19e-01 | -2.60e-02 | 8.40e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 50 | 7.51e-01 | -2.60e-02 | 9.35e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 43 | 7.68e-01 | -2.60e-02 | 9.41e-01 |
| GOCC PRONUCLEUS | 12 | 8.76e-01 | 2.60e-02 | 9.68e-01 |
| GOBP SPERM EGG RECOGNITION | 18 | 8.49e-01 | -2.60e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1076 | 1.57e-01 | 2.59e-02 | 5.66e-01 |
| GOMF COPPER ION BINDING | 31 | 8.03e-01 | -2.59e-02 | 9.51e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 8.99e-01 | 2.58e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 36 | 7.89e-01 | -2.58e-02 | 9.47e-01 |
| GOBP ENDODERM FORMATION | 23 | 8.31e-01 | -2.58e-02 | 9.59e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 11 | 8.82e-01 | 2.58e-02 | 9.70e-01 |
| GOCC CILIARY BASE | 30 | 8.07e-01 | 2.58e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 60 | 7.30e-01 | 2.58e-02 | 9.30e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 8.46e-01 | -2.57e-02 | 9.63e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 18 | 8.50e-01 | -2.57e-02 | 9.63e-01 |
| GOBP ENDODERM DEVELOPMENT | 37 | 7.87e-01 | -2.57e-02 | 9.46e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 46 | 7.63e-01 | 2.57e-02 | 9.40e-01 |
| GOBP ANIMAL ORGAN MATURATION | 15 | 8.63e-01 | -2.57e-02 | 9.67e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 17 | 8.55e-01 | 2.57e-02 | 9.64e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 220 | 5.13e-01 | -2.57e-02 | 8.37e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 37 | 7.87e-01 | -2.57e-02 | 9.46e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 83 | 6.87e-01 | 2.56e-02 | 9.13e-01 |
| GOBP ENDOSOME ORGANIZATION | 87 | 6.80e-01 | 2.56e-02 | 9.10e-01 |
| GOMF CAMP BINDING | 12 | 8.78e-01 | -2.56e-02 | 9.68e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 13 | 8.73e-01 | 2.56e-02 | 9.68e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.07e-01 | -2.56e-02 | 9.75e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 197 | 5.37e-01 | 2.56e-02 | 8.47e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 9.21e-01 | -2.56e-02 | 9.81e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 6 | 9.14e-01 | 2.56e-02 | 9.78e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 228 | 5.07e-01 | 2.56e-02 | 8.36e-01 |
| GOBP MESODERM MORPHOGENESIS | 29 | 8.12e-01 | 2.55e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1079 | 1.62e-01 | 2.55e-02 | 5.75e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 99 | 6.62e-01 | -2.55e-02 | 9.01e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 18 | 8.52e-01 | 2.55e-02 | 9.63e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 59 | 7.35e-01 | 2.55e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 18 | 8.52e-01 | 2.54e-02 | 9.63e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 30 | 8.09e-01 | 2.54e-02 | 9.53e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 191 | 5.46e-01 | 2.54e-02 | 8.52e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 56 | 7.43e-01 | -2.54e-02 | 9.35e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 83 | 6.90e-01 | -2.54e-02 | 9.13e-01 |
| GOBP VASCULATURE DEVELOPMENT | 393 | 3.90e-01 | 2.54e-02 | 7.72e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 54 | 7.47e-01 | -2.54e-02 | 9.35e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 37 | 7.90e-01 | -2.53e-02 | 9.47e-01 |
| GOBP CELLULAR EXTRAVASATION | 48 | 7.62e-01 | 2.53e-02 | 9.40e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 6 | 9.15e-01 | 2.52e-02 | 9.78e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 69 | 7.18e-01 | -2.52e-02 | 9.22e-01 |
| GOBP MUCOCILIARY CLEARANCE | 5 | 9.22e-01 | -2.51e-02 | 9.81e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 74 | 7.09e-01 | 2.51e-02 | 9.20e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 44 | 7.73e-01 | -2.51e-02 | 9.42e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 183 | 5.59e-01 | 2.51e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 9.15e-01 | -2.51e-02 | 9.78e-01 |
| GOBP VACUOLAR TRANSPORT | 148 | 5.99e-01 | 2.51e-02 | 8.73e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 19 | 8.50e-01 | -2.51e-02 | 9.63e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 9.09e-01 | 2.50e-02 | 9.75e-01 |
| GOBP COPII COATED VESICLE BUDDING | 41 | 7.82e-01 | 2.50e-02 | 9.45e-01 |
| GOBP GLIAL CELL ACTIVATION | 39 | 7.87e-01 | -2.50e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 22 | 8.39e-01 | -2.50e-02 | 9.61e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 28 | 8.19e-01 | 2.50e-02 | 9.55e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 47 | 7.67e-01 | 2.50e-02 | 9.41e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 7 | 9.09e-01 | -2.50e-02 | 9.76e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 29 | 8.16e-01 | 2.49e-02 | 9.54e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 113 | 6.48e-01 | -2.49e-02 | 8.94e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 36 | 7.96e-01 | -2.49e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 5 | 9.23e-01 | -2.49e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 106 | 6.59e-01 | -2.49e-02 | 9.00e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 37 | 7.94e-01 | -2.48e-02 | 9.48e-01 |
| GOMF CTPASE ACTIVITY | 5 | 9.23e-01 | 2.48e-02 | 9.81e-01 |
| GOBP MAPK CASCADE | 447 | 3.71e-01 | 2.48e-02 | 7.60e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 217 | 5.30e-01 | 2.48e-02 | 8.45e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 44 | 7.76e-01 | 2.48e-02 | 9.43e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 47 | 7.70e-01 | -2.47e-02 | 9.41e-01 |
| GOCC ESCRT I COMPLEX | 10 | 8.93e-01 | 2.47e-02 | 9.72e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 713 | 2.66e-01 | 2.47e-02 | 6.80e-01 |
| GOMF KINETOCHORE BINDING | 5 | 9.24e-01 | 2.46e-02 | 9.82e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 47 | 7.71e-01 | 2.46e-02 | 9.41e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 31 | 8.13e-01 | 2.45e-02 | 9.54e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 43 | 7.81e-01 | 2.45e-02 | 9.45e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 11 | 8.88e-01 | 2.45e-02 | 9.71e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 27 | 8.26e-01 | -2.44e-02 | 9.57e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 75 | 7.15e-01 | -2.44e-02 | 9.21e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 42 | 7.85e-01 | -2.44e-02 | 9.46e-01 |
| GOCC CILIARY TIP | 39 | 7.92e-01 | -2.44e-02 | 9.48e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 27 | 8.27e-01 | 2.44e-02 | 9.57e-01 |
| GOBP MITOCHONDRIAL FUSION | 32 | 8.12e-01 | 2.44e-02 | 9.53e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 48 | 7.71e-01 | 2.43e-02 | 9.41e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 8 | 9.05e-01 | 2.43e-02 | 9.75e-01 |
| GOBP NCRNA TRANSCRIPTION | 95 | 6.83e-01 | 2.43e-02 | 9.11e-01 |
| GOMF MYOSIN II BINDING | 7 | 9.11e-01 | -2.43e-02 | 9.77e-01 |
| GOBP ARTERY DEVELOPMENT | 49 | 7.69e-01 | 2.42e-02 | 9.41e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 14 | 8.75e-01 | 2.42e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 79 | 7.10e-01 | -2.42e-02 | 9.20e-01 |
| GOBP TISSUE MIGRATION | 182 | 5.74e-01 | 2.42e-02 | 8.61e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 11 | 8.90e-01 | -2.41e-02 | 9.71e-01 |
| GOBP GAMETE GENERATION | 409 | 4.04e-01 | 2.41e-02 | 7.80e-01 |
| GOBP RESPONSE TO ALKALOID | 56 | 7.56e-01 | -2.41e-02 | 9.38e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 23 | 8.42e-01 | -2.41e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 10 | 8.95e-01 | 2.40e-02 | 9.72e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 8.90e-01 | -2.40e-02 | 9.71e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 50 | 7.69e-01 | -2.40e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 8 | 9.06e-01 | 2.40e-02 | 9.75e-01 |
| GOMF SNARE BINDING | 76 | 7.18e-01 | 2.40e-02 | 9.22e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 361 | 4.35e-01 | 2.40e-02 | 7.98e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 33 | 8.12e-01 | 2.40e-02 | 9.53e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 157 | 6.05e-01 | -2.40e-02 | 8.76e-01 |
| GOCC MICROTUBULE | 330 | 4.56e-01 | 2.39e-02 | 8.08e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 9.19e-01 | 2.39e-02 | 9.80e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 28 | 8.27e-01 | -2.39e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 21 | 8.50e-01 | 2.39e-02 | 9.63e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 9.26e-01 | -2.39e-02 | 9.83e-01 |
| GOCC MALE GERM CELL NUCLEUS | 36 | 8.05e-01 | 2.38e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 11 | 8.91e-01 | -2.38e-02 | 9.71e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 197 | 5.67e-01 | -2.37e-02 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 29 | 8.25e-01 | 2.37e-02 | 9.57e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 6 | 9.20e-01 | 2.37e-02 | 9.80e-01 |
| GOBP ASSOCIATIVE LEARNING | 43 | 7.88e-01 | -2.37e-02 | 9.47e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 20 | 8.55e-01 | -2.37e-02 | 9.64e-01 |
| GOBP VESICLE TARGETING | 60 | 7.52e-01 | 2.36e-02 | 9.35e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 33 | 8.15e-01 | 2.36e-02 | 9.54e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 12 | 8.88e-01 | -2.36e-02 | 9.71e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 5 | 9.27e-01 | -2.36e-02 | 9.83e-01 |
| GOBP RESPONSE TO CYTOKINE | 606 | 3.26e-01 | 2.35e-02 | 7.27e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 9.14e-01 | 2.35e-02 | 9.78e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 213 | 5.56e-01 | -2.35e-02 | 8.56e-01 |
| GOCC CYTOSOLIC REGION | 18 | 8.63e-01 | 2.34e-02 | 9.67e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 19 | 8.60e-01 | 2.34e-02 | 9.66e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 11 | 8.93e-01 | 2.34e-02 | 9.72e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 53 | 7.68e-01 | 2.34e-02 | 9.41e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 251 | 5.25e-01 | -2.34e-02 | 8.42e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 13 | 8.84e-01 | 2.34e-02 | 9.70e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 17 | 8.68e-01 | -2.34e-02 | 9.67e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 14 | 8.80e-01 | 2.34e-02 | 9.69e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 62 | 7.51e-01 | 2.33e-02 | 9.35e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 44 | 7.90e-01 | -2.33e-02 | 9.47e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 30 | 8.26e-01 | 2.33e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 252 | 5.28e-01 | -2.31e-02 | 8.44e-01 |
| GOBP SINGLE FERTILIZATION | 57 | 7.63e-01 | -2.31e-02 | 9.40e-01 |
| GOBP REGULATION OF TUBE SIZE | 56 | 7.65e-01 | -2.31e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 21 | 8.55e-01 | -2.31e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 46 | 7.87e-01 | 2.31e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 32 | 8.21e-01 | 2.31e-02 | 9.57e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 60 | 7.58e-01 | -2.30e-02 | 9.38e-01 |
| GOBP RUFFLE ORGANIZATION | 45 | 7.90e-01 | 2.30e-02 | 9.47e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 26 | 8.40e-01 | 2.29e-02 | 9.61e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 9.23e-01 | 2.28e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 17 | 8.71e-01 | 2.28e-02 | 9.68e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 37 | 8.10e-01 | -2.28e-02 | 9.53e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 11 | 8.96e-01 | -2.28e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 8 | 9.11e-01 | -2.28e-02 | 9.77e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 7 | 9.17e-01 | -2.27e-02 | 9.78e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 106 | 6.86e-01 | -2.27e-02 | 9.13e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 8.87e-01 | -2.27e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 17 | 8.71e-01 | 2.27e-02 | 9.68e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 123 | 6.64e-01 | -2.27e-02 | 9.03e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 6 | 9.23e-01 | -2.27e-02 | 9.81e-01 |
| GOBP RESPONSE TO ACTIVITY | 41 | 8.02e-01 | -2.26e-02 | 9.51e-01 |
| GOCC AGGRESOME | 27 | 8.39e-01 | -2.26e-02 | 9.61e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 9.01e-01 | 2.26e-02 | 9.73e-01 |
| GOBP FEEDING BEHAVIOR | 33 | 8.22e-01 | 2.26e-02 | 9.57e-01 |
| GOBP RESPONSE TO IRON ION | 19 | 8.65e-01 | -2.26e-02 | 9.67e-01 |
| GOBP CELL PART MORPHOGENESIS | 383 | 4.50e-01 | 2.26e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 15 | 8.80e-01 | -2.26e-02 | 9.69e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 9 | 9.07e-01 | 2.26e-02 | 9.75e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 111 | 6.82e-01 | 2.26e-02 | 9.11e-01 |
| GOCC SIDE OF MEMBRANE | 390 | 4.47e-01 | 2.25e-02 | 8.03e-01 |
| GOBP LOCOMOTION | 696 | 3.15e-01 | 2.25e-02 | 7.19e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 10 | 9.02e-01 | -2.25e-02 | 9.73e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 111 | 6.83e-01 | -2.25e-02 | 9.11e-01 |
| GOMF ACTIN BINDING | 292 | 5.10e-01 | 2.25e-02 | 8.37e-01 |
| GOBP ACUTE PHASE RESPONSE | 20 | 8.62e-01 | 2.24e-02 | 9.67e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 24 | 8.49e-01 | 2.24e-02 | 9.63e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 42 | 8.02e-01 | 2.24e-02 | 9.51e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 10 | 9.02e-01 | 2.24e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 89 | 7.15e-01 | 2.24e-02 | 9.21e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 8.59e-01 | -2.23e-02 | 9.66e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 48 | 7.89e-01 | -2.23e-02 | 9.47e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 33 | 8.25e-01 | 2.23e-02 | 9.57e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 417 | 4.37e-01 | 2.23e-02 | 7.98e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 8 | 9.13e-01 | 2.23e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 11 | 8.98e-01 | 2.23e-02 | 9.72e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 25 | 8.47e-01 | -2.22e-02 | 9.63e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 73 | 7.43e-01 | -2.22e-02 | 9.35e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 181 | 6.08e-01 | 2.21e-02 | 8.79e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 38 | 8.14e-01 | -2.21e-02 | 9.54e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 44 | 8.00e-01 | -2.21e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 12 | 8.95e-01 | -2.21e-02 | 9.72e-01 |
| GOMF DEATH DOMAIN BINDING | 11 | 8.99e-01 | -2.21e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 631 | 3.48e-01 | 2.21e-02 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 55 | 7.78e-01 | 2.20e-02 | 9.43e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 146 | 6.47e-01 | 2.20e-02 | 8.94e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 12 | 8.95e-01 | -2.20e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 79 | 7.36e-01 | 2.20e-02 | 9.31e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 15 | 8.83e-01 | 2.19e-02 | 9.70e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 48 | 7.93e-01 | 2.19e-02 | 9.48e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 6 | 9.26e-01 | -2.19e-02 | 9.83e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 50 | 7.89e-01 | -2.19e-02 | 9.47e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 9.14e-01 | -2.19e-02 | 9.78e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 17 | 8.76e-01 | -2.19e-02 | 9.68e-01 |
| GOMF NADP BINDING | 39 | 8.13e-01 | 2.19e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 21 | 8.62e-01 | -2.19e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 102 | 7.03e-01 | 2.19e-02 | 9.18e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 42 | 8.07e-01 | -2.19e-02 | 9.51e-01 |
| GOCC CATION CHANNEL COMPLEX | 69 | 7.54e-01 | -2.18e-02 | 9.37e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 15 | 8.84e-01 | -2.18e-02 | 9.70e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 11 | 9.01e-01 | 2.17e-02 | 9.73e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 16 | 8.81e-01 | -2.17e-02 | 9.69e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 103 | 7.04e-01 | 2.17e-02 | 9.18e-01 |
| GOMF JUN KINASE BINDING | 9 | 9.10e-01 | 2.17e-02 | 9.77e-01 |
| GOCC AXON | 366 | 4.78e-01 | 2.17e-02 | 8.18e-01 |
| GOBP OVULATION CYCLE | 34 | 8.27e-01 | -2.17e-02 | 9.57e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 18 | 8.74e-01 | 2.16e-02 | 9.68e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 14 | 8.89e-01 | 2.16e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 18 | 8.74e-01 | 2.16e-02 | 9.68e-01 |
| GOBP RNA SURVEILLANCE | 17 | 8.78e-01 | 2.15e-02 | 9.68e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 20 | 8.68e-01 | -2.15e-02 | 9.67e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 123 | 6.82e-01 | -2.15e-02 | 9.11e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 215 | 5.89e-01 | 2.14e-02 | 8.70e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 6 | 9.28e-01 | 2.14e-02 | 9.83e-01 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 9.34e-01 | -2.14e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 37 | 8.22e-01 | -2.14e-02 | 9.57e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 10 | 9.07e-01 | -2.14e-02 | 9.75e-01 |
| GOBP SYNCYTIUM FORMATION | 32 | 8.34e-01 | -2.14e-02 | 9.59e-01 |
| GOBP BONE REMODELING | 52 | 7.90e-01 | -2.14e-02 | 9.47e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 19 | 8.72e-01 | -2.13e-02 | 9.68e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 40 | 8.16e-01 | -2.13e-02 | 9.54e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 135 | 6.70e-01 | -2.12e-02 | 9.05e-01 |
| GOBP DNA CATABOLIC PROCESS | 22 | 8.63e-01 | 2.12e-02 | 9.67e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 12 | 8.99e-01 | -2.12e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 34 | 8.31e-01 | 2.12e-02 | 9.59e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 9 | 9.13e-01 | -2.11e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 28 | 8.47e-01 | 2.11e-02 | 9.63e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 10 | 9.08e-01 | 2.11e-02 | 9.75e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 105 | 7.09e-01 | 2.11e-02 | 9.20e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 405 | 4.70e-01 | 2.10e-02 | 8.16e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 196 | 6.13e-01 | -2.10e-02 | 8.82e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 12 | 9.00e-01 | -2.10e-02 | 9.73e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 8.88e-01 | 2.10e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 81 | 7.45e-01 | -2.10e-02 | 9.35e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 8.88e-01 | 2.09e-02 | 9.71e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 48 | 8.02e-01 | 2.09e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 49 | 8.00e-01 | -2.09e-02 | 9.50e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 6 | 9.29e-01 | 2.09e-02 | 9.83e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 37 | 8.26e-01 | 2.09e-02 | 9.57e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 14 | 8.92e-01 | -2.09e-02 | 9.72e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 30 | 8.43e-01 | -2.09e-02 | 9.61e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 8.69e-01 | 2.09e-02 | 9.67e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 227 | 5.89e-01 | 2.08e-02 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 67 | 7.68e-01 | 2.08e-02 | 9.41e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 16 | 8.85e-01 | -2.08e-02 | 9.70e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 21 | 8.69e-01 | -2.08e-02 | 9.67e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 138 | 6.74e-01 | -2.08e-02 | 9.07e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 61 | 7.79e-01 | -2.08e-02 | 9.44e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 9 | 9.14e-01 | 2.07e-02 | 9.78e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 312 | 5.31e-01 | 2.07e-02 | 8.46e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 57 | 7.87e-01 | 2.07e-02 | 9.46e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 15 | 8.90e-01 | -2.07e-02 | 9.71e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 47 | 8.07e-01 | -2.06e-02 | 9.51e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 7 | 9.25e-01 | 2.06e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 23 | 8.64e-01 | 2.06e-02 | 9.67e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 15 | 8.90e-01 | -2.06e-02 | 9.71e-01 |
| GOBP INNER EAR MORPHOGENESIS | 39 | 8.24e-01 | -2.06e-02 | 9.57e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 14 | 8.94e-01 | -2.06e-02 | 9.72e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 9.31e-01 | 2.06e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 23 | 8.65e-01 | 2.05e-02 | 9.67e-01 |
| GOBP RESPONSE TO ZINC ION | 29 | 8.48e-01 | 2.05e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 62 | 7.80e-01 | -2.05e-02 | 9.44e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 15 | 8.91e-01 | -2.05e-02 | 9.71e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 9.31e-01 | 2.05e-02 | 9.84e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 92 | 7.35e-01 | 2.05e-02 | 9.31e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 8.91e-01 | -2.04e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 38 | 8.28e-01 | 2.04e-02 | 9.57e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 8.99e-01 | 2.04e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 185 | 6.34e-01 | 2.04e-02 | 8.90e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 9.31e-01 | 2.04e-02 | 9.84e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 14 | 8.95e-01 | -2.03e-02 | 9.72e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 46 | 8.11e-01 | 2.03e-02 | 9.53e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 57 | 7.91e-01 | 2.03e-02 | 9.48e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 9 | 9.16e-01 | 2.02e-02 | 9.78e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 51 | 8.03e-01 | -2.02e-02 | 9.51e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 133 | 6.88e-01 | -2.02e-02 | 9.13e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 24 | 8.65e-01 | -2.01e-02 | 9.67e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 12 | 9.04e-01 | -2.01e-02 | 9.74e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 494 | 4.50e-01 | 2.00e-02 | 8.04e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 86 | 7.49e-01 | 2.00e-02 | 9.35e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 23 | 8.68e-01 | -2.00e-02 | 9.67e-01 |
| GOBP PHAGOSOME MATURATION | 24 | 8.66e-01 | -1.99e-02 | 9.67e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 85 | 7.51e-01 | 1.99e-02 | 9.35e-01 |
| GOCC PARASPECKLES | 8 | 9.22e-01 | -1.99e-02 | 9.81e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 52 | 8.04e-01 | -1.99e-02 | 9.51e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 41 | 8.26e-01 | -1.99e-02 | 9.57e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 68 | 7.77e-01 | 1.98e-02 | 9.43e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 53 | 8.03e-01 | 1.98e-02 | 9.51e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 12 | 9.05e-01 | -1.98e-02 | 9.75e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 15 | 8.94e-01 | -1.98e-02 | 9.72e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 8 | 9.23e-01 | -1.98e-02 | 9.81e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 16 | 8.91e-01 | 1.98e-02 | 9.71e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 43 | 8.23e-01 | 1.97e-02 | 9.57e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 13 | 9.02e-01 | -1.97e-02 | 9.73e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 40 | 8.29e-01 | -1.97e-02 | 9.58e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 69 | 7.77e-01 | 1.97e-02 | 9.43e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 28 | 8.57e-01 | -1.97e-02 | 9.65e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 9.39e-01 | -1.97e-02 | 9.85e-01 |
| GOBP RESPIRATORY BURST | 29 | 8.55e-01 | 1.97e-02 | 9.64e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 30 | 8.52e-01 | 1.96e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 6 | 9.34e-01 | 1.96e-02 | 9.84e-01 |
| GOBP AXIS ELONGATION | 11 | 9.11e-01 | -1.95e-02 | 9.77e-01 |
| GOMF NUCLEOSIDE BINDING | 7 | 9.29e-01 | 1.95e-02 | 9.83e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 385 | 5.14e-01 | -1.95e-02 | 8.37e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 187 | 6.47e-01 | 1.95e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 14 | 9.00e-01 | 1.94e-02 | 9.73e-01 |
| GOBP LONG TERM MEMORY | 20 | 8.80e-01 | -1.94e-02 | 9.69e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 43 | 8.26e-01 | 1.94e-02 | 9.57e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 25 | 8.67e-01 | -1.94e-02 | 9.67e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 74 | 7.73e-01 | -1.94e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 9.00e-01 | 1.94e-02 | 9.73e-01 |
| GOBP RESPONSE TO TUMOR CELL | 32 | 8.50e-01 | 1.93e-02 | 9.63e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 39 | 8.35e-01 | -1.92e-02 | 9.60e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 6 | 9.35e-01 | -1.92e-02 | 9.84e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 94 | 7.48e-01 | 1.92e-02 | 9.35e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 42 | 8.29e-01 | -1.92e-02 | 9.58e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 18 | 8.88e-01 | 1.92e-02 | 9.71e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 12 | 9.08e-01 | -1.92e-02 | 9.75e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 16 | 8.95e-01 | 1.91e-02 | 9.72e-01 |
| GOBP LIVER REGENERATION | 19 | 8.85e-01 | 1.91e-02 | 9.70e-01 |
| GOBP XENOPHAGY | 14 | 9.01e-01 | 1.91e-02 | 9.73e-01 |
| GOMF CYTOKINE BINDING | 81 | 7.66e-01 | 1.91e-02 | 9.41e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 93 | 7.51e-01 | -1.91e-02 | 9.35e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 9.31e-01 | 1.90e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 90 | 7.56e-01 | -1.90e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 142 | 6.96e-01 | 1.90e-02 | 9.16e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 66 | 7.90e-01 | 1.90e-02 | 9.47e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 78 | 7.72e-01 | -1.90e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 88 | 7.59e-01 | -1.89e-02 | 9.39e-01 |
| GOBP REGULATION OF CELL DIVISION | 115 | 7.26e-01 | 1.89e-02 | 9.28e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 9 | 9.22e-01 | -1.89e-02 | 9.81e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 69 | 7.87e-01 | 1.89e-02 | 9.46e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 5 | 9.42e-01 | 1.88e-02 | 9.85e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 110 | 7.33e-01 | 1.88e-02 | 9.31e-01 |
| GOBP REGULATION OF APPETITE | 8 | 9.27e-01 | -1.88e-02 | 9.83e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 17 | 8.93e-01 | 1.88e-02 | 9.72e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 9 | 9.22e-01 | 1.88e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 98 | 7.49e-01 | 1.87e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 25 | 8.71e-01 | 1.87e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 93 | 7.56e-01 | -1.87e-02 | 9.38e-01 |
| GOBP RELAXATION OF MUSCLE | 20 | 8.85e-01 | 1.87e-02 | 9.70e-01 |
| GOBP REGULATION OF GLIOGENESIS | 57 | 8.07e-01 | -1.87e-02 | 9.52e-01 |
| GOBP PHOTOTRANSDUCTION | 17 | 8.94e-01 | -1.87e-02 | 9.72e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 40 | 8.39e-01 | 1.86e-02 | 9.61e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 16 | 8.98e-01 | -1.86e-02 | 9.72e-01 |
| GOCC CELL PROJECTION MEMBRANE | 199 | 6.52e-01 | -1.86e-02 | 8.97e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 134 | 7.11e-01 | 1.86e-02 | 9.20e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 179 | 6.70e-01 | 1.85e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 21 | 8.83e-01 | -1.85e-02 | 9.70e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 106 | 7.43e-01 | -1.85e-02 | 9.35e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 9.05e-01 | 1.85e-02 | 9.74e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 15 | 9.02e-01 | -1.84e-02 | 9.73e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 9.43e-01 | -1.84e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 45 | 8.31e-01 | 1.84e-02 | 9.59e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 22 | 8.81e-01 | 1.84e-02 | 9.70e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 606 | 4.43e-01 | 1.84e-02 | 8.02e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 37 | 8.47e-01 | 1.84e-02 | 9.63e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 36 | 8.49e-01 | -1.83e-02 | 9.63e-01 |
| GOBP REGULATION OF BEHAVIOR | 32 | 8.58e-01 | 1.83e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 27 | 8.70e-01 | 1.82e-02 | 9.68e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 101 | 7.52e-01 | -1.82e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 58 | 8.11e-01 | 1.82e-02 | 9.53e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 8 | 9.29e-01 | 1.81e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 7 | 9.34e-01 | 1.81e-02 | 9.84e-01 |
| GOBP REGULATION OF AXON EXTENSION | 56 | 8.15e-01 | 1.81e-02 | 9.54e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 7 | 9.34e-01 | -1.80e-02 | 9.84e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 7 | 9.34e-01 | 1.80e-02 | 9.84e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 20 | 8.89e-01 | -1.80e-02 | 9.71e-01 |
| GOBP KERATINOCYTE MIGRATION | 11 | 9.18e-01 | -1.79e-02 | 9.79e-01 |
| GOBP BONE RESORPTION | 42 | 8.41e-01 | 1.79e-02 | 9.61e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 264 | 6.17e-01 | -1.79e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 10 | 9.22e-01 | -1.79e-02 | 9.81e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 136 | 7.19e-01 | 1.79e-02 | 9.23e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 702 | 4.24e-01 | 1.79e-02 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 12 | 9.15e-01 | -1.79e-02 | 9.78e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 263 | 6.20e-01 | -1.78e-02 | 8.84e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 16 | 9.02e-01 | 1.78e-02 | 9.73e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 6 | 9.40e-01 | 1.78e-02 | 9.85e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 59 | 8.14e-01 | -1.77e-02 | 9.54e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 74 | 7.92e-01 | -1.77e-02 | 9.48e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 9.45e-01 | 1.77e-02 | 9.86e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 6 | 9.40e-01 | -1.77e-02 | 9.85e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 198 | 6.69e-01 | 1.76e-02 | 9.04e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 9 | 9.27e-01 | 1.76e-02 | 9.83e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 10 | 9.23e-01 | -1.76e-02 | 9.81e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 19 | 8.95e-01 | -1.75e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 234 | 6.45e-01 | 1.75e-02 | 8.93e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 6 | 9.41e-01 | -1.75e-02 | 9.85e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 79 | 7.88e-01 | -1.75e-02 | 9.47e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 7 | 9.36e-01 | 1.75e-02 | 9.85e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 9.41e-01 | -1.75e-02 | 9.85e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 21 | 8.90e-01 | -1.75e-02 | 9.71e-01 |
| GOBP EAR MORPHOGENESIS | 48 | 8.34e-01 | 1.74e-02 | 9.59e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 40 | 8.49e-01 | 1.74e-02 | 9.63e-01 |
| GOCC COHESIN COMPLEX | 9 | 9.28e-01 | -1.74e-02 | 9.83e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 238 | 6.45e-01 | -1.74e-02 | 8.93e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 33 | 8.63e-01 | -1.74e-02 | 9.67e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 92 | 7.73e-01 | -1.74e-02 | 9.42e-01 |
| GOMF ACTIVIN BINDING | 8 | 9.32e-01 | 1.73e-02 | 9.84e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 15 | 9.08e-01 | 1.73e-02 | 9.75e-01 |
| GOBP STEROL HOMEOSTASIS | 44 | 8.43e-01 | 1.73e-02 | 9.61e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 211 | 6.66e-01 | -1.73e-02 | 9.04e-01 |
| GOBP GLYCINE TRANSPORT | 6 | 9.42e-01 | 1.73e-02 | 9.85e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 80 | 7.90e-01 | -1.72e-02 | 9.47e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 14 | 9.11e-01 | -1.72e-02 | 9.77e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 31 | 8.68e-01 | 1.72e-02 | 9.67e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1055 | 3.51e-01 | 1.72e-02 | 7.46e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 24 | 8.84e-01 | -1.72e-02 | 9.70e-01 |
| GOBP RESPONSE TO ALCOHOL | 144 | 7.22e-01 | 1.72e-02 | 9.25e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 12 | 9.18e-01 | 1.71e-02 | 9.79e-01 |
| GOBP RESPONSE TO LIPID | 526 | 5.04e-01 | 1.71e-02 | 8.34e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 100 | 7.68e-01 | -1.71e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 42 | 8.48e-01 | 1.71e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 25 | 8.83e-01 | 1.70e-02 | 9.70e-01 |
| GOCC EXOCYTIC VESICLE | 134 | 7.34e-01 | 1.70e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 22 | 8.91e-01 | 1.70e-02 | 9.71e-01 |
| GOBP RESPONSE TO LEPTIN | 12 | 9.19e-01 | 1.69e-02 | 9.80e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 32 | 8.68e-01 | 1.69e-02 | 9.67e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 390 | 5.69e-01 | 1.69e-02 | 8.59e-01 |
| GOMF ALPHA ACTININ BINDING | 16 | 9.07e-01 | 1.69e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 7 | 9.39e-01 | 1.68e-02 | 9.85e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 56 | 8.28e-01 | 1.68e-02 | 9.57e-01 |
| GOBP RHYTHMIC PROCESS | 184 | 6.96e-01 | 1.68e-02 | 9.16e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 47 | 8.43e-01 | -1.67e-02 | 9.61e-01 |
| GOMF PROFILIN BINDING | 8 | 9.35e-01 | 1.67e-02 | 9.84e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 61 | 8.22e-01 | 1.67e-02 | 9.57e-01 |
| GOMF DEACETYLASE ACTIVITY | 33 | 8.68e-01 | -1.67e-02 | 9.67e-01 |
| GOCC CELL BODY | 295 | 6.25e-01 | 1.66e-02 | 8.86e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 98 | 7.77e-01 | 1.66e-02 | 9.43e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 7 | 9.40e-01 | 1.66e-02 | 9.85e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 70 | 8.11e-01 | -1.66e-02 | 9.53e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 96 | 7.80e-01 | -1.65e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 21 | 8.96e-01 | -1.65e-02 | 9.72e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 194 | 6.94e-01 | 1.64e-02 | 9.15e-01 |
| GOBP LIPID METABOLIC PROCESS | 864 | 4.19e-01 | 1.64e-02 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 12 | 9.22e-01 | 1.64e-02 | 9.81e-01 |
| GOBP RUFFLE ASSEMBLY | 35 | 8.67e-01 | 1.64e-02 | 9.67e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 46 | 8.48e-01 | 1.63e-02 | 9.63e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 89 | 7.90e-01 | -1.63e-02 | 9.47e-01 |
| GOCC OMEGASOME | 5 | 9.50e-01 | -1.63e-02 | 9.87e-01 |
| GOBP TUBULIN DEACETYLATION | 20 | 9.00e-01 | 1.63e-02 | 9.73e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 22 | 8.95e-01 | 1.63e-02 | 9.72e-01 |
| GOBP PRENYLATION | 10 | 9.29e-01 | -1.63e-02 | 9.83e-01 |
| GOBP LIPID LOCALIZATION | 280 | 6.41e-01 | 1.63e-02 | 8.93e-01 |
| GOBP PROTEIN HYDROXYLATION | 19 | 9.02e-01 | -1.62e-02 | 9.73e-01 |
| GOCC BLEB | 9 | 9.33e-01 | 1.62e-02 | 9.84e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 10 | 9.29e-01 | 1.62e-02 | 9.83e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 54 | 8.37e-01 | 1.62e-02 | 9.61e-01 |
| GOBP REGULATION OF LOCOMOTION | 602 | 5.01e-01 | 1.62e-02 | 8.32e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 9.50e-01 | 1.61e-02 | 9.87e-01 |
| GOBP GLUCOSE IMPORT | 45 | 8.51e-01 | 1.61e-02 | 9.63e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 133 | 7.48e-01 | -1.61e-02 | 9.35e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 15 | 9.14e-01 | -1.61e-02 | 9.78e-01 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 9.37e-01 | 1.61e-02 | 9.85e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 44 | 8.54e-01 | -1.60e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 240 | 6.70e-01 | -1.60e-02 | 9.04e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 18 | 9.06e-01 | -1.60e-02 | 9.75e-01 |
| GOBP ADULT BEHAVIOR | 72 | 8.14e-01 | -1.60e-02 | 9.54e-01 |
| GOBP RESPONSE TO FORSKOLIN | 5 | 9.51e-01 | 1.60e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 651 | 4.92e-01 | -1.59e-02 | 8.27e-01 |
| GOBP GROWTH | 550 | 5.27e-01 | 1.59e-02 | 8.43e-01 |
| GOBP T CELL EXTRAVASATION | 10 | 9.31e-01 | 1.59e-02 | 9.84e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 9.46e-01 | 1.58e-02 | 9.86e-01 |
| GOCC CILIUM | 434 | 5.74e-01 | -1.58e-02 | 8.61e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 60 | 8.32e-01 | -1.58e-02 | 9.59e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 10 | 9.31e-01 | -1.58e-02 | 9.84e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 38 | 8.66e-01 | 1.58e-02 | 9.67e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 29 | 8.84e-01 | -1.57e-02 | 9.70e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 36 | 8.71e-01 | -1.57e-02 | 9.68e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 14 | 9.19e-01 | -1.57e-02 | 9.80e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 58 | 8.38e-01 | -1.56e-02 | 9.61e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 19 | 9.07e-01 | -1.56e-02 | 9.75e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 37 | 8.70e-01 | 1.55e-02 | 9.68e-01 |
| GOBP EAR DEVELOPMENT | 92 | 7.98e-01 | 1.55e-02 | 9.49e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 9.43e-01 | -1.55e-02 | 9.85e-01 |
| GOBP RESPONSE TO CALCIUM ION | 81 | 8.10e-01 | 1.54e-02 | 9.53e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 59 | 8.38e-01 | -1.54e-02 | 9.61e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 34 | 8.77e-01 | -1.54e-02 | 9.68e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 54 | 8.45e-01 | -1.54e-02 | 9.62e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 10 | 9.33e-01 | 1.54e-02 | 9.84e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 81 | 8.11e-01 | -1.54e-02 | 9.53e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 9.27e-01 | -1.54e-02 | 9.83e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 77 | 8.16e-01 | 1.53e-02 | 9.54e-01 |
| GOBP DENDRITE DEVELOPMENT | 148 | 7.48e-01 | -1.53e-02 | 9.35e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 6 | 9.48e-01 | -1.53e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 25 | 8.95e-01 | -1.53e-02 | 9.72e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 13 | 9.24e-01 | -1.53e-02 | 9.82e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 6 | 9.48e-01 | 1.53e-02 | 9.87e-01 |
| GOBP SYNAPTIC SIGNALING | 370 | 6.16e-01 | 1.52e-02 | 8.83e-01 |
| GOCC IGG IMMUNOGLOBULIN COMPLEX | 6 | 9.49e-01 | 1.52e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 9.45e-01 | 1.52e-02 | 9.86e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 9.28e-01 | 1.51e-02 | 9.83e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 133 | 7.64e-01 | 1.51e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 9.38e-01 | -1.50e-02 | 9.85e-01 |
| GOBP GERM CELL PROLIFERATION | 7 | 9.45e-01 | 1.50e-02 | 9.86e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 8 | 9.41e-01 | -1.50e-02 | 9.85e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 23 | 9.01e-01 | 1.50e-02 | 9.73e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 44 | 8.64e-01 | 1.49e-02 | 9.67e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 11 | 9.32e-01 | -1.49e-02 | 9.84e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 350 | 6.34e-01 | -1.49e-02 | 8.90e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 154 | 7.52e-01 | 1.48e-02 | 9.35e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 185 | 7.30e-01 | 1.48e-02 | 9.29e-01 |
| GOBP NEURON REMODELING | 5 | 9.55e-01 | 1.47e-02 | 9.89e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 9.43e-01 | 1.47e-02 | 9.85e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 9.27e-01 | -1.47e-02 | 9.83e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 15 | 9.22e-01 | 1.46e-02 | 9.81e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 17 | 9.17e-01 | 1.46e-02 | 9.78e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 22 | 9.06e-01 | -1.46e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 41 | 8.71e-01 | -1.46e-02 | 9.68e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 10 | 9.37e-01 | 1.45e-02 | 9.85e-01 |
| GOBP RESPONSE TO DSRNA | 34 | 8.83e-01 | -1.45e-02 | 9.70e-01 |
| GOBP REPRODUCTION | 761 | 5.01e-01 | 1.45e-02 | 8.32e-01 |
| GOCC NUCLEAR LAMINA | 11 | 9.34e-01 | 1.45e-02 | 9.84e-01 |
| GOMF DAMAGED DNA BINDING | 65 | 8.41e-01 | 1.44e-02 | 9.61e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 61 | 8.46e-01 | 1.44e-02 | 9.63e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 9.26e-01 | 1.44e-02 | 9.83e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 8 | 9.44e-01 | 1.43e-02 | 9.86e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 28 | 8.96e-01 | 1.43e-02 | 9.72e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 55 | 8.54e-01 | 1.43e-02 | 9.64e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 167 | 7.50e-01 | 1.43e-02 | 9.35e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 486 | 5.91e-01 | 1.43e-02 | 8.70e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 368 | 6.40e-01 | -1.43e-02 | 8.92e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 27 | 8.98e-01 | 1.43e-02 | 9.72e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 51 | 8.60e-01 | -1.42e-02 | 9.66e-01 |
| GOMF CASPASE BINDING | 8 | 9.45e-01 | -1.42e-02 | 9.86e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 293 | 6.79e-01 | 1.41e-02 | 9.09e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 20 | 9.13e-01 | 1.41e-02 | 9.78e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 10 | 9.38e-01 | 1.41e-02 | 9.85e-01 |
| GOCC CIS GOLGI NETWORK | 56 | 8.56e-01 | 1.41e-02 | 9.65e-01 |
| GOCC PRESYNAPSE | 309 | 6.73e-01 | 1.40e-02 | 9.06e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 11 | 9.36e-01 | -1.40e-02 | 9.84e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 49 | 8.65e-01 | -1.40e-02 | 9.67e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 133 | 7.81e-01 | 1.40e-02 | 9.45e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 5 | 9.57e-01 | -1.39e-02 | 9.89e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 106 | 8.04e-01 | -1.39e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 38 | 8.82e-01 | -1.39e-02 | 9.70e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 14 | 9.28e-01 | 1.39e-02 | 9.83e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 13 | 9.31e-01 | 1.39e-02 | 9.84e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 477 | 6.06e-01 | 1.39e-02 | 8.77e-01 |
| GOBP SECRETION | 536 | 5.87e-01 | 1.38e-02 | 8.69e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 37 | 8.85e-01 | -1.38e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 9.57e-01 | 1.38e-02 | 9.90e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 9.29e-01 | 1.37e-02 | 9.83e-01 |
| GOBP AXON DEVELOPMENT | 261 | 7.04e-01 | 1.37e-02 | 9.18e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 56 | 8.59e-01 | 1.37e-02 | 9.66e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 8 | 9.47e-01 | 1.37e-02 | 9.86e-01 |
| GOBP MOTOR BEHAVIOR | 15 | 9.27e-01 | -1.37e-02 | 9.83e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 9.35e-01 | 1.37e-02 | 9.84e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 9.43e-01 | -1.37e-02 | 9.85e-01 |
| GOBP MIRNA METABOLIC PROCESS | 68 | 8.46e-01 | -1.36e-02 | 9.63e-01 |
| GOCC CYTOPLASMIC REGION | 183 | 7.51e-01 | -1.36e-02 | 9.35e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 9.47e-01 | -1.36e-02 | 9.86e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 13 | 9.32e-01 | 1.36e-02 | 9.84e-01 |
| GOBP ICOSANOID TRANSPORT | 23 | 9.10e-01 | -1.36e-02 | 9.77e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 208 | 7.37e-01 | -1.35e-02 | 9.32e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 9.51e-01 | -1.35e-02 | 9.87e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 6 | 9.54e-01 | 1.35e-02 | 9.89e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 74 | 8.41e-01 | -1.35e-02 | 9.61e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 54 | 8.64e-01 | -1.35e-02 | 9.67e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 79 | 8.37e-01 | 1.34e-02 | 9.61e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 142 | 7.83e-01 | -1.34e-02 | 9.45e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 19 | 9.20e-01 | 1.34e-02 | 9.80e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 27 | 9.05e-01 | 1.33e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 16 | 9.27e-01 | -1.33e-02 | 9.83e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 11 | 9.39e-01 | 1.33e-02 | 9.85e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 133 | 7.93e-01 | 1.32e-02 | 9.48e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 60 | 8.60e-01 | -1.32e-02 | 9.66e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 47 | 8.76e-01 | -1.32e-02 | 9.68e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 41 | 8.85e-01 | -1.31e-02 | 9.70e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 9.56e-01 | -1.31e-02 | 9.89e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 433 | 6.43e-01 | 1.31e-02 | 8.93e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 14 | 9.33e-01 | 1.30e-02 | 9.84e-01 |
| GOBP REGULATION OF OSSIFICATION | 61 | 8.61e-01 | 1.30e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 33 | 8.97e-01 | -1.30e-02 | 9.72e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 7 | 9.53e-01 | -1.29e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 9.46e-01 | 1.29e-02 | 9.86e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 270 | 7.16e-01 | 1.29e-02 | 9.21e-01 |
| GOMF THIOESTERASE BINDING | 9 | 9.47e-01 | -1.29e-02 | 9.86e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 216 | 7.44e-01 | -1.29e-02 | 9.35e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 35 | 8.95e-01 | -1.29e-02 | 9.72e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 35 | 8.95e-01 | -1.29e-02 | 9.72e-01 |
| GOBP TUBE FORMATION | 83 | 8.40e-01 | 1.29e-02 | 9.61e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 73 | 8.50e-01 | -1.29e-02 | 9.63e-01 |
| GOMF ISOMERASE ACTIVITY | 129 | 8.03e-01 | -1.27e-02 | 9.51e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 10 | 9.44e-01 | 1.27e-02 | 9.86e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 215 | 7.50e-01 | 1.26e-02 | 9.35e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 23 | 9.17e-01 | -1.26e-02 | 9.78e-01 |
| GOBP VACUOLE FUSION | 11 | 9.42e-01 | -1.26e-02 | 9.85e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 17 | 9.28e-01 | -1.26e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 38 | 8.93e-01 | 1.26e-02 | 9.72e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 88 | 8.39e-01 | -1.25e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 809 | 5.50e-01 | 1.25e-02 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 51 | 8.78e-01 | 1.25e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 76 | 8.51e-01 | -1.25e-02 | 9.63e-01 |
| GOMF NOTCH BINDING | 13 | 9.38e-01 | 1.25e-02 | 9.85e-01 |
| GOBP MITOPHAGY | 35 | 8.99e-01 | 1.25e-02 | 9.73e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 19 | 9.25e-01 | -1.24e-02 | 9.82e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 10 | 9.46e-01 | 1.24e-02 | 9.86e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 9.52e-01 | 1.24e-02 | 9.88e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 9.62e-01 | 1.24e-02 | 9.91e-01 |
| GOMF CARBOHYDRATE BINDING | 143 | 7.99e-01 | 1.23e-02 | 9.50e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 14 | 9.36e-01 | -1.23e-02 | 9.85e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 54 | 8.76e-01 | 1.23e-02 | 9.68e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 9 | 9.49e-01 | 1.22e-02 | 9.87e-01 |
| GOBP CAMP MEDIATED SIGNALING | 19 | 9.26e-01 | -1.22e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 9 | 9.49e-01 | 1.22e-02 | 9.87e-01 |
| GOCC PSEUDOPODIUM | 12 | 9.42e-01 | -1.22e-02 | 9.85e-01 |
| GOBP ARGININE METABOLIC PROCESS | 12 | 9.42e-01 | -1.22e-02 | 9.85e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 11 | 9.44e-01 | -1.22e-02 | 9.86e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 9.53e-01 | -1.21e-02 | 9.88e-01 |
| GOMF HORMONE ACTIVITY | 17 | 9.31e-01 | -1.21e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 8 | 9.53e-01 | 1.20e-02 | 9.89e-01 |
| GOBP T CELL CHEMOTAXIS | 17 | 9.32e-01 | 1.20e-02 | 9.84e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 147 | 8.03e-01 | 1.19e-02 | 9.51e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 9.51e-01 | 1.18e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 7 | 9.57e-01 | 1.18e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 9.57e-01 | -1.18e-02 | 9.89e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 82 | 8.54e-01 | -1.18e-02 | 9.64e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 13 | 9.41e-01 | 1.18e-02 | 9.85e-01 |
| GOBP TUBE MORPHOGENESIS | 455 | 6.70e-01 | 1.17e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 14 | 9.40e-01 | -1.17e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 51 | 8.86e-01 | -1.16e-02 | 9.71e-01 |
| GOBP DENDRITIC CELL MIGRATION | 21 | 9.27e-01 | -1.16e-02 | 9.83e-01 |
| GOBP DOSAGE COMPENSATION | 28 | 9.16e-01 | 1.15e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 6 | 9.61e-01 | 1.14e-02 | 9.91e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 30 | 9.14e-01 | 1.14e-02 | 9.78e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 18 | 9.33e-01 | -1.14e-02 | 9.84e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 13 | 9.43e-01 | -1.14e-02 | 9.85e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 7 | 9.58e-01 | -1.14e-02 | 9.90e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 19 | 9.32e-01 | -1.14e-02 | 9.84e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 194 | 7.86e-01 | -1.13e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 9.56e-01 | 1.13e-02 | 9.89e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 9.10e-01 | -1.13e-02 | 9.76e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 33 | 9.11e-01 | -1.13e-02 | 9.77e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 7 | 9.59e-01 | 1.12e-02 | 9.90e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 10 | 9.51e-01 | 1.12e-02 | 9.87e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 601 | 6.41e-01 | 1.12e-02 | 8.93e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 162 | 8.06e-01 | -1.12e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 64 | 8.77e-01 | 1.12e-02 | 9.68e-01 |
| GOCC MITOTIC SPINDLE POLE | 32 | 9.13e-01 | 1.11e-02 | 9.78e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 19 | 9.33e-01 | 1.11e-02 | 9.84e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 9.62e-01 | -1.11e-02 | 9.91e-01 |
| GOCC SITE OF POLARIZED GROWTH | 123 | 8.32e-01 | -1.11e-02 | 9.59e-01 |
| GOCC CENTRIOLAR SATELLITE | 95 | 8.52e-01 | -1.11e-02 | 9.63e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 270 | 7.58e-01 | 1.09e-02 | 9.39e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 5 | 9.66e-01 | 1.09e-02 | 9.92e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 11 | 9.50e-01 | -1.09e-02 | 9.87e-01 |
| GOMF DNA BINDING BENDING | 10 | 9.53e-01 | 1.09e-02 | 9.88e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 8 | 9.58e-01 | 1.09e-02 | 9.90e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 14 | 9.44e-01 | -1.08e-02 | 9.86e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 36 | 9.11e-01 | 1.08e-02 | 9.77e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 16 | 9.40e-01 | -1.08e-02 | 9.85e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 9.58e-01 | -1.08e-02 | 9.90e-01 |
| GOCC BORC COMPLEX | 8 | 9.58e-01 | -1.08e-02 | 9.90e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 314 | 7.45e-01 | -1.07e-02 | 9.35e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 107 | 8.49e-01 | 1.07e-02 | 9.63e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 12 | 9.49e-01 | 1.06e-02 | 9.87e-01 |
| GOMF CYCLIN BINDING | 26 | 9.25e-01 | 1.06e-02 | 9.82e-01 |
| GOBP GASTRULATION | 95 | 8.59e-01 | -1.06e-02 | 9.66e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 151 | 8.23e-01 | 1.06e-02 | 9.57e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 47 | 9.01e-01 | 1.05e-02 | 9.73e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.56e-01 | 1.05e-02 | 9.89e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 7 | 9.62e-01 | -1.05e-02 | 9.91e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 62 | 8.87e-01 | 1.05e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 13 | 9.48e-01 | 1.05e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 17 | 9.41e-01 | 1.04e-02 | 9.85e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 8 | 9.59e-01 | 1.04e-02 | 9.90e-01 |
| GOMF MRNA 3 UTR BINDING | 84 | 8.69e-01 | 1.04e-02 | 9.67e-01 |
| GOBP OSSIFICATION | 219 | 7.92e-01 | -1.04e-02 | 9.48e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 127 | 8.40e-01 | -1.04e-02 | 9.61e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 46 | 9.04e-01 | 1.03e-02 | 9.74e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 22 | 9.34e-01 | 1.02e-02 | 9.84e-01 |
| GOCC MEMBRANE MICRODOMAIN | 174 | 8.16e-01 | -1.02e-02 | 9.54e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 159 | 8.24e-01 | 1.02e-02 | 9.57e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 79 | 8.75e-01 | 1.02e-02 | 9.68e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 67 | 8.85e-01 | 1.02e-02 | 9.70e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 34 | 9.18e-01 | -1.02e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 10 | 9.56e-01 | 1.02e-02 | 9.89e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 147 | 8.32e-01 | 1.01e-02 | 9.59e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 334 | 7.52e-01 | 1.01e-02 | 9.35e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 70 | 8.85e-01 | 1.00e-02 | 9.70e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 22 | 9.35e-01 | 1.00e-02 | 9.84e-01 |
| GOBP REGULATION OF NEUROGENESIS | 217 | 8.00e-01 | 1.00e-02 | 9.50e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 22 | 9.35e-01 | 9.98e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 12 | 9.52e-01 | -9.94e-03 | 9.88e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 14 | 9.49e-01 | 9.90e-03 | 9.87e-01 |
| GOBP CIRCADIAN RHYTHM | 131 | 8.46e-01 | 9.87e-03 | 9.63e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 237 | 7.94e-01 | -9.87e-03 | 9.48e-01 |
| GOMF CALCIUM ION BINDING | 310 | 7.66e-01 | -9.86e-03 | 9.41e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 9 | 9.59e-01 | 9.85e-03 | 9.90e-01 |
| GOBP RESPONSE TO SALT | 202 | 8.10e-01 | 9.85e-03 | 9.53e-01 |
| GOBP BEHAVIOR | 320 | 7.63e-01 | 9.84e-03 | 9.40e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 8 | 9.62e-01 | 9.78e-03 | 9.91e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 9.64e-01 | -9.74e-03 | 9.92e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 42 | 9.14e-01 | -9.60e-03 | 9.78e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 9.25e-01 | -9.59e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 53 | 9.04e-01 | -9.57e-03 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 20 | 9.41e-01 | 9.56e-03 | 9.85e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 100 | 8.69e-01 | 9.55e-03 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 74 | 8.88e-01 | 9.51e-03 | 9.71e-01 |
| GOBP BONE DEVELOPMENT | 109 | 8.64e-01 | 9.49e-03 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 61 | 8.98e-01 | -9.49e-03 | 9.72e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 9.16e-01 | -9.48e-03 | 9.78e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 9.59e-01 | 9.46e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 9.55e-01 | -9.42e-03 | 9.89e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 62 | 8.98e-01 | 9.41e-03 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 69 | 8.93e-01 | 9.41e-03 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 28 | 9.31e-01 | -9.39e-03 | 9.84e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 9.71e-01 | -9.39e-03 | 9.92e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 7 | 9.66e-01 | -9.37e-03 | 9.92e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 5 | 9.71e-01 | 9.36e-03 | 9.92e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 34 | 9.25e-01 | -9.34e-03 | 9.82e-01 |
| GOBP LIPID HOMEOSTASIS | 87 | 8.81e-01 | -9.29e-03 | 9.69e-01 |
| GOMF GATED CHANNEL ACTIVITY | 101 | 8.72e-01 | 9.26e-03 | 9.68e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 13 | 9.54e-01 | -9.25e-03 | 9.89e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 9 | 9.62e-01 | -9.23e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 16 | 9.49e-01 | -9.21e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 9 | 9.62e-01 | -9.20e-03 | 9.91e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 25 | 9.37e-01 | -9.17e-03 | 9.85e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 62 | 9.01e-01 | -9.12e-03 | 9.73e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 36 | 9.25e-01 | -9.10e-03 | 9.82e-01 |
| GOMF REGULATORY RNA BINDING | 42 | 9.19e-01 | 9.09e-03 | 9.80e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 218 | 8.18e-01 | -9.09e-03 | 9.54e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 171 | 8.39e-01 | 9.02e-03 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 12 | 9.57e-01 | -9.01e-03 | 9.89e-01 |
| GOBP SEXUAL REPRODUCTION | 565 | 7.16e-01 | 9.00e-03 | 9.22e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 9.70e-01 | -8.99e-03 | 9.92e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 11 | 9.59e-01 | -8.99e-03 | 9.90e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 7 | 9.67e-01 | -8.99e-03 | 9.92e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 30 | 9.32e-01 | 8.98e-03 | 9.84e-01 |
| GOCC HAUS COMPLEX | 8 | 9.65e-01 | 8.94e-03 | 9.92e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 9 | 9.63e-01 | 8.91e-03 | 9.91e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 98 | 8.79e-01 | 8.90e-03 | 9.69e-01 |
| GOBP SPLEEN DEVELOPMENT | 26 | 9.38e-01 | -8.88e-03 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 29 | 9.34e-01 | -8.86e-03 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 111 | 8.72e-01 | -8.85e-03 | 9.68e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 9 | 9.63e-01 | 8.84e-03 | 9.91e-01 |
| GOBP SODIUM ION TRANSPORT | 102 | 8.78e-01 | 8.82e-03 | 9.68e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 609 | 7.12e-01 | -8.81e-03 | 9.20e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 17 | 9.50e-01 | -8.80e-03 | 9.87e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 151 | 8.54e-01 | 8.68e-03 | 9.64e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 103 | 8.79e-01 | 8.66e-03 | 9.69e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 8 | 9.66e-01 | -8.62e-03 | 9.92e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 7 | 9.69e-01 | 8.62e-03 | 9.92e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 10 | 9.62e-01 | -8.62e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 34 | 9.31e-01 | 8.59e-03 | 9.84e-01 |
| GOBP VACUOLAR LOCALIZATION | 70 | 9.01e-01 | -8.59e-03 | 9.73e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 9.63e-01 | 8.56e-03 | 9.91e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 20 | 9.47e-01 | -8.55e-03 | 9.86e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 6 | 9.71e-01 | 8.52e-03 | 9.92e-01 |
| GOBP PARAXIAL MESODERM MORPHOGENESIS | 5 | 9.74e-01 | 8.49e-03 | 9.93e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 141 | 8.62e-01 | 8.47e-03 | 9.67e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 15 | 9.55e-01 | -8.47e-03 | 9.89e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 5 | 9.74e-01 | 8.46e-03 | 9.93e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 21 | 9.47e-01 | -8.45e-03 | 9.86e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 29 | 9.37e-01 | -8.43e-03 | 9.85e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 155 | 8.57e-01 | 8.39e-03 | 9.65e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 29 | 9.38e-01 | -8.37e-03 | 9.85e-01 |
| GOBP CELL CHEMOTAXIS | 169 | 8.51e-01 | 8.37e-03 | 9.63e-01 |
| GOBP EMBRYO IMPLANTATION | 26 | 9.41e-01 | 8.33e-03 | 9.85e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 15 | 9.55e-01 | -8.33e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 26 | 9.41e-01 | 8.32e-03 | 9.85e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 7 | 9.70e-01 | 8.32e-03 | 9.92e-01 |
| GOBP REGULATION OF MYELINATION | 28 | 9.39e-01 | 8.32e-03 | 9.85e-01 |
| GOBP P38MAPK CASCADE | 40 | 9.28e-01 | -8.32e-03 | 9.83e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 25 | 9.43e-01 | -8.29e-03 | 9.85e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 261 | 8.18e-01 | 8.29e-03 | 9.54e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 493 | 7.55e-01 | 8.24e-03 | 9.38e-01 |
| GOMF CYCLOSPORIN A BINDING | 16 | 9.55e-01 | -8.22e-03 | 9.89e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 8 | 9.68e-01 | -8.19e-03 | 9.92e-01 |
| GOBP ACTION POTENTIAL | 57 | 9.16e-01 | -8.12e-03 | 9.78e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 110 | 8.83e-01 | -8.11e-03 | 9.70e-01 |
| GOBP POSTREPLICATION REPAIR | 33 | 9.36e-01 | 8.11e-03 | 9.84e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 9.70e-01 | -8.09e-03 | 9.92e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 54 | 9.18e-01 | 8.07e-03 | 9.79e-01 |
| GOBP CELL MOTILITY | 938 | 6.79e-01 | 8.06e-03 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 24 | 9.46e-01 | 8.06e-03 | 9.86e-01 |
| GOBP EXPORT FROM CELL | 513 | 7.56e-01 | 8.06e-03 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 9.63e-01 | -8.00e-03 | 9.91e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 89 | 8.97e-01 | -7.98e-03 | 9.72e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 32 | 9.38e-01 | 7.98e-03 | 9.85e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 25 | 9.45e-01 | 7.94e-03 | 9.86e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 9.76e-01 | 7.92e-03 | 9.93e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 9.76e-01 | 7.89e-03 | 9.93e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 164 | 8.62e-01 | -7.88e-03 | 9.67e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 103 | 8.90e-01 | -7.86e-03 | 9.71e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 73 | 9.08e-01 | 7.85e-03 | 9.75e-01 |
| GOCC PLATELET ALPHA GRANULE | 49 | 9.25e-01 | -7.77e-03 | 9.82e-01 |
| GOMF ACTIN FILAMENT BINDING | 140 | 8.74e-01 | 7.76e-03 | 9.68e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 62 | 9.16e-01 | -7.76e-03 | 9.78e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 8 | 9.70e-01 | 7.73e-03 | 9.92e-01 |
| GOBP ORGANIC ACID TRANSPORT | 181 | 8.58e-01 | 7.72e-03 | 9.66e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 9.76e-01 | 7.67e-03 | 9.93e-01 |
| GOBP GERM CELL DEVELOPMENT | 170 | 8.64e-01 | -7.63e-03 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 10 | 9.67e-01 | -7.62e-03 | 9.92e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 37 | 9.37e-01 | -7.57e-03 | 9.85e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 17 | 9.57e-01 | -7.56e-03 | 9.89e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 98 | 8.97e-01 | -7.54e-03 | 9.72e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 79 | 9.08e-01 | 7.54e-03 | 9.75e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 74 | 9.11e-01 | -7.52e-03 | 9.77e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 8 | 9.71e-01 | 7.51e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 26 | 9.47e-01 | -7.46e-03 | 9.86e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 6 | 9.75e-01 | 7.45e-03 | 9.93e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 21 | 9.53e-01 | 7.37e-03 | 9.89e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 5 | 9.77e-01 | 7.32e-03 | 9.93e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 164 | 8.72e-01 | -7.31e-03 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 899 | 7.14e-01 | 7.28e-03 | 9.21e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 118 | 8.92e-01 | -7.25e-03 | 9.72e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 7 | 9.74e-01 | -7.23e-03 | 9.93e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 163 | 8.74e-01 | 7.22e-03 | 9.68e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 9 | 9.70e-01 | -7.19e-03 | 9.92e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 63 | 9.22e-01 | -7.17e-03 | 9.81e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 91 | 9.06e-01 | 7.15e-03 | 9.75e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 169 | 8.73e-01 | 7.14e-03 | 9.68e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 35 | 9.42e-01 | -7.06e-03 | 9.85e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 9.72e-01 | 7.05e-03 | 9.93e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 6 | 9.76e-01 | 7.02e-03 | 9.93e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 44 | 9.36e-01 | 7.01e-03 | 9.84e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 11 | 9.68e-01 | -7.01e-03 | 9.92e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 30 | 9.47e-01 | 7.00e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 9.78e-01 | -6.96e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 9.76e-01 | -6.95e-03 | 9.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 35 | 9.44e-01 | 6.92e-03 | 9.85e-01 |
| GOMF CLATHRIN BINDING | 47 | 9.35e-01 | -6.90e-03 | 9.84e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 48 | 9.34e-01 | 6.87e-03 | 9.84e-01 |
| GOCC TIGHT JUNCTION | 66 | 9.23e-01 | 6.86e-03 | 9.81e-01 |
| GOBP NEURAL TUBE FORMATION | 71 | 9.21e-01 | 6.81e-03 | 9.81e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 9.79e-01 | -6.80e-03 | 9.93e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 720 | 7.60e-01 | -6.75e-03 | 9.39e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 7 | 9.75e-01 | -6.75e-03 | 9.93e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 14 | 9.65e-01 | 6.70e-03 | 9.92e-01 |
| GOMF FIBRONECTIN BINDING | 11 | 9.70e-01 | 6.64e-03 | 9.92e-01 |
| GOBP MRNA MODIFICATION | 31 | 9.50e-01 | -6.56e-03 | 9.87e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 9.80e-01 | -6.50e-03 | 9.94e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 47 | 9.39e-01 | -6.48e-03 | 9.85e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 67 | 9.27e-01 | 6.46e-03 | 9.83e-01 |
| GOCC MICROFIBRIL | 5 | 9.80e-01 | 6.45e-03 | 9.94e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 5 | 9.80e-01 | -6.42e-03 | 9.94e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 41 | 9.44e-01 | -6.40e-03 | 9.85e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 25 | 9.56e-01 | -6.38e-03 | 9.89e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 755 | 7.68e-01 | 6.37e-03 | 9.41e-01 |
| GOBP RESPONSE TO KETONE | 117 | 9.06e-01 | 6.36e-03 | 9.75e-01 |
| GOBP ORGAN GROWTH | 92 | 9.16e-01 | 6.35e-03 | 9.78e-01 |
| GOBP FEMALE MEIOSIS I | 7 | 9.77e-01 | -6.34e-03 | 9.93e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 43 | 9.43e-01 | -6.33e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 169 | 8.88e-01 | 6.28e-03 | 9.71e-01 |
| GOBP OVULATION CYCLE PROCESS | 23 | 9.58e-01 | 6.28e-03 | 9.90e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 6 | 9.79e-01 | -6.27e-03 | 9.93e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 9.81e-01 | -6.25e-03 | 9.94e-01 |
| GOCC AUTOPHAGOSOME | 100 | 9.14e-01 | -6.25e-03 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 7 | 9.77e-01 | -6.22e-03 | 9.93e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 42 | 9.44e-01 | -6.22e-03 | 9.86e-01 |
| GOBP BIOLOGICAL PHASE | 5 | 9.81e-01 | 6.20e-03 | 9.94e-01 |
| GOCC DISTAL AXON | 158 | 8.93e-01 | -6.20e-03 | 9.72e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 126 | 9.05e-01 | -6.17e-03 | 9.74e-01 |
| GOBP MEIOTIC CELL CYCLE | 177 | 8.88e-01 | -6.16e-03 | 9.71e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 15 | 9.67e-01 | -6.16e-03 | 9.92e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 9.79e-01 | -6.16e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 31 | 9.53e-01 | 6.15e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 26 | 9.57e-01 | -6.15e-03 | 9.89e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 433 | 8.27e-01 | 6.14e-03 | 9.57e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 13 | 9.69e-01 | -6.13e-03 | 9.92e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 28 | 9.56e-01 | -6.08e-03 | 9.89e-01 |
| GOCC SNARE COMPLEX | 40 | 9.47e-01 | 6.02e-03 | 9.86e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 9 | 9.75e-01 | 5.99e-03 | 9.93e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 10 | 9.74e-01 | -5.98e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 12 | 9.71e-01 | 5.96e-03 | 9.92e-01 |
| GOBP BONE MATURATION | 13 | 9.71e-01 | -5.91e-03 | 9.92e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 388 | 8.42e-01 | 5.91e-03 | 9.61e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 137 | 9.05e-01 | -5.89e-03 | 9.75e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 248 | 8.74e-01 | 5.87e-03 | 9.68e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 9.77e-01 | -5.84e-03 | 9.93e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 26 | 9.59e-01 | 5.82e-03 | 9.90e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 16 | 9.68e-01 | 5.80e-03 | 9.92e-01 |
| GOBP LUNG MORPHOGENESIS | 26 | 9.59e-01 | -5.78e-03 | 9.90e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 29 | 9.57e-01 | 5.78e-03 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 28 | 9.58e-01 | -5.77e-03 | 9.90e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 113 | 9.16e-01 | 5.75e-03 | 9.78e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 9 | 9.76e-01 | -5.73e-03 | 9.93e-01 |
| GOBP DETECTION OF STIMULUS | 101 | 9.21e-01 | 5.69e-03 | 9.81e-01 |
| GOBP CHOLESTEROL STORAGE | 17 | 9.68e-01 | -5.68e-03 | 9.92e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 9 | 9.76e-01 | -5.67e-03 | 9.93e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 9 | 9.77e-01 | 5.64e-03 | 9.93e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 15 | 9.70e-01 | -5.63e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 19 | 9.66e-01 | 5.60e-03 | 9.92e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 55 | 9.43e-01 | -5.59e-03 | 9.85e-01 |
| GOMF MRNA 5 UTR BINDING | 23 | 9.63e-01 | 5.59e-03 | 9.91e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 206 | 8.90e-01 | 5.58e-03 | 9.71e-01 |
| GOBP TRANSLESION SYNTHESIS | 24 | 9.62e-01 | 5.58e-03 | 9.91e-01 |
| GOBP DEVELOPMENTAL GROWTH | 381 | 8.54e-01 | 5.51e-03 | 9.64e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 13 | 9.73e-01 | 5.51e-03 | 9.93e-01 |
| GOBP GROWTH HORMONE SECRETION | 8 | 9.79e-01 | -5.50e-03 | 9.93e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC SPECIALIZATION MEMBRANE | 5 | 9.83e-01 | 5.49e-03 | 9.94e-01 |
| GOBP GLAND DEVELOPMENT | 229 | 8.87e-01 | 5.48e-03 | 9.71e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 6 | 9.81e-01 | 5.47e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 15 | 9.71e-01 | -5.47e-03 | 9.92e-01 |
| GOBP COCHLEA DEVELOPMENT | 18 | 9.68e-01 | 5.46e-03 | 9.92e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 6 | 9.82e-01 | 5.43e-03 | 9.94e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 43 | 9.52e-01 | 5.35e-03 | 9.88e-01 |
| GOBP MALE GAMETE GENERATION | 315 | 8.71e-01 | -5.35e-03 | 9.68e-01 |
| GOBP REGULATION OF WOUND HEALING | 54 | 9.46e-01 | -5.34e-03 | 9.86e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 24 | 9.64e-01 | 5.32e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 95 | 9.29e-01 | -5.28e-03 | 9.83e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 41 | 9.53e-01 | -5.28e-03 | 9.89e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 119 | 9.21e-01 | 5.28e-03 | 9.81e-01 |
| GOMF TETRAPYRROLE BINDING | 65 | 9.42e-01 | -5.21e-03 | 9.85e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 654 | 8.22e-01 | -5.20e-03 | 9.57e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 70 | 9.40e-01 | 5.19e-03 | 9.85e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 31 | 9.60e-01 | -5.15e-03 | 9.91e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 11 | 9.77e-01 | 5.12e-03 | 9.93e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 95 | 9.32e-01 | -5.11e-03 | 9.84e-01 |
| GOCC INTERCALATED DISC | 24 | 9.66e-01 | 5.07e-03 | 9.92e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 9.74e-01 | -5.04e-03 | 9.93e-01 |
| GOBP GLIOGENESIS | 190 | 9.05e-01 | 5.04e-03 | 9.74e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 9.84e-01 | -5.03e-03 | 9.95e-01 |
| GOBP UTERUS DEVELOPMENT | 11 | 9.77e-01 | -5.03e-03 | 9.93e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 79 | 9.39e-01 | -5.00e-03 | 9.85e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 37 | 9.58e-01 | 4.98e-03 | 9.90e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 10 | 9.78e-01 | -4.98e-03 | 9.93e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 331 | 8.77e-01 | 4.97e-03 | 9.68e-01 |
| GOBP LYSOSOMAL TRANSPORT | 115 | 9.27e-01 | 4.96e-03 | 9.83e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 23 | 9.67e-01 | -4.93e-03 | 9.92e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 28 | 9.64e-01 | -4.92e-03 | 9.92e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 9.82e-01 | 4.90e-03 | 9.94e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 172 | 9.12e-01 | -4.89e-03 | 9.77e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 43 | 9.56e-01 | -4.86e-03 | 9.89e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 9.78e-01 | -4.85e-03 | 9.93e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 108 | 9.31e-01 | -4.85e-03 | 9.84e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 9.68e-01 | -4.82e-03 | 9.92e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 69 | 9.46e-01 | -4.68e-03 | 9.86e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 33 | 9.63e-01 | -4.65e-03 | 9.91e-01 |
| GOBP EOSINOPHIL ACTIVATION | 6 | 9.84e-01 | -4.63e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 499 | 8.60e-01 | -4.63e-03 | 9.66e-01 |
| GOMF OXYGEN BINDING | 14 | 9.76e-01 | 4.63e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 156 | 9.21e-01 | 4.61e-03 | 9.81e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 79 | 9.44e-01 | 4.61e-03 | 9.85e-01 |
| GOBP TRANSPOSITION | 20 | 9.72e-01 | 4.54e-03 | 9.92e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 9.84e-01 | 4.49e-03 | 9.94e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 7 | 9.84e-01 | 4.43e-03 | 9.95e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 90 | 9.42e-01 | -4.41e-03 | 9.85e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 9.81e-01 | 4.39e-03 | 9.94e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 46 | 9.59e-01 | 4.38e-03 | 9.90e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 96 | 9.41e-01 | -4.37e-03 | 9.85e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 32 | 9.67e-01 | 4.29e-03 | 9.92e-01 |
| GOBP LACTATE METABOLIC PROCESS | 13 | 9.79e-01 | 4.26e-03 | 9.93e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 9 | 9.82e-01 | -4.25e-03 | 9.94e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 39 | 9.63e-01 | 4.25e-03 | 9.91e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 35 | 9.65e-01 | 4.23e-03 | 9.92e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 33 | 9.66e-01 | 4.23e-03 | 9.92e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 9.83e-01 | -4.23e-03 | 9.94e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 130 | 9.34e-01 | -4.19e-03 | 9.84e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 151 | 9.29e-01 | 4.19e-03 | 9.83e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 18 | 9.76e-01 | -4.15e-03 | 9.93e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 6 | 9.86e-01 | -4.13e-03 | 9.95e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 255 | 9.10e-01 | 4.11e-03 | 9.77e-01 |
| GOBP APPENDAGE DEVELOPMENT | 93 | 9.46e-01 | 4.09e-03 | 9.86e-01 |
| GOBP VACUOLE ORGANIZATION | 198 | 9.22e-01 | -4.06e-03 | 9.81e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 9 | 9.83e-01 | 4.02e-03 | 9.94e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 22 | 9.74e-01 | -4.01e-03 | 9.93e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 11 | 9.82e-01 | -4.00e-03 | 9.94e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 244 | 9.16e-01 | 3.95e-03 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 42 | 9.65e-01 | -3.95e-03 | 9.92e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 50 | 9.62e-01 | -3.91e-03 | 9.91e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 124 | 9.40e-01 | 3.90e-03 | 9.85e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 217 | 9.22e-01 | 3.85e-03 | 9.81e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 7 | 9.86e-01 | 3.85e-03 | 9.95e-01 |
| GOBP RESPONSE TO INSULIN | 185 | 9.28e-01 | 3.84e-03 | 9.83e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 279 | 9.13e-01 | -3.82e-03 | 9.78e-01 |
| GOBP BODY MORPHOGENESIS | 30 | 9.71e-01 | 3.81e-03 | 9.92e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 9.87e-01 | 3.79e-03 | 9.96e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 24 | 9.75e-01 | 3.74e-03 | 9.93e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 147 | 9.38e-01 | 3.71e-03 | 9.85e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 43 | 9.67e-01 | -3.69e-03 | 9.92e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 14 | 9.81e-01 | 3.66e-03 | 9.94e-01 |
| GOMF SODIUM ION BINDING | 6 | 9.88e-01 | -3.57e-03 | 9.96e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 114 | 9.48e-01 | 3.54e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 9 | 9.85e-01 | 3.52e-03 | 9.95e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 39 | 9.70e-01 | -3.49e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 9.89e-01 | -3.47e-03 | 9.97e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 112 | 9.50e-01 | -3.47e-03 | 9.87e-01 |
| GOBP FILOPODIUM ASSEMBLY | 49 | 9.67e-01 | 3.46e-03 | 9.92e-01 |
| GOBP WALKING BEHAVIOR | 21 | 9.78e-01 | 3.41e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 8 | 9.87e-01 | 3.41e-03 | 9.96e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 78 | 9.60e-01 | -3.28e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 7 | 9.88e-01 | 3.24e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 29 | 9.76e-01 | -3.23e-03 | 9.93e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 15 | 9.83e-01 | 3.19e-03 | 9.94e-01 |
| GOBP TAXIS | 241 | 9.34e-01 | 3.13e-03 | 9.84e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 74 | 9.63e-01 | 3.11e-03 | 9.91e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 17 | 9.82e-01 | -3.11e-03 | 9.94e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 24 | 9.79e-01 | -3.09e-03 | 9.93e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 210 | 9.39e-01 | -3.06e-03 | 9.85e-01 |
| GOBP JNK CASCADE | 121 | 9.54e-01 | 3.03e-03 | 9.89e-01 |
| GOCC RECEPTOR COMPLEX | 202 | 9.42e-01 | -3.00e-03 | 9.85e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 10 | 9.87e-01 | 3.00e-03 | 9.96e-01 |
| GOBP MEMBRANE BIOGENESIS | 49 | 9.71e-01 | 3.00e-03 | 9.92e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 9.85e-01 | -2.99e-03 | 9.95e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 76 | 9.64e-01 | 2.97e-03 | 9.92e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 44 | 9.73e-01 | -2.90e-03 | 9.93e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 481 | 9.14e-01 | -2.90e-03 | 9.78e-01 |
| GOBP LEARNING | 77 | 9.65e-01 | 2.88e-03 | 9.92e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 70 | 9.67e-01 | 2.88e-03 | 9.92e-01 |
| GOBP L AMINO ACID TRANSPORT | 54 | 9.71e-01 | -2.86e-03 | 9.92e-01 |
| GOCC BASEMENT MEMBRANE | 29 | 9.79e-01 | -2.85e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 762 | 8.95e-01 | 2.82e-03 | 9.72e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 23 | 9.82e-01 | -2.78e-03 | 9.94e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 9.89e-01 | -2.76e-03 | 9.97e-01 |
| GOBP TUBE DEVELOPMENT | 578 | 9.12e-01 | -2.70e-03 | 9.77e-01 |
| GOBP GASTRIC ACID SECRETION | 7 | 9.90e-01 | -2.70e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 110 | 9.61e-01 | -2.70e-03 | 9.91e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 58 | 9.72e-01 | 2.68e-03 | 9.92e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 106 | 9.62e-01 | 2.67e-03 | 9.91e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 21 | 9.83e-01 | -2.66e-03 | 9.94e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 36 | 9.78e-01 | -2.65e-03 | 9.93e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 109 | 9.62e-01 | 2.64e-03 | 9.91e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 9.91e-01 | -2.63e-03 | 9.97e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 52 | 9.74e-01 | 2.59e-03 | 9.93e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 64 | 9.72e-01 | 2.54e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 105 | 9.65e-01 | -2.50e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 12 | 9.88e-01 | 2.45e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 13 | 9.88e-01 | -2.44e-03 | 9.96e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 205 | 9.53e-01 | 2.41e-03 | 9.88e-01 |
| GOBP REGULATION OF AXONOGENESIS | 90 | 9.69e-01 | 2.40e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 53 | 9.76e-01 | -2.35e-03 | 9.93e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 21 | 9.85e-01 | 2.34e-03 | 9.95e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 333 | 9.42e-01 | 2.32e-03 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 30 | 9.82e-01 | -2.32e-03 | 9.94e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 87 | 9.71e-01 | -2.29e-03 | 9.92e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 99 | 9.69e-01 | -2.28e-03 | 9.92e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 196 | 9.56e-01 | 2.27e-03 | 9.89e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 40 | 9.80e-01 | -2.26e-03 | 9.94e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 9 | 9.91e-01 | 2.22e-03 | 9.97e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 24 | 9.85e-01 | -2.19e-03 | 9.95e-01 |
| GOBP REGULATION OF JNK CASCADE | 96 | 9.71e-01 | 2.17e-03 | 9.92e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 9.92e-01 | 2.15e-03 | 9.98e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 9.89e-01 | 2.12e-03 | 9.97e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 7 | 9.92e-01 | -2.11e-03 | 9.98e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 55 | 9.79e-01 | -2.09e-03 | 9.93e-01 |
| GOBP MIRNA PROCESSING | 41 | 9.82e-01 | 2.04e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 24 | 9.86e-01 | 2.02e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 12 | 9.90e-01 | -2.01e-03 | 9.97e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 68 | 9.77e-01 | -2.01e-03 | 9.93e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 55 | 9.80e-01 | 1.98e-03 | 9.94e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 160 | 9.66e-01 | 1.97e-03 | 9.92e-01 |
| GOBP TISSUE HOMEOSTASIS | 153 | 9.67e-01 | 1.92e-03 | 9.92e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 9.94e-01 | -1.91e-03 | 9.99e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 74 | 9.77e-01 | 1.90e-03 | 9.93e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 9.93e-01 | 1.88e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 9.93e-01 | 1.84e-03 | 9.99e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 70 | 9.79e-01 | -1.82e-03 | 9.93e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 13 | 9.91e-01 | 1.79e-03 | 9.97e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 6 | 9.94e-01 | -1.77e-03 | 9.99e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 18 | 9.90e-01 | -1.75e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 9.95e-01 | -1.73e-03 | 9.99e-01 |
| GOMF SPLICING FACTOR BINDING | 5 | 9.95e-01 | 1.73e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 9 | 9.93e-01 | -1.66e-03 | 9.99e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 92 | 9.78e-01 | 1.65e-03 | 9.93e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 100 | 9.78e-01 | -1.63e-03 | 9.93e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 10 | 9.93e-01 | 1.61e-03 | 9.99e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 9.95e-01 | 1.57e-03 | 9.99e-01 |
| GOBP MEMBRANE DOCKING | 74 | 9.82e-01 | -1.56e-03 | 9.94e-01 |
| GOBP PODOCYTE CELL MIGRATION | 5 | 9.95e-01 | 1.51e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 18 | 9.91e-01 | -1.49e-03 | 9.98e-01 |
| GOBP PML BODY ORGANIZATION | 6 | 9.95e-01 | -1.48e-03 | 9.99e-01 |
| GOCC VACUOLAR LUMEN | 120 | 9.78e-01 | 1.45e-03 | 9.93e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 541 | 9.55e-01 | 1.43e-03 | 9.89e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 215 | 9.71e-01 | -1.42e-03 | 9.92e-01 |
| GOMF AMYLOID BETA BINDING | 54 | 9.86e-01 | 1.40e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 338 | 9.66e-01 | 1.37e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 28 | 9.90e-01 | -1.36e-03 | 9.97e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 26 | 9.90e-01 | -1.35e-03 | 9.97e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 47 | 9.87e-01 | -1.35e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 23 | 9.91e-01 | 1.34e-03 | 9.97e-01 |
| GOBP CELL CELL SIGNALING | 824 | 9.49e-01 | 1.33e-03 | 9.87e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 63 | 9.85e-01 | 1.33e-03 | 9.95e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 17 | 9.93e-01 | -1.27e-03 | 9.99e-01 |
| GOBP CELL CELL SIGNALING BY WNT | 265 | 9.72e-01 | 1.26e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 5 | 9.96e-01 | 1.24e-03 | 9.99e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 101 | 9.83e-01 | -1.21e-03 | 9.94e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 10 | 9.95e-01 | 1.19e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 9.97e-01 | -1.13e-03 | 9.99e-01 |
| GOBP REGULATION OF SECRETION | 335 | 9.73e-01 | -1.07e-03 | 9.93e-01 |
| GOBP SENSORY PERCEPTION | 205 | 9.79e-01 | -1.06e-03 | 9.93e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 142 | 9.83e-01 | 1.05e-03 | 9.94e-01 |
| GOBP NUCLEOPHAGY | 17 | 9.94e-01 | 9.91e-04 | 9.99e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 83 | 9.88e-01 | 9.88e-04 | 9.96e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 51 | 9.91e-01 | -9.18e-04 | 9.97e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 9 | 9.96e-01 | 8.71e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 19 | 9.95e-01 | -8.51e-04 | 9.99e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 133 | 9.87e-01 | 8.49e-04 | 9.96e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 18 | 9.95e-01 | 8.11e-04 | 9.99e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 256 | 9.82e-01 | 8.04e-04 | 9.94e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 210 | 9.85e-01 | 7.71e-04 | 9.95e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 9.97e-01 | -7.69e-04 | 9.99e-01 |
| GOBP GLYCOSYLATION | 164 | 9.88e-01 | 6.83e-04 | 9.96e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 23 | 9.96e-01 | -6.73e-04 | 9.99e-01 |
| GOBP REGULATION OF VESICLE SIZE | 18 | 9.96e-01 | -6.67e-04 | 9.99e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 17 | 9.96e-01 | -6.46e-04 | 9.99e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 37 | 9.95e-01 | -6.33e-04 | 9.99e-01 |
| GOMF HORMONE BINDING | 32 | 9.95e-01 | 6.23e-04 | 9.99e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 60 | 9.93e-01 | 6.18e-04 | 9.99e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 8 | 9.98e-01 | -5.45e-04 | 9.99e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 16 | 9.97e-01 | -5.37e-04 | 9.99e-01 |
| GOCC X CHROMOSOME | 7 | 9.98e-01 | -5.16e-04 | 9.99e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 34 | 9.96e-01 | -4.94e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 9 | 9.98e-01 | 4.92e-04 | 9.99e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 22 | 9.97e-01 | -4.59e-04 | 9.99e-01 |
| GOBP CILIUM ORGANIZATION | 301 | 9.90e-01 | 4.40e-04 | 9.97e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 96 | 9.94e-01 | -4.36e-04 | 9.99e-01 |
| GOBP REGULATION OF COAGULATION | 26 | 9.97e-01 | -4.36e-04 | 9.99e-01 |
| GOMF ANKYRIN REPEAT BINDING | 5 | 9.99e-01 | 3.68e-04 | 9.99e-01 |
| GOBP STEM CELL DEVELOPMENT | 41 | 9.97e-01 | -3.58e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 9 | 9.99e-01 | 3.56e-04 | 9.99e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 29 | 9.97e-01 | -3.55e-04 | 9.99e-01 |
| GOBP DEVELOPMENTAL MATURATION | 162 | 9.94e-01 | -3.22e-04 | 9.99e-01 |
| GOCC CCR4 NOT COMPLEX | 14 | 9.98e-01 | 3.21e-04 | 9.99e-01 |
| GOBP RESPONSE TO NUTRIENT | 84 | 9.96e-01 | 3.20e-04 | 9.99e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 9.99e-01 | -2.73e-04 | 9.99e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 9.98e-01 | -2.62e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 118 | 9.96e-01 | 2.58e-04 | 9.99e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 249 | 9.95e-01 | -2.42e-04 | 9.99e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 36 | 9.99e-01 | 1.44e-04 | 9.99e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 33 | 9.99e-01 | 1.10e-04 | 9.99e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 7 | 1.00e+00 | 1.07e-04 | 1.00e+00 |
| GOCC EMC COMPLEX | 10 | 1.00e+00 | -1.36e-05 | 1.00e+00 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 6 | 1.00e+00 | 0.00e+00 | 1.00e+00 |
Detailed Gene set reports
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION
Top enriched genes
Click HERE to show all gene set members
GOMF ADENYLATE CYCLASE BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION
Top enriched genes
Click HERE to show all gene set members
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOMF NERVE GROWTH FACTOR BINDING
Top enriched genes
Click HERE to show all gene set members
GOMF NEUROTROPHIN BINDING
Top enriched genes
Click HERE to show all gene set members
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOCC PARANODAL JUNCTION
Top enriched genes
Click HERE to show all gene set members
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC ZONULA ADHERENS
Top enriched genes
Click HERE to show all gene set members
GOMF GALACTOSIDE BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOMF T CELL RECEPTOR BINDING
Top enriched genes
Click HERE to show all gene set members
GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOMF TELOMERASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC GAMMA DELTA T CELL RECEPTOR COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOCC PARANODE REGION OF AXON
Top enriched genes
Click HERE to show all gene set members
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE
Top enriched genes
Click HERE to show all gene set members
GOMF ATP GATED ION CHANNEL ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOCC PROTEIN PHOSPHATASE 4 COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF PLASMA MEMBRANE REPAIR
Top enriched genes
Click HERE to show all gene set members
GOBP CAP DEPENDENT TRANSLATIONAL INITIATION
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN
Top enriched genes
Click HERE to show all gene set members
GOBP HEPATIC STELLATE CELL ACTIVATION
Top enriched genes
Click HERE to show all gene set members
GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY
Top enriched genes
Click HERE to show all gene set members
GOBP PSEUDOPODIUM ORGANIZATION
Top enriched genes
Click HERE to show all gene set members
GOCC PLATELET DENSE GRANULE MEMBRANE
Top enriched genes
Click HERE to show all gene set members
GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE
Top enriched genes
Click HERE to show all gene set members
GOBP MACROPHAGE APOPTOTIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOCC MHC CLASS II PROTEIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP DETOXIFICATION OF COPPER ION
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE
Top enriched genes
Click HERE to show all gene set members
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY
Top enriched genes
Click HERE to show all gene set members
GOCC MHC CLASS I PROTEIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC MHC PROTEIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOMF MHC CLASS II RECEPTOR ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOMF CYCLOHYDROLASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION
Top enriched genes
Click HERE to show all gene set members
GOCC ARP2 3 PROTEIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOMF LIPASE INHIBITOR ACTIVITY
Top enriched genes
Click HERE to show all gene set members
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.3.3 (2024-02-29)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4 GGally_2.2.1
## [3] ggplot2_3.5.0 reshape2_1.4.4
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] gplots_3.1.3.1 kableExtra_1.4.0
## [11] limma_3.58.1 mitch_1.15.0
## [13] DESeq2_1.42.0 muscat_1.16.0
## [15] beeswarm_0.4.0 stringi_1.8.3
## [17] SingleCellExperiment_1.24.0 SummarizedExperiment_1.32.0
## [19] Biobase_2.62.0 GenomicRanges_1.54.1
## [21] GenomeInfoDb_1.38.6 IRanges_2.36.0
## [23] S4Vectors_0.40.2 BiocGenerics_0.48.1
## [25] MatrixGenerics_1.14.0 matrixStats_1.2.0
## [27] hdf5r_1.3.9 Seurat_5.0.1
## [29] SeuratObject_5.0.1 sp_2.1-3
## [31] plyr_1.8.9
##
## loaded via a namespace (and not attached):
## [1] spatstat.sparse_3.0-3 bitops_1.0-7
## [3] httr_1.4.7 RColorBrewer_1.1-3
## [5] doParallel_1.0.17 numDeriv_2016.8-1.1
## [7] backports_1.4.1 tools_4.3.3
## [9] sctransform_0.4.1 utf8_1.2.4
## [11] R6_2.5.1 lazyeval_0.2.2
## [13] uwot_0.1.16 mgcv_1.9-1
## [15] GetoptLong_1.0.5 withr_3.0.0
## [17] prettyunits_1.2.0 gridExtra_2.3
## [19] progressr_0.14.0 cli_3.6.2
## [21] spatstat.explore_3.2-6 fastDummies_1.7.3
## [23] labeling_0.4.3 sass_0.4.8
## [25] mvtnorm_1.2-4 spatstat.data_3.0-4
## [27] blme_1.0-5 ggridges_0.5.6
## [29] pbapply_1.7-2 systemfonts_1.0.5
## [31] svglite_2.1.3 scater_1.30.1
## [33] parallelly_1.37.0 rstudioapi_0.15.0
## [35] generics_0.1.3 shape_1.4.6
## [37] ica_1.0-3 spatstat.random_3.2-2
## [39] Matrix_1.6-5 ggbeeswarm_0.7.2
## [41] fansi_1.0.6 abind_1.4-5
## [43] lifecycle_1.0.4 yaml_2.3.8
## [45] edgeR_4.0.15 SparseArray_1.2.4
## [47] Rtsne_0.17 grid_4.3.3
## [49] promises_1.2.1 crayon_1.5.2
## [51] miniUI_0.1.1.1 lattice_0.22-5
## [53] beachmat_2.18.1 cowplot_1.1.3
## [55] pillar_1.9.0 knitr_1.45
## [57] ComplexHeatmap_2.18.0 rjson_0.2.21
## [59] boot_1.3-28.1 corpcor_1.6.10
## [61] future.apply_1.11.1 codetools_0.2-19
## [63] leiden_0.4.3.1 glue_1.7.0
## [65] data.table_1.15.2 vctrs_0.6.5
## [67] png_0.1-8 spam_2.10-0
## [69] Rdpack_2.6 gtable_0.3.4
## [71] cachem_1.0.8 xfun_0.42
## [73] rbibutils_2.2.16 S4Arrays_1.2.0
## [75] mime_0.12 survival_3.5-8
## [77] iterators_1.0.14 statmod_1.5.0
## [79] ellipsis_0.3.2 fitdistrplus_1.1-11
## [81] ROCR_1.0-11 nlme_3.1-164
## [83] pbkrtest_0.5.2 bit64_4.0.5
## [85] EnvStats_2.8.1 progress_1.2.3
## [87] RcppAnnoy_0.0.22 bslib_0.6.1
## [89] TMB_1.9.10 irlba_2.3.5.1
## [91] vipor_0.4.7 KernSmooth_2.23-22
## [93] colorspace_2.1-0 ggrastr_1.0.2
## [95] tidyselect_1.2.0 bit_4.0.5
## [97] compiler_4.3.3 BiocNeighbors_1.20.2
## [99] xml2_1.3.6 DelayedArray_0.28.0
## [101] plotly_4.10.4 scales_1.3.0
## [103] caTools_1.18.2 remaCor_0.0.18
## [105] lmtest_0.9-40 stringr_1.5.1
## [107] digest_0.6.34 goftest_1.2-3
## [109] spatstat.utils_3.0-4 minqa_1.2.6
## [111] variancePartition_1.32.5 rmarkdown_2.25
## [113] aod_1.3.3 XVector_0.42.0
## [115] RhpcBLASctl_0.23-42 htmltools_0.5.7
## [117] pkgconfig_2.0.3 lme4_1.1-35.1
## [119] sparseMatrixStats_1.14.0 highr_0.10
## [121] fastmap_1.1.1 rlang_1.1.3
## [123] GlobalOptions_0.1.2 htmlwidgets_1.6.4
## [125] shiny_1.8.0 DelayedMatrixStats_1.24.0
## [127] farver_2.1.1 jquerylib_0.1.4
## [129] zoo_1.8-12 jsonlite_1.8.8
## [131] BiocParallel_1.36.0 BiocSingular_1.18.0
## [133] RCurl_1.98-1.14 magrittr_2.0.3
## [135] scuttle_1.12.0 GenomeInfoDbData_1.2.11
## [137] dotCall64_1.1-1 patchwork_1.2.0
## [139] munsell_0.5.0 Rcpp_1.0.12
## [141] viridis_0.6.5 reticulate_1.35.0
## [143] zlibbioc_1.48.0 MASS_7.3-60.0.1
## [145] ggstats_0.5.1 listenv_0.9.1
## [147] ggrepel_0.9.5 deldir_2.0-2
## [149] splines_4.3.3 tensor_1.5
## [151] hms_1.1.3 circlize_0.4.15
## [153] locfit_1.5-9.8 igraph_2.0.2
## [155] spatstat.geom_3.2-8 RcppHNSW_0.6.0
## [157] ScaledMatrix_1.10.0 evaluate_0.23
## [159] nloptr_2.0.3 foreach_1.5.2
## [161] httpuv_1.6.14 RANN_2.6.1
## [163] tidyr_1.3.1 purrr_1.0.2
## [165] polyclip_1.10-6 future_1.33.1
## [167] clue_0.3-65 scattermore_1.2
## [169] rsvd_1.0.5 broom_1.0.5
## [171] xtable_1.8-4 fANCOVA_0.6-1
## [173] RSpectra_0.16-1 later_1.3.2
## [175] viridisLite_0.4.2 lmerTest_3.1-3
## [177] glmmTMB_1.1.9 cluster_2.1.6
## [179] globals_0.16.2END of report